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 Abstract 
At the end of electricity generation through nuclear power, spent nuclear fuel remains highly 
radiotoxic due to the presence of the minor actinides, americium(III), curium(III) and 
neptunium(III). The separation of these requires highly selective ligands with soft N-donor atoms 
that are capable of distinguishing between the actinides and the much more abundant and 
chemically similar trivalent lanthanides.  
This thesis discusses the development of novel classes of N-donor ligands, using an innovative 
ligand design approach, to improve on the current benchmark ligands developed. In particular the 
ligand design will take inspiration from the pharmaceutical industry, introducing hydrogen bond 
donor and/or acceptor groups and limiting the aromaticity introduced. This approach is hoped to 
improve the two drawbacks of currently available ligands, most notably poor solubility and slow 
rates of extraction. 
 
Figure 1: Molecular structure of the benchmark BTPhen ligand and the most promising novel 
ligands developed in this thesis. 
 
Introduction of an amine bridge between the triazine and linker (e.g. phenanthroline) was found 
to have a drastically negative impact on the ability of the ligands to extract. The additional 
flexibility that was introduced into these ligands resulted in a ligand conformation incapable of 
forming a complex with the minor actinides. Efforts to introduce some rigidty into these 
molecules offered no improvements. 
A further investigation considered two of the dominant diketones used to form the 1,2,4-triazine 
ring, notably tetramethyl-cyclohexyl-1,2-diketone and camphorquinone. These groups were 
functionalised further to validate the proposed design approach. The most promising novel 
 
 
ligands developed were based upon the BTPhens, with additional hydrogen bond donor and 
acceptor groups present, Figure 1. These ligands showed improved rates of extraction as well as 
achieving a sufficiently high separation factor of the minor actinides from the trivalent 
lanthanides. Studies on the complexing properties of some of the ligands with trivalent 
lanthanides are also reported.  
Further ligand designs and synthesis, and the subsequent extraction results, are discussed in this 
thesis. Analysis of the subsequent results supports the proposed design approach as a potentially 
effective method in which to streamline future ligand design.  
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Abbreviations 
 
Ac2O Acetic anhydride 
AcOH Acetic acid 
ACSEPT Actinide recycling by separation and transmutation 
AgNO3 Silver nitrate 
Am(III) Americium(III) 
An(III) Trivalent actinides 
BODO 2,6-Bis(benzoazol-2-yl)-4-dodecyloxypyridine 
BTBP 6,6-Bis-(1,2,4-triazin-3-yl)-2,2’-bipyridine 
BTP 2,6-Bis-(1,2,4-triazin-3-yl)pyridines 
BTPhen 2,9-Bis-(1,2,4-triazin-3-yl)-1,10-phenanthroline 
CDCl3 Deutrated chloroform 
CD3CN-d3 Deutrated acetonitrile 
CDTA Trans-1,2-diaminocyclohexane-N,N,N’,N’-tetraacetic acid 
CHCl3 Chloroform 
Cm(III) Curium(III) 
Cs2CO3 Caesium carbonate 
CuMeSal Copper(I) 3-methylsalicylate 
CyMe4 Tetramethyl-cyclohexyl 
D Distribution ratio 
DBU 1,8-Dizabicyclo(5.4.0)undec-7-ene 
DCM Dichloromethane 
DEHBA N,N-Di-2-ethylhexyl-butyramide 
DIAMEX Diamide extraction 
DMDBTDMA N,N’-Dimethyl-N,N’-dibutyltetradecylmalonamide 
DMDOHEMA N,N’-Dimethyl-N,N’-dioctyl[(hexyloxy)ethyl]malonamide 
DMSO Dimethyl sulfoxide 
DTPA Diethylenetriaminepentaacetic acid 
ESI-MS Electrospray ionisation mass spectrometry 
EtOH Ethanol 
Eu(III) Europium(III) 
EXAFS Extended X-ray absorption fine structure 
FS-13 Phenyl trifluoromethyl sulfone 
Fsp3 Fraction of saturated carbon atoms 
GANEX Grouped actinide extraction 
GENIORS Generation IV integrated oxide fuels recycling strategies 
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HBD/HBA Hydrogen bond donor/hydrogen bond acceptor 
HDEHP Di(2-ethylhexyl)phosphoric acid 
HEDTA N-(2-Hydroxyethyl)ethylenediamine-N, N’, N’-triacetic acid 
HLLW High level liquid waste 
HNO3 Nitric acid 
HRMS High resolution mass spectrometry 
H2SO4 Sulphuric acid 
ICP-MS Inductively coupled plasma mass spectrometry 
KMnO4 Potassium permanganate 
La(NO3)3 Lanthanum nitrate 
Ln(III)  Trivalent lanthanides 
Lu(NO3)3 . H2O Lutetium(III) nitrate hydrate 
LWR Light water reactors 
MeCN Acetonitrile 
MeOH Methanol 
MOX Mixed oxide (fuel) 
NaBH4 Sodium borohydide 
Na2CO3 Sodium bicarbonate 
NaH Sodium hydride 
NH4Cl Ammonium chloride 
NH4OH Ammonium hydroxide solution 
NMR Nuclear Magnetic Resonance 
P & T Partitioning and Transmutation 
Pd2(dba)3 Tris(dibenzylideneacetone)dipalladium (0) 
Pd(OAc)2 Palladium acetate 
PUREX Plutonium and uranium extraction 
SACSESS Safety of actinide separation processes 
SANEX Selective actinide extraction 
SeO2 Selenium dioxide 
SF Separation factor 
SOCl2 Thionyl chloride 
t-BuOK Potassium tert-butoxide 
TALSPEAK Trivalent actinide from lanthanide separation by phosphorus reagent 
extraction from aqueous komplexes 
TBP Tributyl phosphate 
TEDGA Tetraethyl diglycolamide 
TERPY 2,6-Bis(2-pyridyl)pyridine 
THF Tetrahydrofuran 
TODGA N,N,N’,N’-Tetraoctyl diglycolamide 
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TPTZ 2,4,6-Tri(2-pyridyl)-1,3,5-triazine 
TRLFS Time-Resolved laser fluorescence spectroscopy 
TRLIL Time resoled laser-induced luminescence 
Xantphos 4,5-Bis(diphenylphosphino)-9,9-dimethylxanthene 
XAS X-Ray spectroscopy 
XRD X-Ray diffraction 
Y(NO3)3.6H2O Yttrium(III) nitrate hexahydrate 
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1. Introduction  
In the last decade a ‘nuclear renaissance’ has taken hold. As stricter rules regarding carbon dioxide 
(CO2) emissions are enforced but global electricity demand continues to increase, especially in 
the developing world, many countries are turning to nuclear power as a low carbon energy 
source.[1],[2] With this increasing demand, preservation of natural resources, such as uranium 
supplies, waste minimisation and increasing the resistance to proliferation of spent nuclear fuel 
needs to be considered in order to increase the sustainability of civil nuclear energy. Currently 
nuclear power is the optimum choice for providing the required energy output, with renewable 
energy sources, including wind, solar, tidal and geothermal, suffering from issues in their scale 
up and their own environmental impact. When considering solar power, the farms themselves 
require mass land use, affecting the natural habitat and the use hazardous materials during their 
manufacturing. Nuclear power has advantages in the reduced carbon-emissions and continuous 
supply it offers once the reaction begins, although it isn’t without its own drawbacks.  
In this chapter, a review of the literature will give an overview of the nuclear fuel cycle, 
reprocessing considerations and the separation processes currently employed or in development 
for the reprocessing of spent nuclear fuel. A discussion on the key developments of relevant 
hydrophobic extractant molecules to this thesis will be given before the project aims and 
objectives are outlined. 
1.1. The Nuclear Fuel Cycle 
The Nuclear Fuel Cycle encompasses all processes that are involved in electricity production via 
nuclear power, Figure 2. It can be split into two distinct sections; the ‘front end’ of the cycle; 
considering everything from the mining of the uranium ore up until fuel fabrication and the back 
end of the cycle; which constitutes the reprocessing and storage of the spent nuclear fuel. The 
Earth’s crust contains uranium deposits which, although abundant, are not an unlimited resource. 
Its natural isotope has low levels of radioactivity, with the radiotoxicity associated with uranium 
coming from its decay products. An outline of the Nuclear Fuel Cycle is discussed in the following 
section.[3]  
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Figure 2: Diagram representing the Nuclear Fuel Cycle. Reference: world-nuclear.org [4] 
The ‘front end’ of the cycle includes the steps required to prepare the uranium for use in a nuclear 
reactor. Uranium-235 (U-235) is the form required for fission within a nuclear reactor, but 
constitutes less than 1% of the natural uranium that is mined (the rest is composed of uranium-
238). After mining the uranium ore, milling is a technique used to extract triuranium octoxide 
U3O8 (or ‘yellow cake’). This product then needs to be refined in order to increase the 
concentration of the U-235 isotope.  
Preparing this uranium concentrate for use in nuclear reactors requires enrichment, which include 
a number of chemical processes to increase the concentration of the fissile U-235 isotope to 3-5% 
for use in light water reactors (LWR). Firstly the uranium oxide is converted to uranium 
hexafluoride via uranium dioxide. For those reactors that don’t require enriched uranium this 
uranium dioxide can be used directly as a fuel, although this is not the norm. The enriched uranium 
is produced by utilising the mass difference between the isotopes to ensure U-235 can be 
separated, typically using a centrifuge or gaseous diffusion. This produces two streams, a product 
stream which is reconverted to give enriched uranium oxide (UO2) and the depleted uranium 
product.   
The enriched UO2, containing approximately 3 to 5% of the U-235 isotope, is encased into fuel 
rods for use within the nuclear reactor during fuel fabrication. Within the nuclear reactor these 
fuel rods undergo fission in a continuous chain reaction. The fission process involves the splitting 
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of the uranium nucleus when impacted by a neutron, producing more neutrons in the process. 
Plutonium-239 is a decay product formed when a U-235 atom collides with U-238, with further 
products formed when Pu-239 itself undergoes the fission process. This reaction produces 
considerable heat which is used to produce steam, which in turn drives a turbine and electric 
generator, providing the electricity.  
A nuclear reactor typically produces electricity for over 20 years. However, radioactive impurities 
building up within the reactor affect the efficiency of the fission process. As a consequence this 
‘spent fuel’, with the composition represented in Figure 3, needs to be removed and the reactor 
refuelled after a minimum period of 18 months. The spent fuel is stored in a body of water (a 
spent fuel pond), which acts as a radiation shield in addition to cooling the fuel through absorbing 
the heat. Once a decreased radiation level is reached, the spent fuel can be reprocessed to recover 
and recycle some of the components or be prepared for long-term storage in geological 
repositories. Further attempts to ‘close’ the nuclear fuel cycle will see the recycling of as many 
components of the waste as is feasible, to maximise the efficiency of the process, through 
enhancing the use of natural resources and reducing the hazards associated with the remaining 
spent fuel.  At the end of 2015 there were over 350,000 tonnes of spent nuclear fuel produced by 
the civil nuclear energy sector, which will only continue to grow as nuclear energy programmes 
expand around the world.[5]  
 
Figure 3: Representative composition of spent fuel from light water reactors (LWR), taken 
from reference [1]. 
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Exploiting the energy released in nuclear fission has resulted in electricity generation through 
nuclear reactors. When comparing the energy from the complete combustion of 1 kg of coal and 
the complete fission of 1 kg of U-235, the uranium produces almost three million times more 
energy than the coal. The energy density of coal is 9.0 kWh/kg compared to the approximately 
24,000,000 kWh/kg for 100% U-235.[6] The enriched uranium used in a typical LWR produces 
960,000 kWh/kg, still one hundred thousand times more than that of an equal mass of coal. The 
appeal in nuclear power is clearly perceived for an increasing electricity demand.  
1.2. Spent Nuclear Fuel Reprocessing 
In order to make nuclear power more appealing to the wider public it is necessary to make 
electricity production through nuclear power as safe as possible, especially in the wake of well 
publicised nuclear incidents, such as the Fukushima incident of 2011. One of the factors found to 
cause concern to the general public is the disposal of the radioactive waste at the end of electricity 
production.[7] The reprocessing of spent nuclear fuel from nuclear reactors is essential in reducing 
the radiotoxicity of the subsequent waste as well as ensuring sustainable use of the uranium 
resource. A current method of reprocessing spent fuel that is employed worldwide is the PUREX 
process (Plutonium and Uranium Extraction),[8] which recycles the plutonium and uranium from 
the spent nuclear fuel rods as Mixed Oxide (MOX) fuel in advanced (generation IV) reactors.  
The remaining waste stream, or high level liquid waste (HLLW), still contains the minor actinides 
(An(III)); americium (Am) and curium (Cm) and the trivalent lanthanides (Ln(III)). It is the minor 
An(III) that account for most of the remaining long-lived radiotoxicity and heat load, despite 
comprising only 0.1% by mass of the waste.[9] After the removal of uranium and plutonium the 
remaining waste, containing the minor actinides, remains radiotoxic for approximately 9,000 
years before reaching the radiotoxicity level of the natural uranium found in the earth’s crust, 
Figure 4. This is too long a timeframe for the safe management of the remaining waste if this 
material was to be disposed of in geological repositories at this stage. It has several implications 
for the long-term integrity and resistance to leaching of the waste in a geological site. The 
remaining waste is also comprised of other transition metals (corrosion products) as a result of 
radiolysis and corrosion of the steel cladding used to encase the fuel rods. 
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Figure 4: The relative radioactive decay of nuclear waste at various waste management stages, 
taken from reference [1]. 
 
 Partitioning and Transmutation Strategy 
Various European initiatives are and have been working towards realising a safer and more 
efficient industrial process for removing these minor actinides from spent nuclear fuel. Projects 
including ACSEPT (Actinide reCycling by SEParation and Transmutation),[10] part of the 
Euratom FP7 collaboration, and SACSESS (Safety of Actinide SEparation ProceSSes),[11] aimed 
to develop and improve minor actinide separation (partitioning) processes to remove the minor 
actinides and ultimately close the nuclear fuel cycle. The current European project, GENIORS 
Horizon 2020 (GEN IV Integrated Oxide fuels Recycling Strategies),[12] aims to continue 
improving current recycling processes and have recycling strategies implemented in anticipation 
of the 4th generation of reactors becoming operational by 2030.  
One European proposal arising from these initiatives is the Partitioning and Transmutation (P&T) 
strategy. This uses a liquid-liquid solvent extraction process to remove or partition the minor 
actinides from the remaining waste, which includes the Ln(III), reducing the remaining 
radiotoxicity of the PUREX raffinate.[13] The partitioning of the An(III) is necessary to ensure 
transmutation efficiency as a result of the chemically similar, and much more abundant Ln(III), 
having a much higher neutron affinity.[14] This is followed by high-energy neutron-induced fission 
(transmutation) of the minor actinides to shorter-lived or stable, non-radioactive elements in 
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advanced reactors.[15] The removal of the minor actinides reduces the radiotoxicity of the 
remaining waste down to 300 years, Figure 4, which is a much more manageable timeframe for 
disposal in a geological repository. Due to the chemical similarities between the Ln(III) and 
An(III) this partitioning poses a complex chemical challenge. Once implemented, the strategy 
would substantially reduce the radiotoxicity and heat load of the remaining waste, allowing for a 
less complex future waste management programmes and reducing the strain on future geological 
repositories.  
1.3. The Lanthanides and Actinides 
The lanthanides (Ln) and actinides (An) are metallic elements found in the f-block of the periodic 
table and contain valence electrons in the 4f and 5f orbitals, respectively. They have similar 
chemical properties, especially in aqueous solution, such as oxidation states, ionic radii, charges 
and they tend to be both strongly hydrated.[16] As the An(III) and Ln(III) are both hard Lewis 
acids, as defined by Pearson,[17] their coordination chemistry with Lewis bases containing hard 
donor atoms, for example oxygen, is very similar. Due to these similarities, the separation of the 
minor actinides, Am(III) and Cm(III), from the Ln(III) fission products is a massive undertaking 
within nuclear reprocessing.  
 The Lanthanides 
The Ln or “rare-earth” elements have chemistry which is defined by their f-orbital electrons. 
Across the series, the outer 5d and 6s electrons are more susceptible to the influence of the nuclear 
charge resulting in a higher than expected decrease in atomic radius, as the atomic number 
increases, known as the Lanthanide Contraction. The contraction is the result of the poor shielding 
of the nuclear charge by the inner 4f electrons, thus causing a greater attraction between the 
nucleus and the outer 5d and 6s electrons and a subsequent decrease in atomic radius. The 
dominant oxidation state is +3 across the lanthanide series. The Ln(III) prefer to coordinate with 
hard donor atoms of high electronegativity, such as the oxygen atom, explaining the ligand design 
for the DIAMEX process, section 1.4.  
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 The Actinides 
The actinides (An), containing elements actinium to lawrencium, have a more complex chemistry 
then the lanthanides due to their varying valence. A handful of actinides are naturally occurring, 
including uranium and thorium, but the rest are a consequence of transmutation in laboratory 
synthesis or as a by-product of thermonuclear testing, particularly during the Second World War 
and the Cold War.[18] Early An show comparable chemistry to the d-block metals and the later An 
show similar chemistry to the Ln(III) elements themselves. They are hard Lewis acids and 
therefore are strong electron acceptors.  
They have unstable nuclear configurations and as a result exhibit spontaneous radioactive decay, 
and emit alpha particles and gamma rays. The half-life of the element quantifies its radiotoxicity 
and the time taken for this to reach safe levels. Through utilising the alpha decay, and resulting 
gamma rays emitted this can be used to identify the isotopes present, with each actinide having 
its own distinct energy (keV).[19] In terms of solvent extraction this can give an indication of the 
distribution of these elements across two immiscible phases. Within a nuclear reactor there can 
be two processes occurring, nuclear fission causing the splitting of a nucleus to form lighter 
elements, and neutron capture, resulting in the production of heavier isotopes.  
The actinides have complex coordination chemistry due to their ability to lose valence electrons, 
leading to many oxidation states and ionic forms. Within aqueous solutions in particular, where 
two or more oxidation states can co-exist, it can lead to complex systems.[20] The lighter actinides, 
of particular interest to the nuclear industry (U, Np and Pu), can exist in multiple oxidation states 
in solution, +III, +IV, +V and +VI are prevalent. The heavier actinides, after plutonium, exist 
predominantly in a stable +III oxidation state.  
The lack of shielding from the 6s and 6p electrons in the actinides results in a 5f orbital expansion, 
hence a greater ionic radii when compared to the lanthanides. As a consequence the orbitals are 
more readily available for overlap with ligand orbitals, which is utilised in separation techniques, 
section 1.4. Some of the first evidence of this increased covalent interaction, caused by greater 
orbital overlap, came from a 15N NMR spectroscopic study utilising a 15N labelled BTP ligand.[21] 
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This effect is somewhat limited however, as the nuclear charge increases, there is a slight 
contraction of the 5f orbitals going across the actinide series (‘Actinide Contraction’), resulting 
in a smaller orbital overlap between the 5f orbitals and ligand orbitals.  
1.4. Solvent Extraction 
Solvent extraction has long been a dominant technique in separation experiments, in particular 
the purification of metals in hydrometallurgy. Liquid-liquid extraction is the most established 
technique within the nuclear reprocessing industry to separate the radionuclides from the waste, 
ensuring recycling is possible. Other separations include chromatographic methods, in which the 
extractant is loaded onto a solid phase, i.e. porous silica/polymer particles.[22]  
Liquid-liquid extraction in the nuclear reprocessing industry involves an acidic aqueous layer, 
containing the radioactive waste dissolved in an aqueous acid (usually nitric acid), and an organic 
layer of a diluent immiscible with water, such as kerosene or 1-octanol. The process utilised 
dictates in which layer the extractant molecules will exist, as either a hydrophobic or hydrophilic 
ligand, and in which direction the radioactive species will go when moving between the two 
immiscible liquids. For the purpose of this project the focus will be upon hydrophobic ligands, 
which are dissolved within the organic phase and the separation will occur by the movement of 
the actinides from the aqueous into the organic phase.  
Solvent extraction has advantages in terms of the development of a suitable system for the nuclear 
reprocessing industry, one of which being its ability to achieve quantitative recovery of the 
radionuclide(s) of interest. Large impacts on extraction and separation efficiency can be 
influenced by making small chemical and physical changes in the composition of the system, i.e. 
through changing the extractants utilised of altering the acidity of the aqueous phase. Various 
processes are under investigation within the nuclear reprocessing industry, in particular those that 
tackle the HLLW remaining after the PUREX process or offer a replacement. This project focuses 
upon novel ligands for use in the SANEX and potentially GANEX processes within Europe, 
Figure 5. In this section these processes, among others will be summarised to gain an 
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understanding of the environments the ligands are proposed to work under and current 
developments.  
 
Figure 5: Outline of the proposed routes for the future processing of spent nuclear fuel. 
 PUREX 
The PUREX (Plutonium and Uranium EXtraction) process involves the separation of uranium 
and plutonium from the spent nuclear fuel waste stream where it is then recycled as mixed oxide 
fuel (MOX). Since the 1960’s, where it was first used at the Sellafield site in the UK, the MOX 
fuel has become widely used throughout Europe as a source of low enriched uranium for use in 
LWR.[23] As this is one of the first steps in the reprocessing of spent nuclear fuel, it is necessary 
to dissolve the irradiated fuel in a nitric acid (HNO3) solution, typically at 3-4 M, and remove the 
insoluble solids.  
The most prominent extractant used to date is tributyl phosphate 1.01 (TBP), Figure 6, which is 
diluted within aliphatic hydrocarbon diluents such as kerosene or dodecane, so that its typical 
concentration in the organic phase is 20-30%. The ligand exhibits good stability against the highly 
acidic aqueous phase as well as showing selectivity towards hexavalent uranium (U(VI)) and 
Pu, Np, Am, Cm  
Ln and fission 
products 
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tetravalent plutonium (Pu(IV)) to achieve quantitative recovery. The minor actinides (An(III)) 
and fission products remain in the aqueous phase, becoming the PUREX raffinate. A recent 
development sees the co-extraction of neptunium (Np) in this step in an advanced PUREX 
process, although with slightly lower distribution (D) ratios being observed than for U(VI) or 
Pu(IV).[24]  
 
Figure 6: Structure of tributyl phosphate (1.01) and N,N-diethyl-hydroxylamine (1.02). 
There are an additional two steps that achieve the partitioning and decontamination of the U(VI) 
and Pu(IV) from the HLLW. The reduction of Pu(IV) to Pu(III) using hydrazine reduces its 
affinity for the TBP 1.01 extractant, ensuring the element can be back-extracted into the aqueous 
phase. By using N,N-diethyl-hydroxylamine 1.02 as the reducing agent the simultaneous 
reduction of Np(VI) to Np(V) can be achieved allowing its back-extraction alongside Pu(III).[25] 
The final step is the back-extraction of uranium using dilute nitric acid solutions. The organic 
solution undergoes a solvent purification step to remove any degraded extractant before being 
recycled for further use. One downfall to the use of TBP 1.01 is the presence of the undesirable 
phosphorus atom, which can’t be fully incinerated to gases at the end of its use. This ultimately 
leads to the production of additional waste from the process.  
A drawback of the PUREX process is the sensitivity of certain species to the pH of the aqueous 
phase, requiring additional considerations to ensure stability is maintained, such as the specific 
control of the oxidation states of the actinides present in solution. At higher pH, the solubility of 
uranium and plutonium become a concern in the aqueous phase as a result of the formation of 
their insoluble oxides through hydrolysis.  
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 DIAMEX 
The DIAMEX (DIAMide EXtraction) process, developed in France in the 1980’s, simultaneously 
extracts the An(III) and Ln(III) from the PUREX raffinate using O-donor extractants such as the 
malonamide and diglycoamide ligands.[26] Previous diamide extractant molecules have included 
N,N’-dimethyl-N,N’-dibutyltetradecylmalonamide (DMDBTDMA) 1.03 and N,N’-dimethyl-
N,N’-dioctyl[(hexyloxy)ethyl]malonamide (DMDOHEMA) 1.04, Figure 7. These ligands have 
the benefit of abiding by the ‘CHON’ principle, unlike TBP 1.01, meaning they are only 
composed of the elements carbon, hydrogen, oxygen and nitrogen. This leads to minimal waste 
generation at the end of the cycle, as the extractant can be fully incinerated to a harmless gases. 
DMDOHEMA 1.04 has replaced DMDBTDMA 1.03 as the extractant of choice as a result of its 
increased lipophilicity and the increased solubility of its degradation products when compared to 
previous DIAMEX extractants.[27] 
 
Figure 7: Structure of the DIAMEX ligands; DMDBTDMA (1.03), DMDOHEMA (1.04), and 
TODGA (1.05).  
 
A successful ‘hot-test’ has been demonstrated with a PUREX raffinate using the DMDOHEMA 
1.04 extractant, achieving high separation of the An(III) and Ln(III).[28] As well as co-extraction 
of An(III) and Ln(III), co-extraction of some of the lighter fission products; ruthenium, yttrium 
and technetium was observed. Prevention of this can be achieved through the addition of further 
chemical complexing or ‘hold-back’ reagents. Some examples include oxalic acid 1.06 and N-(2-
hydroxyethyl)ethylenediamine-N,N’,N’-triacetic acid (HEDTA) 1.07, which avoid the co-
extraction of molybdenum, zirconium and palladium, Figure 8. These additional reagents are a 
necessity, in some form, for most processes to ensure effective decontamination. 
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Figure 8: Structures of two representative hold-back reagents; oxalic acid (1.06) and HEDTA 
(1.07) 
 
The current reference ligand for use in this process is the N,N,N’,N’-tetraoctyl diglycolamide 
(TODGA) 1.05. This has a notable difference in structure, when compared to the previously 
developed diamide extractants 1.03 and 1.04, in which it contains an ether bridge between the 
carbonyl functional groups. It has been shown that the extraction efficiency of TODGA 1.05 is 
increased compared to other diglycolamides, as a result of increased hard O-donor ability. Its 
extraction affinity for the fission products has meant its concentration needs to be limited in 
solution, but this doesn’t impact on its An(III) and Ln(III) extraction efficiency. Demonstration 
of this ligand in batch tests with PUREX raffinate have shown that, when combined with TBP 
1.01, the co-extraction of the actinides(III) and lanthanides(III) is successfully achieved, Figure 
9.[26, 29], [30] 
 
Figure 9: Diagram illustrating the principle of the DIAMEX process with a representative 
diglycolamide ligand. 
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Research through various European initiatives, e.g. ASCEPT, propose the combined use of the 
DIAMEX-SANEX process in the future. This will ensure that at the end of these processes, 
separation of the actinides alone from the PUREX raffinate will have been achieved, with the 
radiotoxicity of the remaining waste reduced to 300 years for disposal in geological repositories.  
 SANEX 
The SANEX (Selective ActiNide EXtraction) process, proposed for use in Europe,[31] aims to use 
soft and selective N- and S- donor ligands to extract and separate the remaining actinides, Am(III) 
and Cm(III), from the lanthanide fission products, after both the PUREX and DIAMEX processes, 
Figure 10.[32] Due to the chemical similarity between the An(III) and Ln(III) this separation 
requires careful tuning with a highly An(III) selective ligand. The lanthanide to actinide ratio is 
approximately 40:1 in the PUREX raffinate. The process uses ligands that can take advantage of 
the greater overlap of the 5f orbitals of the An(III) with the orbitals of the ligand donor atoms, 
when compared to the 4f orbitals of the Ln(III), hence achieving separation of the two groups of 
elements.  
 
Figure 10: Diagram illustrating the principle of the SANEX process with a representative bis-
1,2,4-triazine ligand. 
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Figure 11: Structures of SANEX suitable reagents; a general BTP (1.08) and CyMe4-BTBP 
(1.09). 
 
Some of the first N-donor extractants capable of achieving this separation were the 2,6-bis(5,6-
dialkyl-1,2,4-triazin-3-yl)pyridines (BTPs) 1.08, which suffered from poor hydrolytic stability, 
Figure 11. Further advancements, discussed in detail in section 1.5, led to the development of 
CyMe4-BTBP 1.09, which showed high selectivity for the An(III) over Ln(III) but slow extraction 
kinetics. This ligand, in combination with DMDOHEMA 1.04, shows fast kinetics, reaching 
equilibrium within 5 minutes of phase mixing.[33] This same ligand has been proven capable of 
achieving this separation in a SANEX process ‘hot-test’ with genuine spent fuel.[34] Further 
discussion regarding the SANEX process can be found in 1.5., when ligands used in this process 
are mentioned.  
 GANEX 
Research focus has shifted towards the development of the GANEX (Grouped Actinide 
Extraction) process with the hope to simplify the reprocessing methods available and to close the 
nuclear fuel cycle. The GANEX process aims to carry out the homogeneous partitioning of the 
trans-uranic actinides, including Pu, Np and the minor actinides, from the lanthanides and other 
fission and corrosion products.[35] Currently the PUREX, and recently proposed DIAMEX-
SANEX processes, offer a multi-step method for separating the actinides for recycling and 
disposal purposes. The GANEX proposal offers an economically beneficial and safer alternative 
to these. By ensuring all TRU actinides can be recovered in a single step, it ensures the number 
of steps is reduced and waste management simplified.  
The 1st GANEX cycle extracts the bulk of the uranium, using a monoamide extractant, so that the 
uranium can be utilised in generation IV nuclear reactors. The second extraction step, which 
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separates the trans-uranic actinides, requires a combination of extractants that are capable of 
recovering the tri-, tetra-, penta- and hexavalent actinides simultaneously. This poses additional 
challenges to those of the SANEX process, where only the separation of the trivalent actinides 
are completed, as the varied oxidation states need to be taken into consideration when choosing 
suitable extractants. These extractants should still abide by the ‘CHON’ principle and preferably 
not require the use of added reagents to control the oxidation states of the elements. There are two 
notable processes that have been proposed as part of the European projects; the EURO-GANEX 
and CHALMEX processes. [36],[37] 
The EURO-GANEX process has been successfully demonstrated to co-extract both the 
lanthanides and the actinides prior to their separation through the selective back-extraction of the 
actinides.[38] The hydrophobic diglycolamide, TODGA 1.05, is known to be a successful actinide 
extractant that could be employed in this process,[39] but this alone is incapable of handling the 
high concentration of Pu that would be present.[40] The combination of DMDOHEMA 1.04 is 
required to prevent precipitate forming at the interphase whilst maintaining effective co-
extraction.[35] Separation of the actinides is then achieved by back-extraction (stripping) of the 
actinides from the loaded organic phase with a hydrophilic sulfonated bis-triazinyl pyridine ligand 
(SO3-Ph-BTP) 1.10, Figure 12. This extractant is known to be effective in the aqueous i-SANEX 
(innovative-SANEX) process with a separation factor for Am(III) from Eu(III) of 1000 
achieved.[41] A flowsheet for this process has successfully been tested with a spiked feed solution 
using the proposed solvent system.[42] There was some loss of Np into the aqueous raffinate at the 
end of the tested flow sheet, as a result of poor extraction conditions for this actinide. It is known 
that altering the acidity of the cycle can influence the oxidation state of Np and aid its extraction, 
which can be achieved by using acetohydroxamic acid 1.11, Figure 12.[43] 
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Figure 12: Structures of reagents used in the GANEX process; SO3-Ph-BTP (1.10) and 
acetohydroxamic acid (1.11). 
 
The Chalmers method combines two hydrophobic extractants with different properties to ensure 
all actinides across the series are extracted from the feed solution, suitably called the CHALMEX 
process.[37] The combined extractants are the bis-triazinyl-bipyridine (BTBP) ligands, which can 
selectively extract trivalent and pentavalent actinides, alongside the TBP ligand 1.01, which has 
a proven record of extracting plutonium Pu(VI) and uranium U(VI) in the PUREX process.[44] 
These ligands are stable against radiolysis and hydrolysis and have been shown to extract their 
respective An(III) independently of each other.[45] The TBP molecule 1.01 suffers from drawbacks 
including not abiding by the CHON principle and plays a part in the undesirable nitric acid 
(HNO3) extraction into the organic phase. Alternatives to TBP 1.01 have included N,N-di-2-
ethylhexyl-butyramide (DEHBA) 1.12 as a 20% solution in cyclohexanone, which is known to 
extract both uranium and plutonium, Figure 13.[46] A hot test using genuine HLLW was completed 
at the Atalante facility in France with DEHBA 1.12 recovering more than 99.99 % of the uranium 
in a GANEX 1st cycle.[47] However, the use of the DEHBA 1.12 solvent was found to negatively 
impact the extraction of Am(III) and Eu(III) and more problematically Np, in which the 
distribution (D) ratio drops below 1 after 42 days.[48] Unlike TBP 1.01, the degradation products 
of DEHBA 1.12 have a greater negative impact on the extraction of the actinides. It also sees the 
amplified extraction of fission and corrosion products that is not observed with the TBP extractant 
1.01, increasing the distribution ratios for all lanthanides and reducing separation efficiency. 
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Figure 13: Structure of an alternative GANEX ligand, DEHBA (1.12).  
 
The undesired co-extraction of fission and corrosion products within the GANEX process has 
been investigated by various research groups. An important understanding of their process 
behaviour is a necessity for the safe running of a future process. Palladium is known to be a 
problematic element as it can be extracted as a 1:1 complex with the CyMe4-BTBP ligand 1.09, 
preventing the ligand from coordinating to an actinide.[49] Suppressing the extraction of zirconium 
and palladium can be achieved using hydrophilic masking agents such as trans-1,2-
diaminocyclohexane-N,N,N’,N’-tetraacetic acid (CDTA) 1.13, Figure 14.[50] Alternatively it has 
been found that the complexing agents of bimet 1.14 and mannitol 1.15 can suppress the 
extraction of molybdenum, zirconium and palladium simultaneously.[51] 
 
Figure 14: Structures of example suppression and ‘hold-back’ reagents for the fission and 
corrosion products; CDTA (1.13), bimet (1.14) and mannitol (1.15). 
 
The GANEX process still requires optimisation, but the potential of streamlining the separation 
of the actinides ensures a continued focus. Ligands disclosed in this thesis have the potential for 
application in both the CHALMERS-GANEX and SANEX processes. 
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 1c-SANEX 
The 1-cycle SANEX process aims to selectively extract the trivalent actinides from a waste 
solution in one step, replacing the sequential DIAMEX-SANEX processes. In taking the PUREX 
raffinate and undertaking the extraction in a single step the number of cycles necessary for 
reprocessing are reduced, ensuring ease and economic benefits. A solvent mixture including 
CyMe4-BTBP 1.09 and TODGA 1.05 has been successfully demonstrated to achieve selective 
actinide extraction directly from PUREX raffinate with high selectivity.[52] The undesirable co-
extraction of some fission and corrosion products was observed but this could be suppressed by 
the addition of other hydrophilic compounds. In the case of the abundant zirconium and 
molybdenum fission products, oxalic acid 1.06 could be added to the aqueous phase to ensure 
their retention. The use of L-cysteine 1.16 could be used to strip palladium following its extraction 
by the BTBP ligand, Figure 15. Both oxalic acid 1.06 and L-cysteine 1.16 were found to have no 
impact on the selectivity towards the actinides. However, drawbacks to this process are the 
relatively slow kinetics of An(III) extraction. The separation from Am(III) alone from a synthetic 
PUREX raffinate can be achieved with minor impurities, however, there is a necessity to maintain 
a slow flow rate as a consequence of the slow extraction kinetics of the 1c-SANEX process.[53]   
 
Figure 15: Structure of L-cysteine (1.16), a palladium suppression reagent. 
More recently the combination of the hydrophobic CyMe4-BTPhen ligand 1.17 with the 
hydrophilic extractant tetraethyldiglycolamide (TEDGA) 1.18 was observed to selectively extract 
Am(III) alone from a PUREX raffinate, Figure 16.[54] This included the additional separation of 
Am(III) from Cm(III), which is desirable for the future fabrication of a new fast reactor fuel, with 
a separation factor for Am(III) over Cm(III) (SFAm/Cm) of 4.9. Cm(III) has a limited impact on the 
final radiotoxicity and heat-load of the sample compared to Am(III) (half-life of 244Cm is 18 years) 
but has strong neutron radiation impacts and requires additional shielding when handling or 
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processing. In achieving this separation it ensures the safety of those personnel working on the 
new reactors.  
 
Figure 16: Structures of extractants for the 1c-SANEX process; CyMe4-BTPhen (1.17) and 
TEDGA (1.18). 
 Processes involving selective aqueous complexation of An 
Alongside the aforementioned, there are processes that achieve the An(III) partitioning by 
selectively retaining the An(III) in the aqueous phase, rather than selectively extracting them into 
the organic phase. These processes involve hydrophilic ligands that will either back-extract the 
An(III) selectively into the aqueous phase (after they have been extracted into the organic phase 
by a hydrophobic ligand), or retain the An(III) in the aqueous phase during an extraction step. 
Typically the co-extraction of the An(III) and Ln(III) into the organic phase is achieved at high 
acidity by a hydrophobic ligand before a hydrophilic ligand selectively back-extracts the An(III) 
into a fresh aqueous phase, with the ligand and specific conditions depending on the process 
employed. As hydrophilic ligands are not the focus of this thesis, these ‘aqueous’ processes will 
only be mentioned briefly here.  
One of the most well-known processes involving hydrophilic ligands is the TALSPEAK 
(Trivalent Actinide from Lanthanide Separation by Phosphorus Reagent Extraction from Aqueous 
Komplexes) process which utilises polyaminocarboxylate ligands to achieve the separation.[55] In 
this process these ligands selectively retain the An(III) in the aqueous phase while a hydrophobic, 
non-selective ligand extracts the Ln(III) into the organic phase, hence achieving separation of 
An(III) from Ln(III). An alternative, typically using the same ligands (di[2-ethylhexyl]phosphoric 
acid) HDEHP 1.19 and DTPA (diethylenetriaminepentaacetic acid) 1.20, known as the reverse 
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TALSPEAK process sees the co-extraction of An(III) and Ln(III) by HDEHP 1.19 prior to the 
partitioning of the An(III) into the aqueous phase with DTPA 1.20, Figure 17.[56] 
 
Figure 17: Structures of extractants used in the TALSPEAK process; HDEHP (1.19) and 
DTPA (1.20). 
 
 
Figure 18: Diagram illustrating the principle of the i-SANEX process in which the lanthanides 
are selectively extracted into the organic phase.  
 
An alternative process known as the innovative SANEX (i-SANEX) process involves co-
extraction of the An(III) and Ln(III) prior to partitioning of the An(III), Figure 18. A 
diglycolamide such as TODGA 1.05 (the preferred ligand for the DIAMEX process) is used to 
co-extract the An(III) and Ln(III) prior to the use of a hydrophilic stripping agent, such as the 
sulfonated BTP 1.10, to selectively strip the An(III) into the aqueous phase. This has additionally 
been considered to achieve the difficult separation of Am(III) from Cm(III), similar to what was 
achieved in the 1-cycle SANEX process.  
25 
 
The use of the hydrophilic SO3-Ph-BTP ligand 1.10 has been found to suppress the extraction of 
Am(III) into the organic phase by TODGA 1.05 so that a separation factor for Am(III) over Eu(III) 
of approximately 1000 could be achieved.[41] The combination of SO3-Ph-BTP 1.10 and TODGA 
1.05 has demonstrated excellent separation of Am(III) and Cm(III) from Ln(III) starting from a 
simulated PUREX raffinate solution, with 99.8% of the An(III) recovered with minimal 
impurities. Additionally the BTP complexant 1.10 was found to have some selectivity for Am(III) 
over Cm(III) specifically with a separation factor of 2.5.[57] 
This is not an exhaustive discussion of the aqueous processes available for the partitioning of 
An(III) but it provides a general overview of the basic principles of all aqueous solvent extraction 
processes. The only differences typically lie in the specific ligands, solvents and conditions used 
to achieve the required separations.  
1.5. Ligands for Selective Actinide Extraction 
In this section the complex criteria in which ligands developed for the SANEX and GANEX 
processes must meet is discussed, with three families standing out. Alongside the chemical 
ingenuity required to ensure the separation of two chemically similar groups, An(III) and Ln(III), 
the ligand itself has to abide by multiple criteria for future use in the nuclear fuel reprocessing 
industry. This has in no doubt resulted in the limited number of ligands being developed that have 
potential application in the reprocessing industry. Below is an indication of the criteria that has 
been established over the 20 years An(III) partitioning ligands have been investigated.  
In terms of ligand design, they must be soluble in the required inert hydrocarbon-based organic 
diluents (kerosene, 1-octanol) requiring some consideration when functionalising, i.e. limiting 
aromaticity. It is preferred the ligand abide by the ‘CHON’ principle, dictating that a material 
should only be comprised of the elements; carbon, hydrogen, oxygen and nitrogen so that it can 
be completely incinerated to gases, hence reducing the final volume of waste for disposal in a 
geological repository.  
In order to achieve the optimum extraction, the ligand requires a distribution (D) ratio, a measure 
of extraction affinity, high enough to ensure An(III) separation from wastes with high metal 
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loading. However, this D ratio must not be so high that it hinders the subsequent stripping of the 
metal from the ligand after separation, to enable ligand recycling. An ability to extract the An(III) 
at high acidities is essential as the partitioning is completed at acidities of >4 M nitric acid 
(HNO3). In line with the conditions experienced during extraction the ligand must be resistant to 
radiolysis and hydrolysis, to withstand degradation.   
A large dipole is favoured so that the ligand interacts more favourably at the interface between 
the organic and aqueous layers, facilitating a faster rate of extraction, by ensuring the ligand has 
more opportunity to come into contact with the metal ions. Finally, for industrial implementation, 
a ligand that is relatively cheap and/or easy to synthesise at scale is desirable.  
With considerations made to the above criteria, a wide number of ligands have been investigated 
that achieve the partitioning of the An(III) from nuclear waste, albeit to varying degrees of 
success. Traditional ligands focused on the co-extraction of the f-elements and included 
organophosphorus compounds and diamides (i.e. diglycolamides) for use in the PUREX and 
DIAMEX processes, section 1.4. Most recently, ligand developments have focused on N-
heterocyclic containing components for use in the SANEX and GANEX processes, which have 
been shown capable of separating the An(III) from the Ln(III). Each class of ligands have been 
extensively investigated with structural modifications and different solvent systems considered 
for optimum performance.[58] 
This project focuses on ligands containing soft N- and S-donor atoms which have been found 
capable of distinguishing between the An(III) and Ln(III).[59],[60] They typically fall into two 
categories; hydrophobic or hydrophilic ligands, dependent upon which phase they are designed 
to dissolve in. There have been significant developments in the hydrophilic ligands, but they 
won’t be discussed in this thesis.[61] The selectivity of the soft donor ligands is thought to be a 
result of the increased covalent interaction between the donor atoms of the ligands and the 5f 
orbitals of the actinides.[62],[21] These 5f orbitals are more diffuse and hence more available for 
metal-ligand bonding than the 4f orbitals of the lanthanides. Thermodynamic studies and X-ray 
crystal structures have been used to determine the difference in metal-ligand bond lengths 
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between the actinide and lanthanide complexes (An-M and Ln-M), to aid in the understanding of 
the origin of the selectivity. X-ray crystal structures have shown a shorter bond length for the 
actinide-ligand complexes with both the 2,2’:6’,2’’-terpyridine (TERPY) 1.21 and 2,6-bis(5,6-
dimethyl-1,2,4-triazin-3-yl)pyridines (Me-BTP) 1.22 ligands, suggesting the presence of π back-
bonding interactions.[63],[64] Computational studies have supported the theory that the more diffuse 
d- and f-orbitals of the actinides can form bonds, covalent in character, with soft N-donor 
atoms.[65]  
In the following section the ‘early’ classes of N-donor ligands and the three most prominent N-
heterocyclic ligand classes will be discussed; from early discovery, functionalisation, extracting 
ability and complexation studies. 
 Early N-donor ligands 
The TERPY 1.21 ligands were one of the earliest classes of ligands to selectively separate the 
An(III) from the Ln(III), Figure 19. In combination with 2,6-bis(2-pyridyl)pyridine, TERPY 1.21 
was shown to form 1:1 complexes with the Ln(III) in solid state studies. At low acidities TERPY 
1.21 was able to separate Am(III) from Eu(III) with a separation factor (SFAm/Eu) of 7.2, but due 
to ligand protonation this decreased progressively at nitric acid acidities above 0.1 M.[66] This 
stoichiometry suggests their inability to completely enclose the metal and may result in their poor 
separation factors. Crystal structures revealed the tendency of the TERPY ligands 1.21 to form 
hydrogen bonds through intramolecular interactions.[67] 2,4,6-tri(2-pyridyl)-1,3,5-triazine (TPTZ) 
1.23 showed slightly improved distribution (D) ratios of Am(III) when compared to TERPY 
ligands 1.21, with a SFAm/Eu of above 10.[68] Similar to that observed with the TERPY ligands 
1.21, TPTZ 1.23 exhibited weak extraction ability at high concentrations of nitric acid due to the 
competition between metal complexation and ligand protonation.[69] 
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Figure 19: General structures of five classes of N-heterocyclic ligands; terpy (1.21), Me-BTP 
(1.22), TPTZ (1.23), BODO (1.24) and hemi-BTP (1.25).  
 
The 2,6-bis(benzoazol-2-yl)-4-dodecyloxypyridine (BODO) 1.24 and its derivatives showed 
comparable separation of Am(III) from Eu(III) to the previous ligands.[70] In contrast to previous 
ligands, BODO 1.24 showed an increased resistance to protonation at higher acidities but the 
distribution (D) of Am(III) and SFAm/Eu still observed a decrease, a result of increasing competition 
from the nitrate ions for complexation to the metal.[71] 
In further developments, the hemi-BTPs 1.25 were synthesised and were shown to achieve the 
separation of Am(III) from Eu(III).[72] Their properties exist between those of the TERPY 1.21 
and BTP families, which will be discussed in section 1.5.2. The formation of 1:1 and 1:2 
lanthanide complexes were observed through crystallography and NMR studies and it was found 
that intramolecular bonding plays a key role in metal complexation.[73] For a complete review of 
ligands capable of extraction of the f-elements see papers by W. Verboom and co-workers or L.M. 
Harwood and co-workers.[58, 68] 
 Bis-triazinyl pyridine (BTP) ligands  
Research by Z.Kolarik and co-workers in 1999 found that alkyl-BTPs were one of the first 
examples of N-donor 1,2,4-triazine ligands, Figure 20. These BTPs demonstrate high extraction 
efficiency and selectivity for the An(III) over the Ln(III), without the need of a phase transfer 
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agent, with separation factors (SFAm/Eu) of close to 150 being observed, compared to that observed 
for terpy 1.21 and TPTZ 1.23.[74] Electrospray ionisation mass spectrometry (ESI-MS), time-
resolved laser-induced luminescence (TRLIL) and extended x-ray absorption fine structure 
(EXAFS) studies saw the formation of 1:3 complexes in the form of [M(BTP)3]3+,[75] with An(III) 
complexes showing increased complex stability compared to equivalent Ln(III) complexes, 
independent of the solvent used.[76] A 15N NMR titration study with 2,6-bis(5,6-n-propyl-1,2,4-
triazin-3-yl)-pyridine (n-PrBTP) 1.26 concluded that the bonding in its Am(III) complex was 
more covalent in character than that of a comparable Ln(III) complex, as observed by the large 
15N chemical shift for the coordinating atoms.[21]  
 
Figure 20: Molecular structures of representative alkylated-BTP ligands; n-PrBTP (1.26), Cl-
Pr-BTP (1.27), OMe-Pr-BTP (1.28), i-Pr-BTP (1.29). 
 
Functionalisation of n-Pr-BTP 1.26 with chlorine (Cl) 1.27 and methoxy (OMe) 1.28 groups 
investigated electronic effects and hence the basicity of the final ligands upon selectivity.[77] It 
was found that the D ratios and SFAm/Eu increased as basicity of the ligand increased, hence the 
ligand 1.28, containing the OMe group, observed the greatest extraction properties as a result of 
the higher electron density in the pyridine ring. 
These simple alkylated-BTP ligands were found to extract from high HNO3 concentrations but 
had poor resistance towards radiolysis and hydrolysis in hot tests. A SANEX hot test was carried 
out with n-PrBTP 1.26, however, it was found that some ligand degradation occurred during the 
‘hot-test’.[78] The degradation of the ligands was found to occur by attack of the free radical 
species (formed during radiolysis of the organic and aqueous phases) on the reactive benzylic 
positions adjacent to the triazine rings, leading to abstraction of a benzylic hydrogen. Trapping of 
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the resulting benzylic radical with a NO2 radical initially forms a nitro compound before further 
degradation to the corresponding alcohol or ketone, as determined by gas chromatography (GC) 
and ESI-MS. Additional degradation ultimately leads to cleavage of the alkyl groups. Further 
studies found that branching of the alkyl groups at the benzylic α-position, as is the case for i-Pr-
BTP 1.29, can increase resistance to radiolysis and hydrolysis.  
The Harwood group at Reading University found that introducing the tetramethyl cyclohexyl 
(CyMe4) group led to the CyMe4-BTP ligand 1.30 with resistance to radiolysis and hydrolysis, 
Figure 21, with separation factors SFAm/Eu of up to 5000 being observed, compared to that for i-
Pr-BTP 1.29 which is 400. [79], [80] Unfortunately, despite the excellent extraction properties and 
high distribution ratio for Am(III) exhibited by CyMe4-BTP 1.30, stripping of the metal from the 
loaded organic phase, and subsequent recycling of the ligand in a future SANEX process, were 
not possible.  
 
Figure 21: Molecular structure of the CyMe4-BTP ligand (1.30). 
 
The selectivity of these 1,2,4-triazine ligands is thought to result from the α-effect that occurs 
when two non-bonding nitrogen electron lone pairs are adjacent to each other, which can result 
in an increased covalent interaction upon complexation.[81] To confirm the impact of the α-effect 
the 1,2,4-triazine was replaced by 1,3,5-triazine ring to see if it impacted on the ligands extraction 
capability, Figure 22. It was found that upon replacement with the 1,3,5-triazine, the ligands 
performed significantly worse under the same solvent extraction conditions, suggesting that the 
1,2,4-triazine ring is essential for good extraction and separation efficiency.[68] 
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Figure 22: General structures of the 1,2,4-triazine and 1,3,5-triazine rings, showing the 
positioning of the adjacent lone pairs (highlighted in blue).   
 
The development of the camphor-BTP ligand 1.31, Figure 23, by Geist and co-workers was 
investigated to overcome the difficult back-extraction shown by CyMe4-BTP 1.30 and the slow 
extraction kinetics shown by CyMe4-BTBP 1.09, as discussed in section 1.4.2. This ligand was 
found to be resistant to hydrolysis, in addition to showing fast extraction kinetics and high 
solubility in comparison to previously developed triazine ligands.[82] It has a solubility of 200 
mmol/L in 1-octanol, compared to 10 mmol/L for the CyMe4-BTBP ligand 1.09. One downside 
was found to be the increasing tendency to form a precipitate when the organic phase was mixed 
with high HNO3 concentrations in a kerosene/1-octanol diluent. The precipitate was thought to 
be the protonated ligand. This ligand 1.31 is discussed in more detail in chapter 3.  
 
Figure 23: Molecular structure of camphor-BTP (1.31).  
Consequently as discussed, BTPs with high D ratios and separation factors have been prepared 
and investigated. One major drawback of these ligands is the highly stable complexes, 
[M(BTP)3]3+, formed and the resulting impacts on back-extraction of the metal ions.  
 
 Bis-triazinyl bi-pyridine (BTBP) ligands  
The BTBPs were developed by adding an additional pyridine ring to the BTP structures, extending 
the aromaticity and making it a tetradentate ligand. As with the BTP compounds, one of the first 
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BTBPs tested for selective actinide extraction was an alkylated derivative, 6,6’-bis-(5,6-dipentyl-
[1,2,4]triazin-3-yl)-[2,2’]bipyridinyl (C5-BTBP) 1.32, Figure 24. This ligand has the ability to 
separate Am(III) from the Ln(III)s, although with lower D ratios then with the BTPs, with a DAm 
of 2 at 1.0 M HNO3, it does demonstrate that metal back-extraction is possible.[83] At the 
conditions back-extraction would occur, a HNO3 concentration of 0.1 M, the C5-BTBP ligand 
1.32 has a DAm of 0.02. Additionally, this ligand observes some selectivity towards the transition 
metals; palladium and cadmium, so may have the potential to remove traces of these metals from 
solutions. The dependence of extraction capability on diluent choice is clearly evident in studies 
with the C5-BTBP extractant 1.32, suspected to be influenced by intermolecular interactions 
between the ligand or metal complex with the diluent. Consistent with the alkylated-BTPs, this 
ligand was also susceptible to radiolysis on account of its benzylic hydrogens, making it 
unsuitable for future industrial use.[84] 
 
Figure 24: Structure of an alkylated-BTBP, C5-BTBP (1.32). 
The CyMe4-BTBP ligand 1.09, which does not contain benzylic hydrogens, showed resistance to 
hydrolysis and radiolysis and a similar extraction selectivity to its BTP analogue 1.30, Figure 25. 
Crucially however, stripping of the metal from the loaded organic phase was possible with 
CyMe4-BTBP 1.09, in contrast to CyMe4-BTP 1.30. On the other hand, the slow extraction 
kinetics observed with this family of ligands, required a contact time of one hour before reaching 
extraction equilibrium.[33] This impacts the final phase mixing times required to achieve 
separation and the ability of the ligand to extract from a waste solution with high quantities of 
radioisotopes. The addition of a phase transfer agent, such as DMDOHEMA 1.04 or TBP 1.01, is 
required to improve the rates of extraction of the ligand by ensuring that extraction equilibrium is 
achieved within 5 minutes.[85] The phase transfer agent exists at the interface and can complex the 
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metal cation to transfer it into the bulk organic phase, where it is replaced by the CyMe4-BTBP 
1.09 to form a stable complex.[33]   
 
Figure 25: Structure of CyMe4-BTBP (1.09), the current reference molecule for SANEX 
processes.  
 
The combination of CyMe4-BTBP 1.09 and DMDOHEMA 1.04 was analysed in a continuous 
counter current process using a genuine fuel solution, covering all extraction, scrubbing (Ln(III) 
back-extraction) and stripping (An(III) back-extraction) steps. The partitioning of the actinides 
was achieved with high selectivity with almost quantitative recovery of both Am(III) and 
Cm(III).[34] One drawback is still the slow kinetics, which results in a low flow rate during this 
process. For waste solutions in which large volumes are to be treated, as to be expected in industry, 
this would increase the time and cost of the process. These slow rates of extraction are thought to 
result from the conformation that the BTBPs adopt in solution. The major conformer is found to 
be the non-chelating trans-conformer or linear conformer, with a large energy barrier to overcome 
before rotation to the cis-conformer, Figure 26.[86] In addition the trans-conformer has a zero 
dipole moment, making it more hydrophobic than the cis-conformer and hence more likely to 
repel the water molecules at the interphase.  
 
Figure 26: The molecular conformation of a general BTBP in solution and the solid-state 
showing both the trans- and the cis-conformation required for metal complexation.  
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In attempts to influence the ligands slow extraction kinetics and solubility in preferred diluents, 
recent research has focused on functionalisation of the bipyridine backbone, Figure 27. Aneheim 
and co-workers introduced a tert-butyl group to the 4-position of the bis-pyridinyl backbone to 
produce an asymmetric ligand, t-BuCyMe4-BTBP 1.33. The addition of this group led to an 
increase in solubility (1110 mmol/L in cyclohexanone) which was found to be a consequence of 
the higher entropy of dissolution of the ligands.[87]  Further modifications by L. M. Harwood and 
co-workers involved the introduction of a chloro and bromo substituent at the same position on 
the pyridine rings to produce two asymmetric ligands, 1.34 and 1.35 respectively.[88] Both ligands 
observed an increased solubility in the diluents 1-octanol (>170 mmol/L) and cyclohexanone 
(>230 mmol/L) compared to their predecessor 1.09, and comparable separation factors for 
Am(III) and Eu(III) were observed, without the need for a phase-transfer agent.  
Functionalisation in both the 4- and 4’- positions of the bis-pyridyl backbone with alkyl 
substituents, methyl and tert-butyl; leading to symmetric ligands 1.36 and 1.37 respectively, was 
expected to increase ligand solubility further due to the presence of the additional aliphatic 
groups.[89] However, the opposite was found to be the case, and both ligands 1.36 and 1.37 showed 
lower solubilities in several diluents and slower rates of metal-ion extraction. Am(III) distribution 
ratios of >1 were observed only after 30 hours of contact time, in 1-octanol and cyclohexanone. 
It is clear that substituent effects on the bipyridine backbone can have drastic impacts on ligand 
properties. 
 
Figure 27: Molecular structures of functionalised BTBP ligands. 
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The structures of the complexes formed between CyMe4-BTBP 1.09 and both Am(III) and Eu(III) 
where established by EXAFS studies to be largely constituting of [Am(CyMe4-BTBP)2(NO3)]2+ 
and [Eu(CyMe4-BTBP)2]2+ respectively.[90] Changing the solvent system can have drastic effects 
on the stability of these complexes within solution and a careful balance of ligand solubility and 
high separation factor is necessary.[91] Again, an increased covalent interaction is indicated in 
theoretical studies with the actinide-BTBP complexes in comparison to the lanthanides, through 
the stronger interactions between Am(III) and the triazine N-2 atoms of the BTBP ligand.[92] A 
time-resolved laser fluorescence spectroscopy (TRLFS) study found a thermodynamic driving 
force behind the selectivity of BTBPs for the An(III) over the Ln(III), in particular the selectivity 
for Cm(III) over Eu(III), with stability constants of their complexes; of log K = 11.1 (for Cm(III)) 
and 9.0 (for Eu(III)) respectively.[93] The stability constants are consistently higher for the 
Cm(III)-ligand complexes suggesting there is a thermodynamic driving force for the 
complexation reaction, which is higher for Cm(III) than Eu(III). Further TRLFS studies have 
shown a 1:2 complex is formed with Eu(III) and Cm(III) in equilibrated samples and the space 
for the coordination of other anions and solvents can depend upon the bulkiness of ligands.[94]  
Through these investigations it is clear the CyMe4-BTBP 1.09 emerges as the prominent 
extractant of choice, with the most suited properties for the future reprocessing industry. 
However, this ligand suffers from poor extraction kinetics, requiring increased phase mixing 
times to achieve separation.   
 Bis-triazinyl phenanthroline (BTPhen) ligands 
As discussed previously, CyMe4-BTBP 1.09 suffers from slow extraction kinetics, even in the 
presence of a phase transfer agent. In order to tackle this issue the introduction of pre-organisation 
into the 2,2-bipyridine system led to the development of the 2,9-bis(1,2,4-triazin-3-yl)-1,10-
phenanthroline (BTPhen) derivatives, Figure 28.[95] This pre-organised structure locks the 2,2’-
bipyridine core of the ligand into the cis-conformation required for metal binding through the 
addition of a phenyl ring, giving rise to a 1,10-phenanthroline core. A stopped-flow technique 
revealed that the pre-organisation of the BTPhen observed a correlation with the kinetics of metal 
ion complexation.[96] X-ray crystallography of the free CyMe4-BTPhen 1.17 shows a slight twist 
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of the two outer triazine rings out of the required conformation for metal complexation, although 
this would still be a significantly reduced conformational change than that required by CyMe4-
BTBP 1.09. 
 
Figure 28: Molecular structure of CyMe4-BTPhen (1.17), showing position numbering.  
The extraction equilibrium with the CyMe4-BTPhen 1.17 is achieved in approximately 15 minutes 
of phase mixing, showing a dramatic improvement on the extraction kinetics found with the 
equivalent CyMe4-BTBP ligand 1.09. This is in addition to increased extraction efficiency and 
high extraction selectivity for Am(III) over Eu(III).[97] Interfacial tension measurements reveal 
that a higher concentration of ligand sits at the interface during extraction, which suggests this 
plays a role in its improved extraction kinetics when compared to the BTBPs.  
Computational studies have been completed to gain a greater theoretical understanding of the 
origin of the promising extraction properties of these ligands. One such study revealed that the 
size of the ligand cavity, influenced by the conformation of the ligands and orientation of the 
1,2,4-triazine rings, can impact the ease of metal complexation.[98] In addition to the cis-locked 
structure, these ligands have a greater dipole moment than the BTBPs as well as the capability to 
accommodate a water molecule in the cavity, which is thought to contribute to its increased 
concentration at the interface.[95] The coordinated water molecule could form hydrogen bonds 
with water molecules at the interface leading to higher concentrations of the ligand at the interface 
and consequently faster extraction kinetics. The use of surface tension measurements, using the 
du Noüy ring method, provided further evidence for the increased activity of the CyMe4-BTPhen 
1.17 at the interface when compared to the CyMe4-BTBP 1.09, in which the CyMe4-BTPhen 
observed increased surface activity in all diluents tested.  
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This ligand has been investigated for its potential to separate exclusively Am(III) from a PUREX 
raffinate. A separation factor (SFAm/Cm) of 4.9 was observed between Am(III) and the other minor 
actinide Cm(III) when this ligand is used in combination with TEDGA 1.18.[54] When silica 
magnetic nanoparticles functionalised with the CyMe4-BTPhen 1.17 are utilised a SFAm/Cm of 2 is 
achieved at 4 M HNO3, without the need for additional reagents.[99] This separation would be 
advantageous for the recycling of Am(III) alone for use as a new reactor fuel; Cm(III) has a higher 
neutron activity and would require additional shielding, but is relatively short-lived in comparison 
to Am(III).[100] The use of magnetic nanoparticles has been proposed as a viable option to reduce 
the secondary waste generated when using solvent extraction, as the use of large volumes of 
diluents are avoided.[101]   
 
Figure 29: General structures of various BTPhen ligands, showing both triazine 
functionalisation and derivatisation at the 5,6-positions. 
 
Investigating the impact of functionalisation on solubilities was completed with the BTPhen by 
modifying the triazine substituents to include alkyl, branched and cyclic groups, Figure 29. 
Increasing the length of the alkyl substituent chain saw a correlation with increasing solubility in 
all diluents investigated including; dodecane, 1-octanol and cyclohexanone, with pentyl-BTPhen 
1.41 showing the greatest solubility of all ligands tested.[102] This BTPhen ligand 1.41 in particular 
was investigated further for the effect on electronic properties through functionalisation at the 
5,6-position leading to ligands 1.45 and 1.46. This modification resulted in a decrease in the 
distribution ratio of Eu(III), which consequently meant the SFAm/Eu was increased in comparison 
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to the analogous C5-BTPhen 1.41.[103] However, based upon research regarding the alkylated-
BTP 1.26, this C5-BTPhen ligand 1.41 would also be susceptible to radiolysis on account of the 
benzylic hydrogens.  
 
 
Figure 30: General structures of various BTPhen ligands, showing the derivatisation at both the 
the 5,6- and the 4,7-positions. 
 
The position of functionalisation on the 1,10-phenanthroline backbone can have pronounced 
effects on the metal ion distribution ratios at equilibrium, Figure 30. Studies into the 
functionalisation of CyMe4-BTPhen 1.17 at the 5-position with bromine 1.47 and 4-
hydroxyphenyl 1.48 substituents explored the effects on selectivity and distribution (D) ratios, 
with a focus on the selectivity between Am(III) and Cm(III).[104] The addition of bromine in 1.47 
results in lower selectivity for Ln(III) than is observed with the benchmark CyMe4-BTPhen 1.17 
as a result of its inductive electron-withdrawing effect. This results in a decrease in the availability 
of the lone pair of electrons on the phenanthroline N-donor atom for taking part in complexation 
to the metal. This, in combination with the poor orbital overlap between the Ln(III) and the N-
donor atoms, is thought to result in the lower selectivity. The 4-hydroxyphenyl substituent sees 
an opposite mesomeric electron-donating effect, and the lone pair of electrons on the N-donor 
atom are more available for orbital overlap with the metal ion, resulting in increased D values for 
some of the Ln(III).  
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A comparison of the relative position of functionalisation found that there is a greater influence 
on the extraction properties when there is functionalisation at the 4,7-positions over the 5,6-
positions. This is proposed to result from enhanced electronic modulation due to the para-
positioning of the substituents relative to the nitrogen atoms of the phenanthroline, which are 
known to coordinate to the metal ion.[105] A 1:2 metal:ligand complex species was observed 
exclusively for those ligands derivatised at the 4,7-positions using TRLFS studies.[106] 
 
Figure 31: General structures of BTPhen derivatives functionalised at the 5,6-positions of the 
1,2,4-trizaine rings by S.L.Heath and co-workers; aliphatic-BTPhens (1.55), isatin-BTPhens 
(1.56) and benzil-BTPhens (1.57).[107] 
 
Further research has been completed into the functionalisation of the 5,6-positions of the 1,2,4-
triazine rings and these studies indicate functionality can be utilised to tune properties such as 
solubility, extraction rate and extraction affinity. S.L.Heath and co-workers introduced further 
functionality using commercially available diketones to replace the CyMe4 diketone such as isatin 
1.56, benzil 1.57 and various aliphatic diketones 1.55, Figure 31.[107] Where additional aromaticity 
was introduced, with the isatin-BTPhens 1.56 and benzil-BTPhens 1.57, they were all found to 
have poor solubility regardless of the groups at the R positions. The isatin-BTPhens 1.56 were 
found to co-extract Eu(III) whereas this effect was less pronounced for the benzil-BTPhens 1.57. 
For the alkylated derivatives there was an increasing solubility as the alkyl chain length increased, 
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as observed in the research by Harwood and co-workers.[102] However, this correlated to a 
decreasing separation factor for Am(III) over Eu(III), potentially as a result of the negatively 
impacted hydrolytic and radiolytic stability.  
The differences between the selectivity of the BTPhen ligands towards the An(III) and Ln(III) 
have been studied using various methods. X-ray diffraction (XRD), X-ray absorption 
spectroscopy (XAS) and luminescence spectroscopy studies revealed the formation of 10-
coordinate 1:2 [M:L] complexes, with two CyMe4-BTPhen 1.17 molecules surrounding the 
respective Ln(III) centres. Additional coordination sites usually being occupied by a bidentate 
nitrate ion.[32] A TRLFS study revealed both Cm(III) and Eu(III) complexes with CyMe4-BTPhen 
1.17 exist predominantly as 1:2 [M:L] complexes at equilibrium, with a greater stability constant 
observed for the Cm(III) complex.[94a] This study also provided additional evidence for the 
increased stability of the CyMe4-BTPhen 1.17 complexes when directly compared to the CyMe4-
BTBP complexes 1.09, although this is less pronounced for the Eu(III) complex.  
The radiolytic stability of the benchmark BTPhen ligand, CyMe4-BTPhen 1.17, was studied in 
cyclohexanone-based solvents and found that, with an increasing dose of (γ) radiation, the 
concentration of this ligand and the respective D ratios for Am(III) and Eu(III) both decreased.[108] 
This effect is somewhat limited by the presence of ligand-diluent adducts, formed through the 
degradation of the parent ligand under radiolysis, with the dominant 1-octanol-ligand product 
observed by MS.[109] Interestingly those samples in contact with HNO3 during irradiation observed 
a greater stabilisation of the distribution ratios of Am(III) and Eu(III). When the radiolytic 
stability of the ligand 1.17 is tested in the phenyl trifluoromethyl sulfone (FS-13) 1.58 diluent, 
Figure 32, an opposite trend is observed in which the distribution ratios increase with an 
increasing radiation dose. This is despite an increased degradation rate of CyMe4-BTPhen 1.17 in 
comparison to CyMe4-BTBP 1.09 when in contact with the acidic aqueous phase, suggesting the 
degradation products of the BTPhen are themselves efficient extractants.[110] 
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Figure 32: Structure of diluent FS-13 (1.58).  
The functionalisations discussed in this section give a clear indication of the impact that 
introducing certain groups can have on the extraction properties of the ligands. Currently from 
those BTPhens discussed here, the CyMe4-BTPhen 1.17 remains the most appropriate ligand for 
use in a SANEX or GANEX type process.  
1.6. Project aims and objectives. 
New ligands with improved solubilities and rates of extraction are needed for a feasible, economic 
and safe SANEX or GANEX separation process to be developed. The current European 
benchmark ligand, CyMe4-BTBP 1.09, has a solubility limit of approximately 10 mmol/L in 1-
octanol and requires the use of a phase transfer agent to ensure sufficiently fast rates of 
extraction.[33] Increased solubility would reduce the chances of precipitation or third phase 
formation occurring during the extraction process, hence the process becomes safer to manage. 
Additionally less diluent would be needed to ensure dissolution of the ligand, reducing the costs 
of reprocessing those fuels with a higher minor actinide content, such as those that will be 
produced by future GEN(IV) reactors. However, attempts to increase the solubility of the BTBP, 
without adversely affecting the extraction kinetics, has been largely unsuccessful to date, see 
section 1.5.3.  
Faster rates of extraction are essential in reducing the time and ultimately the costs required for 
an industrial process to achieve efficient extraction of the An(III). A ligand with faster rates of 
extraction would not require an additional phase transfer agent and hence the costs of running the 
process would be reduced. It would also mean that extraction can be achieved with shorter mixing 
times and faster flow rates, reducing the operating time and hence the cost of the process. 
Currently, the time taken for solutions of CyMe4-BTBP 1.09 in 1-octanol to reach extraction 
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equilibrium is over one hour, which would be undesirable for an industrial process due to the 
increased costs and time necessary to ensure efficient extraction of the An(III).  
This project will consider a novel approach to designing new families of bis-1,2,4-triazine ligands 
that show improvements on the aforementioned drawbacks. The synthesis and evaluation of these 
ligands will ultimately lead to validation of the design approach utilised to inform future research 
in this area. 
 Project Aims 
Aim 1: To design and synthesise new classes of multidentate ligands based around the 
crucial 1,2,4-triazine moiety that will be suitable for future industrial use in the separation 
of the actinides from the lanthanides. 
Aim 2: To investigate the ability of the new ligands to selectively extract and separate 
actinides from lanthanides (including measuring their solubilities and rates of extraction). 
Aim 3: Where applicable, to investigate how the new ligands complex the trivalent 
lanthanides (used as surrogates for the trivalent actinides) and selected fission and corrosion 
products that are present in spent nuclear fuel.   
Aim 4: To validate our approach to improving the solubilities and rates of extraction of the 
novel ligands using the solvent extraction data obtained in (aim 2) above.  
 Novel Ligand Design Approach 
In an attempt to establish a set of guidelines to improve ligand solubility and rates of extraction 
in future ligand developments, a novel ligand design approach will be investigated. This approach 
takes inspiration from various aspects of the pharmaceutical industry and their drug discovery 
protocols. Christopher Lipinski formulated the “Rule of Five” (RO5) over 20 years ago to 
streamline drug discovery by defining what properties would make a drug orally active in 
humans.[111],[112],[113] The RO5 sets parameters that can predict the permeability and solubility of a 
compound based upon its physical and chemical properties, such as the molecular mass being 
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below 500 and a log P maximum of 5. Importantly for the design approach the focus will be on 
those factors relating to lipophilicity, solubility and polarity.  
The number of hydrogen bond donors (HBD), those functional groups containing N-H, O-H or 
S-H groups in which a proton can be removed, i.e. donated, must be no more than 5. The number 
of hydrogen bond acceptor (HBA) functional groups, those functional groups containing 
heteroatoms with lone electron pairs, must be no more than 10 and include all heteroatoms with 
lone pairs of electrons present. These HBD/HBA functional groups are valuable in the ligand 
design approach as they can potentially participate in hydrogen bonding with water molecules at 
the phase interface, ensuring higher concentrations of the ligands exist at the interface and hence 
faster rates of metal extraction. As discussed in section 1.5.4, the higher polarity of the BTPhens 
compared to the BTBPs are beneficial to its rates of extraction by ensuring it has a higher 
concentration at the phase interface than BTBP, which was confirmed by surface tension 
measurements on CyMe4-BTPhen 1.17 and CyMe4-BTBP 1.09 using the du Noüy ring method.[95] 
In addition, the X-ray crystal structure of CyMe4-BTPhen 1.17 shows a water molecule within 
the ligand’s coordination cavity, which is suspected to be able to form hydrogen bonds with water 
molecules at the interface, hence aiding in its faster extraction rates compared to CyMe4-BTBP 
1.09.[95] 
Log P is used to measure the lipophilicity of a drug and is the calculated partition coefficient of a 
drug molecule between 1-octanol and water, or an aqueous and lipophilic phase (eq. 1.). This is 
significant, as one of the preferred diluents for reprocessing spent nuclear fuel is 1-octanol, so a 
molecule with a high log P value is likely to have a high solubility within this diluent. However, 
the value can’t be taken as a predictor of absolute solubility of a ligand, as log P is calculated as 
a ratio of the relative solubility of a ligand in octanol compared to that in water. The log P can be 
calculated to predict the limitation of adding HBD/HBA functional groups (which tend to 
decrease log P) and at which point their addition can cause too large a decrease in this value. The 
limitation point is vital in ensuring the ligand doesn’t become too polar that it partitions into the 
aqueous phase, rendering the lipophilic ligand ineffective for the proposed An(III) extraction. The 
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log P value will be calculated theoretically from the ligand structure using the ACD/I-labs 
software (ACD/Labs, 2010-2018).  
log 𝑃𝑜𝑐𝑡/𝑤𝑎𝑡 = log(
[𝑠𝑜𝑙𝑢𝑡𝑒]𝑜𝑐𝑡𝑎𝑛𝑜𝑙
[𝑠𝑜𝑙𝑢𝑡𝑒]𝑤𝑎𝑡𝑒𝑟
) 
Additional research by Lovering and co-workers demonstrated that there exists a correlation 
between drug solubility and its degree of saturation.[114] The fraction of saturated carbon atoms in 
the molecule (Fsp3), calculated by taking the number of sp3 carbons in the molecule and dividing 
it by the total number of carbon atoms (eq. 2.), can hence be used to predict its solubility. For the 
purpose of this project the degree of saturation will be investigated as a means of predicting the 
solubility of a ligand in an industry relevant diluent i.e. 1-octanol. Implications for ligand 
development in this field include limiting the development of ligands with too high a degree of 
unsaturation, i.e. by having too many aromatic rings, which would have low Fsp3 values. Indeed, 
many such ligands are known to have very low solubilities in 1-octanol.[107] Therefore the only 
aromaticity to be included within the new families of ligands will be the 1,2,4-triazine rings and 
potentially an aromatic linker (typically one or more pyridine rings), as these are required to 
ensure strong metal ion coordination and high selectivity for An(III) over the Ln(III). Improving 
solubility will be achieved by using alkyl and cycloalkyl groups attached to the outer 1,2,4-trizine 
rings that follow the ‘like dissolves like’ principle. The relevance in designing novel ligands is 
that those ligands with less aromatic rings and more aliphatic groups will be structurally more 
‘like’ the aliphatic diluent, 1-octanol, and hence should be more soluble in it. Previous research 
on hydrophobic ligands such as DMDOHEMA 1.04 and TODGA 1.05 for use in the DIAMEX 
process, section 1.4.2, has shown that these ligands which contain long alkyl chains and no 
aromatic rings and have very high solubilities (up to approximately 0.1 M) in the required 
diluents.[26] Significantly, despite being very hydrophobic, these ligands still exhibit very fast rates 
of metal extraction, and extraction equilibrium is typically reached within 5 minutes.[61c] 
𝐹𝑠𝑝3 = (
#𝑠𝑝3 ℎ𝑦𝑏𝑟𝑖𝑑𝑖𝑠𝑒𝑑 𝐶
#𝑐𝑎𝑟𝑏𝑜𝑛
) 
Eq. 1 
Eq. 2 
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The above design criteria can be calculated from the chemical structure of the ligands themselves 
by using a chemical structure drawing software package such as ChemSketch, ChemDraw or the 
online resource ACD ILab. 
In the subsequent chapters the synthesis of a variety of novel ligands will be discussed. 
Derivatisation of the adjacent side groups to the 1,2,4-triazine as well as changing the connecting 
bond between the pyridine(s) and external 1,2,4-triazines have been investigated, Figure 33. Each 
derivatisation or new functionality investigated has been attempted to give novel BTPs, BTBPs 
and BTPhen ligands.  
 
Figure 33: Example structures of BTPs and a BTBP indicating the positions where 
derivatisation will be focused, both on groups adjacent to the 1,2,4-triazine ring and in the 
connecting bond(s) between the pyridine and external 1,2,4-triazine rings. 
  
46 
 
Chapter 2 
 
 
Ligands derived from 3-amino-1,2,4-triazines 
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2. Ligands derived from 3-amino-1,2,4-triazines  
2.1. Introduction 
In the 1990s, research by Buchwald and Hartwig found that palladium (Pd) can be utilised to 
promote the amination of aryl, vinyl and heteroaryl halides with a variety of amines.[115] The 
reaction provides an alternative method to traditional amination routes, such as the Ullmann 
coupling reaction,[116] which employ harsher reaction conditions and has limited substrate scope 
and versatility. Since this initial discovery, the palladium catalysed Buchwald-Hartwig C-N 
amination reaction has been extensively investigated, demonstrating its flexibility with a wide 
range of substituents on both reacting partners, including electron-withdrawing, electron-donating 
and sterically hindered groups. The potential of the Buchwald Hartwig reaction between 3-amino-
1,2,4-triazines (2.1.1) and aryl halides (2.1.2), to synthesise novel families of ligands (2.1.3), will 
be explored, Figure 34. 
 
Figure 34: Proposed Buchwald Hartwig amination reaction to form a novel family of ligands 
(2.1.3). General conditions: Palladium catalyst, ligand, base, solvent.  
 
Various articles have explored the reaction mechanism, both experimentally and theoretically, 
[117] and a general outline is shown in Figure 35. Following traditional cross coupling mechanisms, 
after the initial formation of the Pd(0)-ligand precatalyst, oxidative addition across the C-halogen 
bond is achieved with the electrophile, in this case an aryl halide. The nucleophilic amine then 
coordinates to the Pd(II) centre in a ligand substitution step and is deprotonated by the base to 
leave a neutral Pd(II) complex. The base, used in excess, additionally aids in the stabilisation of 
the leaving anionic halide species. The final reductive elimination step sees the formation of the 
carbon-nitrogen bond of the product as well as regeneration of the active catalyst, Pd(0)-ligand. 
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The specific order of coordination and deprotonation, especially involving the base and ligand, 
remain unclear due to the complexity of studying an equilibrium involving many rapidly 
interconverting complexes. Having a detailed mechanistic understanding would undoubtedly lead 
to easier tuning of the amination reaction parameters to ensure maximum yields, but due to the 
difficulty in isolating the intermediates in solution or solid-state the catalytic cycle is still debated. 
 
Figure 35: General scheme outlining the Buchwald Hartwig reaction mechanism. 
In order to maximise the scope of the Buchwald Hartwig amination the choice of catalyst, ligand, 
base and other reaction parameters needs to be tailored dependent on the starting substrates. 
[118],[119] Due to the variable nature of the amines that can be employed in the reaction, optimising 
the reaction conditions can prove challenging. Each amine can have a different pKa and 
nucleophilicity, which in turn alters the rate determining step of the catalytic cycle.[120] In most 
cases the ligand is key to the success of the reaction as it can be tuned depending on the properties 
of the substrates, i.e. electronic, steric etc. to limit the effect of the rate determining step.[121] For 
example electron-rich complexes have been found to slow down the reductive elimination 
step.[122] 
Some isolated examples of Buchwald Hartwig amination reactions with substrates containing 
1,2,4-triazine rings as the amine nucleophile have been reported in the literature. These reactions 
typically use tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3) 2.1.4 and 4,5-
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bis(diphenylphosphino)-9,9-dimethylxanthene (xantphos) 2.1.5, Figure 36.[123],[124] Xantphos 
2.1.5, a bulky electron-rich, tridentate bisphosphine, is the prominent ligand for this amination 
due to its strong σ-donor ability and wide bite angle (110.0 °), which promotes the ease of 
reductive elimination of the product from the Pd(II) intermediate.[125] Xantphos 2.1.5 is 
additionally hemilabile, meaning one of its coordinating phosphines can be displaced from the 
metal centre with ease, freeing up a coordination site on the metal and lowering the energy barrier 
for binding, whilst the other phosphine remains bound to the Pd centre.[126] In the cases where 
long reaction times are necessary, an extra equivalent of ligand to metal can aid in stabilising the 
catalyst. 
 
Figure 36: Structures of the Palladium Pd2(dba)3 2.1.4 source and Xantphos ligand 2.1.5. 
Additionally, the palladium source needs to be considered. The presence of the coordinating 
dibenzylideneacetone (dba) group in Pd2(dba)3 2.1.4 or Pd(dba)2 2.1.6 can hinder the formation 
of the active catalyst.[127] The use of palladium acetate, Pd(OAc)2, 2.1.7 requires the reduction of 
Pd(II) to Pd(0) prior to entering the cross coupling cycle. The use of pre-catalyst systems have 
seen a greater focus due to their benefits, which include; high activity, greater stability (to air and 
moisture) and activation under the basic conditions used in the cross coupling reaction.[128] 
Research using 1,2,4-triazines as the nucleophilic amine partner have been successfully 
demonstrated in Buchwald Hartwig amination reactions.[124, 129] It was decided to use caesium 
carbonate (Cs2CO3) as the preferred base, founded on similar reactions, as it offers a wide 
functional group tolerance and greater solubility than K2CO3 in organic solvents. Research 
recently published by the Carrick Group demonstrated the first successful double amination of 
functionalised heteroaryl-1,2,4-triazines 2.1.8, Figure 37.[130] This has been achieved with various 
aliphatic, benzylic and functionalised amines to result in the formation of aminated-1,2,4-
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triazinylpyridines 2.1.9. Currently however, no examples of a Buchwald Hartwig double-
amination reaction directly utilising 3-amino-1,2,4-triazines 2.1.1 as the nucleophile partner have 
been reported in the literature.  
 
Figure 37: General reaction scheme for the di-amination via the Buchwald Hartwig 
methodology used by the Carrick group [152]. Reaction conditions; i) Pd2(dba)3 (2.5 mol%) 
2.1.4, ligand (5 mol%), NH2R3 (3 equiv), potassium phosphate (3 equiv). 
 
Realising the potential of the Buchwald Hartwig amination reaction to access novel families of 
multidentate bis-1,2,4-triazine ligands, the Buchwald Hartwig reactions were explored with 
various heteroaryl halides 2.1.2 and readily synthesised 3-amino-1,2,4-triazines 2.1.1. By 
building on previous work, the parameters for the successful amination involving this group will 
be investigated to enable the synthesis of two novel families of multidentate ligands. The amine 
partner will be varied based upon the diketone used to synthesise the 3-amino-1,2,4-triazine, and 
the aryl halide will be varied depending upon the aryl moiety used, and the desired denticity of 
the target ligands; pyridine, pyrazine, 2,2-bipyridine or 1,10-phenanthroline. 
2.2. Ligands derived from di-amination of 2,6-dibromopyridine and related 
compounds 
In order to establish the best synthetic protocol for the Buchwald Hartwig amination with the 3-
amino-1,2,4-triazines 2.1.1, the commercially available and inexpensive diketone, 3,4-
hexanedione 2.2.1, was used. The final ligands synthesised from this diketone will not be screened 
for their extraction capabilities, due to their unsuitability in the reprocessing industry. These 
ligands contain benzylic hydrogens on the carbon adjacent to the triazine ring which are easily 
abstracted by oxygen free radicals, i.e. a hydroxyl radical. These free radicals are common within 
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nitric acid solutions in the nuclear industry and there abstraction would result in decomposition 
of the ligand, as discussed in section 1.5.[131]   
Due to the predominance of the CyMe4 diketone 2.2.5 in currently reported bis-1,2,4-triazine 
ligands, it was decided to also utilise this diketone in the synthesis of the new family of ligands. 
Its synthesis was achieved following the procedure by Lewis and co-workers outlined in the 
literature, Figure 38.[95] Firstly, ethyl isobutyrate 2.2.2 was deprotonated by the in situ formation 
of lithium diisopropylamide to form an enolate. Alkylation of this is then achieved with ethylene 
bis(trifluoromethanesulfonate) to form diethyl 2,2,5,5-tetramethylhexanedioate 2.2.3. The ring 
closure of 2.2.3 was achieved via an intramolecular acyloin type condensation with metallic 
sodium and chlorotrimethylsilane forming an enediolate bis-silyl ether intermediate 2.2.4. A silyl 
deprotection and final oxidation, using bromine in dichloromethane, gave the final diketone 2.2.5. 
An alternative diketone, 3,3,5,5-tetramethylcyclopentane-1,2-dione 2.2.7, can be prepared 
through a one-step oxidation of 2,2,4,4-tetramethylcyclopentan-1-one 2.2.6 with selenium 
dioxide. This step was completed by a colleague in the group, Figure 39. 
 
Figure 38: Reaction scheme for formation of CyMe4 diketone 2.2.5. Reaction conditions; i) 
LDA, ethylene bis(trifluoromethanesulfonate), anhydrous diethyl ether; ii) Na metal, Me3SiCl, 
anhydrous toluene; iii) Br2, DCM. 
 
 
Figure 39: General synthesis of diketone 2.2.7. Reaction conditions; i) SeO2, 1,4-dioxane. 
 
The final diketone under consideration as a viable alternative is the commercially available, chiral 
diketone (1S)-(+)-camphorquinone 2.2.8, to provide an alternative to the multi-step synthesis 
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required to give the CyMe4 diketone 2.2.5. Other research groups have investigated racemic (±)-
camphorquinone as a replacement diketone and despite an increased solubility of the camphor-
BTP ligand 1.31 being observed, third phase formation occurred in extraction experiments upon 
contact of the organic phase with a HNO3 aqueous phase of 3 mol/L or above.[132] Despite this, it 
was hoped the new family of ligands would not be susceptible to this precipitation. The selection 
of an enantiomerically pure diketone, (1S)-(+)-camphorquinone 2.2.8, as opposed to racemic 
camphorquinone, will limit the potential formation of diastereomers of the final ligand.[132] The R 
groups from each diketone considered ultimately occupy the 5- and 6-positions of the triazine 
ring and this is where variability is introduced, Figure 40. 
 
Figure 40: Molecular structure of camphor-BTP 1.31. The absolute stereochemistry at the 
aliphatic carbons adjacent to carbons 5 and 6 is not specified since racemic (±)-camphorquinone 
was used by the authors. 
 
For the purpose of forming the N-C bonds the 1,2,4-triazine compounds are required to have a 
nucleophilic amino group in the 3-position, to act as the nucleophile in the cross-coupling 
reaction. The commercially available and inexpensive aminoguanidine bicarbonate 2.2.9 was 
selected to ensure the amino group exists at the 3-position. The synthesis of the 3-amino-1,2,4-
triazine compounds 2.1.1 was achieved through a condensation reaction between aminoguanidine 
bicarbonate 2.2.9 and each of the diketones; hexane-3,4-dione 2.2.1, CyMe4 2.2.5, Cy5Me4-
diketone 2.2.7 and (1S)-(+)-camphorquinone 2.2.8, Table 1 and Figure 42. Additionally utilised 
was 5,6-dimethyl-3-amino-1,2,4-triazine 2.2.10, which was synthesised previously in the Lewis 
group. Due to four of the diketones being symmetrical the formation of only one regioisomer was 
observed. However, when (1S)-(+)-camphorquinone 2.2.8 was used, Table 1, entry 4, there is the 
potential for the formation of two regioisomers. In most cases this was not observed, with only 
one regioisomer dominating due to steric and electronic effects, Figure 41. The methyl group at 
the C-1 position of (1S)-(+)-camphorquinone 2.2.8, results in steric hindrance around the adjacent 
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carbonyl group at C-2 and this is therefore the least favourable position for attack by the nitrogen 
nucleophile. The electronic effect across the N-C-N bond within aminoguanidine 2.2.9 makes the 
lone pair of the amine less available to act as a nucleophile. As a result of these effects there is 
some regioisomeric control in the reaction. The five 3-amino-1,2,4-triazine diketone compounds 
synthesised, Table 1, are used to form the final ligands through the Buchwald Hartwig reaction.  
 
Figure 41: Reaction mechanism for the formation of the dominant regioisomer 2.2.14. 
 
Figure 42: Example reaction scheme for the formation of 3-amino-1,2,4-triazines. Reaction 
conditions: i) aminoguanidine bicarbonate 2.2.9, H2O. 
 
 
Figure 43: General reaction scheme for Buchwald Hartwig coupling. Reaction conditions: 
Pd2(dba)3 2.1.4, Xantphos 2.1.5, CsCO3, 1,4-dioxane, Δ.  
 
The 3-amino-5,6-diethyl-1,2,4-triazine 2.2.11 and 2,6-dibromopyridine 2.2.15 were then used to 
optimise the reaction conditions and reagent stoichiometries in the Buchwald Hartwig reaction, 
to determine the optimum conditions required for the di-amination reaction, outlined in Table 3, 
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page 54. The optimum stoichiometry of the Pd catalyst 2.1.4 and phosphine ligand 2.1.5 were 
found to be 10 mol% and 20 mol% respectively to ensure the maximum yields of product were 
obtained, Figure 43. 
Table 1: Summary of 3-amino-1,2,3-triazines formed through the condensation reaction of 
different diketones with aminoguanidine bicarbonate 2.2.9. 
Entry 
Number 
Diketone  Product Reaction 
Time (hr) 
Yield 
(%) 
1 
Hexane-3,4-dione 
2.2.1 
 
 
2.2.11 26 79 
2 
CyMe4-diketone 
2.2.5 
 
 
2.2.12 72 53 
3 
Cy5Me4-diketone 
2.2.7 
 
 
2.2.13 18 93 
4 
(1S)-(+)-
Camphorquinone 
2.2.8 
 
 
2.2.14 18 72 
 
Xantphos 2.1.5 was chosen as the phosphine ligand of choice, as discussed in section 2.1, and 
hence further screening of other phosphine ligands was deemed unnecessary. A study by S.L. 
Buchwald’s group found that there are two species formed when Pd2(dba)3 2.1.4 and xantphos 
2.1.5 are mixed; Pd(Xantphos)2 2.2.16 and Pd(Xantphos)(dba) 2.2.17, Figure 44.[133] The 
formation of the Pd(Xantphos)2 species 2.2.16 was found to significantly impact the reaction as a 
consequence of the large binding constant which in turn prevents the conversion to the active 
catalyst species, Pd(Xantphos)(dba) 2.2.17. The xantphos 2.1.5 stoichiometry was limited at 20 
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mol% to limit the impact of this species. Utilising Pd(OAc)2 2.1.7 gave poorer yields than the 
alternative catalyst so was not considered further for this traditional route. 
 
Figure 44: Structures of the two Pd-ligand species formed when Pd2(dba)3 2.1.4 and xantphos 
2.1.5 are mixed; Pd(Xantphos)2 2.2.16 and Pd(Xantphos)(dba) 2.2.17. 
 
The initial investigations using the 3-amino-5,6-diethyl-1,2,4-triazine 2.2.10 resulted in poor 
conversion to the di-aminated product L1 in low yields. The mono-aminated product L2 was 
observed initially, Figure 45, most likely resulting from the low ratio between the 3-amino-1,2,4-
triazine 2.2.10 and 2,6-dibromopyridine 2.2.15, resulting in the decision to use at least 2 
equivalents of the 3-amino-1,2,4-triazine 2.2.10. The formation of the di-aminated product L1 
could be easily observed through the integrations and number of signals in the 1H NMR spectrum 
of the product as a result of the ligand’s symmetry. The 1H NMR spectrum, Figure 46, 
demonstrates the ease with which the mono- L2 and di-aminated L1 products are distinguished, 
in particular when focusing on the aromatic region. The mono-aminated product L2 displays two 
doublets at δ 8.48 and 7.13 ppm and a broad signal at δ 7.87 ppm as a result of the lack of 
symmetry, each with an integration of 1H. A convergence of the two doublets at δ 7.74 ppm and 
a downfield shift of the broad singlet to δ 9.27 ppm indicate the presence of the di-aminated 
product L1, supported by a doubling of their respective integrations.  
 
Figure 45: Structures of the di-aminated L1 and mono-aminated L2 products of the Buchwald 
Hartwig reaction.   
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Figure 46: Overlaid 1H NMR spectra for the a) mono-aminated ligand L2 (bottom spectrum) 
and b) di-aminated ligand L1 (top spectrum). Solvent impurities present. 
 
Table 2: Assignment of signals for the comparison of the mono-aminated ligand L2 and di-
aminated ligand L1. 
Mono-aminated ligand L2 Di-aminated ligand L1 
1H (ppm) Proton integration and 
multiplicity (Hz) 
1H (ppm) Proton integration and 
multiplicity (Hz) 
8.48 1H, d, J = 7.79 Hz 9.27 1H, s, br 
7.87 1H, s, br 8.07 1H, t, J = 8.24 Hz 
7.56 1H, t, J = 7.79 Hz 7.74 1H, d, J = 8.24 Hz 
7.13 1H, d, J = 7.79 Hz - - 
2.93 4H, q, J = 7.79, 7.33 Hz 2.91 4H, q, J = 7.79, 7.33 Hz 
2.80 4H, q, J = 7.33 Hz 2.78 4H, q, J = 7.33 Hz 
1.39 6H, t, J = 7.79, 7.33 Hz 1.37 6H, t, J = 7.79, 7.33 Hz 
1.34 6H, t, J = 7.33 Hz 1.31 6H, t, J = 7.33 Hz 
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Table 3: Summary of reaction conditions attempted for Buchwald Hartwig reactions of 3-amino-1,2,4-triazines with different electrophiles; R = representative 
diketone. a) Mono-aminated compound formed only. 
Entry Nucleophile Electrophile Pd catalyst Ligand Base Solvent 
Reaction 
Time (hr) 
Yield 
1 2.2.10 2.0 eq 2.2.15 1.5 eq Pd2(dba)3 5 mol% Xantphos 15 mol% Cs2CO3 1,4-dioxane 21 14 % a  L2 
2 2.2.10 2.5 eq 2.2.15 1.0 eq Pd2(dba)3 4 mol% Xantphos 12 mol% Cs2CO3 1,4 -dioxane 71 14 %   L1 
3 2.2.10 2.5 eq 2.2.15 1.0 eq Pd2(dba)3 5 mol% Xantphos 15 mol% Cs2CO3 1,4-dioxane 48 26 %   L1 
4 2.2.14 2.0 eq 2.2.15 1.0 eq Pd2(dba)3 10 mol% Xantphos 20 mol% Cs2CO3 1,4-dioxane 72 81 %   L3 
5 2.2.18 1.0 eq 2.2.19 2.2 eq. Pd(OAc)2 10 mol% 
Xantphos 20 mol% 
CuMeSal (4 eq) 
t-BuOK Toluene 22 - 
6 2.2.18 1.2 eq. 2.2.19 2.2 eq. Pd(OAc)2 10 mol% 
Xantphos 20 mol% 
CuMeSal (4 eq) 
K2CO2 Toluene 24 - 
7 2.2.18 1.2 eq. 2.2.19 2.2 eq. Pd2(OAc)3 10 mol% 
Xantphos 20 mol% 
CuMeSal (4 eq) 
Cs2CO3 Toluene 20 - 
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Attempts to further improve the yield involved increasing the reaction time and altering the 
stoichiometry of the catalyst 2.1.4 and phosphine ligand 2.1.5, however this was to no avail, Table 
3, entry 2 and 3. It is suspected that the weak nucleophilicity of the 3-amino-1,2,4-triazine 
compounds could be hindering the reaction, hence the coordination of the amine to the Pd centre 
may be the rate determining step. Hartwig and co-workers found that a large difference in the 
electronic properties of the reagents can result in an increased rate of reductive elimination, with 
electronic-withdrawing groups slowing the rate of reductive elimination.[134]  
The use of the stronger base potassium tert-butoxide was investigated due to the evidence that 
amines more resistant to deprotonation, such as dialkyl amines, require a stronger base to achieve 
the reaction.[135] Its use in the reaction with 2.2.10 and 2.2.15 revealed a greater conversion of the 
starting reagents to the final ligand L1 through examination of the 1H NMR spectrum of the crude 
product, Figure 47. It is clear when utilising potassium tert-butoxide that there is a greater 
conversion to the product by examining the CH2 of the ethyl groups, in which the peak intensities 
of the CH2 groups from the starting material are significantly reduced. As this is a crude NMR 
spectrum, the other peaks within this region are a result of solvent impurities. Purification of the 
crude mixture resulted in comparable yields as observed previously. Going forward, Cs2CO3 will 
be utilised as a result of the high yield obtained for the camphor ligand L3, Table 3. 
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Figure 47: 1H NMR overlaid spectra of the crude material for L1 in the aliphatic region 
representing the CH2 signals of the diethyl chain when a) using t-BuOK and b) Cs2CO3. 
 
To determine whether poor nucleophilicity of the 3-amino-1,2,4-triazine is a limiting factor in 
this synthetic methodology and in an attempt to improve the yields of the reaction, an alternative 
synthetic method was considered. This involved carrying out the Pd-catalysed cross-coupling 
reaction between 2,6-diaminopyridine 2.2.18 and 3-methylthio-5,6-diethyl-1,2,4-triazine 2.2.19, 
Figure 48.  A role reversal of the 1,2,4-triazine from nucleophile to electrophile was hoped to 
limit the effect of the presumed poor nucleophilicity of the 3-amino-1,2,4-triazine. Having the 
nucleophilic amino-groups directly attached to the pyridine, as in 2,6-diaminopyridine 2.2.18, 
which is less electron withdrawing than the 1,2,4-triazine ring, should increase the nucleophilicity 
of the nitrogen lone pairs and make them more readily available for the cross coupling 
reaction.[136] Electron withdrawing groups attached to one of the reactive partners has been found 
to result in an increased strength of the bond between this partner and the metal centre; this 
increase in bond strength can slow the rate of reductive elimination.[137] As the 3-amino-1,2,4-
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triazine would fit into this electron withdrawing criteria, there is a potential that the reductive 
elimination step may also be hindering the reaction. 
 
Figure 48: Alternative Pd(0)-catalysed C-N cross coupling reaction to synthesise L1. Reaction 
conditions: i) Pd(OAc)2 2.1.4, Xantphos 2.1.5, CuMeSal 2.2.20, t-BuOK, toluene. 
 
The alternative methodology uses copper(I) 3-methylsalicylate (CuMeSal) 2.2.20 alongside 
xantphos 2.1.5 and palladium(II) acetate 2.1.7 as the catalytic system. It has been shown that 
CuMeSal 2.2.20 is necessary in this reaction, in which the electrophilic methylthio compound 
2.2.19 is used, to aid the oxidative addition of Pd(0) across the C-S bond, which is less susceptible 
to oxidative addition than a C-Br bond.[136a] The starting electrophile, 3-methylthio-5,6-diethyl-
1,2,4-triazine 2.2.19 was synthesised in a two-step reaction starting with an initial methylation of 
thiosemicarbazide 2.2.21 using iodomethane followed by a condensation reaction with hexane-
3,4-dione 2.2.1 to form the 1,2,4-triazine ring 2.2.19, Figure 49.  
 
Figure 49: Reaction scheme to form triazine 2.2.19. Reaction conditions: i) iodomethane, 
ethanol; ii) hexane-3,4-dione 2.2.1, sodium bicarbonate, ethanol, H2O. 
 
The C-N palladium-catalysed amination of 3-methylthio-1,2,4-triazines, like 2.2.19, has been 
reported previously using a combination of Pd(OAc)2 2.04, xantphos 2.02 and CuMeSal 
2.2.20.[136] The CuMeSal 2.2.20 is an important addition in the cross coupling reaction as it 
promotes the displacement of the methylsulfur (SMe) group and aids oxidative addition. 
Generally it was found that electron-rich amines, such as 4-methoxyaniline and 5-amino-2-
methoxypyridine, produced the best yields in this reaction under microwave conditions. 
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Employing 2,6-diaminopyridine 2.2.18 and the electrophile 2.2.19  in this C-N bond forming 
reaction resulted in unreacted starting material, and none of the desired product L1 was formed, 
Figure 48. The most likely cause is an imbalance in the stoichiometry of the different reagents, in 
particular the base and CuMeSal 2.2.20 equivalents. Further investigations would be necessary to 
optimise the reaction by combining two alternative procedures alongside employing microwave 
conditions.  
Coinciding with this line of research, the (1S)-(+)-camphorquinone 2.2.8 was successfully 
employed in the cross-coupling reaction following the established method, Figure 43, leading to 
the successful synthesis of the camphor-1,2,4-triazine ligand L3 in an 81% yield, see Table 3, 
entry 4. In subsequent reactions, the optimised Buchwald Hartwig method using 2.1 eq. 3-amino-
1,2,4-triazine, 10 mol% Pd catalyst 2.1.4, 20 mol% xantphos 2.1.5 and 4 eq. CsCO3, was 
determined to be the most effective and versatile to synthesise further novel bis-1,2,4-triazine 
ligands, as outlined in Figure 50. Replacement of 2,6-dibromopyridine 2.2.15 with 2,6-
dibromopyrazine 2.2.22 was considered to investigate the effect of an additional nitrogen atom 
within this bridging group synthesising L6. The 1H NMR, 13C NMR and HRMS were all used to 
confirm the presence of the di-aminated ligands with example 1H NMR spectra shown in Figure 
51 and Figure 52 for the ligands L3 and L5 respectively.  
 
Figure 50: Novel bis-1,2,4-triazine ligands formed via the Buchwald Hartwig cross-coupling 
reactions of 3-amino-1,2,4-triazines with dibromoheteroarenes.
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Figure 51: 1H NMR spectrum of ligand L3, in CDCl3. 
Table 4: Assignment of NMR signals for ligand L3. 
1H (ppm) Proton integration 
and multiplicity 
(Hz) 
13C (ppm) Assignment 
8.98 2H, s, br - 2 x NH 
8.09 2H, d, J = 8.02 107.4 2 x ArCH 
7.76 1H, t, J = 8.02 140.2 ArCH 
3.12 2H, d, J = 4.12 50.6 CH 
2.27 – 2.19 2H, m 31.4 2 x CHexo 
2.03 – 1.96 2H, m  24.6 2 x CHexo 
1.45 – 1.36 4H, m 24.6, 31.4 4 x CHendo 
1.26 6H, s 20.1 2 x CH3 
1.06 6H, s 18.3 2 x CH3 
0.66 6H, s 9.1 2 x CH3 
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Figure 52: 1H NMR spectrum of ligand L5, in CDCl3.  
Table 5: Assignment of NMR signals for ligand L5. 
1H (ppm) Proton integration 
and multiplicity 
(Hz) 
13C (ppm) Assignment 
8.35 2H, s, br - 2 x NH 
8.13 2H, d, J = 8.24 107.0 2 x ArCH 
7.75 1H, t, J = 8.24 140.3 ArCH 
1.98 4H, s 53.1 2 x CH2 
1.46 12H, s 29.8 4 x CH3 
1.36 12H, s 28.8 4 x CH3 
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The use of the commercially available 6,6’-dibromo-2,2’-bipyridine 2.2.23 as the electrophile 
instead of 2,6-dibromopyridine 2.2.15 was considered to synthesise a new family of potentially 
tetradentate ligands, closely related to the BTBPs, Figure 53. It was hoped that having the two N-
donor atoms of the bipyridine group, known to complex to the metal in the BTBPs, would aid in 
the ability of this ligand to act as a strong chelating ligand and hence as an efficient extractant of 
the An(III).  
 
Figure 53: Reaction scheme to synthesise ligand L8. Reaction conditions; Pd2(dba)3 2.1.4, 
Xantphos 2.1.5, Cs2CO3, 1,4-dioxane, Δ. 
 
Initially, the Buchwald Hartwig reaction of 6,6’-dibromo-2,2’-bipyidine 2.2.23 with 2.2.14, using 
the standard conditions mentioned previously, failed to produce the desired product L8. After 48 
hours at reflux, only starting material remained. It was deemed necessary to ensure the separate 
formation of the active catalyst by combining Pd2(dba)3 2.1.4 and xantphos 2.1.5 in a separate 
flask, prior to the addition of the aryl halide 2.2.23. This ensures that the aryl halide 2.2.23, itself 
a strong chelating ligand, doesn’t outcompete the xantphos ligand 2.1.5 in binding to the 
palladium centre, and prevent its participation in the formation of the C-N bond. In achieving this 
slightly modified reaction set up, the product L8 was successfully formed in a yield of 67% using 
the same conditions as previously, as easily observed via a bright yellow spot on the TLC plate. 
A triplet at δ 7.72 ppm and an overlapped doublet at δ 7.40 ppm were observed for the protons of 
the 2,2’-bipyridine backbone in the 1H NMR spectrum of the crude product. The integrations of 
all the relevant peaks confirmed the production of the ligand L8, Figure 54. 
Further synthesis of related ligands derived from commercially available but expensive 6,6’-
dibromo-2,2’-bipyridine 2.2.23 were not investigated until the extraction capability of ligand L8 
had been determined.   
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Figure 54: 1H NMR spectrum of the ligand L8 in CDCl3. 
Table 6: Assignment of NMR signals for ligand L8. 
1H (ppm) Proton integration 
and multiplicity 
(Hz) 
13C (ppm) Assignment 
7.72 2H, t, J = 7.79 136.6 2 x ArCH 
7.40 4H, m 124.9, 112.3 4 x ArCH 
2.81 2H, m 50.3 CH 
2.25 – 2.18 2H, m 31.4 2 x CHexo 
2.02 – 1.97 2H, m 24.8 2 x CHexo 
1.57 – 1.47 4H, m 31.4, 24.8 4 x CHendo 
1.33 6H, s 9.3 2 x CH3 
1.07 6H, s 18.2 2 x CH3 
0.77 6H, s 20.5 2 x CH3 
 
After the successful synthesis of the novel bis-1,2,4-triazine ligands with the pyridine, pyrazine 
and bipyridine linkers, attempts were made to synthesise the related 1,10-phenanthroline 2.2.24 
based ligand L9, Figure 56. The synthesis of the aryl halides, 2,9-dichloro-1,10-phenanthroline 
2.2.27 and 2,9-dibromo-1,10-phenanthroline 2.2.28, was achieved according to literature 
procedures in three steps, Figure 55. The first step sees the formation of a salt 2.2.25 by reaction 
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of 1,10-phenanthroline 2.2.24 with 1,3-dibromopropane in nitrobenzene prior to its oxidation to 
give 2.2.26. The initial oxidation reaction, using potassium ferricyanide was found to be low 
yielding. However, following a procedure first reported by Zhengand co-workers the yield was 
found to be quadrupled using a combination of tert-butanol, potassium tert-butoxide and air as 
the oxidising agent.[138] The final chlorinated 2.2.27 and brominated 2.2.28 products could be 
obtained in high yields. The aromatic region of the 1H NMR spectrum for both compounds 
showed two doublets and a singlet from the symmetrical phenanthroline backbone. The 
chlorinated product 2.2.27 showed the two doublets at δ 7.66 and δ 8.22 ppm with the brominated 
2.2.28 compound showing signals with a chemical shift to δ 7.81 and δ 8.11 ppm respectively, 
Figure 57.  
Figure 55: Optimised reaction scheme to synthesise the 2,9-dihalo-1,10-phenanthroline 
compounds 2.2.27 and 2.2.28. Reaction conditions; i) 1,3-dibromopropane, nitrobenzene, ii) t-
butanol, t-BuOK, air iii) phosphorus oxychloride, phosphorus pentachloride or phosphorus 
oxybromide, phosphorus pentabromide. 
 
 
Figure 56: Proposed reaction scheme for the Buchwald Hartwig coupling using 2,9-dibromo-
1,10-phenanthroline 2.2.28 as the electrophile to give L9. Reaction conditions: i) 3-amino-1,2,4-
triazine 2.2.14, Pd2(dba)3 2.1.4, xantphos 2.1.5, Cs2CO3, 1,4-dioxane.  
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Figure 57: Overlaid 1H NMR spectra of 2,9-dichloro-1,10-phenanthroline 2.2.27 (bottom 
spectrum) and 2,9-dibromo-1,10-phenanthroline 2.2.28 (top spectrum). 
 
The chlorinate phenanthroline 2.2.27 was initially utilised as the electrophile within the Buchwald 
Hartwig reactions using conditions depicted in Figure 56. The reactive catalytic species was 
formed prior to the addition of the phenanthroline compound 2.2.27, as carried out previously 
with the 6,6’-dibromo-2,2’-bipyridine 2.2.23. Unfortunately, evidence from both TLC 
measurements and 1H NMR data, showed that the reaction was unsuccessful, with the starting 3-
amino-1,2,4-triazine 2.2.14 remaining unreacted. A similar outcome was observed when utilising 
2,9-dibromo-1,10-phenanthroline 2.2.28 as the electrophile. 
1,10-Phenanthroline 2.2.24 is known to act as a catalyst in other reactions acting as a N,N-
bidentate chelator for a variety of metals.[139a, 139b] This includes a copper-catalysed N-arylation 
reaction which found that the addition of 1,10-phenanthroline 2.2.24 and dibenzylideneacetone is 
crucial to the success of the process. Although the role of the ligands is not clear, it is suspected 
they are involved in the stabilisation of the Cu(I) complex or that they prevent aggregation.[140] It 
is proposed that the stability of the intermediate complex formed between the catalytic palladium 
ab
u
n
d
an
ce
-2
.0
-1
.0
0
1
.0
2
.0
3
.0
X : parts per Million : Proton
8.8 8.7 8.6 8.5 8.4 8.3 8.2 8.1 8.0 7.9 7.8 7.7 7.6 7.5 7.4 7.3 7.2 7.1 7.0 6.9 6.8
68 
 
species and the phenanthroline-halide 2.2.27 or 2.2.28 may be hindering further reaction with the 
amine compound and hence terminating the cross-coupling reaction. Due to the poor solubility of 
the palladium complexes formed in these reactions, which can be collected via filtration, the 
determination of the species present was unable to be completed.  
Further derivatisation of the secondary amine group of the bis-1,2,4-triazine ligands synthesised 
above was next carried out to explore the effects of N-alkyl substituents on the solubility of the 
compounds. It was decided to consider both short and long alkyl chain derivatives by using two 
representative electrophiles; iodomethane and 1-iodobutane. The N-alkylation reaction involves 
the deprotonation of the secondary amine with sodium hydride prior to subsequent addition of the 
alkylating agent. Potassium carbonate was also explored as a milder base to achieve this 
deprotonation. The electron-withdrawing resonance effects of the surrounding 1,2,4-triazine and 
pyridine rings was expected to stabilise the anion formed. However, reaction of ligand L3 with 
potassium carbonate and iodomethane failed to generate substantial amount of product L10 and 
the starting material L3 was recovered. The use of sodium hydride as the base gave more 
encouraging results. 
 
Figure 58: Reaction scheme for the N-alkylation of the ligand L3 using iodomethane. Reaction 
conditions: i) sodium hydride, iodomethane, THF. 
It was noted after an overnight reaction with ligand L3 and iodomethane that the N-alkylation 
reaction proceeded to give both a mono- L11 and a bis-alkylated ligand L10. The combined yields 
of the ligands was collectively below 50% for the methylated ligands (L10, L11), Figure 58. 
However, the mono-alklated product L11 could be separated by column chromatography. The 
sacrifice in the overall yield obtained was made to ensure the formation of both products for each 
reaction, although undoubtedly a higher yield could have been obtained by employing longer 
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reaction times and using more forceful conditions. However, previous research published by 
Chalmers University,[87] found that unsymmetrical BTBP ligands resulted in higher solubilities 
compared to their symmetrical analogues, such as CyMe4-BTBP 1.09. As a consequence, it was 
decided to continue with the proposed conditions to obtain both symmetrical and unsymmetrical 
ligands in the present N-alkylation reactions, enabling the screening of each of these for minor 
actinide extraction and ligand solubility. In addition to ligand solubility, it was hoped that adding 
the alkyl chains could influence the hydrophobicity of the ligands (and hence their extraction 
affinity, as measured by the metal distribution ratios), and possibly their preferred conformation. 
The N-alkylation with 1-iodobutane successfully gave the di- and mono-butylated ligands L12 
and L13, respectively, Figure 59.  
Figure 59: Reaction scheme for the N-alkylation of the ligand L3 using 1-iodobutane. Reaction 
conditions: i) sodium hydride, 1-iodobutane, THF. 
 
2.3. Ligands derived from mono-amination of 3-(6-bromo-2-pyridyl)-1,2,4-
triazines  
3-(6-Bromo-2-pyridyl)-1,2,4-triazines have been previously reported in the literature by the 
Carrick group.[141] Realising their potential use in the above Pd-catalysed Buchwald Hartwig 
reactions described above, their reaction with 3-amino-1,2,4-triazines 2.1.1 in the cross-coupling 
reactions was studied, to access another novel family of terdentate triazines ligands, Figure 60.  
The ligands were synthesised in order to determine whether these unsymmetrical ligands would 
have beneficial extraction properties compared to the symmetrical ligands synthesised above. A 
notable difference between these ligands and those described above was the removal of one NH 
group, and its replacement with a direct C-C bond between the pyridine and triazine rings, Figure 
61. This could reduce the torsional energy barrier needed for both rings to rotate into the 
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conformation required to chelate the metal. With this in mind, a range of ligands were synthesised 
based upon starting 3-(6-bromo-2-pyridyl)-1,2,4-triazine scaffolds; 2.3.3 and 2.3.4, Table 7. 
 
Figure 60: Reaction scheme to form the final ligand L14. Reaction conditions; i) 3-amino-
1,2,4-trazine 2.2.13, Pd2(dba)3 2.1.4, xantphos 2.1.5, Cs2CO3, 1,4-dioxane, Δ. 
 
Figure 61: Comparison between symmetrical ligands discussed in Section 2.2 and the 
unsymmetrical ligands discussed in Section 2.3, showing the different bond torsions; C-N-C in 
red and C-C in blue.  
 
The precursor to the 3-(6-bromo-2-pyridyl)-1,2,4-triazine scaffolds 2.3.1 and 2.3.2 was 
synthesised by treatment of 6-bromopyridine-2-carbonitrile 2.3.1 with hydrazine hydrate to obtain 
the hydrazonamide 2.3.2 as described by the Carrick Group.[142] The condensation reaction of this 
product with the representative diketone Cy5Me4-diketone 2.2.7 and the hydrazonamide 2.3.2 
gave 2.3.3, Figure 62. This same reaction was completed with (1S)-(+)-camphorquinone 2.2.8 to 
synthesise 2.3.4. The 3-amino-1,2,4-triazines used to form the final ligands were synthesised in a 
condensation reaction of each diketone with aminoguanidine bicarbonate 2.2.9, as discussed in 
section 2.2. The Buchwald Hartwig procedure, established previously, was used to form the final 
ligands between the 3-(6-bromo-2-pyridyl)-1,2,4-triazine scaffolds, 2.3.3 and 2.3.4, and the 3-
amino-1,2,4-triazines, Table 7. Synthesis of all ligands was verified through 1H NMR, 13C NMR 
and HRMS, with example 1H NMR spectra shown in Figure 63 and Figure 64 for ligands L14 
and L16, respectively. 
The use of the scaffold 2.3.4 appears to yield a disparity in the yields of the final reaction to 
produce the ligands L15 and L16 when compared to the use of the scaffold 2.3.3 under the same 
conditions.  
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Figure 62: Reaction scheme to form the 3-(6-bromo-2-pyridyl)-1,2,4-triazine 2.3.3. Reaction 
conditions; i) hydrazine hydrate, ethanol, ii) Cy5Me4-diketone 2.2.7, AcOH. 
Table 7: Reaction yields for the ligands derived from 3-(6-bromo-2-pyridyl)-1,2,4-triazine. 
General reaction conditions: Pd2(dba)3 2.1.4 10 mol%, Xantphos 2.1.5 20 mol%, CsCO3, 4 
equivalents. 
Aryl Halide Aryl Amine Product Yield 
 
 
  
27 % 
  
36 % 
 
 
  
80% 
  
70 % 
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Figure 63: 1H NMR spectrum of L14, in CDCl3. 
Table 8: Assignment of NMR signals for ligand L14. 
1H (ppm) Proton integration 
and multiplicity (Hz) 
13C (ppm) Assignment 
8.73 1H, d, J = 8.24 114.7 ArCH 
8.64 1H, s, br - NH 
8.24 1H, d, J = 7.79 118.1 ArCH 
7.92 1H, dd, J = 8.24, 7.79 139.1 ArCH 
2.05 2H, s 53.0 CH2 
1.98 2H, s 52.9 CH2 
1.52 6H, s 29.8 CH3 
1.46 6H, s 29.7 CH3 
1.45 6H, s 29.0 CH3 
1.34 6H, s 28.7 CH3 
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Figure 64: 1H NMR spectrum of L16 in CDCl3.  
Table 9: Assignment of NMR signals for ligand L16. 
1H (ppm) Proton integration 
and multiplicity (Hz) 
13C (ppm) Assignment 
8.72 1H, d, J = 8.24 115.0 ArCH 
8.46 1H, s, br - NH 
8.23 1H, d, J = 7.79 118.0 ArCH 
7.92 1H, dd, J = 8.24, 7.79 139.2 ArCH 
3.29 1H, d, J = 4.58 51.2 CH 
3.12 1H, d, J = 4.12 50.6 CH 
2.36 – 2.22 2H, m 24.6, 24.3 2 x CHexo 
2.10 – 2.99 2H, m 31.4, 31.2 2 x CHexo 
1.43 – 1.38 4H, m 31.4, 31.2, 24.6, 
24.3 
4 x CHendo 
1.43 3H, s 9.1 CH3 
1.28 3H, s 9.3 CH3 
1.12  3H, s 18.3 CH3 
1.08  3H, s 18.4 CH3 
0.66 3H, s 20.2 CH3 
0.65 3H, s 20.2 CH3 
 
As described above with the symmetrical ligands, N-alkylation was successfully achieved by 
treatment of L15 with sodium hydride and iodomethane using the same method as stated in 
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section 2.2, Figure 65. Formation of the product was observed on 1H NMR spectrum, but was not 
purified completely, with minor impurities remaining. It was decided that further ligands would 
not be alkylated until initial extraction results on this family of ligands were obtained.  
 
Figure 65: Reaction scheme for the N-alkylation reaction of L15 to give the target ligand L18. 
Reaction conditions: i) NaH, iodomethane, THF. 
 
The ligands described above are anticipated to have quite different properties compared to the 
BTP ligands. They are anticipated to have a higher basicity (ie: higher pKa) than the BTPs, due 
to the resonance delocalisation of the NH lone pairs into the aromatic rings. This may also lead 
to each of the C-NH bonds having a substantial degree of double bond character, which may 
increase the energy barrier to rotation about these bonds. These factors will likely influence the 
ligand extraction properties and solubility.  
 
2.4. Calculated Ligand Parameters 
For each of the ligands synthesised in sections 2.2 and 2.3, their ligand parameters have been 
calculated to enable comparisons between theoretical and experimental data in line with the 
project objectives. It is hoped that a set of predictive guidelines can be established that allows the 
prediction of the potential solubility and extraction kinetics of a given ligand prior to its synthesis. 
This will be based upon the theoretical values and in the case of this project, backed up with 
experimental data if there is a strong correlation between the two. 
Based upon the theoretical results, specifically the Fsp3 and Log P values, in Table 10, the ligands 
L1 and L7 would be expected to have a low lipophilicity and hence solubility in 1-octanol. A low 
log P is predictive of an increased solubility in the aqueous phase and decreased solubility in 1-
octanol, and a low Fsp3 value can correlate to its solubility. Opposing this, ligands L4 and L13 
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have a log P value above 6 in addition to an Fsp3 value above 0.59. Of the ligands synthesised in 
this chapter it is expected that these are the most lipophilic and would therefore have the greatest 
solubility in 1-octanol. In between these extreme values, where the log P values range from 4-6, 
there is very little trend between the log P and Fsp3 values to indicate the potential ligand 
solubility. Ligand L5 has a high log P value of 5.95 but an Fsp3 value of 0.48, suggesting a 
contradiction in the prediction of its solubility. Although the calculated parameters may give a 
good predictability of solubility in the extreme cases, it should be taken as only an indication, as 
these calculations may have minimal accuracy.  
When considering the addition of HBD/HBA groups, which could indicate the potential for a 
ligand to form hydrogen bonds at the interface, there is an increase in these numbers across all 
ligands synthesised in this chapter, when compared to the benchmark ligands. Based upon the 
novel design approach discussed in section 1.7, it is hoped that the higher the number of 
HBD/HBA groups, the greater the concentration of the ligand that may exist at the interphase. It 
is here that the log P value can also give an indication to the limitation point of the addition of 
these groups. Based principally on increasing the number of HBD/HBA groups it would be 
expected that ligands L6 and L8 have the fastest extraction kinetics. However, this increase may 
result in these ligands becoming so polar, as to partition into the aqueous phase. The mono-
aminated ligands L14, L15, L16 and L17 have the lowest HBD/HBA groups of the novel target 
ligands and may show the slowest extraction kinetics based upon the theoretical principle 
outlined. 
In the next two sections the solubility and extraction results will be discussed for the ligands 
synthesised in this chapter. Upon obtaining these results, they will be compared back to the 
theoretical results calculated below in Table 10. 
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Table 10: Table showing calculated parameters (Log P and Fsp3) for novel ligands. The log P 
value was calculated using the ACD ILabs online software. 
Ligand Ligand Number Log P Fsp3 HBD HBA 
 
1.30 5.45 0.59 0 7 
 
1.09 6.01 0.50 0 8 
 
1.31 3.69 0.59 0 7 
 
L7 2.66 0.27 2 9 
 
L1 3.79 0.42 2 9 
 
L3 5.46 0.59 2 9 
 
L4 6.77 0.59 2 9 
 
L5 5.95 0.48 2 9 
 
L6 4.71 0.62 2 10 
 
L8 5.77 0.50 2 10 
 
L10 5.37 0.62 0 9 
 
L11 5.24 0.61 1 9 
 
L12 7.53 0.69 0 9 
 
L13 6.62 0.65 1 9 
 
L14 5.03 0.56 1 8 
 
L16 4.64 0.59 1 8 
 
L17 4.80 0.58 1 8 
 
L15 4.81 0.58 1 8 
 
L18 4.81 0.59 0 8 
 
77 
 
2.5. Solubility Studies 
Solubility studies were completed as outlined in Chapter 6 in 1-octanol. Results were compared 
to the analogous ligand 1.31 to evaluate whether an improvement in solubility was achieved with 
any of the ligands synthesised. Table 11 shows the novel terdentate ligands synthesised through 
the Buchwald Hartwig cross-coupling reactions alongside their individual Fsp3 values and 
measured solubilities. The applicability of the Fsp3 value, in addition to the log P values, in 
predicting the solubility of the ligands will be considered based upon the experimental results 
shown, as discussed in section 1.6.  Ultimately these results will be compared to the theoretical 
data to determine whether the proposed design approach has established the necessary criteria to 
determine ligand solubility. The camphor-BTP ligand 1.31 has a solubility of 200 mmol/L in 1-
octanol.[82] 
A graph showing the correlation between the measured ligand solubility in 1-octanol and Fsp3 
values is presented in Figure 66. There is a generally good correlation observed between the Fsp3 
values of the ligands and their measured solubilities, although individual data points have not 
been assigned to the graph, the corresponding data can be found in Table 12. As suspected during 
their synthesis, ligands L1 and L7 have very low solubilities, so much so that the final solubility 
result for L7 was unable to be obtained. This is an expected result as observed from the Fsp3 value 
and ligand structure, and aligns with the proposed hypothesis, section 1.6. The alkylation at the 
secondary amine in ligands L10, L11, L12 and L13 was suspected to result in an improved 
solubility compared to the parent ligand L3. The solubility results confirm this, with the solubility 
increasing in parallel to the increasing alkyl chain length.  Interestingly, and in contradiction to 
previous work by Aneheim and coworkers,[87] there is no distinct increase in measured solubility 
for the unsymmetrical ligands L11 and L13. Despite this, the solubility results for the alkylated 
derivatives do show a correlation between the Fsp3 value and their resulting solubilities, 
supporting the hypothesis proposed in the novel design approach.  With regards to the mono-
aminated terdentate ligands, there is a distinct decrease in solubility for those ligands with 
different groups adjacent to the 1,2,4-triazine rings, as in L15 and L17.    
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When compared to the camphor-BTP 1.31 there is a decrease in solubility observed for those 
ligands containing the (1S)-(+)-camphorquinone 2.2.8. However, all ligands containing 2.2.8 
show an improved solubility in comparison to the CyMe4-BTP analogue 1.30. Direct comparison 
of L8 with the benchmark ligand CyMe4-BTBP 1.09 shows a slight improvement in solubility. 
Surprisingly the use of the diketone 2.2.7 doesn’t appear to impact the solubility of the ligand L5 
as might be expected in the removal of a CH2 from the well utilised diketone CyMe4 2.2.5. 
 
Figure 66: Graph showing the correlation between a ligands calculated Fsp3 value and its 
measured solubility in 1-octanol. Each data point represents a ligand, see Table 11 for further 
information. 
 
The following section discusses the extraction data obtained for the ligands discussed in this 
chapter.  
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Table 11: The respective Fsp3 value and measured solubility for each novel terdentate ligand. 
Code Structures 
Solubility mmol/L 
in 1-octanol 
Fsp3 value 
L1 
 
34.8 0.42 
L3 
 
69.4 0.59 
L4 
 
27.5 0.59 
L5 
 
105.2 0.56 
L6 
 
106.7 0.62 
L7 
 
- 0.27 
L8 
 
8.5 0.50 
L10 
 
96.8 0.62 
L11 
 
74.7 0.61 
L12 
 
148.8 0.69 
L13 
 
51.0 0.65 
L14 
  
151.3 0.56 
L15 
 
37.3 0.58 
L16 
 
63.0 0.59 
L17 
 
71.4 0.58 
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2.6. Extraction Studies 
Extraction studies were carried out to determine the ability of this new family of ligands to 
selectively extract the An(III) over the Ln(III) from nitric acid (HNO3) solutions. Solutions of the 
ligands were prepared in 1-octanol at a concentration of 0.01 M and subsequently contacted with 
HNO3 solutions containing all the Ln(III) (10-5 mol/L) and the radiotracers 241Am, 152Eu and 
244Cm. See Chapter 6 for a detailed description of this study. The distribution (D) ratio for each 
radioisotope is a quantitative measurement of their relative radioactivity, as analysed by both α- 
and γ-spectroscopy, in both the organic and aqueous phase. It gives an indication of how a metal 
ion distributes between two immiscible phases, and is thus a measure of extraction affinity of a 
ligand for that metal ion. The separation factor (SFAm/Eu and SFCm/Am) is a measure of the 
separation between two radioisopes; i.e. SFAm/Eu = DAm / DEu and this is a measure of the extraction 
selectivity of a ligand. For potential future use in a selective actinide extraction (SANEX) process, 
the ligand should ideally show a distribution ratio for Am(III) (DAm) of ≥ 1, a distribution ratio 
for Eu(III) (DEu) of < 1, and a separation factor for Am(III) over Eu(III) (SFAm/Eu) as high as 
possible (ideally at least 5). 
Under the standard conditions used, the ligand L3 gave very low D ratios for all radioisotopes 
and a resulting negligible separation factor (SFAm/Eu) at all concentrations, Figure 67. This 
indicates that none of the radioisotopes have been extracted into the organic phase by the ligand 
L3 and hence remain in the aqueous phase. This result is mimicked when ligands L4 and L6 were 
screened, suggesting that the structures of the aliphatic parts of the ligands, which are derived 
from the diketones used in the synthesis, have no impact upon the final extraction properties. 
Additionally it appears that varying the aromatic linker, whether it be pyridine or pyrazine, 
between the external triazine rings has no influence upon the extraction properties of these 
ligands. 
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Figure 67: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L3 measured by α- and 
γ-spectroscopy as a function of the nitric acid concentration of the aqueous phase (1 hr, 22 °C at 
2,200 rpm). Organic phase: 10 mM L3 in 1-octanol. 
 
Those ligands derived from (1S)-(+)-camphorquinone 2.2.8 showed no precipitation under 
contact with the nitric acid solutions, Figure 68. This is in contrast with the extraction results 
previously published for camphor-BTP 1.31, which was susceptible to forming precipitates in 
contact with nitric acid solutions.[82]   
 
  
 
It was hoped that the addition of the N-alkyl chain(s) in ligands L10, L11, L12 and L13 would 
influence the preferred conformation of the ligands and improve their extraction properties, Figure 
69. Upon completion of the extraction tests using standard conditions, both low D ratios and low 
SFAm/Eu values were observed for ligand L13, in agreement with the previous screening results 
with this family of ligands, Figure 70. All D ratios remain below 0.1 across all nitric acid 
concentrations used for all four of the alkylated ligands (L10, L11, L12 and L13); further 
extraction data can be found in the appendix. For effective extraction of the An(III) from the 
Ln(III) the D(Am) should be above 1, with the D(Eu) remaining below to 1.  
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Figure 68: (a) Photographs of the sample tubes after the first screening test using L3, c with 
increasing [HNO3] from left to right; (b) molecular structure of L3. 
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Figure 69: (a) Photographs of the sample tubes after first screening test using L13, with 
increasing [HNO3] from left to right; (b) molecular structure of L13. 
 
 
Figure 70: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L13 measured by α- and 
γ-spectroscopy as a function of the nitric acid concentration of the aqueous phase (1 hr, 22 °C at 
2,200 rpm). Organic phase: 10 mM L13 in 1-octanol. 
 
The synthesis of the 2,2’-bipyridine-derived ligand L8 was hoped to influence the extraction 
capability of those ligands containing the amine bridge, by having two N-donor atoms in the 2,2’-
bipyridine group that could coordinate initially. Unfortunately, low D ratios were again obtained 
for all radioisotopes across all HNO3 concentrations, showing that all radioisotopes remained in 
the aqueous phase, Figure 71. The resulting SFAm/Eu values were negligible as well. As a result, 
further investigations into using the 2,2’-bipyridine group to derive further ligands were not 
considered.   
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Figure 71: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L8 measured by α- and 
γ-spectroscopy, as a function of the [HNO3] of the aqueous phase (1hr, 22 °C at 2,200 rpm). 
Organic phase: 10 mM L8 in 1-octanol.  
 
Unfortunately this trend of low D ratios and negligible SF(Am/Eu) was observed across all these 
ligands containing the amine bridge (see the appendix for the full data set). Consequently, it was 
decided to no longer investigate further variations into this family of ligands for the extraction of 
the An(III) over the Ln(III). It was clear that the addition of an amine bridge between the pyridine 
rings and the 1,2,4-triazine rings negatively impacted the extraction capability of the ligands, 
when compared to the analogues BTP and BTBP ligands, section 1.5. 
Potential reasons for the poor extraction capability of the above ligands may be that there is a 
competition between metal ion coordination and ligand protonation as a result of the ligands being 
more basic than the BTP/BTBP ligands. When in contact with the HNO3 solution, the basic 
nitrogen atoms of the pyridine and triazine groups can undergo protonation, preventing their 
ability to coordinate to the actinide ions. Due to the introduction of the amine bridge, it could be 
expected that the resulting ligands are more basic than the BTP analogues due to the delocalisation 
of electron density from the NH lone pairs into the adjacent pyridine and triazine rings, Figure 
72. This additionally gives the C-N-C bridge some double bond character, preventing the free 
rotation of this bond as would be observed for the BTP ligands, where there is a C-C bond with 
no double bond character. In addition, they might be poorer π-acceptor ligands than the BTP 
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ligands due to the electron donating resonance effect of the nitrogen in the amine bridge and the 
hence impact on both the metal-ligand bond strength and complex stability. 
 
Figure 72: Resonance structures of the novel ligand family synthesised by Buchwald Hartwig 
reactions of 3-amino-1,2,4-triazines, showing the delocalisation of the NH lone pairs into both 
the 1,2,4-triazine and pyridine rings. 
 
Alternatively, it could be the ligands adopt the non-chelating trans-trans conformation as the 
preferred conformation in solution, preventing the coordination of the outer 1,2,4-triazine 2-N 
atom with the metal. Potential conformations are summarised in Figure 73, with the cis-cis 
conformation being the only conformation that has the potential for chelating the metal in a 
tridentate fashion. Indeed the obtained X-ray crystal structure for ligand L3, Figure 74, shows 
that the ligand is adopting the non-chelating trans-trans conformation in the solid state and this 
could be the dominant conformation in solution. The outer triazine rings are twisted away from 
the conformation necessary for metal ligation. This conformation is in contrast to that observed 
for the CyMe4-BTP ligand 1.30 which, despite showing the trans-trans conformation, has only 
one torsion to consider, that of the pyridine-triazine C-C bond.[80] Once the CyMe4-BTP ligand 
1.30 is protonated it adopts the cis-cis conformation which may suggest a lower rotational energy 
is required then rotation across the C-N bonds of the amine bridge of ligand L3. With the help of 
computational studies, this could imply that this is the most stable conformation of the ligand and 
not a crystal packing effect.  
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Figure 73: Possible conformations of the novel ligand family synthesised by Buchwald Hartwig 
reactions of 3-amino-1,2,4-triazines. Different conformers are due to rotation across the Cpyridine-
N bonds (denotated in blue). 
 
Figure 74: X-ray crystal structure of terdentate ligand L3. 
 
Computational studies were completed by Dr Mark Sims at Northumbria University on CyMe4-
BTBP 1.09 and CyMe4-BTPhen 1.17. It was confirmed that there is a small energy barrier that 
needs to be overcome to rotate the 1,2,4-triazine rings into their chelating conformations.[96] 
Further computational studies were completed at Northumbria University on L3 to investigate the 
possible conformations that may exist in solution. A relaxed potential energy scan around the four 
dihedral angles, Table 12, was completed. A 30 ° rotation between the dihedral angle of 0 and 
180 ° resulted in a total of 2401 (74) structures investigated at their respective optimised 
geometries. Those conformations within 10 kJ mol-1 of the minimum energy structure, at 298 K, 
were taken forward for fully relaxed geometry optimisations.  
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Table 12: Table showing lowest energy conformations and their populations of the novel ligand 
family synthesised by Buchwald Hartwig reactions of 3-amino-1,2,4-triazines, with torsion 
angles; respective to triazine-N, N-pyridine, pyridine-N and N-triazine. Studies completed by Dr 
Mark Sims of Northumbria University. Alll density functional theory calculations were performed 
using Gaussian 09 software package (Revision C.01). 
Structure Torsion Angles (°) Population (%) 
 
 
180-180-180-180 
 
35 
 
 
0-180-180-180 
 
50 
 
 
0-180-180-0 
 
15 
 
It was found that only 3 conformations dominated the population at 298 K, Table 12, in agreement 
with the conformation observed in the crystal structure of ligand L3 (trans-trans). It should be 
noted that these calculations were completed on simplistic structures and don’t consider any of 
the aliphatic side groups attached to the triazine rings, which could influence dominant 
conformations based upon steric effects. In recalculating the populations based upon the three 
conformations, the percentage populations are also given. The cis-cis conformations, which 
would be expected to coordinate the metal ions, are approximately 70 kcal mol-1 higher in energy 
then the trans-trans conformations. This is a substantial increase from those conformations shown 
in the table and a considerable barrier to overcome in order to achieve the conformation for metal 
ion complexation.  
A further extraction study was completed on these ligands using a 3.1 mol/L simulated waste 
solution containing various fission and corrosion products present in spent nuclear fuel such as 
nickel, palladium, and cadmium. This comes as a consequence of an NMR titration study 
completed with AgNO3 and L3 in which a 1:1 complex was observed, section 2.7. This solution 
was diluted to a concentration of 0.031 mol/L for subsequent ICP-MS measurements and the 
extraction screening was completed using the same conditions as previously (varying HNO3 
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concentration, 22 °C, phase mixing for 1 hour at 2,200 rpm). Results from this study will be 
published in due course once completed by colleagues at the Forschungszentrum Jülich. 
The ligands derived from 3-(6-bromo-2-pyridyl)-1,2,4-triazines L14, L15, L16 and L17 were 
synthesised in order to off-set the poor extraction properties shown above for the symmetrical 
ligands derived from 2,6-dibromoheteroarenes. It was proposed that by removing one of the C-
NH-C bridges, the extraction properties for this family of ligands may be positively impacted. 
The low rotational energy barrier across the bond highlighted in blue, Figure 75, as seen with the 
BTPs, BTBPs and BTPhens, freely rotates even at room temperature, allowing for the two 
highlighted nitrogens in the triazine rings to be orientated for coordination to the metal.[96]  
 
Figure 75: Molecular structure of CyMe4-BTP 1.30, with the bond required to rotate 
highlighted (blue). 
 
Despite the above hypothesis, the extraction experiments carried out with ligands L14, L15 and 
L17 indicated no extraction of Am(III) or Cm(III) across all nitric acid concentrations, Figure 76 
and Figure 77. The D ratios remained below 0.1, as observed with the ligands discussed 
previously. The external aliphatic groups attached to the triazine rings have no impact on the 
ligands extraction capabilities or ability to separate the An(III) from the Ln(III). These SFAm/Eu 
values were uniformly low for all three ligands tested (see appendix for the full data set).  
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Figure 76: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L17 measured by α- and 
γ-spectroscopy, as a function of the [HNO3] of the aqueous phase (1 hr, 22 °C at 2,200 rpm ). 
Organic phase: 10 mM L17 in 1-octanol. 
 
Figure 77: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L14 measured by α- and 
γ-spectroscopy, as a function of the [HNO3] of the aqueous phase (1 hr, 22 °C at 2,200 rpm ). 
Organic phase: 10 mM L14 in 1-octanol. 
 
It was hypothesised that similar reasons to that discussed above are the consequence of the poor 
extraction capability of these ligands. The removal of one of the C-NH-C bridges has no positive 
impact on the extraction properties using these ligands, suggesting that the conformational 
properties of the ligand may still play a role. An X-ray crystal structure has not being successfully 
obtained for any of these ligands to verify this hypothesis. 
As a consequence of the data obtained through the extraction screening of these ligands, it is clear 
that the addition of an amine (C-NH-C) bridge between the pyridine and triazine rings has an 
0.0001
0.001
0.01
0.1
1
0.01 0.1 1 10
D
is
tr
ib
u
ti
o
n
 r
at
io
 (
D
)
nitric acid [mol/L]
Am gamma
Eu gamma
Am Alpha
Cm Alpha
0.0001
0.001
0.01
0.1
1
0.01 0.1 1 10
D
is
tr
ib
u
ti
o
n
 r
at
io
 (
D
)
nitric acid [mol/L]
Am gamma
Eu gamma
Am Alpha
Cm Alpha
89 
 
unquestionably negative impact on the extraction abilities of these ligands. Subsequently, no 
further ligands containing this bridge were considered.  
 
2.7. NMR Titration Studies 
In order to determine the potential species that could be present in an extraction experiment, NMR 
titration studies were completed with the lanthanide nitrate salts acting as actinide surrogates. 
Lanthanum (La(III)) and lutetium (Lu(III)) were selected as the lanthanide salts, along with 
ytterbium (Yb(III)) and yttrium (Y(III)) (all as nitrate salts) due to their diamagnetism and the 
subsequent likelihood of obtaining well resolved NMR spectra.  
A methanol-d4 solution of La(NO3)3 was titrated against a 0.01 M solution of L3 in the same 
solvent. The resulting spectra were overlaid to give stacked 1H NMR spectra, Figure 78. The 
disappearance of the free ligand resonances, and the appearance of new resonances for a complex 
species, as the metal is added to the ligand would be expected if ligand L3 formed complexes in 
solution with La(III). In this event, no new resonances were observed upon titration of ligand L3 
with 0.8 eq. addition of the La(NO3)3 solution. Under the conditions of the titration experiment, 
the ligand shows no complexation with the La(III) metal present, despite an attempt to force 
complexation by increasing the temperature. This is in agreement with the evidence obtained 
during the solvent extraction tests, in which these ligands observed no extraction capability for 
the An(III) or Ln(III)’s present. As a consequence, further di-aminated ligands were not studied 
by NMR titrations with the lanthanide salts.  
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Figure 78: Stack plot for the 1H NMR titration of L3 with increasing equivalents of La(NO3)3 
showing no complex formation. 
 
In further studies it was decided to test the L3 ligand with a deuterated solution of the transition 
metal, silver nitrate (AgNO3), to ascertain the potential scope of these ligands for fission and/or 
corrosion product extraction. As Ag+ is a soft Lewis acid it prefers to complex with soft Lewis 
bases, such as the nitrogen atoms of the N-donor ligands, forming stable complexes. Previously, 
it has been shown that BTBPs can complex the Ag+ fission product with high distribution ratios 
during extraction testing.[49] An X-ray crystal structure revealed a 2:2 stoichiometry with a BTBP 
(C2-BTBP) as a [Ag2(C2-BTBP)2]2+ complex.[49] Each Ag+ metal ion coordinates to two nitrogen 
atoms from each ligand, one from the pyridine and one from the triazine resulting in a distorted 
square pyramidal geometry. NMR titrations revealed little influence from the side groups of the 
BTBP ligands in the same study. In aqueous solutions, hydrophilic bidentate bis-1,2,4-triazine 
ligands have been shown to complex the Ag+ ion and can act as a masking agent, in order to 
supress its extraction by the BTBPs into the organic phase.[143] Further investigation with the L3 
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ligand would open up the potential for these ligands to act as masking agents of the transition 
metals during actinide extractions.   
An NMR titration of ligand L3 with AgNO3 in methanol-d4 shows a shift in the signals in the 
aromatic region upon addition of increasing equivalents of the AgNO3 stock solution, Figure 79. 
The first spectrum of the free ligand shows three signals in the aromatic region at δ 8.0, 8.4 and 
8.6 ppm, although the multiplicity is unclear. There is a gradual upfield shift in the signal at δ 8.6 
to 8.0 ppm upon addition of 0.4 eq. of Ag+ with the other signals remaining unchanged. After 
addition of 0.6 eq. of Ag+ a new doublet appears at δ 7.3 ppm. There are no notable changes in 
the aliphatic region. A high-resolution mass spectrum (HRMS) was obtained for the sample 
containing 1.2 eq. of AgNO3 to confirm the presence of a complex, Figure 80. The mass spectrum 
shows mass peaks for both the protonated free ligand [C27H33N9 +H+] at 484.2920 m/z, with a 
further peak at 590.1892 m/z indicative of a 1:1 or 2:2 complex. The smaller peak at 1075.4762 
m/z is indicative of a 2:1 species, in which two ligand molecules surround the Ag+ ion. Further 
understanding into the mode of binding could be discovered by obtaining an X-ray crystal 
structure of the complex, but unfortunately this was not obtained due to time constraints. 
A further NMR titration was completed on L10 with Ni(NO3)2 in deuterated acetonitrile, but no 
complexation was observed for this ligand, see appendix for details. It is believed that the Ag+ ion 
may be interacting with the amine (C-NH-C) during coordination. Once the position is alkylated 
it is less able to coordinate to the Ag+ ion as a consequence of the hindrance from the alkyl chain.   
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Figure 79: Stack plot for the 1H NMR titration of L3 with increasing equivalents of AgNO3 in 
deuterated methanol. 
 
Figure 80: HRMS of the NMR tube sample from the NMR titration of L3 with AgNO3 after 
addition of 1.2 eq. AgNO3 showing the mass peaks for the protonated ligand, a 1:1 or 2:2 
complex and 1:2 complex. 
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The purpose of investigating the ligands derived from 3-(6-bromo-2-pyridyl)-1,2,4-triazines L14, 
L15, L16 and L17 was to gain a more complete understanding of how these ligands may, or may 
not, be interacting with the actinide metal ions. These non-symmetrical ligands can be considered 
a hybrid between the BTP ligands and the symmetrical ligands such as L3, and they could have a 
conformational rigidity that falls in between the two. It was proposed that this may aid in the 
coordination of these ligands with the An(III) metal ions, in parallel to the previous hypothesis 
regarding the lanthanide ions. An NMR titration of ligand L15 with La(NO3)3 in deuterated 
acetonitrile was completed. During the titration, an upfield chemical shift of one of the proton 
signals in the aromatic region was observed from δ 8.8 to 8.2 ppm, potentially caused by 
interaction of the metal with the ligand. Figure 81 shows the stacked 1H NMR spectra. However, 
a HRMS of the final sample, containing 1.2 eq. of La(NO3)3 was obtained and showed only the 
mass peak for the protonated free ligand. As it stands this is not enough evidence for 
complexation.  
 
Figure 81: Stack plot for the 1H NMR titration of L15 with increasing equivalents of La(NO3)3 
in deuterated methanol. 
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Following on from the results obtained from the NMR titration of L3 with AgNO3, it was decided 
to test the unsymmetrical ligands L15 and L17 with AgNO3 in CD3CN-d3. For the titration 
completed with L17, the spectrum of the free ligand shows four signals in the aromatic region at 
δ 9.81, 8.25, 7.82 and 7.60 ppm. There is a gradual upfield shift of the signal at δ 8.25 to 7.60 
ppm, and a gradual downfield shift of the doublet at δ 7.60 to 7.81 ppm, Figure 82, upon addition 
of 1.0 eq. of Ag+. Additionally the broad singlet representative of the NH signal at δ 9.80 shifts 
upfield to 8.66 ppm. A similar observation was made for L15 (refer to the appendix). Most likely 
the Ag+ is interacting with the N atom of the pyridine and that of the amine (C-NH-C), although 
an X-ray crystal structure would be required to confirm this.  
 
Figure 82: Stack plot for the 1H NMR titration of L17 with increasing equivalents of AgNO3 in 
deuterated acetonitrile. 
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2.8. Conclusion 
In this chapter two families of novel multidentate bis-1,2,4-triazine ligands have been synthesised, 
linked by various aromatic groups; pyridine, pyrazine and 2,2-bipyridine. This is the first time 3-
amino-1,2,4-triazines have been employed as the nucleophilic partner directly in a Buchwald 
Hartwig double amination reaction.  
From the ligands synthesised in this chapter, the majority observe higher solubilities when 
compared to the current benchmark ligand CyMe4-BTBP 1.09, with the exception of L7. Upon 
the addition of alkyl chains there was a positive correlation between the Fsp3 value and their 
respective measured solubilities, with this general trend observed across all ligands, suggesting 
some evidence for the proposed hypothesis, section 1.6. For the mono-aminated ligands L14, 
L15, L16 and L17 there is a distinct difference in solubilities if two different diketone groups are 
attached, adjacent to the 1,2,4-triazine ring, with the highest solubilities obtained when these 
groups are the same.  
Since the ligands did not extract any metals in our extraction experiments, conclusions about 
whether or not the added amino-groups in these ligands have a beneficial effect on extraction 
kinetics were unable to be made. The dominant trans-trans conformers of the ligands, as revealed 
through computational studies, are unable to rotate to the cis-cis conformers to complex the metal 
centre, due to a high C-N rotational energy barrier. As a consequence, it was concluded that the 
addition of an amine bridge between the pyridine and triazine rings should no longer be 
considered in future developments for the separation of the An(III) from the Ln(III).  
An investigation into the potential for these ligands to coordinate with transition metals is 
underway with colleagues at the Forschungszentrum Jülich. The results of this study will be 
published in due course. Those results obtained will indicate the potential applicability of these 
ligands as fission or corrosion product extractants.    
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Ligands derived from a modified 
camphorquinone diketone 
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3. Ligands derived from a modified camphorquinone diketone 
3.1. Introduction 
In research to replace the CyMe4-diketone 2.2.5, the commercially available diketone (1S)-(+)-
camphorquinone 2.2.8 was selected as a potentially viable option, Figure 83. Previously, this 
diketone has been used by Geist and co-workers to synthesise the camphor-BTP ligand 1.31, 
Figure 84. This ligand showed a number of advantages over CyMe4-BTBP 1.09 in extraction 
experiments, namely significantly higher solubilities in organic diluents (up to 200 mM in diluent 
1-octanol), faster extraction kinetics, good selectivity for the An(III) over the Ln(III) and 
hydrolytic stablity.[82] The ligand observed no degradation over a period of 100 days in contact 
with 1 M nitric acid (HNO3) and the extraction equilibrium was achieved in a tetrahydropyran/1-
octanol system within approximately 10 minutes of phase mixing. Despite this, these 
investigations found that camphor-BTP 1.31 exhibited third phase formation in contact with 
higher concentrations of HNO3 solutions, dependent upon the diluent used. When the ligand was 
dissolved in a kerosene/1-octanol mixture (7:3 vol. ratio), a precipitate was observed when 
contacted with 1 M HNO3. Utilising the more polar 1-octanol diluent, the precipitate was not 
observed up until contact with 4 M HNO3. However, in spite of this improved solubility in 1-
octanol, there was a decrease in the distribution (D) ratios of Am(III) (DAm) in comparison to 
when the same ligand was dissolved in the kerosene/1-octanol diluent. The BTPs are known to 
exhibit some HNO3 extraction and it is proposed that the precipitate observed in these solutions 
is a consequence of precipitation of the protonated ligand.[144] In Section 2.0, where the (1S)-(+)-
camphorquinone 2.2.8 was utilised as the diketone, showed no solubility or precipitation issues 
when the ligand came into contact with the HNO3 aqueous phase. As a result, derivatives of this 
group will be considered for their potential application in actinide extractions. 
 
Figure 83: Molecular structure of CyMe4 2.2.5 and (1S)-(+)-camphorquinone 2.2.8. 
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Figure 84: Molecular structure of camphor-BTP 1.31. 
 
Due to the presence of chirality within the diketone it exists as two enantiomers; R- or S-
camphorquinone. The aforementioned work completed by Geist and co-workers was carried out 
using a racemic (±)-camphorquinone, meaning the final camphor-BTP 1.31 ligand may exist as 
diastereomers within solution, Figure 84. Research by D.D. Ensor and co-workers found that 
using a racemic mixture of camphorquinone, as opposed to a single R or S enantiomer, had a 
negative impact on the distribution ratios observed during extraction testing with camphor-BTP 
1.31 in the polar solvent FS-13 1.58 (page 38).[132] In order to investigate the application of the 
camphorquinone group as a viable alternative to CyMe4 2.2.5 the enantiomerically pure 
compounds; (1S)-(+)-ketopinic acid 3.1.2 and (1S)-(+)-10-camphorsulfonyl chloride 3.1.3, will 
be utilised to synthesise a range of novel multidentate ligands containing the core group, Figure 
85. This will limit the potential formation of diastereomers as well as potentially maximising the 
distribution ratios that may be observed during solvent extraction experiments, depending upon 
the starting material utilised.  
 
Figure 85: Comparison between the molecular structures of (+)-camphor 3.1.1, (+)-ketopinic 
acid 3.1.2 and (1S)-(+)-10-camphorsulfonyl chloride 3.1.3; with the common structure 
highlighted in blue. 
 
(1S)-(+)-Ketopinic acid 3.1.2 was selected as the starting material of choice for the synthesis of 
modified derivatives of camphorquinone 2.2.8 as it allows for functionalisation at the carboxylic 
acid moiety. Although ketopinic acid 3.1.2 is a more costly starting material in comparison to 
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camphorquinone 2.2.8, it avoids the multi-step synthesis that would be required to achieve the 
derivatisation of camphor 3.1.1 itself, Figure 86.[145] Alternatively, camphorsulfonyl chloride 
3.1.3 can be purchased at a reasonable cost and oxidised to give ketopinic acid 3.1.2 to provide 
an even more economically beneficial alternative to using ketopinic acid 3.1.2 itself as the starting 
material.  
 
Figure 86: Synthetic scheme for the synthesis of (+)-ketopinic acid 3.1.2 from (+)-camphor 
3.1.1. [170-172]. Reaction conditions: i) H2SO4, Ac2O; ii) SOCl2; iii) KMnO4, Na2CO3, H2O. 
 
In line with the aims and objectives of the project, converting the acid functionality of ketopinic 
acid 3.1.2 into an amide will ensure the inclusion of additional HBD/HBA functional groups into 
the resulting bis-1,2,4-triazine ligands. The introduction of the amide functionality is based on 
previous research into the amide containing extractants; TODGA 1.05 and DMDOHEMA 1.04. 
Both ligands are known to have very high solubilities in the required diluents (octanol, dodecane, 
kerosene). They additionally, despite their hydrophobicity, show very fast rates of metal 
extraction, section 1.4. Amide bonds have traditionally been used where Am/Eu selectivity was 
not required such as in the DIAMEX process. The oxygen atom, as a hard donor, observes no 
selectivity between the An(III) and Ln(III). However, as the amide group will not be part of the 
coordination cavity in these novel ligands and not likely to take part in metal coordination, it is 
anticipated they will have minimal impact on their subsequent selectivity for An(III) over Ln(III). 
Despite this, the amide group should enable the ligands to have a high surface concentration at 
the phase interface, and hence increase the rates of metal extraction, due to its ability to form 
hydrogen bonds with the water molecules at the phase interface. 
This chapter will consider a variety of ligands based upon the functionalised ketopinic acid 3.1.2 
that are analogous of the BTP, BTBP and BTPhen ligands. The ketopinic acid 3.1.2 will be 
coupled with a variety of primary and secondary amines to form amides, which will subsequently 
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be oxidised to form a variety of the final 1,2-diketones, section 3.3. Utilising a variety of amines 
enables us to tune the solubilities and extraction properties of the ligands, which will hopefully 
lead to the discovery of novel camphorquinone-derived ligands suitable for further development. 
In addition, the analogous ligands camphor-BTBP L28 and camphor-BTPhen L29, Figure 87, 
will also be synthesised and screened for comparison purposes, as these ligands have never been 
investigated for their ability to extract and separate An(III) from Ln(III). Camphor-BTPhen L29 
has previously been reported in work by L.M. Harwood and co-workers in which its solubility 
was investigated (18.6 mM in diluent 1-octanol).[102] 
 
Figure 87: Structures of analogous ligands camphor-BTBP L28 and camphor-BTPhen L29. 
3.2. Synthesis of the bis-amidrazones 
In order to synthesise the final ligands in this Chapter and following (Chapter 4), the bis-
amidrazones, corresponding to the final BTP and BTPhen ligands, first need to be synthesised. 
Following a procedure by Therien and co-workers.[146] hydrazine hydrate was added to pyridine-
2,6-dicarbonitrile 3.2.1 to produce the known pyridine-2,6-dicarboxamidrazone 3.2.2 in a 64% 
yield, Figure 88.[147] The corresponding 2,2’-bipyridine-6,6’-dicarboxamidrazone 3.2.5 was 
synthesised previously within the Lewis goup, via the dinitrile compound 3.2.4, and was used as 
obtained, Figure 89.[61c] 
 
Figure 88: Reaction scheme for the synthesis of 3.2.2. Reaction conditions: i) hydrazine 
hydrate, ethanol. 
101 
 
 
Figure 89: Synthesis of the 2,2’-bipyridine-6.6’-dicarboxamide dihydrazone 3.2.5, as 
completed previously within the Lewis group. Reaction conditions: i) hydrogen peroxide, 
AcOH, potassium cyanide, benzoyl chloride, THF, H2O; ii) hydrazine hydrate, EtOH. 
 
The 1,10-phenanthroline-2,9-dicarboxamidrazone 3.2.10 was initially synthesised in three steps 
following the procedure of Harwood and co-workers, Figure 90.[95] The formation of the 
dialdehyde 3.2.7 was achieved by oxidising the starting neocuproine 3.2.6 with selenium dioxide. 
The dialdehyde 3.2.7 was converted to the dinitrile 3.2.9 in a one pot synthesis via the 
intermediate dioxime 3.2.8. The final formation of the bis-amidrazone 3.2.10 was achieved in 
88% yields.  
 
Figure 90: Reaction scheme for the synthesis of bis-amidrazone 3.2.10. Reaction conditions: i) 
SeO2, 1,4-dioxane, ii) hydroxylamine hydrochloride, triethylamine, MeCN, iii) p-
toluenesulfonyl chloride, DBU, iv) hydrazine hydrate, EtOH. 
 
Due to the cumbersome nature of this synthesis, which involves multiple triturations of the 
dialdehyde 3.2.7 in the first step to remove selenium-derived impurities, an alternative synthesis 
of 3.2.10 was explored, as described again by Harwood and co-workers, Figure 91.[148] Although 
this procedure involves a higher number of steps, the ease in completing the reactions and higher 
yields of each step make it appealing to investigate. There is the added benefit of avoiding the use 
of toxic SeO2 in the first step, in which its use results in a more intensive purification process to 
ensure the complete removal of any selenium impurities. This modified route proceeds via the 
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free radical chlorination of the two methyl groups of neocuprione 3.2.6 using N-
chlorosuccinimide and 3-chloroperbenzoic acid to give 3.2.11 prior to hydrolysis to produce the 
diester 3.2.12. The formation of the diamide 3.2.13 was achieved with ammonium chloride in 
concentrated ammonium hydroxide prior to its dehydration to form the dinitrile 3.2.9. The final 
step was completed as above to give final yields of bis-amidrazone 3.2.10 of 84%, Figure 91. 
 
Figure 91: Reaction scheme for the alternative synthesis of bis-amidrazone 3.2.10. Reaction 
conditions: i) N-chlorosuccinimide, 2,2’-azobis(2-methylpropionitrile), CHCl3, ii) H2SO4, 
MeOH, iii) NH4Cl, NH4OH, iv) phosphorus oxychloride, v) hydrazine hydrate, DMSO. 
 
The above bis-amidrazones 3.2.2, 3.2.5 and 3.2.10 were utilised in the synthesis of a range of 
ligands described throughout this Chapter and the subsequent Chapter 4. 
 
3.3. Synthesis of modified camphorquinone ligands. 
In the first efforts to synthesise a range of amide derivatives of ketopinic acid 3.1.2, it was decided 
to initially form the C-N bond via traditional amidation conditions, followed by the oxidation 
reaction to give the final 1,2-diketones.  Following procedures reported by S.M. Cerero and co-
workers,[149] the amidation was explored using the carboxyl activating reagent EDC (1-ethyl-3-
[3-dimethylaminopropyl]carbodiimide) and DMAP (4-dimethylaminopyridine).[149] The DMAP 
is a nucleophile that acts in a preventative measure to stop the unwanted formation of the 
unreactive N-acylurea, through acyl transfer, by reacting faster with the carbodiimide.[150] This 
method produced yields of 19, 52 and 42% for the reactions of (+)-ketopinic acid 3.1.2 with the 
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secondary amines morpholine, piperidine and diethylamine, respectively, Figure 92. As a result 
of the low yields, an alternative methodology was considered. 
 
 
Figure 92: Synthesis of the amides showing the two alternative pathways, where R represents 
the amine. Reaction conditions: i) amine (R), EDC.HCl, DMAP, DCM; ii) amine (R), SOCl2, 
triethylamine, DCM. 
 
B.J. Uang and co-workers demonstrate an alternative pathway in which the acid 3.1.2 is activated 
as the acid chloride prior to forming the amide.[151] The acid chloride forms readily through the 
addition of thionyl chloride (SOCl2) to 3.1.2, prior to the addition of the respective amine and 
triethylamine. This procedure led to improved yields for the formation of the amides using the 
amines morpholine, piperidine and diethylamine, with yields of 86, 90 and 84% being observed, 
respectively. Several amides were successfully synthesised using the amines; morpholine, 
piperidine, diethylamine, isopropylamine, methylamine, propylamine and hexylamine, Figure 93. 
 
Figure 93: Molecular structures and yields of the amide-derivatives of (+)-ketopinic acid 3.1.2. 
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The oxidation step to obtain the final 1,2-diketone compounds proved challenging. Following 
traditional oxidation conditions, selenium dioxide (SeO2) in 1,4-dioxane was employed. Using a 
slight excess of SeO2 resulted in no conversion to the oxidised product 3.3.8 as perceived through 
1H NMR spectroscopy. Minimal impact on conversion was observed when the starting 
stoichiometry of SeO2 was increased. Additionally changing the solvent to acetic acid, as 
observed with similar reactions,[152] had no impact in product conversion. It was subsequently 
decided to sequentially add 2 equivalents of SeO2 to the reaction vessel every 2-3 hours, leading 
to the synthesis of 3.3.8 in 58% yield, after the total addition of 6 equivalents, Figure 94. The 
success of the reaction can be clearly observed through 1H NMR spectroscopy with the 
disappearance of the doublet at δ 1.9 ppm representing the 3-CH2 group that is oxidised to give 
the second ketone carbonyl group. Additionally, upon the formation of the 1,2-diketone the other 
signals see a change in the chemical shifts, Figure 95. A further indication is the doublet at δ 2.6 
ppm of the product, with an integration of 1H (CH), representing the single proton CH at the α-
carbon (C4) with respect to the new carbonyl group.   
 
Figure 94: Oxidation of 3.3.1 to form 3.3.8. Reaction conditions: i) SeO2, AcOH. 
 
This method did not reproduce the desired results when utilised to oxidise the other ketopinic 
acid-amides. The addition of excess SeO2 had minimal impact in facilitating the oxidation 
reaction with these compounds, with only minor conversions to product being observed. As a 
consequence of the low yielding oxidation, and subsequent difficult separation of the product 
from the crude mixture in sufficient quantities, an alternative route was considered.  
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Figure 95: Overlaid 1H NMR spectra showing the starting material 3.3.1 (bottom spectrum) and 
the product 3.3.8 (top spectrum). 
 
Improving the overall synthetic methodology was necessary to give a reliable procedure to 
synthesise a variety of amides from ketopinic acid 3.1.2 regardless of the amine used, Figure 96. 
As a consequence, the oxidation of ketopinic acid 3.1.2 to the diketone, a known reaction 
completed by multiple research groups, was considered prior to the amidation reaction.[152-153] 
This reaction again employed SeO2 in acetic acid, beginning with an equimolar amount of the 
oxidising agent and successively adding 0.2 equivalents. In comparison to the previous attempts 
to synthesise the final 1,2-diketones, the oxidation of ketopinic acid 3.1.2 could be achieved with 
a lower overall quantity of SeO2. In addition to the reduced quantities of SeO2 used, purification 
proved to be much simpler. It was found that 3.3.9 could easily be recrystallized in high purity 
and with reasonable yields from an ethyl acetate-hexane mixture. The 1H NMR spectrum is shown 
in Figure 98.  
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Figure 96: Alternative synthetic pathway to the final ketopinic acid-amide 3.3.10.  Reaction 
conditions: i) SeO2, dioxane, ii) SOCl2, triethylamine, diethylamine, DCM. 
 
Using the oxidised ketopinic acid 3.3.9, the amidation reaction was again performed via the 
intermediate acid chloride to form 3.3.10. The final 1,2-diketones were synthesised via this more 
reliable route with reasonably high yields obtained, Figure 97. In some cases, purification of the 
final product proved more complex than previously observed when forming the amide bond. 
There was a notable decrease in the yields of the final pure compounds when the primary amines, 
methylamine, propylamine and isopropylamine were used to synthesise the 1,2-diketones 3.3.12, 
3.3.13, and 3.1.14. 
 
 
Figure 97: The molecular structure of the amido-camphor 1,2-diketones synthesised. Yields 
shown are for the amide forming step only. 
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Figure 98: 1H NMR spectrum of oxidised (+)-ketopinic acid 3.3.9. 
Table 13: Assignment of NMR signals for (+)-ketopinic acid 3.3.9. 
1H (ppm) Proton integration 
and multiplicity 
(Hz) 
13C (ppm) Assignment 
2.72 1H, d, J = 5.04 58.1 CH 
2.61 1H, td, J = 4.58 26.7 CHexo 
2.29  1H, tt, J = 5.04 21.5 CHexo 
2.06 – 1.99 1H, m 26.7 CHendo 
1.75 – 1.68 1H, m 21.5 CHendo 
1.25 3H, s 22.2 CH3 
1.25 3H, s 18.5 CH3 
 
Due to the toxicity of SeO2 and the difficulty arising in ensuring the complete removal of the 
selenium by-products from the diketones, an alternative method was investigated for the oxidation 
reaction that utilises bromine, Figure 99. The first step in the reaction is the bromination of 
ketopinic acid 3.1.2 itself to form the endo-3-bromo-ketopinc acid 3.3.15.[154] This was used in 
situ to form 3.3.9 via air-oxidation using sodium iodide as a catalyst in DMSO, as following the 
procedure demonstrated by Miyakoshi and co-workers in oxidising 3-bromocamphor to give 
camphorquinone.[155] The resulting low yield obtained in the synthesis of 3.3.9 from ketopinic 
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acid 3.1.2 of 20% was thought to result from the method used to introduce air into the system. 
We used a water-pump to introduce air into the reaction mixture, which may have resulted in the 
ineffective distribution of oxygen into the reaction mixture. Alternative procedures in the final 
oxidation step can use catalysts such as cobalt(II) acetate[128] or tetrabutylammonium iodide to 
achieve the same oxidation as discussed by Miyakoshi and co-workers.[156] Going forward it was 
decided to continue to carry out the oxidation reaction using SeO2 in order to obtain the required 
1,2-diketones, which despite being the more toxic reagent, offered the highest yields.  
 
 
Figure 99: Alternative oxidation protocol to diketone 3.3.9. Reagents and conditions; i) 
Bromine, AcOH, ii) Sodium iodide, DMSO, air. 
 
As discussed briefly in section 3.1, the preparation of ketopinic acid 3.1.2 from the cheaper 
starting material (+)-camphor-10-sulfonyl chloride 3.1.3 was also considered, Figure 100. This 
was deemed necessary for cost considerations should a scaled-up synthesis of any of the ligands 
need to be carried out, both in the present work as well as in future industrial use. Current 
procedures to synthesise ketopinic acid 3.1.2, directly from the (+)-camphor 3.1.1 starting 
material, are cumbersome.[145a] The final step, involving oxidation of camphorsulfonyl chloride 
3.1.3 with potassium permanganate, has previously yielded ketopinic acid 3.1.2 in yields of 38-
43%.[157] Due to the low cost of (+)-camphor sulfonyl chloride 3.1.3, this final oxidation step will 
be considered as an alternative method to purchasing the much more expensive ketopinic acid 
3.1.2. Following a literature procedure,[130] first established in 1965, the successful synthesis of 
ketopinic acid 3.1.2 using potassium permanganate was achieved in yields of 35%. This 
methodology can be applied in the future scaled-up synthesis of the final target ligands that may 
have future industrial application.  
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Figure 100: Synthesis of ketopinic acid 3.1.2. Reaction conditions: i) KMnO4, Na2CO3, H2O 
The final 1,2-diketones successfully synthesised are shown in Figure 97 (page 106) with yields 
ranging from 33 – 77% dependant on the amine. These will be used in the condensation reactions 
with the relevant bis-amidrazones to form the final bis-1,2,4-triazine ligands containing the 1,2,4-
triazine moiety. Efforts to realise analogues of the CyMe4-BTP 1.30, CyMe4-BTBP 1.09 and 
CyMe4-BTPhen 1.17 will be made to directly compare their solubility and rates of extraction 
results.  
 
Figure 101: Structure of L19. 
Synthesis of the final ligands was achieved through a condensation reaction between the novel 
diketones and the appropriate bis-amidrazone. An initial experiment using 3.3.8 and pyridine-2,6-
dicarboxamidrazone 3.2.2 was carried out through refluxing in ethanol and resulted in minimal 
conversion to the final ligand L19, Figure 101. As a consequence of the steric hindrance exhibited 
by the amide group on the C2-carbonyl group of 3.3.8, Figure 102, it was proposed that the 
reaction may require a higher boiling point solvent in order to improve conversion to the product. 
The reaction was thus repeated in 1,4-dioxane in attempts to encourage the reaction to proceed. 
The 1H NMR spectrum of the crude product exhibited an unusual mass of signals between δ 3.5 
– 5.5 ppm that did not appear when the reaction was completed in ethanol. It is proposed that this 
may be a consequence of degradation of the solvent or impurities present within the solvent. 
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Figure 102: Representative conformers of a ketopinic acid-derived diketone 3.3.8, dependent 
on the bond rotation (red) and the resulting steric hindrance (blue) caused by the bulky amide 
group. 
 
In an effort to confirm whether the aforementioned signals are a consequence of the reaction or 
due to of solvent degradation or impurities, two parallel condensation reactions were completed 
in ethanol and 1,4-dioxane. It was decided to investigate the condensation reaction between 
pyridine-2,6-bisamidrazone 3.2.2 and (1S)-(+)camphorquinone 2.2.8 to form camphor-BTP L30 
following the previously reported procedure, with the only variable being the solvent used, Figure 
103.[80] The reaction between the two reagents was chosen as a result of the chemical similarity 
to the reaction under consideration in this chapter, as well as being a known reaction in literature. 
Interestingly, in ethanol the reaction proceeds almost to completion after 3 days at reflux as 
observed by the 1H NMR spectroscopy. In 1,4-dioxane the same phenomena as seen previously 
was observed, Figure 104. There is potential that the bottle of 1,4-dioxane utilised may have 
degraded or contained impurities, but at the time of carrying out the reaction, this was not checked.  
 
Figure 103: Reaction scheme for the formation of camphor-BTP L30. Reaction conditions: (i) 
(1S)-(+)-camphorquinone 2.2.8, ethanol, (ii) (1S)-(+)-camphorquinone 2.2.8, 1,4-dioxane.  
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Figure 104: Overlaid 1H NMR spectra of crude products from the condensation reaction 
between 3.2.2 and 2.2.8 to form L30 in ethanol (bottom spectrum) and 1,4-dioxane (top 
spectrum). 
As 1,4-dioxane appears to be unsuitable for the reaction and ethanol gives limited conversion to 
the product when using the derivatised camphor-diketones, it was decided to use acidic conditions 
by utilising acetic acid as the solvent. As a condensation reaction is, in simplest terms, a 
nucleophilic addition reaction, it is anticipated the use of acetic acid may aid the reaction by 
protonation of the carbonyl group oxygen atom, to encourage attack on the carbonyl group by the 
nucleophilic amino groups of the bis-amidrazones. This is in addition to its increased boiling point 
in comparison with ethanol, both of which should drive the condensation reactions to completion. 
 
The successful synthesis of a range of novel ligands was achieved using acetic acid as the solvent, 
with variable yields being obtained dependent upon on the starting 1,2-diketone used, Figure 105. 
The successful observation of the products was confirmed through full characterisation of the 
ligands (1H NMR, 13C NMR and HRMS).  
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The use of the diketone 3.3.8 resulted in the successful formation of the novel BTP L19, BTBP 
L20 and BTPhen L21 ligands, Figure 106. Similarly the diketone 3.3.10 was used successfully in 
the preparation of the BTP L22, BTBP L23 and BTPhen L24 ligands. It was notable that the 
yields observed in this case were significantly lower than those observed when utilising the 
diketone 3.3.8.  
 
  
Figure 105: Structures of successfully synthesised ligands. Yields are for the condensation 
reaction step alone.  
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Figure 106: Synthesis of morpholine-derived ligand L21. Reaction conditions: i) morpholine-
derived diketone 3.3.8, acetic acid, reflux. 
 
The use of the diketone 3.3.11 resulted in only the BTPhen L27 ligand being isolated with the 
required purity for extraction testing. The purification of the BTP L31 and BTBP L32 was 
unsuccessful through either recrystallization or column chromatography. The use of the diketone 
3.3.12 resulted in the isolation of the BTP L25 and BTBP L26 successfully, Figure 107.  
 
Figure 107: Synthesis of methylamine-derived ligand L25. Reaction conditions: i) 
methylamine-derived diketone 3.3.12, acetic acid, reflux. 
 
Unfortunately, the ligands derived from diketones 3.3.13 and 3.3.14 could not be obtained as pure 
samples. Those proposed ligands that were unable to be obtained are shown in Figure 108.  
114 
 
 
Figure 108: Molecular structures of proposed ligands unsuccessfully synthesised using the 
amide-derived ketopinic acid compounds.  
 
In order to draw effective comparisons between the extraction properties of these novel ligands 
and those of the ligands derived from camphorquinone 2.2.8 itself, such as camphor-BTP 1.31, it 
was decided to also synthesise and screen the analogues of the novel BTBP and BTPhen ligands 
discussed in these chapters; camphor-BTBP L28 and camphor-BTPhen L29. The effect of the 
amide group on the solubilities, extraction properties and extraction kinetics can be discovered 
through the direct comparison to the ‘parent’ ligands derived from an enantiomerically pure 
sample of camphorquinone 2.2.8. The synthesis of camphor-BTBP L28 and camphor-BTPhen 
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L29 was achieved by a condensation reaction between the respective bis-amidrazone and (1S)-
(+)-camphorquinone 2.2.8 in refluxing acetic acid, Figure 109 and Figure 110. The camphor-
BTBP L28 and camphor-BTPhen L29 were obtained in 53 and 59% yields, respectively, which 
is similar to the yield obtained for the camphor-BTP ligand 1.31 (56%).  
 
Figure 109: Reaction scheme for the formation of camphor-BTBP L28. Reaction conditions: (i) 
(1S)-(+)-camphorquinone 2.2.8, AcOH, reflux. 
 
Figure 110: Reaction scheme for the formation of camphor-BTPhen L29. Reaction conditions: 
(i) (1S)-(+)-camphorquinone 2.2.8, AcOH, reflux. 
 
The new ligands based upon the BTP, BTBP and BTPhens synthesised above, are anticipated to 
exhibit faster extraction kinetics than the benchmark ligand CyMe4-BTBP 1.09 and camphor-
derived ligands 1.31, L28 and L29 through the addition of the amide functional group. The 
addition of the HBD and HBA amide functionality should enable increased hydrogen bonding 
with the water molecules at the aqueous/organic interface, hence influencing their extraction 
kinetics.  
3.4. Calculated Ligand Parameters 
For each of the ligands synthesised in section 3.3, their ligand parameters have been calculated to 
enable comparisons between theoretical and experimental data in line with the project objectives. 
Using the experimental data obtained for solubility and extraction kinetics for a given ligand, 
which will be compared to the theoretical data, the potential for using the proposed ligand design 
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guidelines can be established. The theoretical log P values of the ligands were obtained through 
the ACD I-lab software. The calculated properties are shown in Table 14.  
Based upon the theoretical values, specifically the Fsp3 and log P values obtained for the 
methylamine-derived ligand L25 and L26, these ligands would be expected to have poor 
lipophilicity and hence low solubility within the 1-octanol diluent. In comparison, those ligands 
functionalised with diethylamine (L22, L23 and L24) have the greatest calculated log P and Fsp3 
values suggesting they will observe the highest solubility. Those ligands functionalised with 
piperidine (L27) should be expected to show similar solubilities as the diethylamine based upon 
the calculated values.  
There is a contradiction in the log P value and Fsp3 obtained for the morpholine-derived ligands 
L19, L20 and L21, Table 14. The log P values suggest a low lipophilicity and hence poor 
solubility in 1-octanol but the Fsp3 values, if it is established to be a good indication of ligand 
solubility, suggests the opposite. The addition of additional HBA atoms in the amide functionality 
may impact the solubility outside of what the data can predict. Directly comparing L21 and L27 
will indicate the effect of having two HBA oxygen atoms, from the morpholine rings, can have 
upon solubility and the subsequent extraction ability.  
Across all the ligands there is a general trend in increasing log P values along the series BTPs < 
BTBPs < BTPhens, with BTPhens having the highest calculated log P values. This trend is 
reversed for the Fsp3 values in which there is a decrease in this value along the series BTPs > 
BTBPs > BTPhens. This is to be expected based upon the increasing aromaticity as you add an 
additional pyridine ring in going from a BTP to a BTBP and as you add an additional phenyl ring 
in going from a BTBP to a BTPhen. Based upon the Fsp3 values, it is expected that the BTPs L19 
and L22 should have the highest solubilities.   
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Table 14: Table showing calculated Log P and Fsp3 parameters alongside the HBD and HBA 
values for all novel ligands synthesised. Calculated values of log P were obtained using the 
ACD ILabs online software. 
Ligand Ligand Number Log P Fsp3 HBD HBA 
 
1.31 3.69 0.59 0 7 
 
L28 4.59 0.50 0 8 
 
L29 5.33 0.47 0 8 
 
L19 1.46 0.63 0 13 
 
L20 2.24 0.55 0 14 
 
L21 2.86 0.52 0 14 
 
L22 3.20 0.63 0 11 
 
L23 3.99 0.55 0 12 
 
L24 4.67 0.52 0 12 
 
L25 1.23 0.55 2 11 
 
L26 2.06 0.47 2 12 
 
L27 4.62 0.52 0 12 
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In the next two sections the solubility and extraction results will be discussed for the ligands 
synthesised in this chapter. Upon obtaining these results, they will be compared back to the 
theoretical results calculated below in Table 14. 
3.5. Solubility Studies 
The solubility of the ligands were measured in 1-octanol as outlined in Chapter 6. By changing 
the external groups adjacent to the 1,2,4-triazine rings, the influence on the solubilities can be 
determined. These results will then be compared to those of the camphor-BTP 1.31 and the 
synthesised ‘parent’ camphor-BTBP L28 and camphor-BTPhen L29 ligands. Table 15 shows the 
novel terdentate ligands synthesised in this chapter alongside the calculated Fsp3 values and the 
measured solubilities. The applicability of the Fsp3 and log P values in predicting the solubility 
of the ligands will be considered based upon the experimental results shown. Ultimately these 
results will be compared to the theoretical data to determine if a correlation exists between the 
two, and hence whether the proposed ligand design approach can be validated as a means to 
predict ligand solubility more generally.  
There is a general trend, Figure 111, of increasing solubility in 1-octanol as the calculated Fsp3 
increases for each ligand. The lowest measured solubility was for L26, which also has the lowest 
Fsp3 value. This is an expected measurement based upon the ligand structure, which contains only 
an addition CH3 group as part of the methylamine functionality. The ligand L22 observes the 
greatest solubility in 1-octanol, correlating to its high Fsp3 value. In the case of the outlier, in 
which an Fsp3 value above 0.6 correlates to a lower solubility, is representative of L19. This may 
indicate the addition of the morpholine group negatively impact the ligands solubility in 1-octanol 
when compared to L22. When compared to the camphor-BTP 1.31, there is a decrease in 
solubility, suggesting that the maximum solubility of the novel ligands may not have been found. 
Comparison of the functionalised BTBPs, L20 and L23, with the ‘parent’ camphor-BTBP L28 
shows an increased solubility with amide functionalisation. The methylamine-derived ligand L26 
opposes this trend, with a decreased solubility when compared to camphor-BTBP L28, however, 
this decreased solubility correlates to a lower Fsp3 value in comparison to L28. This result is 
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replicated when comparing the ‘parent’ camphor-BTPhen L29 to the functionalised BTPhens; 
L21, L24 and L27.  
 
Figure 111: Graph showing the correlation between a ligands calculated Fsp3 value and its 
measured solubility in 1-octanol (mmol/L). Each data point represents a ligand, see Table 15 for 
further information. 
 
In most cases there is an improved solubility when compared to the camphor-derived parent 
ligands upon introducing the amide functionality, with the exception of the methylamine-derived 
ligand, L26. In the following section the novel BTP, BTBP and BTPhen ligands will be screened 
for their extraction ability to confirm whether the introduction of the amide functional group has 
a positive impact on the extraction of An(III) over the Ln(III) when compared to the ‘parent’ 
camphor-derived ligands. 
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Table 15: The respective Fsp3 value and measured solubility for each novel camphor-derived 
ligand. 
Number Structures 
Solubility 
mmol/L in 1-
octanol 
Fsp3 value 
1.31 
 
200[82] 0.59 
L28 
 
58.1 0.50 
L29 
 
18.6[102] 0.47 
L19 
 
45.1 0.63 
L20 
 
71.4 0.55 
L21 
 
41.8 0.52 
L22 
 
82.1 0.63 
L23 
 
75.2 0.55 
L24 
 
50.4 0.52 
L25 
 
- 0.55 
L26 
 
16.5 0.47 
L27 
 
40.9 0.52 
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3.6. Extraction Studies 
Extraction studies with the novel ligands were carried out to determine the ability of the ligands 
to selectively extract the actinides (An(III)) over the lanthandies (Ln(III)), see Chapter 6 for a 
detailed description. The key focus of this thesis is the separation of, in terms of these 
radioisotopes, Am(III) from Eu(III). Therefore the separation of Am(III) from Cm(III) will only 
be discussed if there is a notable separation achieved by one of the ligands, i.e. SFAm/Cm of 1.5 and 
above. Extraction experiments were completed using 1-octanol as the organic diluent unless 
otherwise specified.  
The extraction studies of the ‘parent’ camphor-BTBP L28 and camphor-BTPhen L29 ligands 
were also completed for comparison with the extraction results for the amide functionalisaed 
ligands discussed in this Chapter. The camphor-BTP 1.31 has been investigated previously for its 
extraction capabilities as discussed in section 1.5.2 and 3.1. When comparing the data obtained 
for the novel BTP ligands discussed in this chapter, considerations will be taken on their different 
concentrations. The camphor-BTP 1.31 was tested at 60 mmol/L and 50 mmol/L in kerosene/1-
octanol and 1-octanol alone, respectively.[82] The novel ligands were all tested at a concentration 
of 10 mmol/L in each diluent used unless specified. The camphor-BTPhen L29, although the 
synthesis and solubility measurements have previously been described,[102] its extraction 
properties have yet to be reported.  
Both the ‘parent’ ligands camphor-BTBP L28 and camphor-BTPhen L29 observed significant 
precipitation at all HNO3 concentrations after 1 hour of contact time with the HNO3 phase, Figure 
112. The top phase is the respective ligand in 1-octanol with the bottom phase being HNO3, 
containing the radioisotopes. This is most likely a consequence of ligand protonation and 
precipitation of the insoluble protonated ligands, as observed previously with the camphor-BTP 
ligand 1.31. As the radioisotope mass balances are indicative of the concentration of these across 
both the aqueous and organic phase, should the precipitate be a ligand complex we would observe 
a decrease in the radioisotope mass balances within the sample. However, this was not observed 
after the screening test for each ligand; L28 and L29. 
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Figure 112: Photographs of the sample tubes after the first screening test with increasing 
[HNO3] from left to right with (a) camphor-BTBP L28; (b) camphor-BTPhen L29. Molecular 
structures are shown alongside the respective photographs. 
 
Figure 113: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L28 measured by α- and 
γ-spectroscopy as a function of the nitric acid concentration of the aqueous phase (1 hr, 22 °C at 
2,200 rpm). Organic phase: 10 mM L28 in 1-octanol. 
 
Figure 114: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L29 measured by α- and 
γ-spectroscopy as a function of the nitric acid concentration of the aqueous phase (1 hr, 22 °C at 
2,200 rpm). Organic phase: 10 mM L29 in 1-octanol. 
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The camphor-BTBP ligand L28 had increasing distribution ratios for all radioisotopes up until a 
concentration of 1.0 M HNO3, after which they decreases again, Figure 113.  The separation 
factor, SFAm/Eu, is over 120 between 0.2 and 1.0 M HNO3, decreasing to 22 at 3.0 M HNO3 as a 
consequence of the fall in distribution ratios. In comparison, for the camphor-BTPhen ligand L29 
the distribution ratios for Am(III) and Cm(III) are significantly higher, indicating more effective 
extraction of these isotopes into the organic phase by the BTPhen ligand L29, Figure 114. The 
subsequent separation factors are in the region of 200 – 250 at 0.1 – 0.8 M HNO3, greater than 
those for the BTBP L28. These extraction results mirror those of the equivalent CyMe4-ligands, 
section 1.5, where it was found that the D values of all metal ions (Am(III), Cm(III) and Eu(III)) 
for CyMe4-BTPhen 1.17 were approximately two orders of magnitude higher than those of 
CyMe4-BTBP 1.09.[95] After 1 M HNO3, as observed with the BTBP L28, there is a drop in the 
distribution ratios, which is most likely due to competing ligand protonation at high HNO3 
concentrations. What is noticeable with this ligand is the deviance in the results obtained by α- 
and γ-spectroscopy for Am(III). This is most likely caused by the increased level of precipitate 
observed after screening this ligand, which can have significant impacts on the α-measurements. 
Solid deposits will prevent the formation of a uniform layer on the alpha disc during analytical 
sample preparation, ensuing some of the alpha particles are unable to pass through the material to 
reach the detector. Within the series of camphor-BTP 1.31, camphor-BTBP L28 and camphor-
BTPhen L29 ligands there is an increased level of precipitate observed when moving from the 
BTP 1.31 to the BTPhen L29 when in contact with the HNO3 phase, which correlates to the 
decrease in Fsp3 values.  
It is difficult to directly compare the camphor-family of ligands to the corresponding CyMe4-
ligands in terms of their extraction ability, due to the tendency of the former ligands to form 
precipitates. A phase modifier or co-diluent could be added to the organic phase to improve their 
solubility and reduce precipitate formation. However, the observed precipitate formation would 
prevent the ligands being considered for future industrial use as a consequence of the safety 
implications that would result from this effect. Going forward, a discussion of the derivatised 
ligands will be made.  
124 
 
The novel ligand L19 was tested under the standard conditions in 1-octanol as above, see Chapter 
6, and observed a gradual increase in the D values for Am(III), Cm(III) and Eu(III) as the HNO3 
concentration increases, Figure 116. This trend has been observed previously with other bis-1,2,4-
triazine ligands, and is to be expected, as metal ion extraction (as nitrate salts) becomes more 
thermodynamically favoured as the nitric acid (and hence nitrate ion) concentration increases. At 
a concentration of 0.30 M HNO3 and above, the D values begin to decrease again. This is probably 
due to competing ligand protonation as the HNO3 concentration increases. The maximum D ratios 
for Am(III) and Eu(III) are 3.41 and 0.65, respectively at 0.3 M HNO3, with a SFAm/Eu of 5.22. At 
lower concentrations the separation factor is at approximately 30, but this is drastically lower at 
higher HNO3 concentrations, at approximately 3 above 0.7 M HNO3. The process conditions the 
ligands have to operate in a future SANEX process are between 3-6 M HNO3, suggesting this 
ligand would be an unsuitable choice for the future reprocessing industry.  
Upon completion of the extraction test with L19 there was a noticeable colour leaching from the 
organic into the aqueous phase upon contact with 1.0 M HNO3, Figure 115. It is assumed that this 
may reflect the suspected dissolution of the protonated ligand into the aqueous phase at higher 
acidities. If the ligand protonation is outcompeting metal complexation, there would be less ligand 
available to complex and extract in Am(III) leading to a reduction in the distribution ratios. As 
precipitation was only observed after contact with the HNO3 the protonated ligand is the likely 
cause.  
 
Figure 115: (a) Photograph of the sample tubes after the first screening test using L19 with 
increasing [HNO3] from left to right; (b) molecular structure of L19. 
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Figure 116: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L19 measured by α- and 
γ-spectroscopy as a function of the nitric acid concentration of the aqueous phase (1 hr, 22 °C at 
2,200 rpm). Organic phase: 10 mM L19 in 1-octanol. 
 
Following the work by Geist and co-workers on camphor-BTP 1.31 it was decided to complete 
the extraction with ligand L19 in a TPH/1-octanol (7:3 vol. ratio) mixture to investigate the impact 
of this solvent system. As discussed in the introduction, camphor-BTP 1.31 saw higher 
distribution ratios in TPH/1-octanol in contrast to 1-octanol alone despite observing a poorer 
solubility in this diluent. The complete dissolution of ligand L19 at a concentration of 0.1 M 
HNO3 was achieved in this diluent mixture. However, upon instant contact with the HNO3 phase 
there was precipitation observed at HNO3 concentrations above 1 M. After completion of the 
screening test, there was a significant brown precipitate observed at HNO3 concentrations up to 
and including 1 M HNO3, Figure 117. At a 3.0 M HNO3 concentration, where no precipitation 
was observed, there was significant discolouration of the aqueous phase, as perceived in the 1-
octanol screening test. This indicates that the precipitate has dissolved in the aqueous phase at 
higher acidities. The obtained extraction data shows low D ratios for the radioisotopes across all 
concentrations, Figure 118. There is a 10-fold decrease in the D ratios in comparison to the same 
ligand when the diluent considered was 1-octanol, in contrast to the reversed observation by Geist 
and co-workers. This is undoubtedly correlated to the decreased solubility of the ligand in this 
diluent mixture. 
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Figure 117: a) Photographs of the sample tubes after the first screening test using L19 after 
phase mixing, increasing [HNO3] from left to right; (b) molecular structure of L19. 
          
Figure 118: Distribution ratios for the extraction of 152Eu, 241Am, 244Cm by L19 measured by α- 
and γ-spectroscopy as a function of the nitric acid concentration of the aqueous phase (1 hr, 22 
°C at 2,200 rpm). Organic phase: 10 mM L19 in TPH/1-octanol (7:3 vol. ratio) 
 
The functionalisation in L19 with morpholine thus has a negative impact on the extraction results 
when directly compared to camphor-BTP 1.31. This poor extraction capability may be explained 
by the increased precipitation observed for L19, which would prevent the ligand from taking part 
in the extraction of An(III) into the organic phase. As the camphor-BTP 1.31 was screened at a 
higher concentration than the L19 in both diluents, this suggests that the precipitate would be 
considerable if tested at the same concentration.  
The ligand L20 observed a similar solubility trend to L19, with increasing precipitation as the 
HNO3 concentration increases, with the exception of the highest HNO3 concentration at 3.0 M, 
Figure 119. Again, at this concentration the same phenomena was noted, in which there was 
colour leaching into the aqueous phase, Figure 120. The D values for all radioisotopes are 
considerably lower than the camphor-BTBP L28, at 2 orders of magnitude across all 
concentrations. The DAm value reaches a maximum value of 0.04 at 1.0 M HNO3 indicating there 
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is negligible extraction of Am(III) or Cm(III). As a result, the SFAm/Eu values are all low and 
essentially meaningless due to the fact that no radioisotopes are being extracted from the aqueous 
phase into the organic phase. In terms of future industry potential, the ligand L20 would thus be 
unsuitable for further development.  
 
Figure 119: Distribution ratios for the extraction of 152Eu, 241Am, 244Cm for L20 measured by α- 
and γ-spectroscopy as a function of the nitric acid concentration of the aqueous phase (1 hr, 22 
°C at 2,200 rpm). Organic phase: 10 mM L20 in 1-octanol. 
  
 
Figure 120: a) Photographs of the sample tubes after the first screening test using L20 after 
phase mixing, increasing [HNO3] from left to right; (b) molecular structure of L20. 
 
The ligand L21 observed the greatest quantity of precipitate formation after the screening test of 
all the morpholine functionalised ligands, the extraction data can be found in the appenxdix. This 
can be attributed to the increased basicity of the BTPhen L21 ligand. At the highest HNO3 
concentration, 3.0 M, the same discolouration of the aqueous phase is observed as with the other 
morpholine-derived ligands (L19 and L20). Again the same reduction in the visual amount of 
precipitation at this HNO3 concentration (3.0 M) is observed, Figure 121. Clearer for this ligand 
L21, is the gradual colour change from deep yellow to a faint yellow as the HNO3 concentration 
increases, and in correlation with the increasing precipitate.  
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Figure 121: (a) Photographs of the sample tubes after the first screening test using L21, 
increasing [HNO3] from left to right; (b) molecular structure of L21. 
 
The results from γ-spectroscopy can be found in the appendix, with low DAm and DEu observed 
across all concentrations, indicating the radioisotopes remain in the aqueous phase, as was 
observed for similar ligands L19 and L20. The mass balances attained for the γ-measurements, 
in which the precipitate was avoided, are consistent across all HNO3 concentrations. This suggests 
the precipitation is not a consequence of a ligand complex with either Am(III), Cm(III) or Eu(III) 
and subsequently it is a sensible suggestion that this precipitation is a consequence of the 
protonated ligand coming out of the solution upon contact with the HNO3 aqueous phase. To gain 
confirmation of the precipitate composition, a technique such as X-ray crystallography or NMR 
spectroscopy would be beneficial. Unfortunately this was not carried out due to the presence of 
the radioisotopes. 
  
The sensitivity of α-spectroscopy to solid deposits on the plates means the analysis was limited 
to γ-spectroscopy. Although this limits the ability to analyse for Cm(III), a good indication of the 
distribution of Am(III) and Eu(III) across the two phases in each sample and hence the ligand’s 
extraction capability was still obtained.  
   
An alternative secondary amine considered was piperidine in which the BTPhen L27 was 
successfully purified to be screened for its extraction capabilities, Figure 122. The extraction test 
for ligand L27 showed an increase in the D values for Am(III) and Cm(III) with increasing HNO3 
concentration, apart from one decrease at 0.7001 M HNO3, Figure 123. At the higher HNO3 
concentrations, a decrease in the distribution ratios for Eu(III) was observed, indicating that a 
greater concentration of this radionuclide remains in the aqueous phase and the subsequent 
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SFAm/Eu increases dramatically. As stated previously, in industry this extraction would be 
completed at HNO3 concentration ranges of 3-6 M HNO3, and at the highest HNO3 concentration 
this ligand has an excellent SFAm/Eu value of 230. An additional benefit with this ligand L27 is the 
low D ratios of Am(III) and Cm(III) observed at low HNO3 concentrations. In a future SANEX 
process, the back-extraction (or stripping) of Am(III) and Cm(III) would be carried out at low 
HNO3 concentrations (0.1 M HNO3) following the extraction step. The low D values for Am(III) 
and Cm(III) observed for L27 at low HNO3 concentrations would facilitate this stripping step.  
 
Figure 122: a) Photographs of the first screening test using L27, increasing nitric acid 
concentration from left to right; b) molecular structure of L27. 
 
Figure 123: Distribution ratios for extraction of 152Eu, 241Am, 244Cm using L27 measured by α- 
and γ-spectroscopy as a function of the nitric acid concentration of the aqueous phase (30 min, 
22 °C at 2,200 rpm). Organic phase: 10 mM L27 in 1-octanol. 
 
Unlike the morpholine-BTPhen L21, there was no precipitation observed with BTPhen ligand 
L27 indicating an increased solubility of this ligand L27 when the organic phase is in contact 
with the HNO3 aqueous phase. The addition of the oxygen atom in the morpholine-derived ligands 
lowers the log P value of L21 by more than 2 when compared to the L27, suggesting a lower 
lipophilicity, Table 16. The lower lipophilicity would decrease the solubility of the protonated 
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ligand in 1-octanol and perhaps increases its solubility in a HNO3 aqueous phase, resulting in 
movement of the ligand across the organic/aqueous interface and hindering its ability to extract 
the An(III). During the extraction screening of L21, it is noted that with an increasing HNO3 
concentration, there is an increased colour change for the aqueous phase and a decrease in the 
level of precipitation observed. This suggests the precipitate is dissolved in the acidic aqueous 
phase, and would support the lower theoretical lipophilicity obtained for L21, from the log P 
values. The piperidine-derived BTP L31 and BTBP L32 were unfortunately not tested for their 
extraction properties due to difficulties in the purification of the samples, subsequently 
comparisons beyond the theoretical values cannot therefore be made. Considering the extraction 
data received for the ligand L27, the piperidine group has a significant impact on the D values 
and hence the SFAm/Eu in comparison to the use of the morpholine, potentially as a result of the 
increased solubility of the ligand when in contact with the HNO3 phase. This may be a 
consequence of an increased basicity of L21 which contains the morpholine group, although the 
pKa values for these ligands were not measured.  
 
Table 16: Respective calculated log P values of the morpholine- and piperidine-derived bis-
1,2,4-triazine ligands from the ACD I-lab software. 
Ligand Code Log P (ACD I-lab) 
Morpholine-BTP L19 3.06 
Morpholine BTBP L20 3.34 
Morpholine BTPhen L21 3.84 
Piperidine BTP L31 517 
Piperidine BTBP L32 5.45 
Piperidine BTPhen L27 5.95 
 
Finally, the BTP L22, BTBP L23 and BTPhen L24 ligands synthesised from the diethylamine-
derived diketone 3.3.10 were screened. The BTP L22 observed an increase in the distribution 
ratios for all radionuclides up until 0.296 M HNO3, after which a decrease was observed. This 
suggests that as the nitric acid concentration is increasing, ligand protonation is outcompeting 
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metal complexation, with the D value for Am(III) dropping below 2 at 3 M HNO3. This is a well-
known phenomenon for the BTP ligands and to a lesser extent the BTBPs and BTPhens, as a 
consequence of the BTP ligand basicity. The SFAm/Eu increases from 53.52 to average at 
approximately 75.00 at higher HNO3 concentrations, Figure 124.  Despite the large DAm, DCm and 
SFAm/Eu, values the DAm falling below 3 at 3.0 M HNO3 isn’t ideal for industrial application. In 
comparison to the corresponding camphor-BTP, this shows an improved extraction capability in 
1-octanol then seen in research by Geist and co-workers, as no precipitate was observed across 
all concentrations tested, Figure 125.[82]  
 
Figure 124: Distribution ratios for extraction of 152Eu, 241Am, 244Cm using L22 measured by α- 
and γ-spectroscopy as a function of the nitric acid concentration of the aqueous phase (30 min, 
22 °C at 2,200 rpm). Organic phase: 10 mM L22 in 1-octanol. 
 
Figure 125: Photographs of the sample tubes after the first screening test using L22, with 
increasing [HNO3] from left to right; (a) molecular structure of L22. 
 
For the ligand L23, the screening for extraction capability was completed at a lower 
concentration, 0.006 M, as a result of a limited quantity of the purified ligand sample being 
obtained. This must be taken into consideration when comparing its results with those of the other 
ligands. At this lower concentration there was no precipitate observed after 1 hour of phase 
mixing, Figure 126. Despite the slightly lower concentration of the sample, at 6 mmol/L organic 
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solution of L23, the separation factor for Am(III) over Eu(III) (SFAm/Eu) was consistently greater 
than 100 when in contact with ≥ 0.3 M HNO3 aqueous phase, Figure 127. The D ratio for Am(III) 
increases until reaching a maximum of 4.68 at 1.0 M HNO3, where it subsequently decreases 
again to 1.31 at 3 M HNO3. This decrease in the D ratio, although it has minimal impact on the 
separation factor, may be a concern for future industrial implementation. Those waste solutions 
with a high metal loading would require a greater D ratio in order to achieve effective separations 
in the required phase mixing times. Since D values depend on the ligand concentration, the D 
values for ligand L22 should increase if a higher concentration of the ligand L22 within the 
organic phase was used than that trialled here, providing ligand solubility doesn’t then pose an 
issue. 
 
Figure 126: (a) Photographs of the sample tubes after the first screening test using L23, with 
increasing [HNO3] from left to right; (b) molecular structure of L23. 
 
 
Figure 127: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L23 measured by α- 
and γ-spectroscopy as a function of the nitric acid concentration of the aqueous phase (1 hr, 22 
°C at 2,200 rpm). Organic phase: 10 mM L23 in 1-octanol. 
 
The extraction test for the BTPhen ligand L24 showed a continuous increase in the D values for 
Am(III) and Cm(III) across the HNO3 concentrations, using the same conditions as dictated in 
0.001
0.01
0.1
1
10
0.001 0.01 0.1 1 10
D
is
tr
ib
u
ti
o
n
 r
at
io
 (
D
)
nitric acid [mol/L]
Am gamma
Eu gamma
Am alpha
Cm alpha
133 
 
Chapter 6 apart from the contact time, which was reduced to 30 minutes. The D ratio of Eu(III) 
increases up until 0.296 M HNO3, where it then decreases again, a phenomena observed with the 
previous BTPhen ligands, at the highest HNO3 concentration, Figure 128.[95] As a consequence, 
the SFAm/Eu is significantly increased to 111 at 3.0 M HNO3, with the D value for Am(III) being 
two orders of magnitude higher than that for Eu(III) at this HNO3 concentration. These results 
show that at higher concentrations of HNO3, above 1.0 M HNO3, high selectivity between Am(III) 
and Eu(III) is achieved with this ligand L24, comparable to that of the benchmark ligand CyMe4-
BTBP 1.09, but without the need for a phase transfer agent. There was no selectivity observered 
between Am(III) and Cm(III), with SFCm/Am values falling between 0.89 – 1.38. The ligand 
showed clear phase separation and no precipitation upon contact with the HNO3 aqueous phase, 
unlike that observed for the camphor-BTPhen L29, Figure 129. 
 
Figure 128: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L24 measured by α- and 
γ-spectroscopy as a function of the nitric acid concentration of the aqueous phase (30 min, 22 
°C at 2,200 rpm). Organic phase: 10 mM L24 in 1-octanol. 
 
Figure 129: (a) Photographs of the sample tubes after the first screening test using L24, 
increasing [HNO3] from left to right; (b) molecular structure of L24. 
 
The ligand L24 does have lower D values and separation factors than those observed for the 
related ligand CyMe4-BTPhen 1.17, but this is not necessarily a hindrance to the ligands potential 
within a future industrial process. When the D values are increasingly high this could cause issues 
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for the back-extraction (or stripping) of the metal from the ligand, so that the ligand can be 
recycled and re-used. Having lower D values is desired to avoid the addition of a hydrophilic 
stripping agent (such as glycolic acid) which would increases costs of the process. Ideally, for the 
purposes of stripping, D values of below 1 are desirable at low HNO3 concentrations, the 
conditions utilised for the metal back-extraction in a process. At 0.01 M HNO3 the DAm and DCm 
values fall just below 1, indicating stripping of both An(III) is possible at these HNO3 
concentrations. Investigation into the ligands extraction kinetics, section 3.6, will give a further 
indication of the plausibility of its potential in industry, as specified in the aims and objectives.  
 
Interestingly, both the piperidine-BTPhen L27 and diethylamine-BTPhen L24 ligands observe 
the same trend regarding the decreasing D ratio of Eu(III) at higher HNO3 concentrations, similar 
to the CyMe4-BTPhen ligand 1.17. This phenomenon isn’t yet fully understood but it is proposed 
that ligand protonation out-competes metal complexation with regards to the formation of a ligand 
complex with Eu(III). The use of TRLFS found that the CyMe4-BTPhen 1.17 forms a 1:2 complex 
with Cm(III) that has an increased stability constant when compared the complex formed with 
Eu(III), with log beta values of 13.8 and 11.6 for the Cm(III)-CyMe4-BTPhen 1.17 and Eu(III)-
CyMe4-BTPhen 1.17, respectively.[94a]  
 
The BTP L25 and BTBP L26 ligands derived from the primary amine, methylamine, were next 
tested for their extraction abilities. The L25 observed increasing D ratios with regards to Am(III) 
and Cm(III) with increasing HNO3 concentration up until 1.0 M HNO3, whereafter these values 
decline, Figure 130. Despite the observation of no precipitation across all samples, there were 
notably low D ratios observed for all radioisotopes, remaining below 0.1 across all concentrations. 
Observation of the sample tubes after the screening test showed a notable colour change as the 
HNO3 concentration increased, although this was less notable then previous ligands tested 
(morpholine-derived ligands) Figure 131. This suggests that some degree of ligand dissolution 
into the aqueous phase is occurring, which would reduce its ability to act as an extractant, in 
agreement with the low D ratios. Alternatively, the ligand may not be hydrophobic enough to 
extract the Am(III) or Cm(III) or forms complexes which are thermodynamically weak. Further 
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studies could investigate the reasoning for this ligands poor solubility including TRLFS and 
EXAFS.  
 
Figure 130: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L25 measured by α- 
and γ- spectroscopy as a function of the nitric acid concentration of the aqueous phase (60 min, 
22°C at 2,200 rpm). Organic phase: 10 mM L25 in 1-octanol. 
 
 
Figure 131: (a) Photograph of the sample tubes after the first screening test using L25, 
increasing [HNO3] from left to right; (b) molecular structure of L25. 
 
The methylamine-derived BTBP ligand L26 displays increasing D ratios for Am(III) and Cm(III) 
across all HNO3 concentrations, which is less pronounced for Eu(III), Figure 132. However, the 
D ratios all remain below 0.1 as was observed for L25. Thus the addition of a N-methyl amide 
substitutent to the camphor backbone has a negative impact on the extraction capabilities or 
corresponding BTP and BTBP ligands when compared to the extraction properties of the 
corresponding secondary amide derivatives. The discolouration of the aqueous phase, as observed 
with L25 again correlate to the ligands decreased lipophilicty and hence improved solubility in 
the aqueous phase. Significant precipitation was observed at the highest HNO3 concentration of 
3.0 M, suggesting ligand protonation, Figure 133. 
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Figure 132: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L26 measured by α- 
and γ- spectroscopy as a function of the nitric acid concentration of the aqueous phase (60 min, 
22°C at 2,200 rpm). Organic phase: 10 mm L26 in 1-octanol. 
 
 
Figure 133: (a) Photograph of the sample tubes after the first screening test by L26, increasing 
[HNO3] from left to right; (b) molecular structure of L26. 
 
Based upon the extraction data obtained for the ligands discussed in this chapter it is clear that 
functionalisation of the camphor moiety can have significant impacts on the extraction properties 
of the ligands. Where poor extraction performance was observed this was generally related to 
ligand precipitation in contact with the HNO3 phase and correlated to a lower calculated log P 
value. Suggesting this may, in future, give an indication for a ligands ability to extraction Am(III) 
and Cm(III) from the aqueous phase containing Eu(III). The extraction kinetics of some ligands 
will be discussed in the following section.  
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3.7. Kinetics studies 
Where reasonably encouraging D values and SFAm/Eu values were observed in the initial extraction 
experiments upon varying the nitric acid concentration, it was decided to complete a kinetics 
study. This would gain an insight into the extraction kinetics, or rates of metal extraction, of these 
ligands as stated in the project aims. The rate of extraction of a given metal by a ligand can be 
measured by the time taken for the D value to reach its equilibrium value. The rates of metal 
extraction are significant and important to measure when designing a future extraction process, 
since the D values for all metal ions need to be at thermodynamic equilibrium during a process. 
The rates of extraction were investigated at specific HNO3 concentrations, typically 0.30 M or 
1.00 HNO3 over the time period of 60 minutes, in order to establish how long the phases need to 
be mixed for before extraction equilibrium is reached. The benchmark ligand CyMe4-BTBP 1.09 
requires a contact time of approximately 60 minutes to reach equilibrium, while CyMe4-BTPhen 
1.17 achieves equilibrium after 15 minutes of phase contact time, without the need for a phase-
transfer agent in both cases.  
 
The ligand L24 shows very fast extraction kinetics for Am(III) and Cm(III) at 0.30 M HNO3, 
Figure 134, with the distribution ratios reaching equilibrium within 5 minutes of phase mixing. 
This shows significantly faster kinetics than CyMe4-BTPhen 1.17, which observes comparable D 
values for Am(III) but requires longer to reach its equilibrium. Direct comparisons should be 
judged with care due to the different nitric acid concentrations utilised, CyMe4-BTPhen 1.17 was 
tested at 1.0 M HNO3. The data obtained for L24 demonstrates the ligands ability to selectively 
extract Am(III) and Cm(III) with short contact times, whilst still achieving a DAm and DCm of 
greater than 20 and a SFAm/Eu of 8. A comparable extraction as obtained for CyMe4-BTPhen 1.17 
as this concentration.[95] The separation factor (SFCm/Am) was found to average at 1 for L24, a 
value not significant enough to suggest the ligand could be utilised to achieve this separation.  
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Figure 134: Distribution ratios and SFCm/Am for the extraction of 241Am, 244Cm and 152Eu by L24 
as a function of contact time. (0.296 M, 22 °C at 2,200 rpm) Organic phase: 10 mM L24 in 1-
octanol. 
 
The ligand L19, which showed the least precipitation amongst the morpholine-derived ligands, 
was examined for its extraction kinetics in the screening for its extraction of Am(III) and Cm(III) 
from the aqueous phase at 0.30 M HNO3, Figure 135. The equilibrium distribution ratios were 
reached within 5 minutes for both the An(III) and Eu(III), but with a lower SFAm/Eu of 
approximately 3, then was observed for L24. A similar SFCm/Am of 1 was observed for L19. These 
extraction kinetics are slightly improved on the comparable camphor-BTP 1.31, as reported in the 
work by Geist and co-workers,[82] in which extraction equilibrium was reached within 10 minutes 
at a HNO3 concentration of 1 M, using the diluent TPH/1-octanol (7:3 vol.).  
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Figure 135: Distribution ratios and SFCm/Am for the extraction of 241Am, 244Cm and 152Eu by L19 
as a function of contact time. (0.296 M, 22 °C at 2,200 rpm) Organic phase: 10 mM L19 in 1-
octanol. 
 
3.8. NMR Titration Studies 
In order to establish the potential species that may be present during an extraction experiment, 
NMR titration studies were completed with the lanthanide nitriate salts acting as actinide 
surrogates. Lanthanum (La(III)) and lutetium (Lu(III)) were selected as the lanthanide salts, along 
with yttrium (Y(III)) (all as nitrate salts) due to their diamagnetism and the subsequent likelihood 
of obtaining a well resolved spectra. A CD3CN-d3 solution of La(NO3)3, Y(NO3)3 and Lu(NO3)3 
were individually titrated against solutions of the ligands functionalised in this chapter, in the 
same solvent. In this section the most significant titrations will be discussed and a complete data 
set for all ligand titrations can be found in the Appendix.  
A 1H NMR titration of a CD3CN-d3 solution of L19 with La(NO3)3 was completed, and the 
formation of a 1:2 metal-ligand complex was observed, Figure 136. The initial spectrum shows 
the free ligand species with a doublet at δ 6.87 ppm and a triplet at δ 8.15 ppm. Upon addition of 
0.3 equivalents of La(NO3)3 the appearance of new signals at δ 9.12, 8.90 and 8.49 ppm were 
observed with complete disappearance of the free ligand resonances occurring upon addition of 
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0.4 equivalents of the lanthanide salt. There were no further spectroscopic changes on further 
addition of the lanthanide salt. This observation corresponds to the 1:3 metal-ligand complex 
suggesting three ligand molecules surround the lanthanum metal centre, as complete 
disappearance of the starting material is seen. A similar observation was made for L22, see 
appendix for the full data set.  
 
Figure 136: 1H NMR titration of L19 with increasing equivalents of La(NO3)3 showing a 1:3 
complexation formation after the addition of 0.3 eq. La(NO3)3. 
 
A 1H NMR titration of ligand L24 with La(NO3)3 in CD3CN-d3 shows the formation of metal-
ligand complexes. After 0.1 eq. addition of the lanthanide salt the formation of a 1:2 complex is 
observed with signals appearing at δ 9.09, 8.82 and 8.46 ppm. Complete disappearance of the free 
ligand signals is perceived after 0.5 eq. of La(III) had been added, indicating the initially formed 
complex is a 1:2 metal:ligand complex. Formation of a 1:2 complex was also observed on further 
additions of the lanthanide salt and complete saturation with this complex is achieved after 0.9 
eq. of the lanthanide salt had been added. When using Lu(NO3)3 in a similar titration study, the 
formation of both 1:1 and 1:2 complexes was also observed after a total of 1.2 equivalents addition 
ab
u
n
d
an
ce
-1
.6
-1
.5
-1
.4
-1
.3
-1
.2
-1
.1
-1
.0
-0
.9
-0
.8
-0
.7
-0
.6
-0
.5
-0
.4
-0
.3
-0
.2
-0
.1
0
0
.1
0
.2
0
.3
0
.4
0
.5
X : parts per Million : Proton
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0
1.0 eq.
0.1 eq.
0.2 eq.
0.3 eq.
0.4 eq.
0.5 eq.
0.6 eq.
0.7 eq.
0.9 eq.
1.1 eq.
0.8 eq. 
Free Ligand
141 
 
of the lanthanide nitrate had been added, Figure 137. La(III) is a larger lanthanide then  Lu(III), 
as a consequence of the lanthanide contraction, and may aid in the explaining why a 1:1 complex 
was still observed after 1.2 equivalents addition. The high D values obtained in the extraction 
experiments, section 3.6 may be attributed to the formation of these 1:2 bis-complexes. 
 
Figure 137: 1H NMR titration of L24 with increasing equivalents of Lu(NO3)3 showing a 1:2 
complex forming upon addition of 0.1 eq. and 1:1 complex upon addition of 0.4 eq.  
  
The 1H NMR titration of L27 with La(NO3) shows the same 1:2 and 1:1 complex formation upon 
increasing addition of the lanthanide nitrate, Figure 137. The 1:2 complex is initially observed 
upon addition of 0.1 equivalents of La(NO3)3, with the 1:1 complex being observed after 0.5 
equivalents of the lanthanide salt had been added. Upon addition of 1.2 equivalents of the 
lanthanide salt there is almost complete saturation with the 1:1 complex. This shows a similar 
trend to that observed for L24. This could potentially be a significant result in explaining why 
these ligands show slightly lower distribution ratios during extraction screening for Am(III) and 
Cm(III). The CyMe4-BTBP 1.09 and CyMe4-BTPhen 1.17 don’t observe this almost complete 
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disassociation of the 1:2 complexes upon increasing equivalents of the lanthanide salt, suggesting 
the 1:2 complexes formed from the novel ligands L27 and L24 may be less stable.[96] 
3.9. Conclusion 
In this chapter a versatile two-step synthesis has been established to obtain a range of amide-
diketone derivatives of ketopinic acid using both primary and secondary amines. These diketones 
were used to synthesise the corresponding BTP, BTBP and BTPhen ligands from the 
corresponding bis-amidrazones, in most cases. Mixed solubility results were observed that 
correlate to the ligand families, with increasing solubility being found generally across the series 
of BTPs > BTBPs > BTPhens.  
 In solvent extraction experiments the BTPhen derivatives observed the greatest separation factor 
for Am(III) over Eu(III) of all the ligand families tested; BTP, BTBP or BTPhen. In particular, 
those ligands containing the diethyl amide and piperidine amide groups showed the most 
encouraging extraction properties, with no precipitates being observed in contact with the HNO3 
aqueous phase. It is apparent that the addition of the morpholine amide group negatively impacts 
ligand solubility upon contact with the HNO3 phase. This may suggest that consideration of the 
log P values can give a good indication as to the potential solubility of a ligand when in contact 
with the HNO3 phase, with the calculated log Ps for the morpholine ligands being some of the 
lowest considered.  
The diethylamide-derived BTPhen ligand L24 observed high D ratios for Am(III) and Cm(III) 
with a SFAm/Eu OF 111.17 at 3.0 M HNO3, in addition to reaching equilibrium within 5 minutes 
of phase mixing. This is significantly improved extraction kinetics compared to the benchmark 
ligand CyMe4-BTPhen 1.17, which achieves extraction equilibrium within 15 minutes. Despite 
the D ratios being lower than those of the CyMe4-BTPhen 1.17, they are still high enough to 
achieve effective and efficient extraction of Am(III) and Cm(III) and can be considered as a viable 
alternative to the benchmark ligands. The piperidine amide-derived BTPhen ligand L27 
additionally shows the same extraction capabilities, with a SFAm/Eu at 3 M HNO3 of 231. This will 
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need to be further investigated to gauge the kinetics of this particular ligand and how it compares 
to both the CyMe4-BTPhen ligand 1.17 and L24.  
The NMR titrations give evidence to the presence of both 1:1 and 1:2 complex formations under 
the titration conditions. The slightly decreased D ratios in comparison to CyMe4-BTPhen may be 
explained by the apparent decreased stability of the 1:2 complexes within solution. However, this 
wouldn’t prevent the potential future implementation of these ligands in a process, as these D 
ratios would still allow for quantitative separation. 
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Chapter 4 
 
 
Modified CyMe4 ligands derived from modified 
CyMe4 diketones. 
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4. Modified CyMe4-ligands derived from modified CyMe4-diketones. 
4.1. Introduction 
The tetramethylcyclohexyl (CyMe4) group 4.1.1 has emerged as the dominant aliphatic side group 
of the bis-triazinyl-pyridine (BTP), bis-triazinyl-bipyridine (BTBP) and bis-triazinyl-
phenanthroline (BTPhen) ligands, section 1.5, Figure 138.  When incorporated into the ligands, 
the CyMe4 group confers good radiolytic and hydrolytic stability to bis-1,2,4-triazine ligands, in 
contrast to simple n-alkyl groups. This is due to the absence of any hydrogen atoms at the benzylic 
positions adjacent to the triazine rings. As a result, the final ligands, in particular CyMe4-BTBP 
1.09 and CyMe4-BTPhen 1.17, are the leading candidates for industrial implementation in the 
SANEX process. However, the complex and time-consuming synthesis of the CyMe4 diketone 
intermediate 4.1.1 used to synthesise these ligands, the limited solubility of the ligands in 
preferred diluents (1-octanol, dodecane etc.) and the relatively slow rates of metal extraction are 
some issues that still remain. New ligand developments have focused in two areas, on replacing 
the CyMe4 moiety 4.1.1 of the ligands altogether or on the functionalisation of the bis-1,2,4-
triazine backbones, both discussed in section 1.5. Currently a satisfactory replacement for the 
CyMe4 diketone 4.1.1 has not been identified that includes its beneficial properties but improves 
on its drawbacks.  
 
Figure 138: Dominant ligand from each family; CyMe4-BTP 1.30, CyMe4-BTP 1.09 and 
CyMe4-BTP 1.17. 
 
The CyMe4 group 4.1.1 was first utilised in the synthesis of a bis-triazinyl-pyridine (BTP) ligand 
1.30 as a result of insufficient chemical stability to radiolysis and hydrolysis of previous n-alkyl 
substituted BTP derivatives, section 1.5.2. This group has the benefit of having no benzylic 
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hydrogens, which can be abstracted by free radicals, nitrite ions or nitrogen oxides when in contact 
with the HNO3 aqueous phase. Upon exposing the CyMe4-BTP 1.30 to boiling nitric acid (3 M) 
there was no degradation after 24 hours. In contrast the alkylated i-Pr-BTP 1.29 ligand showed 
extensive degradation.[80] The addition of an extra aromatic ring in 1.09, improved the resistance 
to radiolysis of the BTP ligands, which was thought to result from the distribution of excess 
energy from the absorbed gamma radiation across the aromatic π-system.[80] The CyMe4-BTBP 
1.09 was found to be resistant to hydrolysis for up to 90 days.[86] 
There has been no attention paid to developing new synthetic protocols that lead to modified 
derivatives of the CyMe4 group 4.1.1 itself. In the current research, the general structure of the 
CyMe4-diketone 4.1.1 will be the basis for modified derivatisatives 4.1.2, Figure 139, with the 
highlighted tetramethylcyclohexane ring being the common feature through all the modified 
diketones. Alternative synthetic methods will be investigated to functionalise the CyMe4-diketone 
4.1.1 with moieties that are intended to improve the solubility and increase the rates of extraction 
of the derived ligands. The introduction of additional hydrogen bond donor and acceptor groups 
(HBD/HBA) should influence the polarity of the ligands when compared to the analogous 
benchmark ligands 1.30, 1.09 and 1.17. This increased polarity may enable a higher concentration 
of the ligand to exist at the phase interface and hence improve the rates of extraction. Introducing 
these groups will also increase the Fsp3 value (if these groups contain sp3-hybridised aliphatic 
carbon atoms), which is thought to directly correlate to ligand solubility. Previous developments, 
such as the addition of the tert-butyl group on the CyMe4-BTBP ligand 1.09 saw an increase in 
solubility but a decrease in the rates of extraction of the resulting ligand 1.37.[87, 89, 158] Thus is has 
been difficult to increase ligand solubility without simultaneously decreasing the ligand’s rates of 
extraction. It is hoped that, through the addition of HBD/HBA functional groups (eg: amide, ether, 
alkoxy groups etc) containing sp3-hybridised carbon atoms, the solubility and rates of extraction 
of the ligands can be simultaneously increased. This could pave the way for the rational design of 
future bis-1,2,4-triazine ligands with improved extraction properties.  
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Figure 139: Molecular structure of the CyMe4 diketone 4.1.1 and the general structure of the 
functionalised CyMe4-diketones containing the (R) at the 4-position 4.1.2. The common 
structure in both is highlighted in blue. 
 
Discussed in this chapter is the synthesis of novel functionalised CyMe4-diketones that are utilised 
to form novel BTP, BTBP and BTPhen ligands. The subsequent solubility and extraction results 
are discussed for those ligands successfully synthesised and compared to the analogous 
unfunctionalised ligands CyMe4-BTP 1.30, CyMe4-BTBP 1.09 and CyMe4-BTPhen 1.17. 
4.2. Synthesis of modified CyMe4 diketones and ligands 
The lost-cost reagent 5,5-dimethylcyclohexane-1,3-dione (dimedone) 4.2.1 was chosen as the 
starting material for the synthesis of all derivatives, due to the presence of the dimethylated-
cyclohexane ring and its similarity to the CyMe4-diketone 4.1.1. Dimedone 4.2.1 was initially di-
methylated with iodomethane in the presence of base to remove the hydrogens present to give the 
2,2,5,5-tetramethylcyclohexan-1,3-dione 4.2.2, Figure 140.[159] The alkylation proceeds to give 
4.2.2 in yields of 80% and above, dependent on the batch.  
 
Figure 140: Reaction scheme for the synthesis of 4.2.3; Reaction conditions: (i) iodomethane, 
K2CO3, EtOH/H2O, (ii) SeO2, toluene. 
 
From the product formed 4.2.2 a variety of reactions can be completed to give novel diketones, 
involving synthetic manipulation of one of the carbonyl groups, followed by oxidation of the 
products with selenium dioxide (SeO2). One of these strategies involves the oxidation of 4.2.2 
with SeO2 to form the 3,3,6,6-tetramethylcyclohexane-1,2,4-trione 4.2.3. Following a procedure 
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by Wenkert and co-workers,[160] this oxidation was initially attempted using 2 equivalents of SeO2 
in refluxing toluene. The over-oxidation that would result in the formation of the corresponding 
tetra-ketone was hoped to be avoided. Only a 12% yield of the final product 4.2.3 was obtained 
after an overnight reaction, with the 1H NMR spectrum of the crude product showing that starting 
material remained. An increase in the SeO2 stoichiometry to 2 and then 3 equivalents, saw an 
increase in the yield to 26%, Table 17, entries 1-3. There was limited, if any, observation of the 
tetra-ketone forming under these conditions. Furthering efforts to improve product conversion, 
alternative solvents were explored which included 1,4-dioxane and acetic acid. The use of either 
solvent resulted in the disappearance of the starting material as followed by 1H NMR with 
additional signals being observed in the aliphatic region. In particular, the use of acetic acid 
resulted in various impurities observed in the 1H NMR spectrum which were not observed in 1,4-
dioxane, in which a cleaner crude product was obtained. The final yields of 4.2.3 when utilising 
1,4-dioxane or acetic acid were similar, at 30 and 32% respectively, Table 17, entries 4-5. Going 
forward it was decided to utilise 1,4-dioxane as the solvent based upon the improvement in the 
purity of the crude product obtained.  
Table 17: Reaction conditions trialled for the formation of the tri-ketone 4.1.3. 
Entry Selenium Dioxide Solvent Reaction Time (hr) Yield 
1 2.0 eq. Toluene 24 12 % 
2 3.0 eq. Toluene 20 15 % 
3 2.5 eq. Toluene 24 26 % 
4 2.0 eq. 1,4-dioxane 24 30 % 
5 2.0 eq. Acetic acid 24 32 % 
6 1.0 eq. 1,4-dioxane 72 26 % 
 
The SeO2 stoichiometry was again varied in the chosen solvent, 1,4-dioxane, but it was found that 
reducing the stoichiometry negatively impacted the product yield. There appears to be little 
sensitivity in the amount of SeO2 used in the reaction, with only trace amounts of the tetra-ketone 
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being observed. Based upon the product yields obtained and observation of the crude 1H NMR 
spectra, there appears to be some loss of product during work up. Column chromatography 
fractions included the starting material 4.2.2, product 4.2.3 and then a third fraction containing 
multiple aliphatic impurities. For the purpose of obtaining the final ligands, it was decided to use 
these reaction conditions, regardless of the yield. Should a scaled-up synthesis of any of the 
ligands need to be developed, this reaction will need to be optimised further by investigating 
alternative, less toxic oxidising reagents.  
 
Figure 141: Molecular structures of the ligands derived from the condensation reactions of the 
triketone 4.2.3 with bis-amidrazones, with one representative regioisomer shown in each case a) 
L31, b) L32 and c) L33 
The condensation reactions between the triketone 4.1.3 and the bis-amidrazone compounds (3.2.2, 
3.2.5 and 3.2.10) in acetic acid successfully yielded the novel final ligands L40, L41 and L42, 
Figure 141. Since the diketone 4.2.3 is non-symmetrical, different regioisomers could in principle 
be formed in the condensation reactions of 4.2.3 with the bis-amidrazones. The purification of the 
BTBP L41 was the easiest to achieve via filtration of the crude product as a solid, with one major 
regioisomer being observed through 1H NMR spectroscopy. The filtrate was analysed by 1H NMR 
which showed the presence of unreacted starting diketone 4.2.3. The purification of the BTP L40 
proved more complicated, with a dark oil produced upon filtration which mainly constituted of 
starting material. Recrystallisation from diethyl ether gave a pure sample of the BTP L40, with 
two regioisomers being detected through 1H NMR, Figure 143, with major and minor 
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regioisomers observed in a ratio of 4:1. Considering the singlets observed for the methyl groups 
at δ 1.70 and 1.52 ppm (minor isomer), δ 1.65 and 1.56 ppm (major isomer), it appears that two 
symmetrical regioisomers have formed. Further product purification to increase the yield was 
unsuccessful with unreacted starting tri-ketone 4.2.3 obtained. The three possible regioisomers 
that could form during the synthesis of the BTP ligand L40 are represented in Figure 142.  
Further difficulties in ligand purification were encountered when the BTPhen L42 was 
synthesised, which upon purification through recrystallization and trituration gave a yellow solid 
as the product contaminated with minor aliphatic impurities. It was decided to attempt column 
chromatography on the sample, with increasing solvent polarity used to elute the ligand. 
Unfortunately, the emergence of the required product was not observed. Ultimately it was deemed 
that the sample had a greater affinity for the silica than the eluting solvent. Repeating the 
condensation reaction of 4.2.3 and 3.2.10 again resulted in product formation, with the 1H NMR 
spectrum of the crude product again showing the presence of aliphatic impurities, Figure 144.  
 
Figure 142: Reaction scheme for the condensation reaction between triketone 4.2.3 and bis-
amidrazone 3.2.2 to form the ligand L40, showing the three regioisomers that could be formed. 
Reaction conditions: i) AcOH. 
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Figure 143: 1H NMR spectrum of two regioisomers of BTP ligand L40, with one example 
structure shown.  
 
Table 18: Assignment of NMR signals for the major regioisomer of the BTP ligand L40. 
1H (ppm) Proton integration 
and multiplicity 
(Hz) 
13C (ppm) Assignment 
8.73 2H, d, J = 7.79 Hz 138.4 2 x ArCH 
8.17 1H, t, J = 7.79 Hz 125.5 ArCH 
2.85 4H, s 50.7 2 x CH2 
1.65 1.65, s 26.1 4 x CH3 
1.56 1.56, s 28.7 4 x CH3 
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Figure 144: 1H NMR spectrum of the BTPhen ligand L42, showing aliphatic impurities. 
Table 19: Assignment of NMR signals for the BTPhen ligand L42. 
1H (ppm) Proton integration 
and multiplicity 
(Hz) 
13C (ppm) Assignment 
8.98 2H, d, J = 7.79 Hz 123.4 2 x ArCH 
8.58 2H, d, J = 7.79 Hz 124.3 2 x ArCH 
8.10 2H, s, J = 7.79 Hz 138.2 2 x ArCH 
2.87 4H, s 50.7 2 x CH2 
1.66 12H, s 26.2 4 x CH3 
1.58 12H, s 28.7 4 x CH3 
 
Introducing an amide functional group into the CyMe4-diketone 4.1.1 was next considered via the 
Wittig reaction of a phosphonium ylide 4.2.6 with 4.2.2. The intended synthesis of the final 
diketone is shown in Figure 147. The ylide was prepared in a two-step synthesis following a 
procedure by Vicente and co-workers to give the final product 4.2.6 in 58% yield.[161] An initial 
reaction between 2-chloro-N,N-dimethylacetamide 4.2.4 and triphenyl-phosphine prior to 
deprotonation of the resulting phosphonium salt yields the final ylide 4.2.6, Figure 145. 
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Unfortunately, on reaction of the ylide 4.2.5 with 4.2.2, there was no observed formation of the 
alkene product 4.2.7. As the initial nucleophilic attack of the ylide onto the carbonyl carbon is the 
rate determining step, Figure 146, it is suspected that the stabilised ylide is reacting very slowly 
or in this case not at all, with the sterically hindered ketone 4.2.2. The presence of the electron 
withdrawing amide group stabilises the carbanion formed when the ylide is deprotonated. As a 
consequence, the ylide has a lower nucleophilicity compared to non-stabilised ylides and their 
reactions with sterically hindered ketones (eg: ketones with a tertiary carbon in the alpha position) 
are much less common. An alternative procedure that can be considered is the Horner-Emmons 
reaction.  
 
Figure 145: General synthesis of the Wittig reagent 4.2.6. Reaction conditions: i) 
Triphenylphosphine, CHCl3, ii) NaH, DCM (anhy). 
 
Figure 146: Proposed mechanism for the Wittig reaction to 4.2.6 form 4.2.7.  
 
Figure 147: Intended synthesis of the final functionalised diketone 4.2.9. Reaction conditions: 
i) phosphonium ylide 4.2.5, NaH, THF; ii) Pd/C, H2, MeOH; iii) SeO2, AcOH. 
 
The Horner-Wadsworth-Emmons (HWE) olefination reaction was examined as an alternative 
method to introduce the amide group into the diketone 4.2.2. In replacement of the stabilised 
ylides of the Wittig reaction above, the more nucleophilic phosphonate ester 4.2.10 was utilised, 
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Figure 148. The phosphonate ester 4.2.10 was synthesised via the Arbuzov reaction of the 
commercially available 2-chloro-N,N-dimethylacetamide 4.2.4 with triethyl phosphite. [162] 
Initially the reaction was completed in THF with considerable starting material remaining upon 
work up of the reaction. The molar equivalents of the phosphonate ester and sodium hydride, were 
increased from 1.2 to 4 equivalents, in an attempt to drive the reaction towards product formation. 
Again, no conversion to the final desired product 4.2.7 was observed. It was thought that the 
sterically hindered nature of the diketone 4.2.2 due to the adjacent dimethyl groups, may have 
prevented this reaction from proceeding.  
 
Figure 148: Proposed synthesis of 4.2.7 by Horner Wadsworth Emmons Olefination of 4.2.4 
with the phosphonate ester 4.2.10. Reaction conditions: i) triethyl phosphite; ii) NaH, 4.2.2, 
THF.  
 
Following the above unsuccessful approaches to alkene 4.2.7 via the Wittig and HWE reactions 
of 4.2.2 with stabilised ylides and carbanions, respectively, an alternative Wittig reaction using a 
non-stabilised ylide was studied. The commercially available phosphonium salt; 
methyltriphenylphosphonium bromide 4.2.11, was considered, to generate a more reactive non-
stabilised phosphonium ylide, which would convert the carbonyl group into a simple 
unfunctionalised alkene 4.2.12. Hydrogenation of the alkene, followed by the oxidation of 4.2.13 
would then generate the novel target diketone 4.2.14, Figure 149. Although this approach would 
not allow introduction of an amide group, it was considered to introduce additional alkyl groups 
into the final diketone 4.2.14, with the aim of increasing the solubility of the final ligands. 
Following procedures by U. Quabeck and co-workers[163] the Wittig reaction of 
methyltriphenylphosphonium bromide with 4.2.2 was initially attempted with potassium tert-
butoxide (t-BuOK) as the base to form the ylide through deprotonation, observed by the formation 
of a yellow mixture in the reaction vessel. The reaction proceeded with a slight excess of the base 
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and ylide (1.3 equivalents) in toluene to give the alkene in 15% yield. Improving the yield was 
attempted by altering the stoichiometric equivalent of the base. At 1.5 equivalents this led to the 
observation of the dialkene compound 4.2.15, Figure 150. An alternative base, n-butyllithium (n-
BuLi) was considered. However, this ultimately led to the formation of no product. Consequently, 
it was decided to continue using t-BuOK as the base of choice.  
 
Figure 149: Proposed reaction scheme for the formation of X. Reaction conditions: i) 
methyltriphenylphosphonium bromide, t-BuOK, toluene; ii) H2, Pd/C, methanol; iii) SeO2, 1,4-
dioxane. 
 
 
Figure 150: 1H NMR spectra overlaid showing the desired alkene product 4.2.12 (bottom 
spectrum) and the formation of the dialkene compound 4.2.15 (top spectrum). 
 
The ylide was formed in a separate flask, as observed by the vivid colour change (cloudy to 
yellow), before it was added in aliquots to the 1,3-diketone 4.2.2 in a separate vessel. As the 
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yield was very low, at 15%, alternative solvents were considered to toluene; in particular THF 
and diethyl ether. Diethyl ether was chosen as a low boiling point solvent as it was suspected 
that the alkene could be a volatile compound and hence evaporating during the evaporation of 
the solvents in the work-up. Utilising this solvent resulted in a doubling of the yield of alkene 
4.2.12 to 31%. Analysis of the 1H NMR spectrum proves that a balance is required in this 
reaction, in which the yield is sacrificed either by starting material remaining or the formation of 
the dialkene compound 4.2.15. Attempts to improve this yield would have been considered if 
the final diketone was obtained.   
The reduction of the alkene 4.2.12 was next investigated through a hydrogenation reaction using 
H2 and palladium on activated carbon. The formation of the chiral product 4.2.13 can be clearly 
observed in the 1H NMR spectrum by the disappearance of the olefinic proton signals of the 
starting material 4.2.12 and the appearance of an AB proton system for the diastereotopic 
methylene protons at C-4, Figure 151. Purification and further investigations could not be 
completed due to time constraints near the end of the project.  
 
 
Figure 151: 1H NMR spectrum of the crude product 4.2.13 from the hydrogenation of alkene 
4.2.12, showing the presence of traces of starting material remaining.  
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Reductive amination was considered as an alternative method of introducing an amide functional 
group into the CyMe4-diketone 4.1.1 to study its effects on extraction kinetics, by converting one 
of the ketone carbonyl groups into a secondary amine, and then into a tertiary amide via N-
acetylation of the amide. The use of the mild reducing agent, sodium triacetoxyborohydride 
(NaBH(OAc)3) and a selected primary alkyl amine was investigated following procedures 
proposed by M.E. Flanagan and co-workers.[164] The use of hexylamine as the amine in the 
reductive amination reaction of ketone 4.2.2 proceeded in 20% yields with the 1H NMR spectrum 
of the crude product 4.2.16 displaying significant starting material, Figure 152. Unsuccessful 
attempts at the reductive amination of 4.2.2 were made with propylamine and methylamine under 
the same conditions, again the 1H NMR spectrum of the crude products showed the presence of 
unreacted starting materials in each case. It has been shown previously that reductive aminations 
with sterically hindered ketones can be low yielding if at all, such as the reaction with 
camphor.[165] As the starting material generally remains it is suspected that the imine formation is 
the rate limiting step in this reaction.  
 
Figure 152: Proposed synthesis of novel diketone 4.2.18. Reaction conditions: i) NaBH(OAc)3, 
hexylamine, THF; ii) acetic anhydride, triethylamine, DCM; iii) SeO2, 1,4-dioxane. 
 
An alternative reaction was the acylation of the amine to form an amide bond with acetic 
anhydride, Figure 152. However, attempted N-acylation of amine 4.2.16 with acetic anhydride 
was unsuccessful and the starting material was recovered. Due to the low yielding nature of the 
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reductive amination reaction, and the limited literature available on the reductive amination 
reactions of sterically hindered ketones, this reaction was not developed any further.  
Other efforts to derivatise the diketone 4.2.2 were studied involving oxime formation from the 
reaction of diketone 4.2.2 with hydroxylamine hydrochloride in the presence of base. If 
successful, the resulting oxime 4.2.19 could be further manipulated to derive amides (by N-
acylation), hydroxylamines (by reduction) or alkoxyamines (by O-alkylation), Figure 153. Initial 
efforts following procedures reported by S. Lochyński and co-workers which utilised pyridine as 
the base, resulted in no conversion of 4.2.2 to the oxime 4.2.19.[166] The use of sodium bicarbonate 
as the base resulted in some conversion of 4.2.2 to the product 4.2.19.[167] The use of sodium 
acetate resulted in the best conversion of starting material, but the bis-oxime 4.2.20 was generally 
formed, even when utilising 1 equivalent of hydroxylamine hydrochloride. Obtaining the required 
product 4.2.19 required a reduction in the reaction time. It was difficult to obtain a reasonable 
yield of the desired product 4.2.19 in order to take forward in the subsequent steps as the bis-
oxime 4.2.20 formed very readily within solution, so this approach was not studied further. The 
crude 1H NMR spectrum, Figure 154, shows the observation of two broad signals at δ 10.7 and 
10.5 ppm, from the –OH groups of the required oxime 4.2.19 and bis-oxime 4.2.20 compounds, 
respectively.   
 
Figure 153: Proposed synthesis of compound 4.2.21. Reaction conditions: i) hydroxylamine 
hydrochloride, NaOAc, EtOH, ii) ammonium acetate, sodium cyanoborohydride, titanium 
chloride, MeOH. 
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Figure 154: 1H NMR spectrum of the crude product from the reaction of 4.2.2 with 
hydroxylamine hydrochloride to give the oximes 4.2.19 and 4.2.20; where (*) represents the 
required product and (+) the bis-oxime 4.2.20. 
 
Next studied was the partial reduction of diketone 4.2.2 with sodium borohydride (NaBH4) to 
obtain the hydroxyketone 4.2.22, which could be then oxidised (SeO2) to derive a novel diketone 
4.2.23, Figure 155. The formation of hydroxyketone 4.2.22 was achieved successfully using 0.25 
equivalents of NaBH4 following procedures reported by J. Petrova and co-workers.[162] A 
maximum yield of 68% of the desired product 4.2.22 was obtained in this reaction. In obtaining 
this yield various conditions were trialled such as low temperatures of 0 °C to control the product 
formation, varying equivalents of NaBH4 and different solvents (ethanol, methanol and water). It 
was found that completing the reaction at room temperature, using a solvent mixture of 
ethanol/water obtained the best yields with the reaction completed in 15 minutes. An overlay of 
the 1H NMR spectra, Figure 156, shows that as the starting material 4.2.2 disappears completely 
the formation of significant amounts of the over-reduced compound, diol 4.2.24 are observed. 
This is a recurring theme in many of the reactions used in this Chapter to functionalise the 1,3-
diketone 4.2.2. Fortunately, the starting 1,3-diketone 4.2.2, desired hydroxyketone 4.2.22 and diol 
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* * 
* 
+ 
+ 
4.2.24 compounds could be cleanly separated by careful column chromatography. The oxidation 
of the hydroxylketone 4.2.22 with selenium dioxide to give the novel diketone 4.2.23 was 
successful in a 46% yield for subsequent use in the condensation reactions to form the final target 
ligands.  
 
Figure 155: Reaction scheme showing the formation of novel dikeotne 4.2.23. Reaction 
conditions: i) NaBH4, H2O, methanol; ii) SeO2, 1,4-dioxane.  
  
 
Figure 156: 1H NMR overlaid spectra of the 3-hydroxyketone reaction stages; the desired 
hydroxyketone 4.2.22 (bottom spectrum), the desired 4.2.22 and the starting material 4.2.2 
(denoted by *) (central spectrum) and the desired compound 4.2.22 and the diol 4.2.24 (denoted 
by +) (top spectrum).  
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The final condensation reactions between the diketone 4.2.23 and each of the three bis-
amidrazones 3.2.2, 3.2.5 and 3.2.9 were completed in ethanol, Figure 158. In the formation of the 
hydroxy-BTPhen L45, Figure 159, only one isomer was isolated which gave a well resolved NMR 
spectrum. It is suspected that there were more soluble isomers forming within the crude reaction 
mixture that were unable to be isolated and characterised. Similarly, the hydroxy-BTBP L44 and 
hydroxy-BTP L43 were obtained in relatively poor yields of 15 and 22%, respectively after 
recrystallization, Figure 157 and Figure 158. Further purification of the filtrate, in which product 
peaks were observed by 1H NMR spectrum, was attempted by column chromatography. However, 
products were not eluted from the column due to the high polarity of the molecules, even when 
utilising the highly polar solvent methanol. It is proposed that reverse phase silica is a necessity 
for use in these purifications, to increase product yields. In terms of the possible isomers that 
could be obtained in these condensation reactions, they include regioisomers, enantiomers and 
diastereoisomers, Figure 160. Three regioisomers are possible as the diketone is non-symmetrical. 
In addition, as the diketone is chiral but racemic, each regioisomer could be obtained as a mixture 
of diastereomers (each existing as a pair of enantiomers). Obviously, this would be expected to 
lead to very complex NMR spectra for the crude products.1H NMR spectroscopy can easily be 
used to distinguish between symmetrical and non-symmetrical regioisomers, as many of the 
proton’s environments would be equivalent in the symmetrical regioisomers. On the other hand, 
the non-symmetrical regioisomer would display a higher number of non-equivalent proton 
resonances due to the lack of a plane of symmetry. The different diastereomers of a given 
regioisomer may not be as easy to distinguish by NMRspectroscopy if some of the resonances for 
each diastereomer overlap. However, all the regio- or stereoisomers of a given ligand should in 
principle exhibit very similar extraction properties as the changes made to the ligand structure are 
far removed from the N-donor atoms that coordinate to the metal. 
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Figure 157: Synthesis of final BTP ligand L43 via condensation reaction of 4.3.23 with 3.2.2. 
The absolute stereochemistry at the chiral carbon atom is not shown. Reagents and conditions: i) 
EtOH, reflux. 
 
 
Figure 158: Synthesis of final BTBP ligand L44 via condensation reaction of 4.3.23 with 3.2.5. 
The absolute stereochemistry at the chiral carbon atom is not shown. Reagents and conditions: i) 
EtOH, reflux. 
 
 
Figure 159: Synthesis of final BTPhen ligand L45 via condensation reaction of 4.3.23 with 
3.2.10. The absolute stereochemistry at the chiral carbon atom is not shown. Reagents and 
conditions: i) EtOH, reflux. 
 
163 
 
 
Figure 160: Representation of the possible regioisomers and diastereoisomers of BTBP ligand 
L44. 
 
With the hydroxyketone 4.2.22 in hand, we next considered that an O-alkylation reaction of this 
compound to afford alkyl ether derivatives would be a useful way to tune the solubilities of the 
final bis-1,2,4-triazine ligands. Thus the O-alkylation of the hydroxy-ketone 4.2.22 with 
iodomethane and NaH as the base was achieved in reasonable yields of 51% to give the methyl 
ether 4.2.25, Figure 161. The 1H NMR spectrum of the crude product showed that some starting 
material remained in this reaction and it was suspected that some of the iodomethane (b.p. 42 °C) 
had evaporated prior to the reaction reaching completion. In an effort to force the reaction towards 
completion, the reaction was completed at a lower temperature, to ensure loss of the iodomethane 
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by evaporation was avoided. Additionally the iodomethane was added sequentially over the 
period of the reaction, improving the isolated yields of the methyl ether 4.2.25 to 82%. The 
oxidation of 4.2.25 using SeO2 in 1,4-dioxane was a high yielding reaction that gave the diketone 
4.2.26 in 86% yield.  
 
Figure 161: Synthesis of novel methoxy-diketone 4.2.26. Reagents and conditions: i) 
iodomethane, NaH, THF; ii) SeO2, 1,4-dioxane. 
 
Finally the condensation reactions of diketone 4.2.26 with each of the bis-amidrazones 3.2.2, 3.2.5 
and 3.2.10 in refluxing acetic acid gave the final novel ligands L46, L47 and L48, Figure 162 and 
Figure 163. The methoxy-BTPhen ligand L48 was isolated as a solid following removal of the 
unreacted amidrazone 3.1.10 by trituration of the filtrate with diethyl ether. The methoxy-BTP 
L46 and methoxy-BTBP L47 were unable to be obtained as a suitably pure sample, as observed 
in the 1H NMR spectrum, for extraction testing through trituration, recrystallisation or column 
chromatography.  
Further alkylation reactions of ketone 4.2.22 with different alkyl iodides would have been 
investigated had time allowed, in order to gain a greater understanding of how increasing the alkyl 
chain length impacts the extraction properties (especially solubility) in the solvent extraction 
experiments.  
 
Figure 162: Condensation reaction of diketone 4.3.26 with 3.2.10 to form the final novel 
BTPhen ligand L48. Reaction conditions: i) AcOH, reflux. 
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Figure 163: Molecular structures of the methoxy-bis-1,2,4-triazine ligands L46 and L47. 
 
The methoxy-BTPhen ligand L48 was purified by a recrystallisation from diethyl ether. The 
ligand 1H NMR spectrum observes a broad signal at δ 3.30 ppm, indicative of a water molecule. 
Completing a D2O shake upon the NMR sample resulted in a complete disappearance of this 
signal, Figure 164. The deuterium in D2O will exchange with those exchangeable protons present 
in the sample, such as those from H2O. The presence of such a water molecule in the ligands 
coordination cavity was similarly observed with CyMe4-BTPhen 1.17, which may aid in the 
ability of this ligand sitting to reside at the phase interface.  
 
Figure 164: Overlaid 1H NMR spectra of the methoxy-CyMe4BTPhen ligand L48; (a) before 
and (b) after a D2O shake. 
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Table 20: Assignment of NMR signals for the major isomer of the methoxy-CyMe4-BTPhen 
L48. 
1H (ppm) Proton integration 
and multiplicity (Hz) 
13C (ppm) Assignment 
8.90 2H, t, J = 7.79 137.3 2 x ArCH 
8.48 2H, d, J = 7.79 127.6 2 x ArCH 
7.95 2H, s 123.5 2 x ArCH 
3.50 6H, s 81.2 2 x CH3 
3.46 2H, dd, J = 6.41, 3.67 57.6 2 x CH 
3.30 2H, br, s - H2O 
2.15 – 2.10 2H, m 36.6, 36.5 2 x CH 
2.03 – 1.96 2H, m 36.6, 36.5 2 x CH 
1.69 – 1.44 24H, m 31.4, 31.0, 30.7, 30.2, 26.4, 
25.9, 23.6, 23.0 
8 x CH3 
 
Introduction of an N,N-dimethylamide group into the hydroxy-ketone 4.2.22 was next 
investigated through an O-alkylation reaction using 2-chloro-N,N-dimethylacetamide 4.2.4, 
Figure 165. Following procedures by K. Ohgane and co-workers this was achieved in a 60% yield 
to give compound 4.2.27, Figure 166.[168] The final oxidation step to the novel diketone 4.2.28 
using SeO2 was achieved in a 44% yield and could be monitored via 1H NMR spectroscopy by 
the disappearance of the AB system adjacent to the carbonyl group in 4.2.27, Figure 166.  
 
Figure 165: Synthetic pathway to form novel diketone 4.2.28. Reaction conditions i) 2-chloro-
N,N-dimethylacetamide, NaH, THF, ii) SeO2, dioxane. 
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Figure 166: 1H NMR spectrum of compound 4.2.27. 
 
The condensation reaction of diketone 4.2.28 with the bis-amidrazones 3.2.2 to form the final 
ligand acetamide-BTP L49 was attempted in acetic acid, Figure 167. In this reaction the crude 1H 
NMR spectrum suggested product formation, with the disappearance of the broad NH2 peaks from 
the respective amidrazone being observed. However, obtaining a clean, well resolved NMR 
spectrum proved difficult in the deuterated solvents available, with broad and unclear signals 
being observed and further attempts at purification were unsuccessful. As a result, these ligands 
were not taken forward for solvent extraction testing.   
 
Figure 167: Representative condensation reaction of 4.2.28 with the bis-amidrazone 3.2.2 to 
give the target ligand L49. 
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The O-alkylation of the hydroxy-ketone 4.2.22 with poly-ethylene glycol (PEG) based alkylating 
agents were then explored as an alternative method of introducing an ether group(s) as hydrogen 
bond acceptors into the ligands. The reaction of 4.2.22 with 2-bromoethyl methyl ether resulted 
in the formation of 4.2.29 in a 16% yield, Figure 168. The final oxidation step to the novel 
diketone 4.2.30 was completed in 51% yield using SeO2, but in order to obtain enough sample of 
the dikeone 4.2.30 for ligand synthesis to be completed, it was necessary to first try and improve 
the yield of the O-alkylation step.  The disappearance of the AB system next to the carbonyl group 
in 4.2.29 can be clearly observed when comparing 1H NMR spectra of 4.2.29 and 4.2.30, Figure 
169. 
 
Figure 168: Synthesis of the novel diketone 4.2.30 via O-alkylation of 4.2.22. Reaction 
conditions: i) 2-bromoethyl methyl ether, NaH, THF (anhy.) ii) SeO2, 1,4-dioxane. 
 
169 
 
* 
 
Figure 169: Overlaid 1H NMR spectra of (a) compound 4.2.29 and (b) diketone 4.2.30 showing 
disappearance of AB proton system (*). 
 
The synthetic chemistry discussed in this section led to the successful formation of novel BTP, 
BTBP and BTPhen ligands derived from modified derivatives of CyMe4-diketone 4.1.1. Due to 
the symmetrical nature of the starting 1,3-diketone dimedone 4.2.2 some of the reactions proved 
difficult to obtain the required diketone, and mixtures of products were obtained. A protecting 
group strategy could be considered, wherein one of the carbonyl groups could be protected (eg: 
as an acetal). Continued optimisation of the synthesis could lead to the successful synthesis of the 
1,2-diketones discussed above that can then be taken forward for further investigations. In 
subsequent sections, the solubilities and solvent extraction properties of the obtained ligands are 
discussed.  
4.3. Calculated ligand parameters 
For each of the ligands synthesised in section 4.2, their ligand parameters that could be used as 
predictors of ligand solubility and rates of extraction have been calculated to enable comparisons 
between theoretical and experimental data in line with the project objectives. It is hoped that a set 
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of general guidelines can be established from this based upon the theoretical values that can be 
used indicate the solubility and rates of extraction of a given ligand prior to its synthesis. For the 
ligands successfully synthesised in section 4.2, their theoretical results are given in Table 21.  
Of those ligands synthesised, the ketone-substituted ligands (L40, L41 and L42) would be 
expected to have a decreased solubility in comparison to the benchmark ligands due to a reduction 
in their theoretical Fsp3 and log P values. On the other hand, the theoretical data for the methoxy-
ligands (L46, L47 and L48) indicate that an increased solubility should be expected in 1-octanol, 
constituting an improvement on the corresponding benchmark CyMe4 ligands 1.30, 1.09 and 1.17. 
There is, as observed previously, a contradicting trend in the log P and Fsp3 values when 
considering the different ligand families derived from the same diketone. There is an increase in 
calculated log P values across the series BTP < BTBP < BTPhen, with the opposite trend being 
observed for the corresponding calculated Fsp3 values.  
As dictated in the aims and objectives the addition of HBD and HBA functional groups was 
intended to confer an increased concentration of the ligand at the phase interface, in order to 
increase the rates of metal extraction (extraction kinetics). With this in mind, a variety of different 
functional groups, (ketone, hydroxyl and methoxy groups) were introduced into the benchmark 
CyMe4-ligands so their effects on ligand solubility and rates of extraction could be investigated. 
Based upon the HBD and HBA values in Table 22, all ligands would be expected to have 
improved extraction kinetics based upon the discussed hypothesis. Of these ligands the hydroxyl-
substituted ligands would be expected to have the greatest increase in rates of extraction.  
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Table 21: Table showing calculated ligand parameters for the novel CyMe4-ligands. Only one 
regioisomer is represented in each case. 
Ligand Code Log P Fsp3 HBD HBA 
 
1.30 5.45 0.59 0 7 
 
1.09 6.01 0.50 0 8 
 
1.17 7.04 0.47 0 8 
 
L40 3.01 0.52 0 9 
 
L41 3.76 0.44 0 10 
 
L42 4.43 0.41 0 10 
 
L43 3.49 0.59 2 9 
 
L44 4.40 0.50 2 10 
 
L45 5.34 0.47 2 10 
 
L46 5.17 0.67 0 9 
 
L47 5.89 0.56 0 10 
 
L48 6.78 0.53 0 10 
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4.4. Solubility Studies 
The solubilities of the novel ligands were investigated in 1-octanol using the procedure disclosed 
in Chapter 6. These ligands will be compared to the benchmark ligands; CyMe4-BTP 1.30, 
CyMe4-BTBP 1.09, CyMe4-BTPhen 1.17. Table 22 present the novel functionalised CyMe4-
ligands synthesised, alongside their individual Fsp3 and measured solubility values. The 
applicability of the Fsp3 and log P values for individual ligands in predicting the solubility will 
be considered based upon the experimental results shown, as discussed in section 1.5.  
Increasing the number of aromatic rings on moving from BTP to BTBP to BTPhen decreases the 
measured solubilities in line with a decreasing Fsp3 value. The lowest solubility that was able to 
be obtained was for the hydroxy-CyMe4-BTPhen L45. In contrast, the methoxy-CyMe4-BTPhen 
L48 shows a much greater solubility in 1-octanol, suggesting the addition of the methyl groups 
has drastically improved the solubility. Similar observations have been made when investigating 
the effect of increasing alkyl chain length with BTPhen ligands against solubilities.[102] 
 
Table 22: The respective Fsp3 values and measured solubilities for the novel CyMe4-
functionalised ligands. 
Number Structures 
Solubility mmol/L 
in 1-octanol 
Fsp3 value 
L40 
 
101.6 0.52 
L41 
 
13.6 0.44 
L42 
 
- 0.41 
L43 
 
- 0.59 
L44 
 
20.3 0.50 
L45 
 
4.9 0.47 
L48 
 
70.6 0.53 
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4.5. Extraction Studies 
The hydroxy and ketone-substituted derivatives of the BTBP (L41 and L44) and BTPhen (L42 
and L45) ligands, respectively, exhibited very low solubilities in the standard solvent used for the 
extraction studies, 1-octanol. This was so drastic for the hydroxy-BTPhen L45 that the extraction 
screening study was unable to be completed. The hydroxy-BTBP L44, ketone-BTBP L41 and 
ketone-BTPhen L42 ligands were tested at concentrations <10 mM as a result of their poor 
solubility. The limited solubility seen with the BTPhens in particular, correlates to the calculated 
Fsp3 values obtained. These values were 0.41 and 0.47 for the ketone-BTPhen L42 and hydroxyl-
BTPhen L45 respectively, both equal to and lower than the corresponding benchmark ligand 
CyMe4-BTPhen 1.17 and the lowest of all the functionalised CyMe4-BTPhen ligands.  
The ligand L43 required the addition of tert-butyl benzene to ensure dissolution of the ligand with 
the concentration adjusted accordingly to maintain a concentration of 0.01 M for the increased 
volume of diluent. After completing the extraction test with varying nitric acid concentrations for 
the standard duration of 1 hour, there was no observed precipitate in the sample, Figure 170.  
 
Figure 170: (a) Photographs of the sample tubes after the first screening test using L43, with 
increasing [HNO3] from left to right; (b) molecular structure of L43. 
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Figure 171: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L43 measured by α- and 
γ-spectroscopy as a function of the nitric acid concentration of the aqueous phase (1 hr, 22 °C at 
2,200 rpm). Organic phase: 10 mM L43 in 1-octanol/tert-butylbenzene (ratio: 7/1). 
 
With increasing HNO3 concentration, the distribution ratios rise gradually before levelling off for 
Am and Cm, Figure 171. It is known that Ln(III) complexes of bis-triazine ligands are 
thermodynamically less stable than those of An(III) complexes and may aid in explaining the drop 
in D ratios for Eu(III). This decrease in the DEu may result from an increased competition between 
ligand protonation and ligand complexation, with the Eu-ligand complexes less likely to form at 
this concentration. Such phenomenon have been observed previously in theoretical and 
experimental investigations with ligands containing the 1,2,4-triazine rings.[169] It can be assumed 
that this effect would similarly be observed in this ligand due to its similarity. The maximum SF 
obtained for this ligand is 38.78, considerably lower than the CyMe4-BTP, which has a SF of 
5000, Section 1.5.2.  
The extraction study with L44 was completed at a concentration lower than 0.1 M in 1-octanol as 
a result of its low solubility. The addition of tert-butyl benzene had little effect on aiding the 
dissolution of the ligand and it was decided to screen the ligand at the lower concentration with 
efforts made to avoid the precipitated ligand. After contact with the HNO3 aqueous phase for 1 
hour there was precipitate observed at the interface and throughout the (organic phase) for RBR-
131, at the lowest HNO3 concentration, Figure 172. This precipitation is deemed to be the 
insoluble material transferred from the prepared organic phase when preparing the extraction. At 
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higher HNO3 concentrations we see minimal to no precipitation after phase contact suggesting 
the acidic aqueous phase somehow aids in dissolution of the ligand sample. As a result of the 
solubility issue, and hence lower concentration of the ligand in the organic phase, lower D ratios 
were expected.  
 
Figure 172: (a) Photographs of the sample tubes after the first screening test using L44, with 
increasing [HNO3] from left to right; (b) molecular structure of L44. 
 
Figure 173: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L44 measured by α- 
and γ- spectroscopy as a function of the nitric acid concentration of the aqueous phase (1hr, 22 
°C at 2,200 rpm). Organic phase: <10 mM L44 in 1-octanol/tert-butylbenzene (ratio: 7:1) 
 
There is a gradual increase in the D ratio for both An(III); Am(III) and Cm(III) as a function of 
the HNO3 concentration, Figure 173. Interestingly, for Eu(III) there is a drop in the D ratio at 
0.296 M HNO3 before it gradually increases again thereafter. This results in an increase in the 
SFAm/Eu to 36.83 where previously it had been minimal at the lowest HNO3 concentrations, at 
2.36. Further research into increasing the HNO3 concentration beyond 3 M may be necessary to 
see if the D ratio continues to increase to values above 1, otherwise this ligand would be unsuitable 
for the reprocessing industry. Additional studies could be completed in the future using this ligand 
and a phase transfer agent, as was carried out with CyMe4-BTBP 1.09, to see how this impacts on 
the extraction performance.  
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The introduction of the ketone group in ligand L40 has a slightly negative impact on the D ratios 
for Am(III) and Cm(III) when compared to the hydroxyl-BTP L43, especially at the lower HNO3 
concentrations, Figure 174. The SFAm/Eu is consistently above 60 from the concentration of 0.01 
M. Although there is a general increase in D ratios as the HNO3 concentration increases this 
reaches a maximum of 0.9 at 1 M HNO3, which would be unsuitable for the reprocessing industry. 
The slight drop in the D value for all radioisotopes at 3 M HNO3 is likely to be a result of the 
precipitate that was observed at the interface during this particular screening test.   
 
Figure 174: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L40 measured by α- and 
γ- spectroscopy as a function of the nitric acid concentration of the aqueous phase (1hr, 22 °C at 
2,200 rpm). Organic phase: 10 mM L40 in 1-octanol. 
 
A parallel observation was made for L41 in comparison to L44, in which the ligand didn’t fully 
dissolve in the diluent. Based upon the calculated parameters for these ligands, in which the log 
P and Fsp3 were low, a reduced solubility in 1-octanol was predicted. Again, at the lowest nitric 
acid concentration there was significant precipitation observed, but this disappears with increased 
HNO3 concentrations, Figure 175. Interestingly, upon contact with the 3 M HNO3 aqueous phase, 
a change in colour of the organic phase and some leaching of colour into the aqueous phase was 
observed. Although the exact reason for this is unclear, it could be a result of dissolution of the 
protonated ligand into the aqueous phase at higher HNO3 concentrations due to the fact the ligand 
is less lipophilic than CyMe4-BTBP 1.09. There is an increase in the D ratios of all radioisotopes 
from 0.1 M to 1.0 M HNO3 concentrations, Figure 176. When in contact with the 3 M HNO3 
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aqueous phase, there is a decrease in the observed D ratios, which may coincide with the observed 
leaching of colour, and most likely dissolution of the ligand L41, into the aqueous phase. The 
SFAm/Eu reaches a maximum of 145 observed at 0.1 M HNO3. At the required conditions for the 
SANEX process (3-6 M HNO3), the SFAm/Eu falls to 96. Despite this, as the D ratio for Am(III) 
and Cm(III) remain below 1 across all concentrations it would be an unsuitable ligand choice for 
the reprocessing industry, as an increased number of extraction steps would be required to extract 
all the An(III) when compared to a ligand with greater D ratios.  
 
Figure 175: (a) Photographs of the sample tubes after the first screening test using L41, with 
increasing [HNO3] from left to right; (b) molecular structure of L41. 
 
Figure 176: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L41 measured by α- 
and γ- spectroscopy as a function of the nitric acid concentration of the aqueous phase (1hr, 22 
°C at 2,200 rpm). Organic phase: 10 mM L41 in 1-octanol. 
  
The methylated ligand L48 was tested for its extraction properties following previous procedures. 
There was no observed precipitate formation for the methoxy-BTPhen ligand L48 across all 
HNO3 concentrations, Figure 177. There was a notable colour change of the organic phase when 
the screening test was completed at 3 M HNO3, which correlates to a decrease in the D ratio for 
all radioisotopes. This could be due to ligand protonation at the higher acidity, which would 
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compete with metal ion complexation. Unfortunately, ligand kinetic studies were unable to be 
completed with this ligand due to time constraints during the research visits.  
 
Figure 177: (a) Photographs of the sample tubes after the first screening test using L48, with 
increasing [HNO3] from left to right; (b) molecular structure of L48. 
 
Figure 178: Distribution ratios for extraction of 152Eu, 241Am, 244Cm by L48 measured by α- 
and γ- spectroscopy as a function of the nitric acid concentration of the aqueous phase (1hr, 22 
°C at 2,200 rpm). Organic phase: 10 mM L48 in 1-octanol. 
 
Across all HNO3 concentrations the D ratios for both Am(III) and Cm(III) by ligand L48 were 
above 10. The maximum D ratio obtained for Am(III) was over 500 (from γ-spectroscopy) at 0.7 
M HNO3, Figure 178. Thus, a very efficient extraction of Am(III) and Cm(III) was observed by 
ligand L48. There is a slight disparity between the results obtained for α- and γ-spectroscopy as 
a result of some solid deposits upon the α-plates, which can have a negative impact upon the 
results obtained. However the D ratio for Am(III), as obtained via α-spectroscopy, is still over 
400 at the same HNO3 concentration. Alongside this, the relatively high D ratios observed for 
Am(III) and Cm(III) at 0.001 M HNO3 may result in non-optimum performance during the back 
extraction (stripping) stages of a future process, where the metal is back-extracted removed from 
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the loaded organic phase into dilute HNO3 so the organic phase/ligand can be recycled. This is 
typically completed at low HNO3 concentrations where ideally the D ratios for Am(III) and 
Cm(III) are below 1. The SFAm/Eu averages at 40 across the HNO3 concentrations, with a maximum 
value over 100 being obtained at 0.001 M HNO3 and 3.0 M HNO3. Thus, the extraction of Am(III) 
and Cm(III) by this ligand is highly efficient and reasonably selective, though the Am(III)/Eu(III) 
selectivity is not as high as that observed previously for CyMe4-BTPhen 1.17.[95] 
4.6. Conclusion 
The addition of the hydroxyl group to the benchmark CyMe4-ligands doesn’t appear to improve 
the solubility of the ligands within required diluents, up until the extreme case where we were 
unable to test L45 as a result of its insolubility. A similar observation was made for the ketone-
derived ligands (L40, L41 and L42). This poor solubility also resulted in difficulty during 
synthesis and analysis meaning it could result in drastic issues during industry implementation 
where precipitation must be avoided at all costs due to the complexity of monitoring the system. 
Although this effect is reduced for the BTBP and then again in the BTP, there is still a solubility 
issue for the L44. These results correlate to the low Fsp3 values for these ligands and confirm the 
methodology. Those ligands with the greatest Fsp3 values, 0.59 and 0.53 for L43 and L48, 
respectively showed no precipitate once in the diluent used for the screening test. 
The introduction of the additional HBD/HBA functional groups in the hydroxyl-derived ligands 
and ketone-derived ligands appears to negatively impact the extraction capabilities of these 
ligands. This is most likely as a consequence of their reduced solubility in the utilised diluent. 
The methoxy-BTPhen L48 in contrast shows excellent extraction properties up until a HNO3 
concentration of 1 M.  
Overall, these ligands offer mixed results in which the addition of HBD/HBA functional groups 
appears to have hindered their extraction capabilities rather than enhanced as previously expected, 
which may be a consequence of the groups used. Further studies would be necessary with this 
ligand in particular, specifically a study on its extraction kinetics as well as considering using 
longer alkyl chains when forming the ether. 
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5. Conclusions and Further Work 
5.1. Future Work 
The use of novel, modified bis-triazine ligands should be subject to more, detailed examination 
in future. A greater range of modified camphor-BTP, camphor-BTBP and especially camphor-
BTPhen ligands should be synthesised and screened for selective actinide extraction. Similarly, 
the synthesis and screening of a greater range of modified CyMe4-ligands (BTP, BTBP and 
especially BTPhen) is also warranted. This will not only identify the best functional groups that 
confer the optimum extraction properties to each family of ligands, but will also allow the novel 
ligand design approach discussed herein to be fully validated for a much greater range of ligands.  
In order to establish more definite solubility values for those ligands with promising applications, 
a more robust method for testing solubility would need to be applied. Due to the limited quantities 
of some of the samples obtained, a different volume of 1-octanol was added to each vial. A more 
precise method may be to see how much of each ligand dissolves in a fixed volume (eg: 1 mL) of 
1-octanol, to determine the saturation point. The results obtained could provide additional 
evidence for the positive correlation observed between the Fsp3 values of the ligands and the 
solubility results obtained.  
 
Figure 179: Structures of the most prominent ligands for future development. 
In terms of those ligands which showed promise for their development for a future industrial 
process, in particular L24, L27 and L48, further studies will need to be completed, Figure 179. 
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Studying the extraction of Am(III) and Cm(III) in the presence of all the trivalent lanthanides as 
well as some interfering fission and corrosion products would determine the likely applicability 
of the ligands for further process development (eg: towards being implemented in a laboratory-
scale ‘hot-test’ using genuine spent fuel solutions). Studying the stabilities of the ligands towards 
radiolysis will establish the likely lifetime of the ligand when used under real process conditions, 
i.e. how many times the ligand can be recycled for continuous use before it degrades. Extraction 
kinetics studies on L27 will allow a comparison between this and the diethylamine-derived 
BTPhen ligand L24, to determine which shows the greatest improvement when compared to the 
benchmark ligand CyMe4-BTBP 1.09. The effects of different solvents will need to be explored 
to determine their impact on the distribution ratios and separation factors. It has previously been 
shown that the diluent can have a drastic impact not only on ligand solubility but also on the 
distribution ratios of individual isotopes, as in the case of camphor-BTP 1.31 when dissolved in 
1-octanol or a kerosene/1-octanol mixture.  
In further developments, it would be interesting to explore in more depth exactly how and why 
these ligands complex and extract trivalent actinides at the molecular level. For example, it would 
be useful to experimentally determine the pKa values of the novel ligands. This would give an 
understanding of how easily these ligands are protonated when in contact with the nitric acid 
aqueous phase. In addition, measurement of the stability constants of the lanthanide and actinide 
complexes (e.g. by UV-vis spectrophotometry or time-resolved laser-induced fluorescence 
spectroscopy) would be useful to determine the different thermodynamic stabilities of the formed 
metal complexes, which has previously been shown to correlate with actinide/lanthanide 
extraction selectivity. Together with further studies aimed at probing the stoichiometries of the 
formed complexes (eg: by NMR titrations, ESI-MS, X-ray crystallography), this would help to 
rationalise some of the observed solvent extraction results, particularly when poor metal 
extraction is observed.  
5.2. Conclusions 
Within the discussed work, the main aims and objectives were to improve both the solubility and 
rates of extraction for the currently available benchmark ligands CyMe4-BTBP 1.09 and CyMe4-
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BTPhen 1.17. A variety of novel bis-1,2,4-triazine ligands were successfully synthesised via three 
different approaches that involved introducing an amine bridge into the BTP ligand structure, 
functionalising the camphor group in the camphorquinone-derived ligands and synthesising a 
range of ligands via functionalised CyMe4-diketone derivatives.  
The Pd(0)-catalysed Buchwald Hartwig reaction allowed the synthesis of a variety of ligands 
containing one or two amine (NH) bridges. The introduction of these bridges resulted in all 
ligands showing poor extraction properties, despite these ligands showing improved solubilities 
in 1-octanol. It has been determined, through X-ray crystallography and computational studies 
that the likely reason for their poor extraction capability results from the ligands existing only in 
the trans-trans conformation, instead of the complexing cis-cis conformation. Introduction of 
alkyl chains onto the amine nitrogens had no impact on their ability to extract trivalent actinides 
or lanthanides, but did improve ligand solubilities in all cases.  
The functionalisation of the camphorquinone group with amide moieties resulted in a general 
improvement in ligand solubility when compared to the benchmark ligand 1.09. In particular the 
diethylamine-derived BTPhen L24 and piperidine-derived BTPhen L27 showed high distribution 
ratios for Am(III) and Cm(III) and a high separation factor for Am(III) over Eu(III) (SFAm/Eu). The 
extraction kinetics for L24 showed a significant improvement in comparison to the benchmark 
ligand 1.09. Further solvent extraction studies on L27 will allow the direct comparison with L24. 
Further studies on both ligands can build upon these positive results to pave the way for possible 
future industrial use. 
The functionalisation of the CyMe4-diketone group via alternative synthesis, to introduce alcohol, 
ether and ketone moieties, had mixed results. There was a comparable, or in the case of the 
functionalised novel CyMe4-BTPhen ligands L42 and L45, decreased solubility in comparison to 
the benchmark ligand 1.17. The introduction of the methoxy group in L48 resulted in improved 
solubility and promising solvent extraction results, suggesting that further O-alkyl derivatives 
with longer alkyl groups could be explored to further improve the ligand solubility in the required 
diluents. 
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In terms of the ligand design approach, there was a correlation between the Fsp3 value and the 
ligand solubility in 1-octanol suggesting that this parameter can be utilised to give an early 
prediction of ligand solubility. The introduction of hydrogen bond donor (HBD) and hydrogen 
bond acceptor (HBA) functional groups, in particular with the camphor-derived ligands, gave 
promising results. In introducing these HBD/HBA groups, care must be executed to ensure that 
the calculated log P value isn’t so drastically reduced as to result in ligands that are so polar that 
they partition into the aqueous phase. Some ligands, in particular those ligands containing the 
morpholine group, saw significant issues with precipitation when in contact with the nitric acid 
aqueous phase in comparison to the piperidine-derived BTPhen ligand L27. The presence of the 
oxygen atom in the morpholine ring, in place of an sp3 carbon atom in the piperidine ring, clearly 
has a noteworthy effect on the ligand solubility during extraction experiments.  
Overall, a variety of novel ligands have been synthesised with mixed results in terms of their 
extraction properties. It is determined that introducing flexibility in the ligands, as is observed 
through the addition of an amine (NH) between the 1,2,4-tiazine and pyridine group, has a 
significant impact on their ability to extract the An(III) from the Ln(III). The functionalisation of 
the camphor group with an amide results in ligands, in particular the BTPhens L24 and L27 show 
improvements when compared to the benchmark ligand 1.09. Functionalisation of the CyMe4-
diketone 1.09 resulted in only one ligand observing promising extraction results and this approach 
may require further investigations. The innovative ligand design approach reported herein has 
been shown to be reasonably robust in predicting the ligand solubility in the required diluent and 
could be used in future developments in this area. Improvement of extraction kinetics will require 
further evaluation on the most promising ligands discussed in this thesis, but has the potential for 
application based upon initial results for L24. 
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6. Methodology 
All NMR titrations, solubility studies and extraction experiments were completed by myself, 
unless otherwise stated. 
6.1. General procedure for NMR titrations  
Stock solutions of the ligands at a concentration of 0.1 M were prepared in deuterated chloroform 
of methanol, dependent upon ligand solubility. A 0.5 mL sample of this stock solution was taken 
for each NMR titration. Stock solutions at a concentration of 0.01 M of the respective nitrate 
lanthanide salt; La(NO3)3, Y(NO3)3, or Lu(NO3)3, and transition metal salts; AgNO3 or NiNO3. 
These stock solutions are prepared in the same deuterated solvent as the ligand stock solution they 
are to be titrated with. One equivalent of the lanthanide or transition metal stock solution, equal 
to 200 µL was added individually to the ligand stock solution up to a maximum of 1.2 equivalents, 
equal to 2.4 mL. A 1H NMR spectra was obtained for each equivalent of stock solution added and 
overlaid. All NMR spectra were recorded on a 400 MHz spectrometer at room temperature.  
6.2. General procedure for solubility studies 
The solubility measurements were carried out at Northumbria University.  A small sample of each 
individual ligand was weighed. This was dosed with 1-octanol dropwise and the sample sonicated, 
this addition was continued until complete dissolution of the ligand. At this point the mass was 
again taken to determine the amount of 1-octanol added. The solubility was calculated by taking 
the mass (g) of ligand dissolved in 1 L of 1-octanol and dividing by the molecular weight of each 
molecule. The sample was then left overnight to ensure complete dissolution. 
6.3. Experimental details for actinide extraction experiments  
All extraction experiments and α- and γ-analytical measurements were performed at the 
Forschungzentrum Jülich, Germany by myself enabled through the aid of a Mobility Grant 
awarded by the Royal Society of Chemistry. Nitric acid solutions were supplied by Merck AG. 
The radiotracers 241Am, 244Cm and 152Eu were purchased from Isotopendienst M. Blaseg GmbH, 
Waldburg, Germany; Oak Ridge National Laboratory, Oak Ridge, TN, USA and Eckert & Ziegler 
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Nuclitec GmbH, Braunschweig, Germany. Lanthanide salts were obtained from a variety of 
commercial sources and used as received.  
Extraction experiments were carried out using equal volumes of 500 µL of each phase; aqueous 
and organic. The aqueous phase was composed of a nitric acid solution (0.001 – 3 M) and 10µL 
of the aqueous tracer. The nitric acid solution contained all lanthanides except promethium in a 
concentration of 10-5 mol L-1 for each lanthanide used. The aqueous tracer contained 278 kBq mL-
1 of 152Eu, 155 kBq mL-1 of 241Am and 151 kBq mL-1 of 244Cm. The organic and aqueous solutions 
were prepared by dissolving weighed quantities of the desired substance in the desired solvent. 
For aqueous dilutions, demineralised water (18.2 MΩcm) was used. Nitric acid solutions were 
prepared by dilution from a 65% nitric acid solution EMSURE® for analysis. The organic 
solutions were prepared in a 0.01 M solution in 3.5 ml of 1-octanol. Where necessary tert-butyl 
benzene was added to aid in dissolution of the ligand. 
The shaking experiments were carried out in a temperature-controlled aluminium block (22 °C) 
using an IKA Vibrax VXR shaking device at a speed of 2,200 rpm, for the required time period. 
Afterwards, centrifugation was applied to maintain a complete separation of the phases and they 
were subsequently separated using pipettes. Gamma measurements of 152Eu (122 keV) and 241Am 
(60 keV) were carried out using a Eurisys EGC35-195-R germanium coaxial N-type detector. 
Alpha measurements were carried out for 241Am (5,486 keV) and 244Cm (5,805 keV) using an 
Ortec Octête-pc eight-chamber alpha measurements system, equipped with Passivated Implanted 
Planar Silicon (PIPS) detectors. Sample preparation was done by homogenizing the 10 µL alpha-
spectroscopy sample in 100 µL of a mixture of Zapon varnish and acetone (1:100 v/v). This 
mixture was distributed over a stainless steel plate obtained from Berthold, Bad Wildbad, 
Germany. The sample was dried under a heating lamp and annealed into the stainless steel plate 
by a gas-flame burner.  
For stable elements, inductively coupled plasma mass spectrometry (ICP-MS) was applied using 
a Perkin Elmer SCIEX Elan 6100 DRC. Aqueous samples were measured after dilution in 1% v/v 
nitric acid solution without further treatment. Organic samples were measured directly in a tenside 
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matrix (Triton-X-100) in 1% v/v nitric acid after dilution. The distribution ratios D were 
calculated as the quotient of the concentration or activity of the metal ion in the organic phase 
over the concentration of activity of the metal ion in the aqueous phase (D = [M](org)/[M](aq)). 
The separation between two metal ions is expressed using the separation factor, being the quotient 
of the distribution ratios of the two metal ions (SF = DM1 / DM2). The uncertainties of the data 
achieved from the method described above is <5% for 0.01 < D < 100. Below and above these 
limits, the uncertainties are lower than 20% for all data shown.  
6.4. Experimental details for fission/corrosion product extraction  
 
The composition of the synthetic PUREX raffinate solution used is shown in X. It was prepared 
by a specific strategy for the dissolution of the reagents, which is mainly based on the use of metal 
nitrate salts. It corresponds to a PUREX raffinate with a volume of 5000 L/t UO2 fuel with an 
initial 235U enrichment of 3.5% and thermal burn-up of 33,000 MWd/tHM after 3 years of cooling. 
The relatively high concentrations of sodium (Na) and iron (Fe) in the raffinate are due to 
purification steps for the U/Pu product produced by the PUREX process and solvent clean-up 
steps.[170] 
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Table 23: Composition of the synthetic PUREX raffinate solution (HAR). 
Element Concentration 
[mg/L]* 
Element Concentration 
[mg/L] 
Element Concentration 
[mg/L] 
Y 78 Ba 247 Rb 67 
La 209 Cd 19 Rh 77 
Ce 480 Cr 80 Ru 368 
Pr 195 Cs 449 Sb 4 
Nd 716 Cu 20 Se 24 
Sm 146 Fe 1979 Sn 11 
Eu 40 Mo 642 Sr 156 
Gd 46 Na 2000 Te 109 
Ag 9 Ni 41 Zr 698 
Al 2 Pd 102   
HNO3 3.1 mol/L     
*or as shown 
6.5. Computational Studies 
The computational studies were completed at Northumbria University by Dr Mark Sims. All 
density functional theory calculations were performed using the Gaussian 09 Software Package 
(Revision C.01), and all calculaions were carried out on molecules in the gas phase. The relaxed 
potential energy scans were carried out using the B3LYP functionl and the 6-31G(d) basis set, 
providing an acceptable compromise between accuracy and speed for the large number of 
calculations that were performed. The final optimisations were carried out using the B3LYP 
functional and the 6-311+G(d,p) basis set. The absence of negative frequencies was checked to 
confirm that the minimum energy structures had been obtained.  
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7. Experimental 
Solvents were purchased from Fisher Scientific, Sigma Aldrich and Alfa Aesar at reagent or 
HPLC grade and used as received. Dichloromethane (DCM), chloroform (CHCl3), toluene and 
acetonitrile (MeCN) were dried over molecular sieves (4 Å) for a minimum of two days. Ethyl 
acetate (EtOAc) was stored over calcium hydride and distilled before use. Ether refers to the use 
of diethyl ether and was dried over sodium wire overnight where required. 
Reagents were used as purchased from Sigma Aldrich, Fluorochem, Alfra Aesar, and Acros 
Organics. 
Column chromatography was performed using Fisher Scientific silica gel Å (35-70 μL) or 
Fluorochem silica gel Å (40-63 μL).  
NMR spectra were recorded using a JEOL ELS400 Delta 400 MHz spectrometer in deuterated 
chloroform, unless otherwise stated. The chemical shifts (δ) were reported in parts per million 
(ppm) downfield from a tetramethylsilane standard and coupling constants (J) are recorded in 
Hertz (Hz). NMR assignments were verified by appropriate experiments including; 13C-DEPT 
and 1H-1H COSY. The multiplicities are denoted as follows: singlet (s), doublet (d), triplet (t), 
quartet (q), quintet (qu), sextet (se), septet (sp), multiplet (m), double doublet (dd), double triplet 
(dt), triple doublet (td), triple triplet (tt), double double doublet (ddd), broad (br).   
Mass spectrometry was completed at the EPSRC National Mass Spectrometry Service Centre at 
Swansea University using spectrometers including a Thermo Scientific LTQ Orbitrap XL Mass 
Spectrometer. Low resolution electrospray (ESI) was the ionisation technique generally 
employed.  
Melting points were obtained on a SRS DigiMelt MPA160 with an upper limit of 260 ºC.  
Note: All experimental procedures follow the order as presented in the thesis, with the exception 
of the final ligands synthesised. The final ligands are grouped together at the end of the 
experimental section, in the order they appear in the thesis. 
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2.2.3: 1,6-Diethyl 2,2,5,5-tetramethylhexanedioate[95] 
 
Anhydrous diethyl ether (100 ml) was placed in oven-dried 250 ml 3-necked flask and sealed 
under a N2 atmosphere. Diisopropylamine (8.4 ml, 59.00 mmol) was added via syringe and the 
solution cooled to -20 °C using a acetone/liquid N2 bath. Upon cooling n-BuLi (1.6 M, 34.0 ml, 
54.00 mmol), was added dropwise via syringe and the solution stirred at -20 °C for 1 hour. Ethyl 
isobutyrate (7.4 ml, 54.00 mmol) was then added dropwise via syringe over 10 minutes and the 
solution allowed to warm to room temperature. The solution was stirred at room temperature for 
1 hour before ethylene glycol bis-p-toluenesulfonate (10.00 g, 27.00 mmol) was added in small 
aliquots over a period of 15 minutes. This was heated under reflux for 24 hour before been allowed 
to cool. The white solid was filtered and washed with diethyl ether (60 ml) and DCM (100 ml) 
and the filtrate quenched with saturated aq. ammonium chloride (60 ml). The phases were mixed 
and separated and the aq. phase extracted with diethyl ether (3 x 20 ml). The combined organic 
extracts were washed with H2O (30 ml) and dried (MgSO4). The solvent was removed under 
reduced pressure to leave the crude product as a yellow liquid (8.75 g). The product was purified 
by vacuum distillation to afford the product as a colourless liquid (4.75 g, 68%). Bp = 72 – 80 °C 
at 0.1 mbar. 
1H-NMR δH (399.8 MHz): 4.06 (4H, q, J = 6.87 Hz, 2 x CH2CH3), 1.39 (4H, s, 3-CH2 and 4-
CH2) 1.19 (6H, t, J = 6.87 Hz, 2 x CH2CH3), 1.10 (12H, s, 2 x 2-CH3, 2 x 5-CH3); 
13C-NMR (100.5 MHz): 177.7 (1-CO and 6-CO), 60.2 (2 x OCH2CH3), 41.9 (2-C and 5-C), 
35.5 (3-CH2 and 4-CH2), 25.1 (2 x 2-CH3 and 2 x 5-CH3), 14.2 (2 x CH2CH3) ppm.  
NMR data was consistent with literature values. 
 
2.2.4: 1,2-Bis(trimethylsilyloxy)-3,3,6,6-tetramethylcyclohex-1-ene[95] 
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Dry toluene (50 ml) was placed in an oven fried flask and sealed under N2 before adding the 
sodium metal (1.15 g, 49.60 mmol). The flask was heated under reflux (150 °C) until the sodium 
had melted. 1,6-Diethyl 2,2,5,5-tetramethylhexanedioate 2.2.3 (2.24 g, 9.90 mmol) and the 
chlorotrimethylsilane (6.3 ml) were subsequently added. The mixture was refluxed for 3 days 
before been allowed to cool to room temperature. The mixture was filtered carefully through a 
Büchner funnel and the sodium metal quenched slowly with EtOH. The solid residue was washed 
with toluene (30 ml) and THF (20 ml). The filtrate was evaporated under reduced pressure to give 
an orange oil, which was taken straight to the next step (1.77 g, 70% crude).   
1H-NMR δH (399.8 MHz): 1.33 (4H, s, 4-CH2 and 5-CH2), 0.92 (12H, s, 2 x 3-CH3 and 2 x 6-
CH3), 0.09 (18H, s, 2 x OSi(CH3)3); 
13C-NMR (100.5 MHz): 140.9 (1-C and 2-C), 37.7 (4-CH2 and 5-CH2), 29.6 (3-C and 6-C), 27.83 
(2 x 3-CH3 and 2 x 6-CH3), 3.6 (2 x OSi(CH3)3) ppm.   
NMR data was consistent with literature values. 
 
2.2.5: 3,3,6,6-Tetramethylcyclohexane-1,2-dione[95] 
 
1,2-Bis(trimethylsilyloxy)-3,3,6,6-tetramethylcyclohex-1-ene 2.2.4 (1.77 g, 7.00 mmol) was 
dissolved in DCM (20 ml) in a 100 ml flask. Bromine (0.3 ml, 7.00 mmol) was added slowly 
dropwise over 5 minutes. Stir at room temperature for 1 hour then dilute the solution with DCM 
(20 ml). The solution was washed with H2O (4 x 10 ml) and saturated aq. sodium sulphite (2 x 15 
ml) and dried (MgSO4). The solvent was removed under reduced pressure to leave an orange oil. 
The product was purified by column chromatography (silica gel: 2:1 hexane:EtOAc) to leave the 
product as a dark orange oil, which crystallised when left (0.47 g, 41%).   
1H-NMR δH (399.8 MHz): 1.88 (4H, s, 4-CH2 and 5-CH2), 1.15 (12H, s, 2 x 3-CH3 and 2 x 6-
CH3) ppm. 
NMR data was consistent with literature values. 
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2.2.11: 5,6-Diethyl-1,2,4-triazin-3-amine[171]  
 
Aminoguanidine bicarbonate (3.1 g, 22.00 mmol) was suspended in H2O (40 ml) and hexane-3,4-
dione (2.8 ml, 22.00 mmol) was added slowly. The reaction mixture was stirred at room 
temperature overnight before being heated to 100 °C for 5 hours. The solution was cooled to room 
temperature and the solid filtered and washed with H2O (20 ml) to collect the product as a yellow 
solid (2.65 g, 79%). 
1H-NMR δH (399.8 MHz): 5.26 (2H, s, br, NH2), 2.86 (2H, q, J = 7.79, 7.33 Hz, CH2), 2.69 (2H, 
q, J = 7.79, 7.33 Hz, CH2), 1.32 (3H, t, J = 7.79, 7.33 Hz, CH3), 1.27 (3H, t, J = 7.79, 7.33 Hz, 
CH3);  
13C-NMR (100.5 MHz):  163.2 (ArC), 161.8 (ArC), 152.8 (ArC), 26.8 (CH2), 25.0 (CH2), 13.0 
(CH3), 11.2 (CH3) ppm.  
LRMS (ESI +ve) m/z: 153.13; calculated for [C7H12N4+H ]+: 153.11 
NMR data was consistent with literature values. 
 
2.2.12: 5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-1,2,4-benzotriazin-3-amine  
 
A suspension of 3,3,6,6-tetramethylcyclohexane-1,2-dione 2.2.5 (0.52 g, 3.00 mmol) and 
aminoguanidine bicarbonate (0.41 g, 2.50 mmol) in EtOH(50 ml) was refluxed for 24 hour. The 
solvent was removed under reduced pressure and the resulting orange residue was recrystallized 
from methanol. Filtration left an off-white solid as the product (0.27 g, 53%). 
1H-NMR δH (399.8 MHz): 4.99 (2H, s, br, NH2), 1.74 (4H, s, 2 x CH2), 1.38 (6H, s, 2 x CH3), 
1.27 (6H, s, 2 x CH3); 
13C-NMR (100.5 MHz): 165.4 (ArC), 161.3 (ArC), 155.5 (ArC), 36.8 (C), 35.5 (C), 34.0 (CH2), 
33.3 (CH2), 29.8 (2 x CH3), 29.0 (2 x CH3) ppm. 
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LRMS (ESI +ve) m/z 207.17; calculated for [C11H18N4 + H]+ 207.16 
  
2.2.13: 5,5,7,7-Tetramethyl-6,7-dihydro-5H-cyclopenta[e][1,2,4]triazin-3-amine  
 
A suspension of 3,3,5,5-tetramethylcyclopentane-1,2-dione 2.2.7 (0.21 g, 1.30 mmol) and 
aminoguanidine bicarbonate (0.17 g, 1.20 mmol) were suspended in the diketone (30 ml) and 
refluxed overnight. The mixture was concentrated under reduced pressure to leave a yellow solid 
(218 mg, 93%).  
m.p: 222.1-223.3 °C  
1H-NMR δH (399.8 MHz): 5.70 (2H, s, br, NH2), 1.93 (2H, s, 6-CH2), 1.41 (6H, s, 2 x CH3), 1.31 
(6H, s, 2 x CH3); 
13C-NMR (100.5 MHz): 171.8 (ArC), 163.0 (ArC), 160.0 (ArC), 53.3 (6-CH2), 40.6 (C), 39.5 
(C), 29.9 (2 x CH3), 28.8 (2 x CH3) ppm. 
HRMS m/z: 193.1445. Calculated for [C10H16N4 + H]+: 193.1448 
 
2.2.14 (1R,8S)-8,11,11-Trimethyl-3,4,6-triazatricyclo[6.2.1.02,7]undeca-2,4,6-trien-5-
amine[172] 
 
A suspension of (1S)-(+)-camphorquinone (1.05 g, 6.00 mmol) and aminoguanidine bicarbonate 
(0.68 g, 5.00 mmol) in EtOH (50 ml) was heated under reflux (120 °C) for 24 hour. The solvent 
was removed under reduced pressure and the resulting residue was recrystallized from hot 
methanol. Filtration left the product as an off-white solid (0.97 g, 95%).  
m.p: 260.1-261.5 °C 
1H-NMR δH (399.8 MHz): 5.16 (2H, s, br, NH2), 3.06 (1H, d, J = 4.12 Hz, 1-CH), 2.20 (1H, tt, J 
= 10.99, 4.12 Hz, CHexo), 1.96 (1H, td, J = 10.99, 3.66 Hz, CHexo), 1.41 – 1.28 (2H, m, 2 x CHendo), 
1.24 (3H, s, CH3), 1.05 (3H, s, CH3), 0.65 (3H, s, CH3);  
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13C-NMR (100.5 MHz): 172.2 (ArC), 161.71 (ArC), 158.5 (ArC), 54.5 (C), 53.9 (C), 50.4 (1-
CH), 31.5 (CH2), 24.7 (CH2), 20.1 (CH3), 18.3 (CH3), 9.1 (CH3) ppm. 
LRMS (ESI -ve) m/z 204.73; calculated for [C11H16N4]: 204.14 
NMR data was consistent with literature values. 
 
(E)-1-[Amino(methylsulfanyl)methylidiene]hydrazine-1-ium iodide[173]  
 
A solution of thiosemicarbazide (5.09 g, 55.00 mmol) in EtOH (50 ml) was cooled to 0 °C before 
iodomethane (4.40 ml, 66.00 mmol) was slowly added dropwise. The mixture was refluxed at 
80 °C overnight before cooling to room temperature. The precipitate that formed was filtered and 
washed with petroleum ether (50 ml). The solvent removed under reduced pressure to leave the 
product as a pale solid (11.96 g, 93%).  
1H-NMR δH (399.8 MHz, DMSO-D6): 10.51 (1H, s, br, NH), 9.07 (2H, s, br, NH2), 5.19 (2H, s, 
br, NH2), 3.31 (3H, s, SCH3) ppm.  
NMR data was consistent with literature values. 
 
2.2.19: 5,6-Diethyl-3-(methylsulfanyl)-1,2,4-triazine  
 
Methylthiosemicarbazide hydrogen iodide (0.42 g, 1.70 mmol) was dissolved in a solution of 
EtOH and H2O (20 ml, 4:1 ratio). This solution was added dropwise, over 5 minutes, to a solution 
of hexane-3,4-dione (0.21 ml, 1.70 mmol) and sodium bicarbonate (0.15 g, 1.90 mmol) in EtOH 
and H2O (20 ml, 4:1). The mixture was stirred at room temperature overnight, then under reflux 
for 5 hour. The mixture was allowed to cool to room temperature and evaporated to dryness. The 
residue was diluted with H2O (30 ml) and extracted with DCM (4 x 10 ml). The combined organic 
layers were dried (MgSO4) and the solvent removed under reduced pressure to leave the product 
as a yellow liquid (0.30 g, 97%). 
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1H-NMR δH (399.8 MHz): 2.94 (2H, q, J = 7.79, 7.33 Hz, CH2), 2.78 (2H, q, J = 7.79, 7.33 Hz, 
CH2), 2.66 (3H, s, SCH3), 1.38 (3H, t, J = 7.33 Hz, CH3), 1.32 (3H, t, J = 7.33 Hz, CH3); 
13C-NMR (100.5 MHz): 170.8 (ArC), 161.9 (ArC), 156.9 (ArC), 26.9 (CH2), 25.3 (CH2), 13.9 
(SCH3), 12.2 (CH3), 11.0 (CH3) ppm.  
 
2.2.25: 1λ⁵,5λ⁵-diazatetracyclo[7.6.2.0⁵,¹⁷.0¹²,¹⁶]heptadeca-1(15),5,7,9,11,13,16-heptaene-
1,5-bis(ylium) dibromide[174]  
 
A mixture of 1,10-phenanthroline (1.07 g, 5.55 mmol) and 1,3-dibromoproane (2.51 ml, 
24.42 mmol) were dissolved in nitrobenzene (25 ml). The reaction mixture was then stirred at 120 
°C for 24 hour. Upon completion the precipitate was collected via filtration and washed with 
toluene. The resulting solid was recrystallized from a solution of EtOH/H2O (5:1, 20 ml) to give 
the yellow solid (1.42 g, 67%).   
1H-NMR δH (399.8 MHz, DMSO D6): 9.84 (2H, d, J = 5.50 Hz, ArH), 9.51 (2H, d, J = 8.24 Hz, 
ArH), 8.69 (2H, s, ArH), 8.68-8.66 (2H, m, ArH), 5.12 (4H, t, J = 6.87 Hz, 2 x CH2), 3.22 (2H, 
qu, 6.87 Hz, CH2); 
13C-NMR (100.5 MHz, DMSO D6): 151.9 (ArCH), 146.8 (ArCH), 134.0 (ArC), 133.8 (ArC), 
130.1 (ArCH), 127.7 (ArCH), 60.2 (2 x CH2), 55.5 (CH2), ppm.  
NMR data was consistent with literature values. 
 
2.2.26: N, N’-Propane-1,10-phenanthroline-3,9-dione[174] 
 
Method A: 
A solution of potassium ferricyanide (1.55 g, 4.71 mmol) and sodium hydroxide (0.71 g, 17.68 
mmol) in H2O (5 ml) was cooled too under 5 °C and stirred for 15 minutes. A solution of 2.2.25 
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(0.21 g, 0.52 mmol) in water (10 ml) was added and the mixture was stirred for 1 hour below 5 
°C before being stirred at room temperature for 2 hour. The resulting solution was neutralised by 
the dropwise addition of concentrated hydrochloric acid and then extracted with chloroform (3 x 
20 ml), dried (MgSO4) and the solvent removed under reduced pressure. Purification was 
achieved by column chromatography (silica gel, DCM:MeOH, 60-30:1) to yield the product as a 
dark brown solid (13.8 mg, 11%).  
Method B:[138] 
A suspension of 2.2.25 (3.04 g, 7.97 mmol) in tert-butanol (80 ml) was refluxed at 40 °C for 
21 hours. Potassium tert-butoxide (3.58 g, 31.87 mmol) was added in small portions slowly and 
refluxed for 24 hours. Upon completion the solution was allowed to cool to room temperature 
before the precipitate was filtered. The filtrant was dissolved in H2O (10 ml) and extracted with 
DCM (4 x 10 ml), dried (MgSO4). The solvent was evaporated to leave the product as a brown 
solid (1.20 g, 69%).  
1H-NMR δH (399.8 MHz): 7.72 (2H, d, J = 9.62 Hz, 2 x ArCH), 7.37 (2H, s, 5-ArCH, 6-ArCH), 
6.81 (2H, d, J = 9.62 Hz, ArCH), 4.32 (4H, br, s, 2 x CH2), 2.44 (2H, qu, J = 6.87, 6.41 Hz, CH2);  
13C-NMR (100.5 MHz): 162.7 (2 x CO), 138.8 (2 x ArCH), 132.1 (2 x ArC), 123.1 (2 x ArCH), 
122.8 (2 x ArCH), 122.7 (ArC), 45.7 (2 x CH2), 25.8 (CH2) ppm.  
LRMS (ESI +ve) m/z 253.16; calculated for [C15H12N2O2 + H]+: 253.09 
NMR data was consistent with literature values. 
 
2.2.27: 2,9-Dichloro-1,10-phenanthroline[138] 
 
A mixture of 2.2.26 (0.22 g, 0.87 mmol), phosphorous pentachloride (0.42 g, 1.84 mmol) and 
phosphorus oxychloride (15 ml) were refluxed for 18 hour under N2. Excess phosphorus 
oxychloride was removed under reduced pressure and ice H2O (30 ml) was added. The solution 
was basified with aq. ammonia (2 M) to give a pale brown precipitate which was filtered and 
dried under vacuum (0.17 g, 78%). 
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1H-NMR δH (399.8 MHz): 8.22 (2H, d, J = 8.70 Hz, ArCH) 7.84 (2H, s, 5-ArCH, 6-ArCH) 7.66 
(2H, d, J = 8.24 Hz, ArCH); 
13C-NMR (100.5 MHz): 152.0 (2 x ArC), 144.9 (2 x ArC), 138.8 (2 x ArCH), 127.7 (2 x ArC), 
126.2 (ArCH), 124.9 (ArCH) ppm. 
LRMS (ESI +ve) m/z 250.11; calculated for [C12H6Cl2N2 + H]: 250.99 
NMR data was consistent with literature values. 
 
2.2.28: 2,9-Dibromo-1,10-phenanthroline[175]  
 
2.2.27 (0.49 g, 1.95 mmol) was suspended in phosphorus tribromide (3 ml) and placed under N2. 
The mixture was heated at 170 °C for 17 hour before cooling to room temperature, then further 
to 0 °C. The mixture was quenched by the slow addition of cold water and neutralised with 
saturated aq. NaHCO3. The solid that precipitated was collected by filtration, washed with H2O 
(20 ml) and left to dry overnight to leave an off white solid (0.35 g, 53 %). 
1H-NMR δH (399.8 MHz): 8.10 (2H, d, J = 8.24 Hz, ArCH, ArCH) 7.83 (2H, s, 5-ArCH, 6-
ArCH) 7.80 (2H, d, J = 8.24 Hz, Ar-CH); 
13C-NMR (100.5 MHz): 145.5 (ArC), 143.1 (ArC), 138.2 (ArCH), 128.5 (ArCH), 127.9 (ArC), 
126.5 (ArCH) ppm.  
LRMS (ESI +ve) m/z: 339.03 calculated for [C29H37N9 + H]+: 339.89 
NMR data was consistent with literature values. 
  
2.3.2: 6-Bromopyridine-2-carbohydrazonamide[142]  
 
6-Bromopyridine-2-carbonitrile (0.40 g, 2.19 mmol) was suspended in EtOH (25 ml) and cooled 
to 0°C. Hydrazine hydrate (50-60%, 5 ml) was added slowly and then stirred at 0°C for 1 hour. 
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Mixture allowed to warm to room temperature and refluxed at 40 °C overnight. The solution was 
allowed to cool and the solid was filtered and washed with minimal hexane. The product was a 
white fluffy solid (414 mg, 88%). 
1H-NMR δH (399.8 MHz): 7.97 (1H, d, J = 7.79 Hz, ArCH), 7.55 (1H, t, J = 7.79 Hz, 4-ArCH), 
7.45 (1H, d, J = 7.79 Hz, ArCH), 5.13 (2H, s, br, NH2), 4.64 (2H, s, br, NH2); 
13C-NMR (100.5 MHz): 153.8 (C), 142.0 (C), 140.1 (C), 139.9 (ArCH), 127.3 (ArCH), 118.9 
(ArCH) ppm. 
NMR data was consistent with literature values. 
  
2.3.3: 2-Bromo-6-(5,5,7,7-tetramethyl-5H, 6H, 7H-cyclopenta[e] [1,2,4] triazin-3-
yl)pyridine 
 
3,3,5,5-Tetramehtylcyclopentane-1,2-dione 2.2.7 (158 mg, 1.02 mmol) and 6-bromopyridine-2-
carbohydrazonamide 2.3.2 (200 mg, 0.93 mmol) was suspended in AcOH (5 ml) and refluxed 
over the weekend. The solution was cooled and the AcOH removed under reduced pressure. 
Purification was achieved through column chromatography (silica gel; DCM 100%, with 
increasing MeOH fraction) to yield the project as a yellow solid (172 mg, 56%).  
m.p: 90.1-92.4 °C 
1H-NMR δH (399.8 MHz): 8.47 (1H, d, J = 7.79 Hz, ArCH), 7.76 (1H, t, J = 7.79 Hz, 4-ArCH), 
7.64 (1H, d, J = 7.79 Hz, ArCH), 2.06 (2H, s, 6-CH2), 1.52 (6H, s, 2 x CH3), 1.46 (6H, s, 2 x 
CH3); 
13C-NMR (100.5 MHz): 171.0 (ArC), 167.9 (ArC), 161.7 (ArC), 154.9 (ArC), 142.7 (ArC), 139.1 
(ArCH), 129.7 (ArCH), 122.8 (ArCH), 52.9 (6-CH2), 41.3 (C), 40.4 (C), 29.7 (2 x CH3), 29.0 (2 
x CH3) ppm. 
HRMS (ESI +ve) m/z 333.0712; calculated for [C15H17BrN4 + H]+: 333.0709 
2.3.4: 2-Bromo-6-{(1R,8S)-8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.02,7]undeca-2,4,6-
trien-5-yl}pyridine  
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(1S)-(+)-Camphorquinone (0.43 g, 2.78 mmol) and 6-bromopyridine-2-carbohydrazonamide 
2.3.2 (0.47 g, 2.19 mmol) was suspended in AcOH (5 ml) and refluxed overnight. The solution 
was cooled and the AcOH removed under reduced pressure. The product was purified by column 
chromatography (silica gel; DCM 100%, with increasing EtOAc fraction). Product was a yellow 
solid (0.67 g, 88%). 
m.p: 156.7-157.5 °C 
1H-NMR δH (399.8 MHz): 8.49 (1H, d, J = 7.33 Hz, ArCH), 7.73 (1H, t, J = 7.79 Hz, 4-ArCH), 
7.63 (1H, d, J = 7.79 Hz, ArCH), 4.58 (1H, d, J =  4.58 Hz, 1-CH), 2.39 – 2.30 (1H, s, CHexo), 
2.11 – 2.03 (1H, s, CHexo), 1.44 (3H, s, CH3), 1.43 – 1.39 (2H, m, 2 x CHendo) 1.12 (3H, s, CH3), 
0.64 (3H, s, CH3); 
13C-NMR (100.5 MHz): 171.3 (ArC), 165.6 (ArC), 160.6 (ArC), 154.9 (ArC), 142.6 (ArC), 139.2 
(ArCH), 129.7 (ArCH), 122.8 (ArCH), 55.6 (C), 54.5 (C), 51.1 (1-CH), 31.1 (CH2), 24.2 (CH2), 
20.1 (CH3), 18.3 (CH3), 9.3 (CH3) ppm. 
HRMS (ESI +ve) m/z: 345.0711; calculated for [C16H17BrN4 + H]+: 345.0709 
 
3.2.2: Pyridine-2,6-bisamidrazone [176] 
 
Pyridine-2,6-dicarbonitrile (1.00 g, 7.74 mmol) was dissolved in hydrazine monohydrate (50-
60%, 10 ml) and EtOH (10 ml) added. The mixture was stirred for 5.5 hour and the white 
precipitate was filtered and washed with EtOH (15 ml). The solid was recrystallized in water and 
filtered to leave a white fluffy solid as the product (0.96 g, 64%).  
1H-NMR δH (399.8 MHz, DMSO-D6): 7.80 (2H, d, J = 7.79 Hz, 2 x ArCH), 7.66 (1H, d, J = 
7.33 Hz, ArCH), 7.64 (1H, d, 7.33 Hz, ArCH), 6.06 (4H, s, br, NH2), 5.26 (4H, s, br, NH2);  
13C-NMR (100.5 MHz, DMSO-D6): 151.8 (C), 145.0 (C), 137.5 (ArCH), 119.4 (2 x ArCH) ppm.  
202 
 
NMR data consistant with literature values. 
 
3.2.7: 1,10-phenanthroline-2,9-dicarbaldehyde [95] 
 
Selenium dioxide (2.28 g, 20.52 mmol) was dissolved in 1,4-dioxane (80 ml) and water (3 ml) 
and heated to reflux. Neocuproine (2.02 g, 9.68 mmol) was dissolved in 1,4-dioxane (60 ml) and 
added dropwise slowly over 30 minutes. The solution was refluxed for 30 minutes before the 
reaction mixture was filtered whilst hot. The filtrate was allowed to cool to room temperature, 
then further to 0 °C and the precipitated solid was filtered and washed with dioxane (15 ml). The 
solid was triturated with chloroform (100 ml) and filtered. The filtrate was evaporated to afford 
the dialdehyde as a pale brown solid (0.76 g). The remaining filtrant was triturated with 
chloroform (50 ml) and filtered then washed with chloroform (20 ml). The filtrate was evaporated 
to afford the dialdehyde as a pale brown solid (0.72 g). Further trituration of the filtrant yielded a 
further (0.60 g) of the dialdehyde; total yield (2.08 g, 91%). 
1H-NMR δH (399.8 MHz): 10.61 (2H, s, CHO), 8.56 (2H, d, J = 8Hz, ArCH), 8.44 (2H, d, J = 
8Hz, Ar-CH), 8.10 (2H, s, ArCH); 
13C-NMR (100.5 MHz): 193.4 (2 x CHO), 152.7 (2 x ArC), 146.0 (2 x ArC), 138.0 (2 x ArCH), 
131.6 (2 x ArC), 129.1 (2 x ArCH), 120.5 (2 x ArCH) ppm. 
NMR data was consistent with literature values. 
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3.2.9: 1,10-Phenanthroline-2,9-dicarbonitrile[95] 
 
Method A: 
To a suspension of dialdehyde 3.2.7 (1.25 g, 5.31 mmol), in dry acetonitrile (100 ml) was added 
hydroxylamine hydrochloric acid (0.76 g, 11.68 mmol) and triethylamine (5 ml). The mixture 
was heated under reflux for 4 hours and then allowed to cool to room temperature. Subsequently 
p-toluenesulfonyl chloride (3.61 g, 17.53 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene  (2.45 
ml, 15.93 mmol) were added and the mixture heated under reflux for 21 hour. The reaction 
mixture was filtered whilst hot and washed with hot acetonitrile (10 ml). The filtrate was 
evaporated to afford a brown semi-solid which was triturated with MeOH (35 ml). The solid was 
filtered and washed with MeOH (30 ml) and Et2O (20 ml) to afford the dinitrile 3.2.9 as a light 
brown solid (0.66 g, 54%). 
1H-NMR δH (399.8 MHz): 8.48 (2H, d, J = 8.24 Hz, ArCH), 8.08 (2H, d, J = 8.24 Hz, ArCH), 
8.02 (2H, s, ArCH); 
Method B:[148] 
1,10-Phenanthroline-2,9-dicarboxamide 3.2.13 (1.39 g, 5.22 mmol) was dissolved in phosphorus 
oxychloride (10 ml) and refluxed for 20 hour. Solution cooled to room temperature and poured 
onto ice-water (100 ml) with external cooling. The slurry was diluted with water (100 ml) and the 
resulting precipitate was filtered and washed with water (2 x 60 ml) and diethyl ether (2 x 60 ml). 
The resulting brown solid was left to dry overnight (0.51 g, 43%). 
1H-NMR δH (399.8 MHz, DMSO-D6): 8.85 (2H, d, J = 8.24 Hz, ArCH), 8.43 (2H, d, J = 8.24 
Hz, ArCH), 8.28 (2H, s, ArCH) ppm. 
NMR data was consistent with literature values. 
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3.2.11: 2,9‐bis(trichloromethyl)‐1,10‐phenanthroline[105] 
 
A stirred solution of 2,9-dimethyl-1,10-phenanthroline (2.06 g, 9.60 mmol), N-chlorosuccinimide 
(9.23 g, 69.14 mmol) and azobisisobutyronitrile (AIBN) (8.00 mg, 0.05 mmol) were refluxed for 
18 hour. The resulting mixture was washed with a 1 M solution of NaOH (6 x 90 ml) and a 
saturated solution of K2CO3 (2 x 90 ml), dried over MgSO4 and evaporated under reduced pressure 
to afford a yellow crystalline solid (3.72 g, 93%).  
1H-NMR δH (399.8 MHz):  8.45 (2H, d, J = 8.47 Hz, 4-ArCH and 7-ArCH), 8.33 (2H, d, J = 
8.47 Hz, 3-ArCH and 8-ArCH), 7.98 (2H, s, 5-ArCH and 6-ArCH); 
13C-NMR (100.5 MHz): 158.0 (CCl3), 143.2 (ArC), 138.2 (4-ArCH and 7-ArCH), 129.2 (ArC), 
127.6 (5-ArCH and 6-ArCH), 120.5 (3-ArCH and 8-ArCH) ppm. 
NMR data was consistent with literature values. 
  
3.2.12: dimethyl 1,10-phenanthroline-2,9-dicarboxylate[105] 
 
A suspension of 3.2.11 (2.00 g, 4.82 mmol) in H2SO4 (3 ml) was heated at 95 °C for 4 hr. The 
resulting solution was cooled to room temperature and CH3OH (2.3 ml) was added dropwise. The 
mixture was heated at reflux for a further 1.5 hr before being allowed to cool. This was then 
neutralised by addition of a saturated solution of NaHCO3 (30 ml). The resulting precipitate was 
filtered and washed with H2O (3 x 25 ml) and diethyl ether (6 x 25 ml) and allowed to dry to leave 
a light tan solid (1.01 g, 70%).  
1H-NMR δH (399.8 MHz): 8.75 (2H, d, J = 8.24 Hz, ArCH and ArCH), 8.43 (2H, d, J = 8.24 Hz, 
ArCH and ArCH), 8.23 (2H, s, ArCH and ArCH), 4.03 (6, s, 2 x OCH3); 
13C-NMR (100.5 MHz): 166.0 (2 x ArCO), 148.2 (2 x ArC), 145.6 (2 x ArC), 138.6 (2 x ArCH), 
131.1 (2 x ArC), 129.1 (2 x ArCH), 124.3 (2 x ArCH), 53.3 (2 x OCH3) ppm. 
205 
 
NMR data was consistent with literature values. 
 
3.2.13: 1,10-phenanthroline-2,9-dicarboxamide [105] 
 
A suspension of 3.2.12 (1.01 g, 3.40 mmol) and NH4Cl (76 mg, 1.41 mmol) in concentrated 
NH4OH (30 ml) was stirred at room temperature for 24 hour. The resulting precipitate was filtered 
and washed with H2O (2 x 40 ml) and diethyl ether (2 x 40 ml). This was left to dry overnight to 
yield the diamide as a beige solid (0.79 g, 87 %). 
1H-NMR δH (399.8 MHz, DMSO-D6): 8.98 (2H, s, br, NH2), 8.72 (2H, d, J = 8.24 Hz, 2 x 
ArCH), 8.47 (2H, d, J = 8.24 Hz, 2 x ArCH), 8.17 (2H, s, 2 x ArCH), 7.90 (2H, s, br, NH2); 
13C-NMR (100.5 MHz, DMSO-D6): 166.6 (2 x ArCO), 150.5 (2 x ArC), 144.5 (2 x ArC), 138.5 
(2 x ArCH), 130.7 (2 x ArC), 128.4 (2 x ArCH), 121.6 (2 x ArCH) ppm. 
NMR data was consistent with literature values. 
 
3.2.10: 1,10-Phenanthroline-2,9-dicarbohydrazonamide[95] 
 
To a suspension of dinitrile 3.2.9 (0.66 g , 2.88 mmol) in EtOH (40 ml) was added hydrazine 
hydrate (50-60%, 20 ml). The suspension was stirred at room temperature for 3 days then at 40 
°C for 4 hour. The solid was filtered and washed with H2O (20 ml) and allowed to dry in air 
overnight to afford the product as a pale yellow solid (0.75 g, 88%). 
1H-NMR δH (399.8MHz, DMSO-D6): 8.38 (2H, d, J = 8.70 Hz, ArCH), 8.28 (2H, d, J = 8.70 
Hz, ArCH), 7.95 (2H, s, ArCH), 6.14 (2H, s, br, NH2), 5.67 (2H, s, br, NH2); 
NMR data was consistent with literature values. 
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General synthesis of ketopinic acid-amide derivatives.  
Method A:[149]  
(1S)-ketopinic acid (0.10 g, 0.55 mmol), N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide 
hydrochloride (0.13 g, 0.66 mmol), 4-(dimethylamino)pyridine (0.08 g, 0.66 mmol) were 
dissolved in DCM (10 ml) and mixture stirred for 30 minutes. Morpholine (0.05 ml, 0.55 mmol) 
was subsequently added and the mixture stirred at room temperature for 24 hour. H2O (5 ml) was 
added and the resulting layers separated. The aqueous layer was extracted with DCM (20 ml) and 
the combined organic layers were washed with aq. hydrochloric acid (2 x 10 ml), H2O (10 ml), 
aq. NaOH (2 x 10 ml), H2O (10 ml), brine (10 ml) and dried (MgSO4). The solvent was removed 
under reduced pressure to leave the product.  
Method B:[151]  
(1S)-ketopinic acid (0.10 g, 0.55 mmol) and thionyl chloride (1.0 ml) were added to a 50 ml flask 
and refluxed for 2 hour. The remaining SOCl2 was removed under reduced pressure. The acyl 
chloride was dissolved in DCM (2 ml) and added to a mixture of trimethylamine (0.2 ml, 0.83 
mmol) and morpholine (0.1 ml, 0.83 mmol) in DCM (2 ml) at 0 °C. The mixture was stirred at 0 
°C for 10 minutes then at room temperature for 18 hour. H2O (10 ml) added and the aqueous layer 
was separated and washed with DCM (3 x 10 ml). The combined organic layers were washed 
with brine (10 ml), dried (Na2SO4) and the solvent removed under reduced pressure to leave the 
product.   
 
3.3.1: 7,7-Dimethyl-1-(morpholine-4-carbonyl)bicyclo[2.2.1]heptan-2-one[151]  
 
Yield (Method A): 27 mg, 19%. 
Yield (Method B): 120 mg, 86% as a white solid. 
1H-NMR δH (399.8 MHz): 3.78 – 3.65 (8H, m, 4 x CH2), 3.58 – 3.30 (2H, m, CH2), 2.52 (1H, 
ddd, J = 18.78, 5.04, 2.75 Hz, CH), 2.27 (1H, td, J = 12.82, 3.21 Hz, CH), 2.15 – 2.06 (1H, m, 
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CH), 2.04 – 1.98 (2H, m, 2 x CH), 1.91 (1H, d, J = 18.78 Hz, CH), 1.46 (1H, ddd, J = 9.16, 6.87, 
3.21 Hz, CH), 1.23 (3H, s, CH3), 1.21 (3H, s, CH3); 
13C-NMR (100.5 MHz): 212.6 (2-CO), 167.7 (CO), 67.3 (1-C), 67.1 (4 x CH2), 50.6 (7-C), 43.7 
(CH2), 43.1 (4-CH), 27.2 (CH2), 27.1 (CH2), 21.3 (CH3), 21.0 (CH3) ppm. 
NMR data was consistent with literature values. 
3.3.2: 7,7-Dimethyl-1-(piperidine-1-carbonyl)bicyclo[2.2.1]heptan-2-one[151]  
 
Yield (Method A): 71 mg, 52%. 
Yield (Method B): 735 mg, 90%.  
1H-NMR δH (399.8 MHz): 3.56 – 3.35 (4H, m, br CH2), 2.50 (1H, ddd, J = 18.32, 4.58, 2.75 Hz, 
4-CH), 2.24 – 2.17 (1H, m, CH), 2.04 – 1.94 (2H, m, 2 x CH), 1.90 (1H, t, J = 4.58 Hz, CH), 1.83 
(1H, d, J = 18.32 Hz, CH), 1.56 – 1.46 (6H, m, br, 3 x CH2), 1.41 – 1.38 (1H, m, CH), 1.14 (3H, 
s, CH3), 1.12 (3H, s, CH3);  
13C-NMR (100.5 MHz): 211.4 (2-CO), 166.3 (CO), 66.4 (1-C), 49.6 (C), 42.7 (2 x CH2), 42.1 
(4-CH), 26.5 (CH2), 26.1 (CH2), 25.3 (3 x CH2), 23.6 (CH2), 20.3 (CH3), 20.1 (CH3) ppm.  
NMR data was consistent with literature values. 
 
3.3.3: N,N-Dimethyl-7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxamide[177]  
 
Yield (Method A): 54 mg, 42%; 
Yield (Method B): 665 mg, 84%, as a beige solid.  
1H-NMR δH (399.8 MHz): 3.58 – 3.41 (2H, m, CH2), 3.16 (2H, sp, J = 7.33, 6.87 Hz, CH2), 2.50 
(1H, ddd, J = 18.32, 5.04, 3.21 Hz, CH), 2.27 (1H, dd, J = 11.91, 4.12 Hz, CH), 2.09 (1H, tq, J = 
11.91, 7.33, 2.75 Hz, CH), 2.02 – 1.95 (2H, m, 2 x CH), 1.91 (1H, d, J = 18.32 Hz, CH), 1.45 
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(1H, ddd, J = 11.91, 4.12, 3.21 Hz, CH), 1.22 (3H, s, CH3), 1.21 (3H, s, CH3), 1.13 (3H, t, J = 
7.33. 6.87 Hz, CH3); 
13C-NMR (100.5 MHz): 212.7 (CO), 168.2 (CO), 67.6 (C), 50.7 (C), 43.9 (CH2), 43.2 (CH), 41.8 
(CH2), 40.3 (CH2), 27.7 (CH2), 27.1 (CH2), 21.6 (CH3), 20.9 (CH3), 14.3 (CH3), 12.8 (CH3) ppm.  
NMR data was consistent with literature values. 
 
3.3.4: 7,7-dimethyl-2-oxo-N-(propan-2-yl)bicyclo[2.2.1]heptane-1-carboxamide[178]  
 
Yield (Method B): 434 mg, 97%, as a light yellow oil.  
1H-NMR δH (399.8 MHz): 7.42 (1H, s, br, NH), 4.12 (1H, se, J = 6.87, 6.41 Hz, NCH), 2.58-
2.47 (2H, m, 2 x CH), 2.19-2.10 (1H, m, CH), 2.09-2.05 (1H, m, CH), 1.97 (1H, d, J = 18.32 Hz, 
CH), 1.61-1.54 (1H, m, CH), 1.42 (1H, ddd. J = 6.62, 6.41, 3.66, CH), 1.25 (3H, s, CH3), 1.19 
(3H, d, J = 6.41, CH3), 1.16 (3H, d, J = 6.41, CH3), 0.97 (3H, s, CH3); 
13C-NMR (100.5 MHz): 217.7 (CO), 168.0 (CO), 64.5 (C), 50.2 (C), 43.9 (CH2), 43.2 (CH), 40.8 
(NCH), 28.2 (CH2), 27.8 (CH2), 23.1 (CH3), 22.5 (CH3), 21.2 (CH3), 20.4 (CH3) ppm.  
NMR data was consistent with literature values. 
 
3.3.5: N,7,7-trimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxamide[179]  
 
Yield (Method B): 523 mg, 81%, as a clear oil.  
1H-NMR δH (399.8 MHz): 7.52 (1H, s, br, NH2), 2.77 (3H, d, J = 4.58 Hz, CH3), 2.49 – 2.41 
(2H, m, 2 x CH), 2.12 – 2.04 (1H, m, CH), 2.01 (1H, t, J = 4.58, 4.12 Hz, CH), 1.90 (1H, d, J = 
18.32, CH), 1.55 – 1.48 (1H, m, CH), 1.39 – 1.33 (1H, m, CH), 1.19 (3H, s, CH3), 0.90 (3H, s, 
CH3); 
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13C-NMR (100.5 MHz): 217.5 (CO), 169.7 (CON), 64.6 (C), 50.1 (C), 43.7 (CH2), 43.2 (CH), 
28.4 (CH2), 27.7 (CH2), 25.7 (CH3), 21.0 (CH3), 20.4 (CH3) ppm.  
NMR data was consistent with literature values. 
 
3.3.6: N-hexyl-7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxamide[180]  
 
Yield (Method B): 434 mg, 88%, as a clear oil.  
1H-NMR δH (399.8 MHz): 7.63 (1H, s, br, NH), 3.35 – 3.18 (2H, m, NCH2), 2.59 – 2.48 (2H, m, 
CH2), 2.15 (1H, tq, J = 12.14, 4.12, 3.66 Hz, CH), 2.08 (1H, t, J = 4.12 Hz, CH), 1.98 (1H, d, J = 
18.78 Hz, CH), 1.63 – 1.51 (3H, m, 1 x CH, 1 x CH2), 1.43 (1H, td, J = 4.12, 3.66 Hz, CH), 1.26 
(3H, s, CH3), 0.98 (3H, s, CH3), 0.93 (3H, t, J = 7.33 Hz, CH3); 
13C-NMR (100.5 MHz): 217.9 (CO), 169.1 (NCO), 64.6 (C), 50.2 (C), 43.9 (CH2), 43.2 (CH), 
40.6 (CH2), 28.4 (CH2), 27.8 (CH2), 22.9 (CH2), 21.1 (CH3), 20.5 (CH3), 11.5 (CH3) ppm.  
NMR data was consistent with literature values. 
 
3.3.7: N-hexyl-7,7-dimethylbicyclo[2.2.1]heptane-1-carboxamide  
 
Yield (Method B): 695 mg, 80%, as a clear oil.  
1H-NMR δH (399.8 MHz): 7.62 (1H, s, br, NH), 3.36 – 3.21 (2H, m, NCH2), 2.58 – 2.48 (2H, m, 
CH2), 2.15 (1H, tq, J = 11.91, 4.12, 3.66 Hz, CH), 2.08 (1H, t, J = 4.58/4.12 Hz, CH), 1.98 (1H, 
d, J = 18.78 Hz, CH), 1.63 – 1.40 (4H, m, 1 x CH, 1 x CH2), 1.35 – 1.28 (6H, td, J = 4.12, 3.66 
Hz, CH), 1.26 (3H, s, CH3), 0.97 (3H, s, CH3), 0.88 (3H, t, J = 6.41 Hz, CH3); 
13C-NMR (100.5 MHz): 217.8 (CO), 169.0 (NCO), 64.6 (C), 50.1 (C), 43.9 (CH2), 43.2 (CH), 
38.9 (CH2), 31.5 (CH2), 29.5 (CH2), 28.4 (CH2), 27.8 (CH2), 26.6 (CH2), 22.6 (CH2), 21.1 (CH3), 
20.4 (CH3), 14.1 (CH3) ppm.  
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3.3.9: 7,7-dimethyl-2,3-dioxobicyclo[2.2.1]heptane-1-carboxylic acid[152]  
 
Method A: 
(S)-(+)-ketopinic acid (0.80 g, 4.40 mmol) and SeO2 (1 eq., 0.50 g, 4.40 mmol) were refluxed in 
acetic acid. A further 0.2 eq. of SeO2 were added and the reaction monitored via TLC to monitor 
completion of the reaction. The reaction mixture was filtered through celite and washed with 
EtOAc before the solvent was removed under reduced pressure. The viscous yellow oil was 
dissolved in DCM and diluted with hexane. The solid was filtered and washed with hexane. 
Method B: 
(S)-(+)-Ketopinic acid (0.50 g, 2.74 mmol) was suspended in AcOH (5 ml) and the solution heated 
to 90 °C. A solution of bromine (0.20 ml, 3.26 mmol) in AcOH (3 ml) was added slowly over 20 
minutes. Upon addition the solution was maintained at 90 °C for a further 2 hours, before cooling 
to room temperature and stirring for a further 20 hours. Upon completion the mixture was added 
dropwise to an ice cooled solution of water with stirring. The resulting precipitate was filtered 
and washed with water. The solid was left to dry overnight to leave the crude solid (0.52 g). The 
crude solid (1.98 mmol) was suspended in DMSO (20 ml) and sodium iodide (0.31 g, 1.98 mmol) 
added. The mixture was heated to 150 °C and air was pumped through the reaction mixture for 7 
hours. Upon completion the solution was cooled and water (60 ml) subsequently added followed 
by sodium thiosulfate (0.20 g). The mixture was extracted with EtOAc (2 x 20 ml), the organic 
phases washed with water (5 x 10 ml) and dried (Na2SO4). The solvent was removed under 
reduced pressure. 
Method A: Yield: 0.15 g, 70%, as a yellow solid.  
Method B: Yield: 0.08 g, 20%, as a pale yellow solid.  
1H-NMR δH (399.8 MHz): 2.72 (1H, d, J = 5.04 Hz, 4-CH), 2.42 (1H, td, J = 12.82, 4.58 Hz, 
CH), 2.28 (1H, tt, J = 5.04, 4.58 Hz, CH), 2.03 (1H, tt, J = 5.04, 4.58 Hz, CH), 1.71 (1H, ddd, J 
= 5.04, 4.58 Hz, CH), 1.25 (3H, s, CH3), 1.25 (3H, s, CH3); 
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13C-NMR (100.5 MHz): 201.0 (CO), 199.5 (CO), 172.6 (CO), 67.3 (C), 58.0 (4-CH), 44.8 (C), 
26.6 (CH2), 22.1 (CH3), 21.4 (CH2), 18.4 (CH3) ppm. 
NMR data was consistent with literature values. 
 
3.3.8: 7,7-Dimethyl-1-(morpholine-4-carbonyl)bicyclo[2.2.1]heptane-2,3-dione 
 
Yield: 480 mg, 58%, as a yellow solid. 
1H-NMR δH (399.8 MHz): 3.81 - 3.44 (8H, m, 4 x CH2), 2.59 (1H, d, J = 5.04 Hz, CH), 2.46 
(1H, td, J = 12.82, 4.58, 4.12 Hz, CH), 2.30 (1H, tt, J = 13.28, 5.04 Hz, CH), 2.17 (1H, ddd, J = 
9.16, 4.58, 4.12 Hz, CH), 1.75 (1H, ddd, J = 9.16, 4.58, 4.12 Hz, CH), 1.37 (3H, s, CH3), 1.28 
(3H, s, CH3); 
13C-NMR (100.5 MHz): 200.1 (CO), 198.0 (CO), 165.3 (CO), 67.0 (4 x CH2), 57.7 (CH), 45.8 
(C), 27.3 (CH2), 22.7 (CH2), 22.3 (CH3), 19.3 (CH3) ppm.  
HRMS (ESI +ve) m/z: 266.1389; calculated for [C14H19NO4 + H]+ 266.1387 
 
3.3.10: N,N-Diethyl-7,7-dimethyl-2,3-dioxobicyclo[2.2.1]heptane-1-carboxamide  
 
Yield: 340 mg, 67%, yellow solid.  
m.p: 144.0-145.5 °C 
1H-NMR δH (399.8 MHz): 3.55 (1H, qu, J = 14.65, 7.33, 6.87 Hz, CH), 3.36 (1H, qu, J = 14.65, 
7.33, 6.87 Hz, CH) 3.23 (2H, qu, J = 14.20, 7.33, 6.87 Hz, 2 x NCH), 2.56 (1H, d, J = 5.04 Hz, 
CH), 2.46 (1H, td, J = 13.28, 4.58, 4.12 Hz, CH), 2.29 (1H, tt, J = 13.74, 5.04 4.58 Hz, CH), 2.14 
(1H, ddd, J = 9.16, 4.58 Hz, CH), 1.74 (1H, ddd, J = 5.04, 4.58, 4.12 Hz, CH), 1.34 (3H, s, CH3), 
1.29 (3H, s, CH3), 1.18 (6H, sp, J = 7.33, 6.87, 6.41 Hz, 2 x CH3);  
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13C-NMR (100.5 MHz): 200.7 (CO), 198.2 (CO), 165.7 (CO), 67.5 (C), 57.7 (CH), 45.9 (C), 41.9 
(NCH2), 40.5 (NCH2), 27.8 (CH2), 22.7 (CH2), 22.5 (CH3), 19.2 (CH3), 14.4 (CH3), 12.7 (CH3) 
ppm.  
 
3.3.11: 7,7-dimethyl-1-(piperidine-1-carbonyl)bicyclo[2.2.1]heptane-2,3-dione  
 
Yield: 500 mg, 70% as a yellow solid. 
1H-NMR δH (399.8 MHz): 3.57 – 3.37 (4H, m, 2 x CH2), 2.55 (1H, d, J = 5.04 Hz, 4-CH), 2.46 
(1H, ddd, J = 4.61, 4.58 Hz, CH), 2.32 – 2.13 (2H, m, 2 x CH), 2.05 – 1.95 (1H, m, CH) 1.76 – 
1.60 (6H, m, 3 x CH2), 1.34 (3H, s, CH3), 1.26 (3H, ,s, CH3); 
13C-NMR (100.5 MHz): 200.7 (2-CO), 198.1 (3-CO), 165.0 (NCO), 65.9 (1-C), 57.8 (4-CH), 
45.8 (7-C), 27.6 (CH2), 24.5 (CH2), 22.4 (CH3), 19.5 (CH3) ppm. 
 
3.3.12: N,7,7-trimethyl-2,3-dioxobicyclo[2.2.1]heptane-1-carboxamide  
 
Yield: 176 mg, 33% as a solid.  
1H-NMR δH (399.8 MHz): 7.20 (1H, s, br, NH), 2.90 (3H, d, J = 4.58 Hz, NCH3), 2.75 (1H, td, 
J = 4.58, 4.12 Hz, CH), 2.67 (1H, d, J = 5.04 Hz, 4-CH), 2.36 (1H, tt, J = 5.04, 4.58 Hz, CH), 
1.82 (1H, ddd, J = 5.04, 4.58, 4.12 Hz, CH), 1.72 (1H, ddd, J = 4.58, 4.12 Hz, CH), 1.37 (3H, s, 
CH3), 1.05 (3H, s, CH3); 
13C-NMR (100.5 MHz): 201.9 (CO), 200.1 (CO), 167.2 (CO), 65.3 (C), 58.0 (CH), 45.6 (C), 
28.5 (CH2), 26.1 (CH3), 22.8 (CH2), 22.1 (CH3), 19.4 (CH3) ppm.  
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3.3.13: 7,7-dimethyl-2,3-dioxo-N-propylbicyclo[2.2.1]heptane-1-carboxamide  
 
Yield (Method B): 200 mg, 45 %, as a yellow oil. 
1H-NMR δH (399.8 MHz): 7.22 (1H, s, br, NH), 3.33-3.18 (2H, m, CH2), 2.73 (1H, td, J = 5.04, 
4.58, 4.12 Hz, 4-CH), 2.64 (1H, d, J = 5.04 Hz, CH), 2.34 (1H, tt, J = 5.04, 4.58 Hz, CH), 1.79 
(1H, ddd, J = 4.58, 4.12 Hz, CH), 1.70 (1H, ddd, J = 4.58, 4.12 Hz, CH), 1.60 – 1.50 (5H, m, CH2 
and CH3), 1.33 (3H, s, CH3), 1.03 (3H, s, CH3); 
13C-NMR (100.5 MHz): 202.0 (CO), 200.1 (CO), 166.6 (NCO), 65.4 (C), 58.1 (CH), 45.6 (C), 
43.9 (CH2), 41.1 (CH2), 28.4 (CH2), 22.9 (CH2), 22.2 (CH3), 19.5 (CH3), 11.50 (CH3) ppm.  
 
3.3.14: 7,7-dimethyl-2,3-dioxo-N-(propan-2-yl)bicyclo[2.2.1]heptane-1-carboxamide  
 
Yield (Method B): 320 mg, 42%, as a pale yellow solid.   
1H-NMR δH (399.8 MHz): 6.96 (1H, s, br, NH), 4.10 (1H, sep, J = 6.41 Hz, CH), 2.71 (1H, td, J 
= 4.58, 4.12 Hz, CH), 2.62 (1H, d, J = 5.04 Hz, 4-CH), 2.31 (1H, tt, J = 5.04, 4.58 Hz, CH), 1.77 
(1H, ddd, J = 4.58, 4.12 Hz, CH), 1.67 (1H, ddd, J = 4.58, 4.12 Hz, CH), 1.31 (3H, s, CH3), 1.19 
(3H, d, J = 6.41 Hz, CH3), 1.15 (3H, d, J= 6.41 Hz, CH3), 1.01 (3H, s, CH3); 
13C-NMR (100.5 MHz): 201.8 (CO), 200.1 (CO), 165.5 (NCO), 65.2 (C), 58.0 (CH), 45.5 (C), 
41.3 (CH), 28.2 (CH2), 27.7 (CH2), 22.9 (CH3), 22.7 (CH3), 22.0 (CH3), 19.3 (CH3) ppm. 
 
4.2.2: 2,2,5,5-Tetramethylcyclohexane-1,3-dione[159]  
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Dimedone (5.00 g, 35.67 mmol) was dissolved in a mixture of EtOH/H2O (1:1, 100 ml), potassium 
carbonate (9.88 g, 71.34 mmol) was added and the mixture cooled to 0 °C. Iodomethane (6.0 ml, 
90.95 mmol) was slowly added and the reaction mixture was stirred at 70 °C for 6 hour. The 
mixture was cooled to room temperature and water added to quench the reaction. The precipitate 
was filtered, dissolved in DCM and dried (MgSO4) to leave the product as a white solid (4.25 g, 
71%).  
1H-NMR δH (399.8 MHz): 1.61 (4H, s, 2 x CH2), 1.30 (6H, s, 2 x CH3), 0.99 (6H, s, 2 x CH3); 
13C-NMR (100.5 MHz):  210.5 (CO), 60.5 (C-5), 51.1 (2 x CH2), 30.7 (2-C), 28.5 (2 x CH3), 22.2 
(2 x CH3) ppm. 
LRMS (ESI -ve) m/z; 167.82; calculated for [C10H15O2 - H]-: 167.11 
NMR data was consistent with literature values. 
 
4.2.3: 3,3,6,6-Tetramethylcyclohexane-1,2,4-trione[160]  
 
2,2,5,5-Tetramethylcyclohexane-1,3-dione 4.2.2 (1.04 g, 5.94 mmol) and selenium dioxide (1.34 
g, 11.89 mmol, eq) were refluxed in 1,4-dioxane (35 ml) for 24 hour. The selenium metal was 
filtered off through celite and this was washed with EtOAc. The product was purified through 
column chromatography (silica gel: EtOAc:Hexane, 1:4) to yield the product as an off white solid 
(0.31 g, 29%). 
1H-NMR δH (399.8 MHz): 2.89 (2H, s, 5-CH2), 1.37 (6H, s, 2 x CH3), 1.21 (6H, s, 2 x CH3); 
13C-NMR (100.5 MHz): 205.5 (CO), 202.3 (CO), 200.7 (CO), 63.2 (3-C), 49.9 (5-CH2), 42.8 (6-
C), 23.5 (2 x CH3), 21.1 (2 x CH3) ppm. 
LRMS (ESI) m/z; 182.0949 calculated for [C10H14O3]: 182.0943  
NMR data was consistant with literature values. 
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4.2.5: N,N-Dimethylcarbamoylmethyltriphenylphosphonium [161] 
 
A solution of triphenylphosphine (0.45 g, 1.65 mmol) and 2-chloro-N,N-dimethylacetamide (0.18 
ml, 1.65 mmol) were suspended in chloroform (10 ml) and refluxed for 3.5 hours. The solution 
was concentrated under reduced pressure and ether added to the residue and left to stir until a 
white solid precipitated. The precipitate was subsequently filtered to leave the product as a white 
solid (0.59 g, 99%). 
 1H-NMR δH (399.8 MHz): 7.94 (3H, d, J = 13.28 Hz, 3 x ArCH), 7.92 (3H, d, J = 13.28 Hz, 3 
x ArCH), 7.73 (3H, m, 3 x ArCH), 7.63 (6H, m, 6 x ArCH), 5.77 (2H, d, J = 12.82 Hz, CH2), 3.48 
(3H, s, CH3), 2.87 (3H, s, CH3);  
13C-NMR (100.5 MHz): 164.0 (CO), 134.3 (2JCP = 2.88 Hz, 3 x ArCH), 134.00 (3JCP = 9.58 Hz, 
ArCH), 129.9 (4JCP = 12.46 Hz, ArCH), 120.2 (C), 119.3 (C), 39.4 (NCH3), 35.8 (NCH3), 34.4 
(CH2);  
13P{1H}-NMR δP (162 MHz): 22.20 ppm.  
NMR data was consistent with literature values. 
 
4.2.6: N,N-Dimethyl-2-(triphenyl-phosphanylidene)acetamide [161] 
 
Sodium hydride (0.21 g, 8.69 mmol) was suspended in anhydrous DCM (10 ml) and a solution of 
N,N-dimethylcarbamoylmethyltriphenylphosphonium 4.2.5 (0.61 g, 1.74 mmol) in anhydrous 
DCM (10 ml) was added slowly under N2 and stirred for 40 minutes. The solution was filtered 
through celite and concentrated to give a pale yellow semi-solid to which hexane (10 ml) was 
added. The resulting off-white solid was filtered to give the product (0.35 g, 58%). 
1H-NMR δH (399.8 MHz): 7.69 (6H, d, J = 7.79 Hz, ArCH), 7.66 (6H, d, J = 7.33 Hz, ArCH), 
5.52 – 7.47 (6H, m, ArCH), 7.44-7.43 (12H, m, ArCH), 2.95 (7H, s, PCH and 2 x NCH3);  
13C-NMR (100.5 MHz): 133.1 (2JCP = 9.58 Hz, 6 x ArCH), 131.4 (3 x ArCH), 129.8 (ArC), 128.5 
(2JCP = 11.50 Hz, 6 x ArCH), 36.8 (PCH and 2 x NCH3); 
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13P{1H}-NMR δP (162 MHz): 29.90 ppm.  
NMR data was consistent with literature values. 
 
4.2.10: diethyl [2-(dimethylcarbamoyl)acetyl]phosphonite[162]  
 
A mixture of 2-chloro-N,N-dimethylacetamide (1.0 ml, 9.72 mmol) and triethyl phosphite (1.7 
ml, 9.72 mmol) were stirred at 180°C for 16 hour before cooling to room temperature. Excess 
triethyl phosphite was removed by vacuum distillation to leave the product as a pale oil (1.75 g, 
80%). 
1H-NMR δH (399.8 MHz): 4.18 (4H, m, OCH2), 3.13 (3H, s, NCH3), 3.04 (2H, d, J = 21.98 Hz, 
PCH2), 2.98 (3H, s, NCH3), 1.35 (6H, t, 1J = 7.33, 6.87 Hz, 2J = 14.20 Hz, CH3CH2O); 
13C-NMR (100.5 MHz): 164.8 (2JCP = 5.75 Hz, CO), 62.61 (2JCP = 6.71 Hz, 2 x CH2CH3), 38.6 
(NCH3), 35.8 (NCH3), 32.7 (COCH2), 16.4 (3JCP = 5.75 Hz, 2 x CH3); 
13P{1H}-NMR δP (162 MHz): 22.25 ppm. 
NMR data was consistent with literature values. 
 
4.2.12: 3-Methylene-2,2,5,5-tetramethylcyclohexan-1-one[181]  
 
Methyltriphenylphosphonium bromide (5.16 g, 14.40 mmol) was suspended in dry diethyl ether 
(30 ml) and placed under N2. t-BuOK (1.65 g, 14.40 mmol) was added and stirred at room 
temperature for 2 hours to leave a yellow solution. 2,2,5,5-Tetramethylcyclohexane-1,3-dione 
4.2.2 (1.21 g, 7.20 mmol) was suspended in dry diethyl ether (20 ml) and the Wittig reagent was 
added dropwise over 10 minutes. The solution was stirred at 40 °C for 24 hours and monitored 
via TLC. The solution was allowed to cool, the precipitate filtered and the solvent removed under 
reduced pressure. The sample was triturated with hexane and the white solid, phosphorus oxide, 
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was filtered. The product was purified by column chromatography (silica gel: hexane:EtOAc, 5:1) 
to leave the product as a clear oil (0.37 g, 31%). 
1H-NMR δH (399.8 MHz): 4.89 (1H, s, C=CH), 4.79 (1H, s, C=CH), 2.37 (2H, s, CH2), 2.34 (2H, 
s, CH2), 1.26 (6H, s, 2 x CH3), 0.90 (6H, s, 2 x CH3); 
13C-NMR (100.5 MHz): 213.9 (1-CO), 151.3 (C=CH2), 110.4 (C=CH2), 51.3 (CH2), 45.9 (CH2), 
27.0 (2 x CH3), 24.4 (2 x CH3) ppm. 
NMR data was consistent with literature values. 
 
4.2.16: 3-(Hexylamino)-2,2,5,5-tetramethylcyclohexan-1-one  
 
Sodium triacetoxyborohydride (0.55 g, 2.50 mmol) was dissolved in anhy. THF (15 ml). 2,2,5,5-
Tetramethylcyclohexane-1,3-dione (0.20 g, 1.20 mmol) dissolved in anhy. THF (5 ml) and 
hexylamine (0.20 ml, 1.40 mmol) were added slowly. The reaction mixture was stirred at room 
temperature for 24hours. Upon completion the reaction was quenched by the slow addition of 
water and then extracted with chloroform (3 x 10 ml) and dried (MgSO4). The solvent was 
removed under reduced pressure and residue purified by column chromatography (silica gel: 100 
% DCM) to leave the product as a clear oil (50 mg, 17 %). 
1H-NMR δH (399.8 MHz): 5.72 (1H, s, br, NH), 3.73 (1H, dd, J = 5.95, 4.58 Hz, 3-CHNH), 3.23 
(2H, q, J = 6.87, 6.41 Hz, CH2CH2NH), 2.50 (1H, d, J = 13.74 Hz, CHexo), 1.98 (1H, dd, J = 
13.74, 1.37 Hz, CHendo), 1.80-1.78 (2H, m, CH2), 1.44 (2H, qu, J = 7.33, 6.87 Hz, CH2), 1.35-1.26 
(6H, m, 2 x CH2, CH3), 1.15 (3H, s, CH3), 1.11 (3H, s, CH3), 1.08 (3H, s, CH3), 0.88 (3H, t, J = 
6.41 Hz, CH2CH3), 0.87 (3H, s, CH3); 
13C-NMR (100.5 MHz): 214.6 (CO), 73.9 (3-CH), 50.6 (2-C), 50.2 (CH2), 43.1 (CH2), 39.7 
(CH2), 31.9 (CH3), 31.8 (5-C), 31.5 (CH2), 29.5 (CH2), 26.7 (CH3), 26.6 (CH2), 22.6 (CH2), 21.2 
(CH3), 18.7 (CH3), 14.0 (CH3) ppm.  
LRMS (ESI +ve) m/z 207.17; calculated for [C11H18N4 + H]+ 207.16 
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4.2.22: 3-Hydroxy-2,2,5,5-tetramethylcyclohexan-1-one[182]  
 
2,2,5,5-Tetramethylcyclohexane-1,3-dione 4.2.2 (3.65 g, 21.68 mmol) was dissolved in MeOH 
(45 ml). A solution of sodium borohydride (0.21 g, 5.56 mmol, 0.25 eq) in H2O (20ml) was added 
dropwise over 15 minutes. The reaction mixture was stirred for 20 minutes and monitored via 
TLC using vanillin. Upon completion the solution was diluted with a sat. ammonium chloride 
solution (20 ml) and extracted with EtOAc (5 x 20 ml). The organic layers were collected and 
washed with sat. brine solution (30 ml) then dried (Na2SO4). The solvent was removed under 
reduced pressure to leave a pale oil which was purified by column chromatography (silica gel: 
EtOAc:Hexane, 1:4) to yield the product as a white solid (2.09 g, 57%).  
1H-NMR δH (399.8 MHz): 3.73 (1H, t, J = 6.87 Hz, CHOH), 2.50 (1H, d, J = 13.74 Hz, CHexo), 
1.96 (1H, dd, J = 13.74, 1.83 Hz, CHendo), 1.91 (1H, s, br, OH), 1.80-1.77 (2H, m, CH2), 1.14 
(3H, s, CH3), 1.11 (3H, s, CH3), 1.08 (3H, s, CH3), 0.87 (3H, s, CH3); 
13C-NMR (100.5 MHz): 214.49 (CO), 74.01 (CHOH), 50.54 (C-3), 50.19 (CH2), 43.04 (CH2), 
31.89 (CH3), 31.86 (C-5), 26.74 (CH3), 21.292 (CH3), 18.63 (CH3) ppm.   
LRMS (ESI +ve) m/z 170.87; calculated for [C10H18O2]: 170.13 
NMR data was consistent with literature values. 
  
4.2.23: 4-Hydroxy-3,3,6,6-tetramethylcyclohexane-1,2-dione  
 
3-Hydroxy-2,2,5,5-tetramethylcyclohexan-1-one 4.2.22 (0.15 g, 0.88 mmol) was suspended in 
1,4-dioxane (10 ml). Selenium dioxide (0.30 g, 2.64 mmol) was added and the mixture refluxed 
for 5.5 hours. Upon completion, diethyl ether (10ml) was added and the solution washed with 
brine (3x 10 ml), dried (NaSO4) and the solvent removed under reduced pressure. The product 
was purified by column chromatography (silica gel: EtOAc : hexane, 1:4) to yield the product as 
a yellow oil (70 mg, 41%). 
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1H-NMR δH (399.8 MHz): 4.03 (1H, q, J = 4.58. 4.12 Hz, 4-CHOH), 2.12-2.00 (3H, m, 5-CH2 
and OH), 1.25 (3H, s, CH3), 1.23 (3H, s, CH3), 1.15 (3H, s, CH3), 1.12 (3H, s, CH3); 
13C-NMR (100.5 MHz): 206.4 (CO), 205.33 (CO), 72.5 (4-CHOH), 53.9 (3-C), 44.9 (6-C), 42.3 
(5-CH2), 24.6 (CH3), 24.1 (CH3), 20.5 (CH3), 16.4 (CH3) ppm. 
 
4.2.25: 3-methoxy-2,2,5,5-tetramethylcyclohexan-1-one  
 
Sodium hydride (0.18 g, 7.56 mmol) was suspended in anhy. THF (10 ml) and placed under N2. 
3-Hydroxy ketone 4.2.22 (0.86 g, 5.04 mmol) in anhy. THF (6 ml) was added slowly and the 
mixture stirred at room temperature for 30 minutes. Iodomethane (1.3 ml, 20.15 mmol) was added 
and the mixture refluxed at 40 °C for 20 hours. Further iodomethane (0.5 ml) was added and the 
mixture stirred for 3 hours. The reaction was quenched with H2O (15 ml), extracted with EtOAc 
(3 x 15 ml). The combined organic phases were washed with brine (15 ml) and dried (MgSO4). 
The product was purified by column chromatography (silica gel: 5:1 hexane:EtOAc) to leave a 
clear oil (0.75 g, 82%).  
1H-NMR δH (399.8 MHz): 3.38 (3H, s, OCH3), 3.13 (1H, dd, J = 11.45, 4.58, 4.12 Hz, 3-CH), 
2.47 (1H, d, J = 13.74 Hz, CHexo), 2.03 (1H, dd, J = 13.74, 2.29 Hz, CHendo), 1.86 (1H, ddd, J = 
6.87, 4.58, 4.12, 2.29 Hz, CHexo), 1.65 (1H, t, J = 13.28 Hz, CHendo), 1.14 (3H, s, CH3), 1.09 (3H, 
s, CH3), 1.07 (3H, s, CH3), 0.86 (3H, s, CH3); 
13C-NMR (100.5 MHz): 214.3 (1-CO), 83.6 (OCH3), 58.1 (3-CH), 50.5 (CH2), 50.4 (C), 38.6 
(CH2), 31.9 (CH3), 31.7 (C), 26.9 (CH3), 21.5 (CH3), 19.5 (CH3) ppm.  
HRMS (ESI +ve) m/z; 184.1459 calculated for [C11H20O2]: 184.1463  
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4.2.26: 4-methoxy-3,3,6,6-tetramethylcyclohexane-1,2-dione  
 
The starting methoxy-ketone 4.2.25 (0.75 g, 4.12 mmol) was dissolved in 1,4-dioxane (15 ml) 
and SeO2 (0.91 g, 8.23 mmol) was added. The mixture was refluxed for 72 hours before cooling 
to room temperature. The resulting selenium metal was filtered through celite and washed with 
EtOAc. The solution was concentrated under reduced pressure to leave the product as an orange 
oil (0.70 g, 86%). 
1H-NMR δH (399.8 MHz): 3.41 (3H, s, CH3), 3.39 (1H, t, J = 4.12 Hz, CH), 2.09 (1H, dd, J = 
4.12 Hz, CH), 2.00 (1H, dd, J = 7.79 Hz, CH), 1.24 (3H, s, CH3), 1.20 (3H, s, CH3), 1.15 (3H, s, 
CH3), 1.12 (3H, s, CH3); 
13C-NMR (100.5 MHz): 206.4 (CO), 204.7 (CO), 82.5 (CH), 58.0 (CH3), 53.8 (C), 45.1 (C), 37.5 
(CH2), 24.9 (CH3), 24.4 (CH3), 21.0 (CH3), 17.6 (CH3) ppm.  
HRMS (ESI +ve) m/z; 199.1328 calculated for [C11H18O3 +H]+: 199.1329  
 
4.2.27: N,N-Dimethyl-2-[(2,2,5,5-tetramethyl-3-oxocyclohexyl)oxy]acetamide  
 
Sodium hydride (0.08 g, 3.50 mmol) was suspended in anhy. DMF (10 ml). A solution of 4-
hydroxy-3,3,6,6-tetramethylcyclohexane-1,2-dione 4.2.22 (0.05 g, 0.30 mmol) in anhy. DMF (5 
ml) was added slowly and the solution stirred for 30 minutes. 2-Chloro-N,N-dimethylacetamide 
(0.3 ml, 3.00 mmol) was added and the reaction mixture stirred at room temperature overnight. 
The reaction was quenched with sat. aq. NH4Cl solution and extracted with EtOAc (3 x 10 ml). 
The combined organic layers were washed with H2O (3 x 10 ml) and brine (2 x 10 ml) and then 
dried (MgSO4). The solvent and remaining 2-chloro-N,N-dimethylacetamide were removed under 
reduced pressure to leave the product as a dark oil (48 mg, 58%). This was taken straight forward 
for the next step.  
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1H-NMR δH (399.8 MHz): 4.18 (2H, q, J = 13.74, 13.28, 12.82 Hz, CH2CO), 3.40 (1H, dd, J = 
6.41, 4.58 Hz, CH), 3.07 (3H, s, NCH3), 2.96 (3H, s, NCH3), 2.47 (1H, d, J = 13.74 Hz, CH), 2.05 
(1H, d, J = 13.74 Hz, CH), 1.93 (1H, dd, J = 13.28, 4.58 Hz, CH), 1.74 (1H, t, J = 12.36, 11.91 
Hz, CH), 1.16 (3H, s, CH3), 1.12 (3H, s, CH3), 1.08 (3H, s, CH3), 0.86 (3H, s, CH3) ppm. 
 
4.2.28: N,N-Dimethyl-2-[(2,2,5,5-tetramethyl-3,4-dioxocyclohexyl)oxy]acetamide  
 
N,N-Dimethyl-2-[(2,2,5,5-tetramethyl-3-oxocyclohexyl)oxy]acetamide 4.2.27 (1.02 g, 4.00 
mmol) was suspended in 1,4-dioxane (25 ml) and SeO2 (0.68 g, 6.02 mmol) was subsequently 
added. The mixture was allowed to reflux for 18 hours before cooling to room temperature. The 
mixture was filtered through celite to remove the precipitated selenium metal and washed with 
EtOAc. The mixture was concentrated and purified by column chromatography (silica gel: DCM 
100%, with increasing EtOAc fraction) to leave the product as a yellow oil (480 mg, 44%).  
1H-NMR δH (399.8 MHz): 4.26 (2H, d, J = 3.21 Hz, CH2), 3.73 (1H, dd, J = 4.12 Hz, CH), 3.06 
(3H, s, CH3), 2.97 (3H, s, CH3), 2.22 – 2.06 (2H, m, CH2), 1.23 (3H, s, CH3), 1.22 (3H, s, CH3), 
1.15 (3H, s, CH3), 1.14 (3H, s, CH3);  
13C-NMR (100.5 MHz): 206.1 (CO), 204.5 (CO), 169.1 (CON), 81.4 (CH), 69.6 (CH2), 53.80 
(C), 44.9 (C), 38.0 (CH2), 36.8 (CH3), 35.5 (CH3), 25.0 (CH3), 24.2 (CH3), 21.0 (CH3), 17.6 (CH3) 
ppm. 
HRMS (ESI +ve) m/z 270.1702; calculated for [C14H23NO4 + H]: 270.1700 
 
4.2.29: 3-(2-Methoxyethoxy)-2,2,5,5-tetramethylcyclohexan-1-one  
 
Sodium hydride (0.18 g, 4.63 mmol) was suspended in anhy THF (10 ml) and a solution of 4-
hydroxy-3,3,6,6-tetramethylcyclohexane-1,2-dione (0.23 g, 1.32 mmol) was added at room 
temperature. The reaction mixture was stirred for 30 minutes before been cooled to 0°C. 
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Potassium iodide (0.80 g, 5.28 mmol) and 1-bromo-2-methoxyethane (0.50 ml, 5.28 mmol) were 
added slowly and the reaction refluxed for 24 hour. The reaction was quenched through the 
addition of water. The product was extracted with EtOAc (5 x 15 ml), the combined organics 
were washed with brine (50 ml) and dried (MgSO4). The solvent was removed under reduced 
pressure to leave an orange residue. This was purified by column chromatography (silica gel: 
hexane:EtOAc, 2:1) to yield the product as a clear oil (50 mg, 16%). 
1H-NMR δH (399.8 MHz): 3.76-3.70 (1H, m, CH), 3.56-3.50 (3H, m, OCH2CHO), 3.39 (3H, s, 
OCH3), 3.29 (1H, dd, J = 10.99, 4.58 Hz, OCH ), 2.47 (1H, d, J = 13.74 Hz, CHexo), 2.03 (1H, dd, 
J = 13.74, 2.29 Hz, CHendo), 1.86-1.84 (1H, m, CHexo), 1.74 (1H, q, J = 12.82, 10.99, CHendo), 1.15 
(3H, s, CH3), 1.10 (3H, s, CH3), 1.08 (3H, s, CH3), 0.86 (3H, s, CH3); 
13C-NMR (100.5 MHz): 214.4 (CO), 82.4 (OCH), 72.3 (OCH2), 69.9 (OCH2), 59.1 (OCH3), 50.5 
(C), 50.4 (CH2), 39.5 (CH2CO), 31.8 (C), 31.7 (CH3), 26.9 (CH3), 21.5 (CH3), 19.6 (CH3) ppm.  
 
4.2.30: 4-(2-Methoxyethoxy)-3,3,6,6-tetramethylcyclohexane-1,2-dione 
 
3-(2-Methoxyethoxy)-2,2,5,5-tetramethylcyclohexan-1-one 4.2.29 (0.05 g, 0.21 mmol) was 
suspended in 1,4-dioxane (10 ml) and selenium dioxide (0.07 g, 0.63 mmol) was added. The 
mixture was refluxed for 2 days and the selenium dioxide was filtered through silica. The product 
was extracted with ether (3 x 10 ml), and the combined organics were washed with H2O (10 ml) 
and brine (10 ml) and dried (Na2SO4). The solvent was removed under reduced pressure to leave 
the product as a pale yellow oil (30 mg, 51%).   
1H-NMR δH (399.8 MHz): 3.78-3.73 (1H, m, OCH), 3.61-3.52 (3H, m, OCH2CHO), 3.38 (3H, 
s, CH3), 2.12 – 2.00 (2H, m, CH2), 1.24 (3H, s, CH3), 1.21 (3H, s, CH3), 1.14 (3H, s, CH3), 1.13 
(3H, s, CH3);  
13C-NMR (100.5 MHz): 206.4 (CO), 204.8 (CO), 81.3 (CH), 72.3 (CH2), 70.0 (CH2), 59.1 (CH3), 
53.9 (C), 45.0 (C), 38.5 (CH2), 24.9 (CH3), 24.3 (CH3), 20.9 (CH3), 17.6 (CH3) ppm. 
HRMS m/z; 243.1593; calculated for [C13H22O4]: 243.1591 
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General Buchwald Hartwig Cross Coupling Synthesis 
Xantphos (0.42 g, 0.73 mmol) was suspended in 1,4-dioxane (20 ml) and degassed with N2 for 
10 minutes. To this was added Pd2(DBA)3 (0.22 g, 0.24 mmol) and the mixture was stirred for a 
further 10 minutes. 5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-1,2,4-benzotriazin-3-amine 2.2.12 
(0.95 g, 4.90 mmol), 2,6-dibromopyridine (0.59 g, 2.45 mmol) and caesium carbonate (3.32 g, 
9.80 mmol) were subsequently added and the reaction mixture was refluxed for 24 hours under 
N2. The resulting solution was filtered and the solid was washed with EtOAc and the solution was 
concentrated to leave an orange solid. Purification was achieved via column chromatography 
(silica gel: EtOAc/Hexane: 2:1).  
 
L1: 2-N,6-N-Bis(5,6-diethyl-1,2,4-triazin-3-yl)pyridine-2,6-diamine 
 
Yield: 53 mg, 26% as a yellow solid. 
m.p: 263.1-264.5 °C 
1H-NMR δH (399.8MHz): 9.27 (2H, s, 2 x NH), 8.07 (2H, d, J = 8.24 Hz, 2 x ArH), 7.74 (1H, t, 
J = 8.24, 7.33 Hz, ArH), 2.91 (4H, q, J = 7.33 Hz, 2 x CH2),  2.78 (4H, q, J = 7.33 Hz, 2 x CH2),  
1.36 (6H, t, J = 7.79 Hz, 2 x CH3), 1.31 (6H, t, J = 7.79 Hz, 2 x CH3); 
13C-NMR (100.5 MHz): 162.8 (2 x ArC), 158.4 (2 x ArC), 154.2 (2 x ArC), 150.8 (2 x ArC), 
140.2 (ArCH), 107.0 (2 x CH), 26.8 (2 x CH2), 25.1 (2 x CH2), 12.5 (2 x CH3), 10.8 (2 x CH3) 
ppm.  
LRMS (ESI +ve) m/z: 380.26 calculated for [C19H25N9 + H]+: 380.23  
HRMS (ESI +ve) m/z: 380.2302 calculated for [C19H25N9 + H]+ : 380.2306 
 
L3: N2-{8,11,11-Trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-trien-5-yl}-N6-
{8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-yl}pyridine-2,6-
diamine  
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Yield: 0.96 g, 81% as a pale yellow solid.  
m.p: 251.3-252.1 °C 
1H-NMR δH (399.8MHz): 8.54 (2H, s, br, 2 x NH), 8.10 (2H, d, J = 8.24 Hz, 2 x ArCH), 7.74 
(1H, t, J = 8.24 Hz, ArCH), 3.10 (2H, d, J = 4.12 Hz, 2 x CH), 2.21 (2H, m, 2 x CHexo), 1.98 (2H, 
m, 2 x CHexo), 1.38 (4H, m, 4 x CHendo), 1.25 (6H, s, 2 x CH3), 1.05 (6H, s, 2 x CH3), 0.65 (6H, s, 
2 x CH3); 
13C-NMR (100.5 MHz): 171.7 (ArC), 162.5 (ArC), 159.7 (ArC), 158.4 (ArC), 151.0 (ArC), 140.2 
(ArCH), 107.4 (2 x ArCH), 60.4 (C), 54..8 (C), 54.1 (C), 53.5 (C), 50.6 (C), 36.5 (C), 31.4 (2 x 
CH2), 23.9 (2 x CH2), 19.4 (2 x CH3), 17.6 (2 x CH3), 8.4 (2 x CH3) ppm.  
LRMS (ESI +ve) m/z: 484.36; calculated for [C27H33N9 + H]+ : 484.29 
HRMS (ESI +ve) m/z: 484.2923 calculated for [C27H33N9 + H]+: 484.2932 
 
L4: N2,N6-Bis(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-1,2,4-benzotriazin-3-yl)pyridine-2,6-
diamine  
 
Yield: 26 mg, 22% as a pale yellow solid.  
m.p: 184.8-186.2 °C 
1H-NMR δH (399.8 MHz): 8.35 (2H, s, br, 2 x NH), 8.06 (2H, d, J = 8.24 Hz, 2 x ArCH), 7.74 
(1H, t, J = 8.24, 7.79 Hz, ArCH), 1.80 (8H, s, 4 x CH2), 1.43 (12, s, 4 x CH3), 1.34 (12, s, 4 x 
CH3); 
13C-NMR (100.5 MHz): 164.9 (ArC), 158.1 (ArC), 156.9 (ArC), 150.8 (ArC), 140.2 (ArCH), 
106.6 (2 x ArCH), 37.1 (C), 35.8 (C), 34.0 (CH2), 33.2 (CH2), 29.8 (CH3), 29.2 (CH3) ppm.  
LRMS (ESI +ve) m/z: 487.59 calculated for [C27H37N9 ]: 487.32  
HRMS m/z: 488.3231 calculated for [C27H37N9+ H]+: 488.3245 
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L5: N2,N6-bis({5,5,7,7-tetramethyl-5H,6H,7H-cyclopenta[e][1,2,4]triazin-3-yl})pyridine-
2,6-diamine  
 
Yield: 285 mg, 95% as a pale yellow solid.  
m.p: 159.9-161.5 °C 
1H-NMR δH (399.8 MHz): 8.35 (2H, s, br, 2 x NH), 8.13 (2H, d, J = 8.24 Hz, 2 x ArCH), 7.75 
(1H, t, J = 8.24, 7.79 Hz, 4-ArCH), 1.98 (4H, s, 2 x 6-CH2), 1.46 (12H, s, 4 x CH3), 1.36 (12H, s, 
4 x CH3); 
13C-NMR (100.5 MHz): 171.3 (ArC), 161.6 (ArC), 159.5 (ArC), 150.7 (ArC), 140.3 (4-ArCH), 
107.0 (2 x ArCH), 53.1 (6-CH2), 40.7 (C), 39.7 (C), 29.8 (4 x CH3), 28.8 (4 x CH3) ppm.  
HRMS m/z: 460.2926 calculated for [C25H33N9 + H]+: 460.2932 
 
L6: N2-{8,11,11-Trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-trien-5-yl}B-N6-
{8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-yl}pyrazine-2,6-
diamine  
 
Yield: 236 mg, 56% as an orange solid.  
m.p: 184.9-186.8 °C 
1H-NMR δH (399.8 MHz): 10.02 (2H, s, br, NH), 9.40 (2H, s, ArCH), 3.15 (2H, d, J = 3.66 Hz, 
CH), 2.29 – 2.24 (2H, m, 2 x CHexo), 2.02 – 1.97 (2H, m, 2 x CHexo), 1.43 – 1.42 (4H, m, 4 x 
CHendo), 1.28 (6H, s, 2 x CH3), 1.08 (6H, s, 2 x CH3), 0.67 (6H, s, 2 x CH3); 
13C-NMR (100.5 MHz): 172.0 (ArC), 160.4 (ArC), 158.2 (ArC), 147.0 (ArC), 129.8 (ArC), 55.0 
(C), 54.3 (C), 50.6 (CH), 31.3 (CH2), 24.5 (CH2), 20.1 (CH3), 18.3 (CH3), 9.1 (CH3) ppm.  
HRMS (ESI +ve) m/z: 485.2871. 
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L7: N2,N6-bis(5,6-dimethyl-1,2,4-triazin-3-yl)pyridine-2,6-diamine 
 
Yield: 217 mg, 53% as an orange solid. 
m.p: 241.1-242.4 °C 
1H-NMR δH (399.8MHz): 8.50 (2H, s, br, 2 x NH), 8.06 (2H, d, J = 8.24 Hz, 2 x ArCH), 7.75 
(1H, t, J = 8.24 Hz, ArCH), 2.60 (6H, s, 2 x CH3), 2.48 (6H, s, 2 x CH3); 
13C-NMR (100.5 MHz): 159.5 (2 x ArC), 158.4 (2 x ArC), 150.7 (2 x ArC), 150.6 (2 x ArC), 
140.3 (ArCH), 107.0 (2 x ArCH), 21.8 (2 x CH3), 18.9 (2 x CH3) ppm.  
HRMS (ESI +ve) m/z: 324.1674 calculated for [C15H17N9 + H]+ : 324.1680 
  
L8: N6-{8,11-dimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-trien-5-yl}-N6'-
{8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-yl}-[2,2'-bipyridine]-
6,6'-diamine  
 
Yield: 118 mg, 67% as an orange solid.  
m.p: 260+ °C 
1H-NMR δH (399.8 MHz): 7.71 (2H, t, J = 7.79 Hz, 2 x ArCH-4), 7.43 (2H, d, J = 7.79, ArCH 
and ArCH), 7.40 (2H, d, J = 7.79, ArCH and ArCH), 2.81 (2H, d, J = 3.66 Hz, 2 x CH), 2.34 – 
2.20 (2H, m, 2 x CHexo), 2.03 – 1.97 (2H, m, 2 x CHexo), 1.57 – 1.44 (2H, m, 4 x CHendo), 1.32 
(6H, s, 2 x CH3), 1.07 (6H, s, 2 x CH3), 0.76 (6H, s, 2 x CH3); 
13C-NMR (100.5 MHz): 172.1 (2 x ArC), 154.5 (2 x ArC), 154.0 (2 x ArC), 153.6 (2 x ArC), 
152.2 (2 x ArC), 136.7 (2 x ArCH), 125.0 (2 x ArCH), 112.3 (2 x ArCH), 54.1 (2 x C), 53.6 (2 x 
C), 50.3 (2 x CH), 31.5 (2 x CH2), 24.9 (2 x CH2), 20.6 (2 x CH3), 18.3 (2 x CH3), 9.2 (2 x CH3) 
ppm.  
HRMS (ESI +ve) m/z: 561.3209 calculated for [C32H36N10 + H]+: 561.3203  
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L14: N,6-Bis({5,5,7,7-tetramethyl-5H,6H,7H-cyclopenta[e][1,2,4]triazin-3-yl})pyridin-2-
amine  
 
Yield: 106 mg, 80% as a yellow solid.  
m.p: 130.9-131.8 °C  
1H-NMR δH (399.8 MHz): 8.73 (1H, d, J = 8.24 Hz, ArCH), 8.64 (1H, s, br, NH), 8.24 (1H, d, J 
= 7.79 Hz, ArCH), 7.92 (1H, t, J = 8.24, 7.79 Hz, ArCH), 2.05 (2H, s, CH2), 1.98 (2H, s, CH2), 
1.52 (6H, s, CH3), 1.46 (6H, s, CH3), 1.45 (6H, s, CH3), 1.34 (6H, s, CH3);  
13C-NMR (100.5 MHz): 171.5 (ArC), 170.7 (ArC), 167.5 (ArC), 162.4 (ArC), 161.8 (ArC), 159.3 
(ArC), 152.6 (ArC), 151.8 (ArC), 139.1 (ArCH), 118.1 (ArCH), 114.7 (ArCH), 53.0 (CH2), 52.9 
(CH2), 41.2 (C), 40.7 (C), 40.3 (C), 39.7 (C), 29.8 (CH3), 29.7 (CH3), 29.0 (CH3), 28.7 (CH3) 
ppm.  
HRMS (ESI +ve) m/z: 445.2813 calculated for [C25H32N8 + H]+: 445.2823 
 
L15: 8,11,11-Trimethyl-N-(6-{5,5,7,7-tetramethyl-5H,6H,7H-cyclopenta[e][1,2,4]triazin-3-
yl}pyridin-2-yl)-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-trien-5-amine  
 
Yield: 103 mg, 50% as a yellow solid.  
m.p: 139.4-141.0 °C 
1H-NMR δH (399.8 MHz): 9.10 (1H, s, br, NH), 8.77 (1H, d, J = 8.24 Hz, ArCH), 8.26 (1H, d, J 
= 7.79 Hz, ArCH), 7.95 (1H, t, J = 8.24, 7.79 Hz, ArCH), 4.12 (1H, d, J = 4.12 Hz, CH), 2.26 – 
2.19 (1H, m, CHexo), 2.01 (1H, s, CH2), 2.00 – 1.94 (1H, m, CHexo), 1.50 (3H, s, CH3), 1.49 (3H, 
s, CH3), 1.41 (3H, s, CH3), 1.40 (3H, s, CH3), 1.38 – 1.32 (2H, m, CHendo), 1.19 (3H, s, CH3), 1.05 
(3H, s, CH3), 0.61 (3H, s, CH3); 
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13C-NMR (100.5 MHz): 171.7 (ArC), 170.6 (ArC), 167.4 (ArC), 162.4 (ArC), 159.8 (ArC), 158.1 
(ArC), 152.8 (ArC), 151.6 (ArC), 139.2 (ArCH), 117.9 (ArCH), 114.9 (ArCH), 54.6 (C), 54.0 
(C), 52.9 (CH2), 50.5 (CH), 41.2 (C), 40.3 (C), 31.3 (CH2), 29.7 (2 x CH3), 29.0 (CH3), 29.9 
(CH3), 24.5 (CH2), 20.1 (CH3), 18.2 (CH3), 9.0 (CH3) ppm.  
HRMS (ESI +ve) m/z: 457.2816 calculated for [C26H32N8 + H]+: 457.2823 
 
L16: 8,11,11-trimethyl-N-(6-{8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-
trien-5-yl}pyridin-2-yl)-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-trien-5-amine 
 
Yield: 54 mg, 27% as a yellow solid.  
m.p: 237.8-239.4 °C 
1H-NMR δH (399.8 MHz): 8.72 (1H, d, J = 8.24 Hz, ArCH), 8.46 (1H, s, br, NH), 8.23 (1H, d, 
J = 7.33 Hz, ArCH), 7.93 (1H, t, J = 8.24, 7.33 Hz, ArCH), 3.29 (1H, d, J = 4.58 Hz, CH), 3.12 
(1H, d, J = 4.12 Hz, CH), 2.36 – 2.22 (2H, m, 2 x CHexo), 2.10 – 1.98 (2H, m, 2 x CHexo), 1.43 
(3H, s, CH3) 1.43 – 1.38 (4H, m, 4 x CHendo), 1.28 (3H, s, CH3), 1.12 (3H, s, CH3), 1.08 (3H, s, 
CH3), 0.66 (3H, s, CH3), 0.65 (3H, s, CH3);  
13C-NMR (100.5 MHz): 170.9 (2 x ArC), 165.3 (2 x ArC), 161.2 (ArC), 160.0 (ArC), 158.1 
(ArC), 152.7 (ArC), 139.2 (ArCH), 117.9 (ArCH), 114.9 (ArCH), 55.5 (C), 54.7 (C), 54.4 (C), 
54.1 (C), 51.1 (CH), 50.5 (CH), 31.4 (CH2), 31.1 (CH2), 24.5 (CH2), 24.3 (CH2), 20.1 (CH3), 18.3 
(CH3), 18.3 (CH3), 9.2 (CH3), 9.0 (CH3) ppm.  
HRMS (ESI +ve) m/z: 469.2815 calculated for [C27H32N8 + H]+: 469.2823  
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L17: N-{5,5,7,7-tetramethyl-5H,6H,7H-cyclopenta[e][1,2,4]triazin-3-yl}-6-{8,11,11-
trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-yl}pyridin-2-amine  
 
Yield: 105 mg, 36% as a yellow solid.  
m.p: 229.8-230.4 °C 
1H-NMR δH (399.8 MHz): 8.74 (1H, d, J = 8.24 Hz, ArCH), 8.69 (1H, s, br, NH), 8.25 (1H, d, J 
= 7.79 Hz, ArCH), 7.93 (1H, t, J = 8.24, 7.79 Hz, ArCH), 3.29 (1H, J = 4.12 Hz, CH), 2.33 (1H, 
J = 4.58, 4.12, 3.66 Hz, CHexo), 2.09 – 2.05 (1H, m, CHexo), 1.98 (2H, s, CH2), 1.46 (6H, s, 2 x 
CH3), 1.42 (3H, s, CH3), 1.42 – 1.40 (2H, m, 2 x CHendo), 1.34 (6H, s, 2 x CH3), 1.11 (3H, s, CH3), 
0.63 (3H, s, CH3);  
13C-NMR (100.5 MHz): 171.4 (ArC), 170.9 (ArC), 165.2 (ArC), 161.8 (ArC), 161.3 (ArC), 159.4 
(ArC), 152.6 (ArC), 151.9 (ArC), 139.1 (ArCH), 118.0 (ArCH), 114.7 (ArCH), 55.5 (C), 54.4 
(C), 53.0 (CH2), 51.1 (CH), 40.7 (C), 39.7 (C), 31.11 (CH2), 29.8 (CH3), 28.8 (CH3), 24.3 (CH2), 
20.1 (CH3), 18.3 (CH3), 9.24 (CH3) ppm.  
HRMS (ESI +ve) m/z: 457.2817 calculated for [C26H32N8 + H]+: 457.2823  
 
General alkylation of Buchwald Hartwig ligands 
L3 (0.49 g, 1.13 mmol) in anhy THF (10 ml) and added to a suspension of sodium hydride (0.05 
g, 2.25 mmol, 2 eq.) in anhy THF (15 ml) with ice cooling under N2. This was stirred at room 
temperature for 30 minutes before warming to 40°C for a following 30 minutes. The reaction 
mixture was allowed to cool to room temperature then iodomethane (0.8 ml, 11.26 mmol) was 
added. The reaction mixture was stirred at room temperature for 1 hour, then at reflux overnight. 
Upon completion the reaction was quenched with NH4Cl (15 ml) and extracted with EtOAc (5 x 
15 ml), dried (MgSO4) and the solvent removed under reduced pressure. The product was purified 
by column chromatography (silica gel: 100% DCM, with increasing EtOAc) to elute firstly the 
unsymmetrical product followed by the symmetrical product.  
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L10: N2,N6-Dimethyl-N2-{8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-
trien-5-yl}-N6-{8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-
yl}pyridine-2,6-diamine  
 
Yield: 135 mg, 23% as an orange solid. 
1H-NMR δH (399.8 MHz): 7.79 (1H, t, J = 8.24 Hz, ArCH), 7.23 (2H, d, J = 8.24 Hz, 2 x ArCH), 
3.90 (3H, s, NCH3), 2.90 (2H, d, J = 4.12 Hz, CH),  2.28 (2H, td, J = 9.62, 4.12, 3.66 Hz, 2 x 
CHexo), 2.11-2.04 (2H, m, 2 x CHexo), 1.56 (4H, q, J = 9.62 Hz, 4 x CHendo), 1.21 (3H, s, CH3), 
1.10 (3H, s, CH3), 0.81 (3H, s, CH3); 
13C-NMR (100.5 MHz):  178.0 (2 x ArC), 154.4 (2 x ArC), 152.3 (2 x ArC), 151.8 (2 x ArC), 
141.1 (ArCH), 110.4 (2 x ArCH), 55.0 (2 x C), 53.2 (2 x C), 49.7 (2 x CH3), 43.8 (2 x CH), 31.5 
(2 x CH2), 24.6 (2 x CH2), 20.6 (2 x CH3), 18.0 (2 x CH3), 9.1 (2 x CH3) ppm.  
LRMS (ESI +ve) m/z: 526.46 calculated for [C29H37N9 + CH3]+: 526.34 
HRMS (ESI +ve)  m/z: 512.3245 calculated for [C29H37N9 + H]+: 512.3245 
 
L11: N2-Methyl-N6-{8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-trien-
5-yl}-N2-{8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-yl}pyridine-
2,6-diamine 
 
Yield: 71 mg, 12% as an orange solid. 
1H-NMR δH (399.8 MHz): 8.10 (1H, d, J = 7.79 Hz, ArCH), 7.63 (1H, t, J = 8.24, 7.79 Hz, 
ArCH) 6.76 (1H, d, J = 7.79 Hz, ArCH), 3.74 (3H, s, NCH3), 3.11 (1H, d, J = 4.12 Hz, CH), 2.72 
(1H, d, J = 4.12 Hz, CH), 2.27–2.13 (2H, m, 2 x CHexo), 2.04–1.87 (2H, m, 2 x CHexo), 1.46 (2H, 
td, J = 7.79, 3.21 Hz, 2 x CHendo), 1.38 (2H, td, J = 7.79, 6.87, 3.21 Hz, 2 x CHendo), 1.28 (3H, s, 
-CH3), 1.07 (3H, s, -CH3), 1.06 (3H, s, -CH3), 1.02 (3H, s, -CH3), 0.78 (3H, s, -CH3), 0.66 (3H, s, 
-CH3); 
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13C-NMR (100.5 MHz):  175.6 (ArC), 171.6 (ArC), 159.5 (ArC), 158.4 (ArC), 151.0 (ArC), 
150.2 (ArC), 148.8 (ArC), 139.3 (ArC), 111.7 (2 x ArCH), 106.2 (ArCH), 54.7 (C), 54.3 (C), 54.1 
(C), 52.0 (C), 50.5 (CH), 49.5 (CH), 41.6 (CH3), 31.5 (CH2), 31.4 (CH2), 24.9 (CH2), 24.6 (CH2), 
20.4 (CH3), 20.1 (CH3), 18.3 (CH3), 17.9 (CH3), 9.1 (CH3), 9.0 (CH3) ppm.  
LRMS (ESI +ve) m/z: 498.35 calculated for [C28H35N9 + H]+: 498.30 
HRMS (ESI +ve) m/z: 498.3079 calculated for [C28H35N9 + H]+: 498.3088 
 
L12: N2,N6-Dibutyl-N2-{8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-
trien-5-yl}-N6-{8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-
yl}pyridine-2,6-diamine  
 
Yield: 100 mg, 13% as an orange solid.  
m.p: 99.8-101.2 °C 
1H-NMR δH (399.8 MHz): 7.82 (1H, t, J =  8.24 Hz, ArCH), 7.19 (2H, d, J =  8.24 Hz, ArCH), 
4.24-4.17 (4H, m, 2 x NCH2), 2.90 (2H, d, J =  4.12 Hz, 2 x CH), 2.33-2.25 (2H, m, 2 x CHexo), 
2.11-2.07 (2H, 2 x CHexo), 1.87 (4H, qu, J = 7.79, 7.33 Hz, 2 x CH2), 1.56 (4H, m, 2 x CH2), 
1.42 (4H, qu, J = 7.79, 7.33 Hz, 4 x CHendo), 1.21 (3H, s, CH3), 1.10 (3H, s, CH3), 1.00 (6H, t, J 
= 7.33 Hz, 2 x CH3) 0.80 (3H, s, CH3);  
13C-NMR (100.5 MHz): 177.6 (ArC), 154.1 (ArC), 152.4 (ArC), 151.7 (ArC), 141.6 (ArCH), 
110.6 (ArCH), 55.3 (CH2), 55.0 (C), 53.2 (C), 49.8 (CH), 31.4 (CH2), 30.2 (CH2), 29.8 (CH2), 
29.7 (C), 24.5 (CH2), 20.5 (CH3), 17.9 (CH3), 14.0 (CH3), 9.2 (CH3) ppm.  
HRMS (ESI +ve) m/z: 596.4178 calculated for [C35H49N9 + H]+: 596.4184 
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L13: N2-Butyl-N6-{8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-trien-5-
yl}-N2-{8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-yl}pyridine-
2,6-diamine  
 
Yield: 0.11 g, 16% as an orange solid.  
1H-NMR δH (399.8 MHz): 8.11 (1H, d, J = 8.24 Hz, ArCH), 7.77 (1H, s, br, ArCH), 6.91 (1H, 
s, br, ArCH), 4.20 (2H, s, br, NCH2), 3.10 (1H, d, J = 4.12 Hz, CH), 2.82 (1H, s, br, CH),  2.30-
2.19 (2H, m, 2 x CHexo), 2.03-1.95 (2H, m, 2 x CHexo), 1.87 (2H, qu, J = 7.79, 7.33 Hz, CH2), 
1.51-1.36 (6H, m, 1 x CH2, 2 x CHendo), 1.32 (3H, s, CH3), 1.09 (3H, s, CH3), 1.06 (3H, s, CH3), 
1.04 (3H, s, CH3), 0.98 (3H, t, J = 7.79, 7.33 Hz, CH3), 0.77 (3H, s, CH3), 0.66 (3H, s, CH3);  
13C-NMR (100.5 MHz): 158.4 (2 x ArC), 112.1 (2 x ArCH), 106.3 (ArCH), 54.8 (C), 54.7 (C), 
54.4 (CH2), 50.6 (CH), 49.7 (CH), 31.3 (CH2), 31.2 (CH2), 29.5 (CH2), 24.7(CH2), 24.5 (CH2), 
20.4 (CH3), 20.2 (CH3), 19.9 (CH2), 18.2 (CH3), 17.9 (CH3), 13.8 (CH3), 9.1 (CH3), 9.0 (CH3) 
ppm. (NB: sample wasn’t concentrated enough to obtain full 13C NMR spectrum.)  
HRMS (ESI +ve) m/z: 540.3552 calculated for [C31H41N9 + H]+: 540.3558 
 
N,8,11,11-tetramethyl-N-[6-(1,1,3,3-tetramethyl-2,3-dihydro-1H-inden-5-yl)pyridin-2-yl]-
L18: 3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-trien-5-amine  
 
Yield: 0.11 g, 15% as an orange solid.  
1H-NMR δH (399.8 MHz): 8.21 (1H, d, J = 7.79 Hz, ArCH), 7.91 (1H, d, J = 8.24 Hz, ArCH), 
7.81 (1H, t, J = 8.24, 7.79 Hz, ArCH), 3.94 (3H, s, NCH3), 3.11 (1H, d, J = 4.12 Hz, CH), 2.27 – 
2.18 (1H, m, CHexo), 1.99 (1H, td, J = 9.62, 4.12 Hz, CHexo), 1.53 (6H, s, 2 x CH3), 1.46 (6H, s, 2 
x CH3), 1.41 – 1.30 (2H, m, 2 x CHendo), 1.22 (3H, s, CH3), 1.06 (3H, s, CH3), 0.66 (3H, s, CH3);  
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13C-NMR (100.5 MHz): 170.6 (ArC), 167.2 (ArC), 162.7 (ArC), 160.7 (ArC), 159.3 (ArC), 156.0 
(ArC), 151.7 (ArC), 137.1 (ArCH), 121.0 (ArCH), 119.1 (ArCH), 54.7 (C), 54.0 (C), 52.9 (CH2), 
50.5 (CH), 41.1 (C), 40.2 (C), 35.6 (CH3), 31.4 (CH2), 29.6 (2 x CH3), 29.0 (2 x CH3), 24.6 (CH2), 
20.0 (CH3), 18.3 (CH3), 9.0 (CH3) ppm. 
 
General synthesis of the camphor-derived ligands: 
The 7,7-dimethyl-1-(morpholine-4-carbonyl)bicycle[2.2.1]heptane-2,3-dione 3.3.8 (0.20 g, 0.75 
mmol) and pyridine-2,6-bisamidrazone (0.11 g, 0.55 mmol) were refluxed in acetic acid 
overnight. The acetic acid was removed under reduced pressure and the ligand recrystallized.   
 
L28: 8,11,11-trimethyl-5-(6'-{8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-
trien-5-yl}-[2,2'-bipyridin]-6-yl)-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-triene 
 
Yield: 203 mg, 53% as a pale yellow solid.  
m.p: 176.3-178.0 °C 
1H-NMR δH (399.8 MHz):  8.93 (2H, d, J = 7.79 Hz, 2 x ArCH), 8.60 (2H, d, J = 7.79 Hz, 2 x 
ArCH), 8.08 (2H, t, J = 7.79 Hz, 2 x ArCH), 3.32 (2H, d, J = 4.12 Hz, 2 x CH), 2.39 – 2.32 (2H, 
m, 2 x CHexo), 2.14 – 2.08 (2H, m, 2 x CHexo), 1.52 – 1.41 (4H, m, 4 x CHendo), 1.49 (6H, s, 2 x 
CH3), 1.15 (6H, s, 2 x CH3), 0.69 (6H, s, 2 x CH3); 
13C-NMR (100.5 MHz): 171.1 (2 x ArC), 165.3 (2 x ArC), 161.7 (2 x ArC), 156.1 (2 x ArC), 
153.0 (2 x ArC), 138.0 (2 x ArCH), 124.3 (2 x ArCH), 123.1 (2 x ArCH), 55.6 (2 x C), 54.5 (2 x 
C), 51.2 (2 x CH), 31.1 (2 x CH2), 24.3 (2 x CH2), 20.2 (2 x CH3), 18.4 (2 x CH3), 9.3 (2 x CH3) 
ppm. 
HRMS (ESI +ve) m/z: 531.2972 calculated for [C32H34N8 + H]+: 531.2979  
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L29: 2-{8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-trien-5-yl}-9-
{8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-yl}-1,10-
phenanthroline  
 
Yield: 111 mg, 59% as a pale yellow solid.  
1H-NMR δH (399.8 MHz):  8.87 (2H, d, J = 8.24 Hz, 2 x ArCH), 8.45 (2H, d, J = 8.24 Hz, 2 x 
ArCH), 7.94 (2H, s, 2 x ArCH), 3.31 (2H, d, J = 4.12 Hz, 2 x CH), 2.12 (2H, m, 2 x CHexo), 2.12 
(2H, td, J = 9.62, 3.66 Hz, 2 x CHexo), 1.60 (6H, s, 2 x CH3), 1.54 (2H, m, 2 x CHendo), 1.45 (2H, 
m, 2 x CHendo), 1.15 (6H, s, 2 x CH3), 0.70 (6H, s, 2 x CH3); 
13C-NMR (100.5 MHz): 171.4 (2 x ArC), 165.5 (2 x ArC), 161.8 (2 x ArC), 153.7 (2 x ArC), 
146.2 (2 x ArC), 137.3 (2 x ArCH), 129.7 (2 x ArC), 127.6 (2 x ArCH), 123.3 (2 x ArCH), 55.6 
(2 x C), 54.7 (2 x C), 51.2 (2 x CH), 31.1 (2 x CH2), 24.3 (2 x CH2), 20.3 (2 x CH3), 18.4 (2 x 
CH3), 9.6 (2 x CH3) ppm. 
HRMS (ESI +ve) m/z: 555.2971 calculated for [C34H34N8 + H]+: 555.2979 
 
L19: (1R,8R)-5-{6-[(1R,8R)-11,11-Dimethyl-8-(morpholine-4-carbonyl)-3,4,6-
triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-yl]pyridin-2-yl}.-11,11-dimethyl-8-
(morpholine-4-carbonyl)-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-triene 
 
Yield: 130 mg, 60% as a beige solid.   
m.p: 201.9-202.9 °C 
1H-NMR δH (399.8 MHz):  8.54 (2H, d, J = 7.79 Hz, 2 x ArCH), 8.12 (1H, t, J = 8.24, 7.79 Hz, 
ArCH), 4.13-3.39 (8H, m, 4 x CH2), 3.28 (2H, d, J = 4.12 Hz, 2 x CH), 2.68 (2H, td, J = 10.99, 
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3.66 Hz, 2 x CH), 2.55-2.56 (2H, m, 2 x CH), 1.92-1.86 (2H, m, 2 x CH), 1.57-1.50 (2H, m, 2 x 
CH), 1.43 (6H, s, 2 x CH3), 0.99 (6H, s, 2 x CH3); 
13C-NMR (100.5 MHz): 166.8 (2 x ArC), 166.6 (2 x ArCO), 165.1 (2 x ArC), 161.1 (2 x ArC) 
154.0 (2 x ArC), 138.1 (ArCH), 124.9 (2 x ArCH), 67.2 (4 x CH2), 62.2 (2 x C), 60.2 (2 x C), 
51.4 (2 x CH), 28.7 (2 x CH2), 24.5 (2 x CH2), 21.5 (2 x CH3), 20.5 (2 x CH3) ppm. 
HRMS (ESI +ve) m/z: 652.3351 calculated for [C35H41N9O4+H]+: 652.3354 
  
L20: (1R,8R)-5-{6'-[(1R,8R)-11,11-Dimethyl-8-(morpholine-4-carbonyl)-3,4,6-
triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-yl]-[2,2'-bipyridin]-6-yl}-11,11-dimethyl-8-
(morpholine-4-carbonyl)-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-triene 
 
Yield: 184 mg, 70% as a pale yellow solid.  
m.p: 231.7-232.3 °C 
1H-NMR δH (399.8 MHz):  8.83 (2H, d, J = 7.79 Hz, 2 x ArCH), 8.56 (2H, d, J = 7.79 Hz, 2 x 
ArCH), 8.07 (2H, t, J = 7.79 Hz, 2 x ArCH), 4.17 – 3.52 (16H, m, 8 x CH2), 3.28 (2H, d, J = 4.12 
Hz, 2 x CH), 2.74 – 2.67 (2H, m, 2 x CH), 2.56 - 2.47 (2H, m, 2 x CH), 1.96 - 1.89 (2H, m, 2 x 
CH), 1.57 (2H, td, J = 3.66 Hz, 2 x CH), 1.43 (6H, s, CH3), 1.01 (6H, s, CH3);  
13C-NMR (100.5 MHz): 167.0 (2 x C), 166.9 (2 x C), 165.0 (2 x C), 161.4 (2 x CO), 156.3 (2 x 
C), 152.9 (2 x C), 138.0 (2 x ArCH), 124.4 (2 x ArCH), 123.2 (2 x ArCH), 67.2 (8 x CH2), 62.4 
(2 x C), 60.2 (2 x C), 51.4 (2 x CH), 28.9 (2 x CH2), 24.5 (2 x CH2), 21.7 (2 x CH3), 20.5 (2 x 
CH3) ppm.  
HRMS (ESI +ve) m/z: 729.3612 calculated for [C40H44N10O4 + H]+: 729.3620 
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L21: 2-[(1R,8R)-11,11-Dimethyl-8-(morpholine-4-carbonyl)-3,4,6-
triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-trien-5-yl]-9-[(1R,8R)-11,11-dimethyl-8-
(morpholine-4-carbonyl)-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-yl]-1,10-
phenanthroline  
 
Yield: 180 g, 86% as a dark beige solid.  
m.p: 255.0-255.6 °C (viscous) 
1H-NMR δH (399.8 MHz):  8.56 (2H, d, J = 8.24 Hz, 2 x ArCH), 8.50 (2H, d, J = 8.24 Hz, 2 x 
ArCH), 7.98 (2H, s, 2 x ArCH), 4.1–3.4 (16H, m, 8 x CH2), 3.29 (2H, d, J = 4.12 Hz, 2 x CH), 
2.70 (2H, td, J = 4.12, 3.66 Hz, 2 x CH), 2.53-2.46 (2H, m, 2 x CH), 2.05-1.94 (2H, m, 2 x CH), 
1.59-1.50 (2H, m, 2 x CH), 1.43 (6H, s, CH3), 1.03 (6H, s, CH3);  
13C-NMR (100.5 MHz): 166.8 (2 x C), 166.7 (2 x C), 164.9 (2 x C), 161.9 (2 x CO), 153.8 (2 x 
C), 146.4 (2 x C), 137.4 (2 x ArCH), 129.6 (2 x C), 127.6 (2 x ArCH), 123.1 (2 x ArCH), 67.2 (8 
x CH2), 62.4 (2 x C), 60.2 (2 x C), 51.4 (2 x CH), 28.9 (2 x CH2), 24.3 (2 x CH2), 21.6 (2 x CH3), 
20.5 (2 x CH3) ppm.  
HRMS (ESI +ve) m/z: 753.3614 calculated for [C42H44N10O4+H]+: 753.3620 
 
L22: (1R,8R)-5-{6-[(1R,8R)-8-(Diethylcarbamoyl)-11,11-dimethyl-3,4,6-
triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-yl]pyridin-2-yl}.-N,N-diethyl-11,11-dimethyl-
3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-triene-8-carboxamide  
 
Yield: 28 mg, 20% as a pale beige solid.  
m.p: 212.9-214.0 °C 
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1H-NMR δH (399.8 MHz):  8.48 (2H, d, J = 7.79 Hz, 2 x ArCH), 8.07 (1H, t, J = 7.79 Hz, ArCH), 
3.75 (2H, q, J = 7.79, 6.87 Hz, NCH2), 3.65 (2H, q, J = 6.87 Hz, NCH2), 3.48 (2H, q, J = 7.33, 
6.87 Hz, NCH2), 3.39 (2H, q, J = 6.87 Hz, NCH2), 3.25 (2H, d, J = 4.12 Hz, 2 x CH), 2.70 (2H, 
td, J = 6.87, 4.12 Hz, 2 x CH), 2.51-2.43 (2H, m, 2 x CH), 1.86 (2H, ddd, J = 12.82, 7.79, 3.66 
Hz, 2 x CH), 1.52 (2H, ddd, J = 12.82, 7.33, 3.66 Hz, 2 x CH), 1.39 (3H, s, CH3), 1.27 (3H, dt, J 
= 6.87, 5.04 Hz, 2 x NCH2CH3), 0.98 (3H, s, CH3);  
13C-NMR (100.5 MHz): 167.4 (2 x ArC) 167.0 (2 x CO), 165.2 (2 x ArC), 161.1 (2 x ArC), 154.3 
(2 x ArC), 138.0 (ArCH) 124.8 (2 x ArCH), 62.6 (2 x C), 60.2 (2 x C), 51.4 (2 x CH), 42.7 (2 x 
CH2), 40.5 (2 x CH2), 29.3 (2 x CH2), 24.3 (2 x CH2), 21.8 (2 x CH3), 20.3 (2 x CH3), 14.7 (2 x 
CH3), 12.9 (2 x CH3) ppm.  
HRMS (ESI +ve) m/z: found 624.3762; calculated for [C35H45N9O2 + H]+: 624.3769  
 
L23: (1R,8R)-5-{6'-[(1R,8R)-8-(Diethylcarbamoyl)-11,11-dimethyl-3,4,6-
triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-yl]-[2,2'-bipyridin]-6-yl-N,N-diethyl-11,11-
dimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-triene-8-carboxamide  
 
Yield: 19 mg, 15% as a pale yellow solid.  
1H-NMR δH (399.8 MHz): 8.88 (2H, d, J = 7.33 Hz, 2 x ArCH), 8.51 (2H, d, J = 8.24 Hz, 2 x 
ArCH), 8.03 (2H, t, J = 8.24, 7.33 Hz, 2 x ArCH), 3.89-3.76 (4H, m, 2 x NCH2), 3.36-3.28 (4H, 
m, 2 x NH2), 3.25 (2H, d, J = 4.12 Hz, 2 x CH), 2.74 – 2.67 (2H, m, 2 x CH), 2,53-2.46 (2H, m, 
2 x CH), 1.89 (2H, ddd, J = 12.36, 7.79, 4.12, Hz, 2 x CH), 1.56 (2H, ddd, J = 12.36, 7.79, 4.12 
Hz, 2 x CH), 1.41 (6H, s, 2 x CH3), 1.32-1.25 (12H, m, 4 x CH3), 1.02 (6H, s, 2 x CH3); 
13C-NMR (100.5 MHz): 167.1 (ArC), 165.2 (ArC), 161.2 (ArC), 156.1 (ArC), 152.8 (ArC), 137.8 
(ArCH), 124.0 (ArCH), 122.9 (ArCH), 62.6 (C), 60.2 (C), 51.4 (CH), 42.5 (CH2), 40.3 (CH2), 
29.3 (CH2), 24.4 (CH2), 21.9 (2 x CH3), 20.3 (2 x CH3), 14.6 (2 x CH3), 12.8 (2 x CH3) ppm.  
HRMS (ESI +ve) m/z: 701.4028; calculated for [C40H48N10O2 + H]+: 701.4034  
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L24: (1R,8R)-5-{9-[(1R,8R)-8-(Diethylcarbamoyl)-11,11-dimethyl-3,4,6-
triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-yl]-1,10-phenanthrolin-2-yl} 
v-N,N-diethyl-11,11-dimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-triene-8-
carboxamide 
 
Yield: 83 mg, 21% as a beige solid. 
m.p: 195.2-195.8 °C 
1H-NMR δH (399.8 MHz): 8.69 (2H, d, J = 8.70 Hz, 2 x ArCH), 8.46 (2H, d, J = 8.70 Hz, 2 x 
ArCH), 7.95 (2H, s, 2 x ArCH), 3.98-3.92 (2H, m, NCH2), 3.76-3.70 (2H, m, NCH2), 3.66-3.61 
(2H, m, NCH2), 3.48-3.43 (2H, m, NCH2), 3.24 (2H, d, J = 4.12 Hz, 2 x CH), 2.70 (2H, ddd, J = 
9.16, 8.70, 3.66 Hz, 2 x CH), 2.53-2.45 (2H, m, 2 x CH), 1.95-1.88 (2H, m, 2 x CH), 1.56 (2H, 
ddd, J = 9.16, 8.70, 3.66 Hz, 2 x CH), 1.42 (6H, s, 2 x CH3), 1.30 (6H, t, J = 7.33 Hz, 2 x 
NCH2CH3), 1.25 (6H, t, J = 7.33 Hz, 2 x NCH2CH3), 1.01 (6H, s, 2 x CH3);  
13C-NMR (100.5 MHz): 167.0 (2 x CO), 165.3 (4 x ArC), 161.3 (2 x ArC), 153.5 (2 x ArC), 
146.5 (2 x ArC), 137.3 (2 x ArCH), 129.7 (2 x ArC), 127.6 (2 x ArCH), 122.9 (2 x ArCH), 62.7 
(2 x C), 60.3 (2 x C), 51.4 (2 x CH), 43.0 (2 x CH2), 40.9 (2 x CH2), 29.3 (2 x CH2), 24.3 (2 x 
CH2), 21.8 (2 x CH3), 20.3 (2 x CH3), 15.3 (2 x CH3), 13.1 (2 x CH3) ppm.  
HRMS (ESI +ve) m/z: 725.4028 calculated for [C42H48N10O2 + H]+: 725.4034  
 
L25: 5-{6-[11,11-dimethyl-1-(methylcarbamoyl)-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-
2,4,6-trien-5-yl]pyridin-2-yl}-N,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-
2(7),3,5-triene-1-carboxamide  
 
Yield: 82 mg, 42% as a pale yellow solid.  
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1H-NMR δH (399.8 MHz): 9.75 (2H, s, br, 2 x NH), 8.08 (2H, d, J = 7.79 Hz, 2 x ArCH), 7.76 
(1H, t, J = 7.79 Hz, ArCH), 3.10 (2H, d, J = 4.12 Hz, 2 x CH), 2.25 - 2.17 (2H, m, 2 x CH), 1.99 
– 1.94 (2H, m, 2 x CH), 1.45 – 1.37 (4H, m, 4 x CH), 1.23 (6H, s, 2 x CH3), 1.05 (6H, s, 2 x CH3), 
0.65 (6H, s, 2 x CH3); 
13C-NMR (100.5 MHz): 171.6 (ArCO), 159.6 (ArC), 158.5 (ArC), 151.1 (ArC), 140.0 (ArCH), 
107.7 (ArCH), 54.7 (C), 54.1 (C), 50.6 (CH), 31.3 (CH2), 24.6 (CH2), 20.1 (CH3), 18.3 (CH3), 9.1 
(CH3) ppm.  
 
L26: (1R,8R)-5-{6'-[(1R,8R)-11,11-Dimethyl-8-(methylcarbamoyl)-3,4,6-
triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-yl]-[2,2'-bipyridin]-6-yl}-N,11,11-trimethyl-
3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-triene-8-carboxamide  
 
Yield: 125 mg, 56% as a pale yellow solid.  
m.p: 260+ °C 
1H-NMR δH (399.8 MHz): 8.86 (2H, d, J = 7.79 Hz, 2 x ArCH), 8.67 (2H, d, J = 7.79 Hz, 2 x 
ArCH), 8.11 (2H, t, J = 7.79 Hz, 2 x ArCH), 3.11 (6H, d, J = 4.58 Hz, 2 x NCH3), 2.93 (2H, td, J 
= 9.62, 3.66 Hz, 2 x CH), 2.62 – 2.55 (2H, m, 2 x CH), 1.63 (2H, td, J = 9.62, 3.66 Hz, 2 x CH), 
1.56 – 1.52 (2H, m, 2 x CH), 1.50 (6H, s, CH3), 0.80 (6H, s, CH3); 
13C-NMR (100.5 MHz): 169.2 (2 x CO), 167.1 (ArC), 165.5 (ArC), 138.2 (2 x ArCH), 136.4 
(ArC), 124.2 (2 x ArCH), 122.9 (2 x ArCH), 61.2 (2 x C), 59.2 (2 x C), 51.8 (2 x CH), 29.8 (2 x 
CH2), 26.8 (2 x CH), 25.2 (2 x CH2), 20.8 (2 x CH3), 20.4 (2 x CH3), 20.3 (2 x CH3) ppm.  
HRMS (ESI +ve) m/z: 617.3089 calculated for [C44H48N10O2 + H]+: 617.3095 
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L27: 2-[(1R,8R)-11,11-Dimethyl-8-(piperidine-1-carbonyl)-3,4,6-
triazatricyclo[6.2.1.0²,⁷]undeca-2(7),3,5-trien-5-yl]-9-[(1R,8R)-11,11-dimethyl-8-
(piperidine-1-carbonyl)-3,4,6-triazatricyclo[6.2.1.0²,⁷]undeca-2,4,6-trien-5-yl]-1,10-
phenanthroline  
 
Yield:  98 mg, 12% as a pale yellow solid.  
m.p: 240.4-241.6 °C  
1H-NMR δH (399.8 MHz): 8.68 (2H, d, J = 8.24 Hz, 2 x ArCH), 8.48 (2H, d, J = 8.70 Hz, 2 x 
ArCH), 7.97 (2H, s, 2 x ArCH), 3.88 – 3.55 (8H, m, 4 x CH2), 3.24 (2H, d, J = 4.12 Hz, 2 x CH), 
2.72 (2H, td, J = 4.12, 3.66 Hz, 2 x CHexo), 2.53 – 2.46 (2H, m, 2 x CHexo), 1.95 (2H, ddd, J = 
4.12, 3.66 Hz, 2 x CHendo), 1.67 (12H, s, br, 6 x CH2), 1.57 – 1.50 (2H, m, 2 x CHendo), 1.43 (6H, 
s, 2 x CH3), 0.99 (6H, s, 2 x CH3); 
13C-NMR (100.5 MHz): 166.9 (CO), 166.2 (ArC), 164.9 (ArC), 162.1 (ArC), 154.1 (ArC), 146.7 
(ArC), 137.0 (ArCH), 129.4 (ArC), 127.5 (ArCH), 123.3 (ArCH), 62.7 (C), 60.1 (C), 51.5 (CH), 
29.3 (CH2), 27.2 (CH2), 26.0 (CH2) 24.5 (CH2), 24.4 (CH2), 21.7 (CH3), 20.7 (CH3) ppm.  
HRMS (ESI +ve) m/z: 749.4028 calculated for [C44H48N10O2 + H]+: 749.4034 
 
L40: 5,5,8,8-tetramethyl-3-[6-(5,5,8,8-tetramethyl-6-oxo-5,6,7,8-tetrahydro-1,2,4-
benzotriazin-3-yl)pyridin-2-yl]-5,6,7,8-tetrahydro-1,2,4-benzotriazin-6-one 
 
Yield: 41 mg, 21% as a yellow solid. 
m.p: 224.4-225.0 °C 
1H-NMR δH (399.8 MHz): 8.73 (2H, d, J = 7.79 Hz, 2 x ArCH), 8.17 (1H, t, J = 7.79 Hz, ArCH), 
2.85 (4H, s, 2 x CH2), 1.65 (12H, s, 4 x CH3), 1.56 (12H, s, 4 x CH3); 
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13C-NMR (100.5 MHz): 209.4 (2 x CO), 162.7 (2 x ArC), 162.1 (2 x ArC), 161.2 (2 x ArC), 
153.7 (2 x ArC), 138.3 (ArCH), 125.4 (2 x ArCH), 50.7 (2 x C), 50.6 (2 x CH2), 37.9 (2 x C), 
28.6 (4 x CH3), 26.0 (4 x CH3) ppm.  
HRMS (ESI +ve) m/z: 486.2601 calculated for [C27H31N7O2 +H]+: 486.2612  
 
L41: 5,5,8,8-Tetramethyl-3-[6'-(5,5,8,8-tetramethyl-6-oxo-5,6,7,8-tetrahydro-1,2,4-
benzotriazin-3-yl)-[2,2'-bipyridin]-6-yl]-5,6,7,8-tetrahydro-1,2,4-benzotriazin-6-one  
 
Yield: 119 mg, 58% as a pale green solid. 
m.p: 260+ °C 
1H-NMR δH (399.8 MHz):  8.98 (2H, d, J = 7.79 Hz, ArCH), 8.58 (2H, d, J = 7.79 Hz, ArCH), 
8.10 (2H, t, J = 7.79 Hz, ArCH), 2.87 (4H, s, 2 x CH2), 1.66 (12H, s, 2 x CH3), 1.58 (12H, s, 2 x 
CH3); 
13C-NMR (100.5 MHz): 209.6 (CO), 162.4 (ArC), 162.1 (ArC), 161.0 (ArC), 156.1 (ArC), 152.2 
(ArC), 138.1 (ArCH), 124.2 (ArCH), 123.3 (ArCH), 50.6 (2 x CH2), 37.9 (2 x C), 28.6 (4 x CH3), 
26.1 (4 x CH3) ppm. 
HRMS (ESI +ve) m/z: 563.2869 calculated for [C32H34N8O2 + H]+: 563.2877 
 
L42: 5,5,8,8-tetramethyl-3-[9-(5,5,8,8-tetramethyl-6-oxo-5,6,7,8-tetrahydro-1,2,4-
benzotriazin-3-yl)-1,10-phenanthrolin-2-yl]-5,6,7,8-tetrahydro-1,2,4-benzotriazin-6-one  
 
Yield: 28 mg, 12% as a yellow solid.  
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1H-NMR δH (399.8 MHz):  8.95 (2H, d, J = 8.24 Hz, 2 x ArCH), 8.54 (2H, d, J = 8.24 Hz, 2 x 
ArCH), 8.00 (2H, s, 2 x ArCH), 2.87 (4H, s, 2 x CH2), 1.76 (12H, s, 4 x CH3), 1.58 (12H, s, 4 x 
CH3); 
13C-NMR (100.5 MHz): 209.6 (CO), 163.1 (ArC), 162.5 (ArC), 161.3 (ArC), 153.3 (ArC), 146.5 
(ArC), 137.7 (ArCH), 130.1 (ArC), 127.9 (ArCH), 123.7 (ArCH), 51.0 (CH), 50.5 (CH2), 38.0 
(CH), 28.6 (CH3), 26.0 (CH3) ppm. 
Further analysis was unable to be completed as a result of a lost sample.  
 
L43: 3-[6-(6-Hydroxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-1,2,4-benzotriazin-3-
yl)pyridin-2-yl]-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-1,2,4-benzotriazin-6-ol 
 
Yield: 104 mg, 39% 
1H-NMR δH (399.8 MHz): 8.68 (2H, d, J = 7.79 Hz, 2 x ArCH), 8.12 (1H, t, J = 7.79 Hz, ArCH), 
4.04 (2H, dd, J = 5.95, 4.12 Hz, 2 x 6-CH), 2.12 – 2.00 (4H, m, 2 x 7-CH2), 1.61 (6H, s, 2 x CH3), 
1.58 (6H, s, 2 x CH3), 1.45 (6H, s, 2 x CH3), 1.38 (6H, s, 2 x CH3); 
13C-NMR (100.5 MHz): 164.0 (2 x ArC), 162.1 (2 x ArC), 160.9 (2 x ArC), 153.7 (2 x ArC), 
138.4 (2 x ArCH), 125.3 (ArCH), 71.3 (2 x 6-CH), 60.4 (2 x C), 41.2 (2 x 7-CH2), 36.9 (2 x C), 
31.0 (2 x CH3), 29.8 (2 x CH3), 25.7 (2 x CH3), 22.9 (2 x CH3) ppm. 
HRMS (ESI +ve) m/z: 490.2913 calculated for [C27H35N7 + H]+: 490.2925 
 
L44: 3-[6'-(6-Hydroxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-1,2,4-benzotriazin-3-yl)-[2,2'-
bipyridin]-6-yl]-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-1,2,4-benzotriazin-6-ol  
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4-Hydroxy-3,3,6,6-tetramethylcyclohexane-1,2-dione (0.15 g, 0.83 mmol) were suspended in 
EtOH (20 ml) and the bis-amidrazone (0.11 g, 0.40 mmol) was added. The mixture was refluxed 
for 40 hours before been allowed to cool to room temperature. The solvent was removed under 
reduced pressure and DCM added. The solid was filtered and triturated in DCM and the solid 
filtered to leave the product as a pale yellow solid (40 mg, 15%). 
m.p: 260+ °C 
1H-NMR δH (399.8 MHz, DMSO D6): 8.97 (2H, d, J = 7.79 Hz, ArCH), 8.56 (2H, d, J = 7.79 
Hz, ArCH), 8.06 (2H, t, J = 7.79 Hz, ArCH), 4.06 (2H, dd, J = 10.07, 4.58 Hz, CH), 2.12-2.02 
(4H, m, CH2), 1.67 (3H, s, CH3), 1.60 (3H, s, CH3), 1.48 (3H, s, CH3), 1.42 (3H, s, CH3);  
13C-NMR (100.5 MHz): 163.4 (2 x ArC), 161.6 (2 x ArC), 161.2 (2 x ArC) 156.1 (2 x ArC), 
152.6 (2 x ArC), 138.0 (2 x ArCH), 124.0 (2 x ArCH), 123.0 (2 x ArCH), 71.7 (2 x CH), 41.1 (2 
x CH2), 36.9 (2 x C), 31.5 (2 x C), 31.2 (2 x CH3), 29.9 (2 x CH3), 25. 7 (2 x CH3), 22.8 (2 x CH3) 
ppm. 
HRMS (ESI +ve) m/z: 567.3189 calculated for [C32H38N8O2 + H]+: 567.3190 
 
L45: 3-[9-(6-Hydroxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-1,2,4-benzotriazin-3-yl)-1,10-
phenanthrolin-2-yl]-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-1,2,4-benzotriazin-6-ol 
 
The BTPhen amidrazone 3.2.10 (0.20 g, 0.66 mmol) and 4-hydroxy-3,3,6,6-
tetramethylcyclohexane-1,2-dione (0.22 g, 1.32 mmol) were suspended in EtOH (40 ml) and 
refluxed at 120 °C for 2 days. Upon completion the reaction was allowed to cool. The solid that 
precipitated was filtered and washed with DCM (10 ml) and EtOH (10 ml). The solid was 
triturated with DCM and filtered again to give the product as a yellow solid (90 mg, 23%).  
m.p: 260+ °C 
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1H-NMR δH (399.8 MHz, DMSO D6):  8.79 (2H, d, J = 8.70 Hz, 2 x ArCH), 8.72 (2H, d, J = 
8.24 Hz, 2 x ArCH), 8.22 (2H, s, 2 x ArCH), 3.93-3.90 (2H, m, 2 x CH), 2.02-1.92 (4H, m, 2 x 
CH2), 1.57 (3H, s, 2 x CH3), 1.54 (3H, s, 2 x CH3), 1.44 (3H, s, 2 x CH3), 1.33 (3H, s, 2 x CH3) 
ppm. 
Due to limited solubility of this sample, a 13C NMR spectra could not be obtained. 
HRMS (ESI +ve) m/z: 591.3179 calculated for [C32H38N8O2 + H]+: 591.3190 
 
L48: 2,9-bis(6-methoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-1,2,4-benzotriazin-3-yl)-
1,10-phenanthroline  
 
Yield:  20 mg, 24% as a pale yellow solid.  
m.p: 248.9-249.8 °C 
1H-NMR δH (399.8 MHz): 8.90 (2H, m, overlapping signals, 2 x ArCH), 8.48 (2H, d, J = 8.24 
Hz, 2 x ArCH), 7.95 (2H, s, 2 x ArCH), 3.50 (6H, s, 2 x OCH3), 3.46 (2H, dd,  J = 10.53, 3.66 
Hz, 2 x CH), 3.30 (2H, s, br, disappears on D2O shake, H2O), 2.16 – 2.10 (2H, m, CH2), 1.99 (2H, 
td, J = 10.53, 3.66 Hz, CH2), 1.69 (3H, s, CH3), 1.66 (6H, s, 2 x CH3), 1.62 (3H, s, CH3), 1.59 
(3H, s, CH3) 1.54 (3H, s, CH3), 1.48 (3H, s, CH3), 1.44 (3H, s, CH3); 
13C-NMR (100.5 MHz): 164.2 (2 x ArC), 162.1 (2 x ArC), 161.9 (2 x ArC), 153.9 (2 x ArC), 
146.6 (ArC), 137.3 (2 x ArCH), 129.8 (2 x ArC), 127.61 (2 x ArCH), 123.5 (2 x ArCH), 81.2 (2 
x CH), 57.6 (2 x OCH3), 43.1 (C), 42.2 (C), 37.0 (C), 36.6 (CH2), 36.5 (CH2), 35.9 (C), 31.5 
(CH3), 31.0 (CH3), 30.8 (CH3), 30.3 (CH3), 26.5 (CH3), 25.9 (CH3), 23.6 (CH3), 23.1 (CH3) ppm.  
HRMS (ESI +ve) m/z: 619.3501 calculated for [C36H42N8O2 + H]+: 619.3503 
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8. Appendix 
8.1. NMR titration studies 
The data below covers all 1H NMR titrations covered during this thesis, as discussed. It includes 
the data of the relative integrations for each ligand titration. With the exception of the ligands that 
observed no movement of the 1H NMR signals.  
Table 24: 1H NMR titration of L19 with La(NO3)3. 
Metal:ligand 
ratio 
Relative integrations (from 1H NMR spectra) 
Free ligand (x) 1:1 Complex (y) 1:2 complex (z) x + y + z 
0.0 1.00 0.00 0.00 1 
0.1 1.00 0.00 0.00 1 
0.2 1.00 0.00 0.00 1 
0.3 0.00 0.00 1.00 1 
0.4 0.00 0.00 1.00 1 
0.5 0.00 0.00 1.00 1 
0.6 0.00 0.00 1.00 1 
0.7 0.00 0.00 1.00 1 
0.8 0.00 0.00 1.00 1 
0.9 0.00 0.00 1.00 1 
1.0 0.00 0.00 1.00 1 
1.1 0.00 0.00 1.00 1 
1.2 0.00 0.00 1.00 1 
 
Table 25: 1H NMR titration of L19 with Y(NO3)3 
Metal:ligand 
ratio 
Relative integrations (from 1H NMR spectra) 
Free ligand (x) 1:1 Complex (y) 1:2 complex (z) x + y + z 
0.0 1.00 0.00 0.00 1 
0.1 0.66 0.00 0.34 1 
0.2 0.00 0.16 0.84 1 
0.3 0.00 0.40 0.60 1 
0.4 0.00 0.58 0.42 1 
0.5 0.00 0.73 0.27 1 
0.6 0.00 1.00 0.20 1 
0.7 0.00 1.00 0.15 1 
0.8 0.00 1.00 0.00 1 
0.9 0.00 1.00 0.00 1 
1.0 0.00 1.00 0.00 1 
1.1 0.00 1.00 0.00 1 
1.2 0.00 1.00 0.00 1 
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Table 26: 1H NMR titration of L24 with La(NO3)3 
Metal:ligand 
ratio 
Relative integrations (from 1H NMR spectra) 
Free ligand (x) 1:1 Complex (y) 1:2 complex (z) x + y + z 
0.0 1.00 0.00 0.00 1 
0.1 0.83 0.00 0.17 1 
0.2 0.55 0.00 0.45 1 
0.3 0.00 0.00 1.00 1 
0.4 0.00 0.00 1.00 1 
0.5 0.00 0.15 0.85 1 
0.6 0.00 0.33 0.67 1 
0.7 0.00 0.56 0.44 1 
0.8 0.00 0.87 0.13 1 
0.9 0.00 1.00 0.00 1 
1.0 0.00 1.00 0.00 1 
1.1 0.00 1.00 0.00 1 
1.2 0.00 1.00 0.00 1 
 
Table 27: 1H NMR titration of L24 with Lu(NO3)3 
Metal:ligand 
ratio 
Relative integrations (from 1H NMR spectra) 
Free ligand (x) 1:1 Complex (y) 1:2 complex (z) x + y + z 
0.0 1.00 0.00 0.00 1 
0.1 0.90 0.00 0.10 1 
0.2 0.79 0.00 0.21 1 
0.3 0.50 0.00 0.50 1 
0.4 0.00 0.12 0.88 1 
0.5 0.00 0.18 0.82 1 
0.6 0.00 0.27 0.73 1 
0.7 0.00 0.32 0.68 1 
0.8 0.00 0.32 0.68 1 
0.9 0.00 0.39 0.61 1 
1.0 0.00 0.41 0.59 1 
1.1 0.00 0.43 0.57 1 
1.2 0.00 0.46 0.54 1 
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Table 28: 1H NMR titration of L24 with Y(NO3)3 
Metal:ligand 
ratio 
Relative integrations (from 1H NMR spectra) 
Free ligand (x) 1:1 Complex (y) 1:2 complex (z) x + y + z 
0.0 1.00 0.00 0.00 1 
0.1 0.78 0.00 0.22 1 
0.2 0.43 0.00 0.57 1 
0.3 0.15 0.00 0.85 1 
0.4 0.00 0.00 1.00 1 
0.5 0.00 0.00 1.00 1 
0.6 0.00 0.53 0.47 1 
0.7 0.00 0.60 0.40 1 
0.8 0.00 0.69 0.31 1 
0.9 0.00 0.72 0.28 1 
1.0 0.00 0.75 0.25 1 
1.1 0.00 0.75 0.25 1 
1.2 0.00 0.78 0.22 1 
 
Table 29: 1H NMR titration of L22 with La(NO3)3 
Metal:ligand 
ratio 
Relative integrations (from 1H NMR spectra) 
Free ligand (x) 1:1 Complex (y) 1:2 complex (z) x + y + z 
0.0 1.00 0.00 0.00 1 
0.1 1.00 0.00 0.00 1 
0.2 1.00 0.00 0.00 1 
0.3 0.87 0.00 0.13 1 
0.4 0.83 0.00 0.17 1 
0.5 0.52 0.00 0.48 1 
0.6 0.00 0.00 1.00 1 
0.7 0.00 0.00 1.00 1 
0.8 0.00 0.00 1.00 1 
0.9 0.00 0.00 1.00 1 
1.0 0.00 0.00 1.00 1 
1.1 0.00 0.00 1.00 1 
1.2 0.00 0.00 1.00 1 
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Table 30: 1H NMR titration of L27 with La(NO3)3 
Metal:ligand 
ratio 
Relative integrations (from 1H NMR spectra) 
Free ligand (x) 1:1 Complex (y) 1:2 complex (z) x + y + z 
0.0 1.00 0.00 0.00 1 
0.1 0.92 0.00 0.08 1 
0.2 0.67 0.00 0.33 1 
0.3 0.52 0.00 0.48 1 
0.4 0.22 0.00 0.78 1 
0.5 0.00 0.10 0.90 1 
0.6 0.00 0.24 0.76 1 
0.7 0.00 0.36 0.64 1 
0.8 0.00 0.56 0.44 1 
0.9 0.00 0.69 0.31 1 
1.0 0.00 0.74 0.26 1 
1.1 0.00 0.75 0.25 1 
1.2 0.00 0.78 0.22 1 
 
Table 31: 1H NMR titration of L44 with La(NO3)3 
Metal:ligand 
ratio 
Relative integrations (from 1H NMR spectra) 
Free ligand (x) 1:1 Complex (y) 1:2 complex (z) x + y + z 
0.0 1.00 0.00 0.00 1 
0.1 0.79 0.00 0.21 1 
0.2 0.56 0.00 0.44 1 
0.3 0.26 0.00 0.74 1 
0.4 0.07 0.00 0.93 1 
0.5 0.00 0.00 1.00 1 
0.6 0.00 0.00 1.00 1 
0.7 0.00 0.00 1.00 1 
0.8 0.00 0.00 1.00 1 
0.9 0.00 0.00 1.00 1 
1.0 0.00 0.00 1.00 1 
1.1 0.00 0.00 1.00 1 
1.2 0.00 0.00 1.00 1 
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Table 32: 1H NMR titration of L44 with Y(NO3)3 
Metal:ligand 
ratio 
Relative integrations (from 1H NMR spectra) 
Free ligand (x) 1:1 Complex (y) 1:2 complex (z) x + y + z 
0.0 1.00 0.00 0.00 1 
0.1 1.00 0.00 0.00 1 
0.2 0.75 0.00 0.25 1 
0.3 0.55 0.00 0.45 1 
0.4 0.36 0.00 0.64 1 
0.5 0.19 0.00 0.81 1 
0.6 0.08 0.00 0.92 1 
0.7 0.00 0.00 1.00 1 
0.8 0.00 0.00 1.00 1 
0.9 0.00 0.00 1.00 1 
1.0 0.00 0.00 1.00 1 
1.1 0.00 0.00 1.00 1 
1.2 0.00 0.00 1.00 1 
 
8.2. Solvent extraction studies 
The data below corresponds to the extraction studies as a function of the nitric acid concentration. 
The extraction of the radionuclides Am(III), Cm(III) and Eu(III) into 1-octanol are represented 
by their individual D ratios (DAm, DCm and DEu) and SFAm/Eu, for the separation of Am(III) and 
Eu(III). The DAm and DEu represent the values received from gamma-spectroscopy and DCm from 
alpha spectroscopy.  
 Data for 3-amino-1,2,4-triazine ligands 
Table 33: Extraction of Am(III), Cm(III) and Eu(IIII) by L3. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.001 0.00 0.001 1.03 
0.111 0.006 0.00 0.005 1.10 
0.296 0.006 0.00 0.005 1.11 
0.700 0.001 0.00 0.001 1.19 
1.031 0.003 0.00 0.002 1.32 
3.110 0.003 0.00 0.002 1.75 
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Table 34: Extraction of Am(III), Cm(III) and Eu(IIII) by L4. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.000 0.00 0.000 2.82 
0.111 0.000 0.00 0.000 1.22 
0.296 0.000 0.00 0.000 0.31 
0.700 0.000 0.00 0.000 0.30 
1.031 0.000 0.00 0.001 0.48 
3.110 0.001 0.00 0.000 1.88 
 
Table 35: Extraction of Am(III), Cm(III) and Eu(IIII) by L6. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.000 0.00 0.000 1.18 
0.111 0.000 0.00 0.000 2.56 
0.296 0.000 0.00 0.000 2.37 
0.700 0.000 0.00 0.000 1.95 
1.031 0.000 0.00 0.000 2.32 
3.110 0.002 0.00 0.001 1.44 
 
Table 36: Extraction of Am(III), Cm(III) and Eu(IIII) by L8 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.009 0.001 0.003 3.13 
0.111 0.008 0.001 0.003 2.56 
0.296 0.026 0.001 0.005 5.62 
0.700 0.010 0.001 0.058 0.17 
1.031 0.019 0.001 0.002 10.64 
3.110 0.022 0.002 0.016 1.39 
Table 37: Extraction of Am(III), Cm(III) and Eu(IIII) by L10. (a) This result is an outlier as a 
result of the Eu gamma measurement.  
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.000 0.01 0.000 1.83 
0.111 0.002 0.00 0.001 1.31 
0.296 0.000 000 0.000 127.60 a 
0.700 0.000 0.00 0.000 0.48 
1.031 0.010 0.00 0.009 1.10 
3.110 0.001 0.00 0.001 1.15 
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Table 38: Extraction of Am(III), Cm(III) and Eu(IIII) by L11. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.001 0.00 0.000 3.04 
0.111 0.000 0.00 0.000 0.36 
0.296 0.000 0.00 0.001 0.32 
0.700 0.000 0.00 0.000 0.72 
1.031 0.000 0.00 0.000 1.96 
3.110 0.001 0.00 0.001 0.71 
 
Table 39: Extraction of Am(III), Cm(III) and Eu(IIII) by L12. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.001 0.00 0.002 0.46 
0.111 0.004 0.02 0.003 1.52 
0.296 0.002 0.00 0.020 0.10 
0.700 0.003 0.01 0.002 1.26 
1.031 0.001 0.00 0.002 0.50 
3.110 0.002 0.00 0.003 0.67 
 
Table 40: Extraction of Am(III), Cm(III) and Eu(IIII) by L13. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.001 0.00 0.002 0.32 
0.111 0.002 0.00 0.002 0.79 
0.296 0.001 0.01 0.002 0.34 
0.700 0.005 0.00 0.003 1.33 
1.031 0.002 0.00 0.002 0.93 
3.110 0.002 0.00 0.003 0.68 
 
Table 41: Extraction of Am(III), Cm(III) and Eu(IIII) by L14. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.001 0.00 0.003 0.30 
0.111 0.001 0.00 0.003 0.28 
0.296 0.001 0.00 0.003 0.34 
0.700 0.001 0.00 0.002 0.45 
1.031 0.001 0.00 0.002 0.53 
3.110 0.002 0.00 0.003 0.75 
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Table 42: Extraction of Am(III), Cm(III) and Eu(IIII) by L15. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.000 0.00 0.000 0.36 
0.111 0.000 0.00 0.000 0.37 
0.296 0.000 0.00 0.000 0.51 
0.700 0.000 0.00 0.000 0.65 
1.031 0.000 0.00 0.000 0.26 
3.110 0.001 0.00 0.001 0.56 
 
Table 43: Extraction of Am(III), Cm(III) and Eu(IIII) by L17. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.001 0.00 0.001 0.54 
0.111 0.001 0.00 0.001 0.77 
0.296 0.001 0.00 0.002 0.39 
0.700 0.001 0.00 0.002 0.46 
1.031 0.001 0.00 0.001 0.79 
3.110 0.001 0.00 0.002 0.67 
 
 Data for modified camphor ligands 
Table 44: Extraction of Am(III), Cm(III) and Eu(IIII) by L19. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.100 0.22 0.002 51.21 
0.111 3.335 3.53 0.105 31.88 
0.296 3.407 2.74 0.653 5.22 
0.700 1.880 1.71 0.618 3.04 
1.031 1.315 1.03 0.360 3.65 
3.110 0.692 0.52 0.201 3.45 
 
Table 45: Extraction of Am(III), Cm(III) and Eu(IIII) by L20. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.003 0.00 0.003 1.03 
0.111 0.015 0.01 0.004 4.12 
0.296 0.033 0.04 0.010 3.25 
0.700 0.037 0.04 0.023 1.63 
1.031 0.039 0.04 0.022 1.77 
3.110 0.035 0.02 0.004 8.18 
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Table 46: Extraction of Am(III), Cm(III) and Eu(IIII) by L21. Note: DCm were unable to be 
obtained due to solid deposits on the α-discs. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.013 - 0.111 0.11 
0.111 0.030 - 0.045 0.67 
0.296 0.064 - 0.090 0.71 
0.700 0.084 - 0.100 0.84 
1.031 0.080 - 0.087 0.92 
3.110 0.187 - 0.037 5.09 
 
Table 47: Extraction of Am(III), Cm(III) and Eu(IIII) by L22. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.740 0.719 0.014 53.52 
0.111 31.861 22.369 0.023 149.55 
0.296 220.718 410.487 2.776 79.50 
0.700 184.676 298.822 2.563 72.05 
1.031 117.327 196.846 1.601 73.30 
3.110 1.889 3.205 0.024 78.29 
 
Table 48: Extraction of Am(III), Cm(III) and Eu(IIII) by L23. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.010 0.005 0.003 3.21 
0.111 0.099 0.040 0.003 28.74 
0.296 0.787 0.300 0.006 123.17 
0.700 3.292 1.342 0.026 124.43 
1.031 4.678 2.076 0.039 120.63 
3.110 1.310 0.552 0.013 102.55 
 
Table 49: Extraction of Am(III), Cm(III) and Eu(IIII) by L24. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.959 0.92 0.116 8.28 
0.111 11.383 12.66 1.418 8.03 
0.296 28.434 18.99 2.757 10.31 
0.700 35.562 29.56 2.205 16.13 
1.031 41.751 31.12 1.736 24.05 
3.110 70.031 44.39 0.627 111.77 
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Table 50: Extraction of Am(III), Cm(III) and Eu(IIII) by L25. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.001 0.00 0.001 0.65 
0.111 0.005 0.01 0.002 2.00 
0.296 0.022 0.02 0.002 11.19 
0.700 0.030 0.03 0.003 11.08 
1.031 0.055 0.03 0.005 12.05 
3.110 0.011 0.01 0.003 4.09 
 
Table 51: Extraction of Am(III), Cm(III) and Eu(IIII) by L26. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.002 0.001 0.003 0.88 
0.111 0.005 0.004 0.003 2.01 
0.296 0.013 0.010 0.004 3.27 
0.700 0.028 0.020 0.007 4.29 
1.031 0.035 0.022 0.008 4.17 
3.110 0.049 0.032 0.006 8.69 
 
Table 52: Extraction of Am(III), Cm(III) and Eu(IIII) by L27. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 2.001 1.16 0.175 11.43 
0.111 18.906 9.05 0.449 42.08 
0.296 44.248 24.36 0.866 21.12 
0.700 54.881 14.82 0.746 73.59 
1.031 55.202 16.78 0.587 94.05 
3.110 42.983 16.59 0.186 230.87 
 
Table 53: Extraction of Am(III), Cm(III) and Eu(IIII) by L28. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.018 0.010 0.003 5.77 
0.111 0.170 0.057 0.003 48.96 
0.296 0.841 0.312 0.007 128.49 
0.700 3.063 1.102 0.020 153.36 
1.031 7.708 1.752 0.058 133.42 
3.110 0.110 0.067 0.005 22.04 
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Table 54: Extraction of Am(III), Cm(III) and Eu(IIII) by L29. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 2.190 0.833 0.017 129.66 
0.111 15.014 4.923 0.067 223.31 
0.296 40.393 7.699 0.153 264.62 
0.700 46.972 12.179 0.178 264.43 
1.031 25.110 12.116 0.238 105.50 
3.110 7.912 2.664 0.037 211.06 
 
 Data for modified CyMe4-ligands 
Table 55: Extraction of Am(III), Cm(III) and Eu(IIII) by L40. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.012 0.013 0.001 15.05 
0.111 0.018 0.020 0.000 58.46 
0.296 0.083 0.087 0.001 84.61 
0.700 0.468 0.499 0.005 86.14 
1.031 0.859 0.851 0.009 95.58 
3.000 0.371 0.411 0.006 63.84 
 
Table 56: Extraction of Am(III), Cm(III) and Eu(IIII) by L41. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.002 0.005 0.000 61.99 
0.111 0.014 0.007 0.000 145.69 
0.296 0.065 0.034 0.001 89.88 
0.700 0.301 0.249 0.004 78.44 
1.031 0.392 0.334 0.006 62.93 
3.110 0.209 0.106 0.002 96.69 
 
Table 57: Extraction of Am(III), Cm(III) and Eu(IIII) by L43. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.128 0.11 0.006 19.82 
0.111 1.226 0.93 0.348 3.52 
0.296 1.038 0.85 0.267 3.89 
0.700 0.669 0.57 0.397 1.69 
1.031 0.591 0.41 0.365 1.62 
3.110 0.984 0.57 0.025 38.78 
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Table 58: Extraction of Am(III), Cm(III) and Eu(IIII) by L44. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 0.004 0.002 0.002 1.56 
0.111 0.091 0.064 0.039 2.36 
0.296 0.276 0.153 0.008 36.83 
0.700 0.499 0.228 0.034 14.49 
1.031 0.550 0.301 0.058 9.47 
3.110 2.084 1.281 0.120 17.37 
 
Table 59: Extraction of Am(III), Cm(III) and Eu(IIII) by L48. 
[HNO3] 
concentration 
(mol/L) 
DAm DCm DEu SFAm/Eu 
0.013 23.173 13.606 0.228 101.54 
0.111 384.945 171.851 5.039 76.39 
0.296 515.981 497.934 11.542 44.68 
0.700 436.918 461.780 10.591 41.25 
1.031 374.838 139.553 9.326 40.19 
3.110 40.788 9.610 0.314 129.73 
 
8.3. Extraction kinetics studies 
Below is the data for extraction studies of those ligands that exhibited some extraction at varying 
contact times, HNO3 concentration remains constant in each study.  
Table 60: Extraction of Am(III), Cm(III) and Eu(III) by L24 at 0.296 mol/L HNO3 with Ln-all-5 
mol/L 
Contact time 
(min) 
DAm DCm DEu SFAm/Eu 
5 23.972 22.244 2.888 8.302 
10 25.141 23.713 3.039 8.274 
20 26.549 24.316 2.982 8.903 
30 24.647 24.863 3.013 8.180 
45 25.818 19.631 3.048 8.471 
60 25.438 24.423 3.051 8.336 
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Table 61: Extraction of Am(III), Cm(III) and Eu(III) by L19 at 0.296 mol/L HNO3 with Ln-all-5 
mol/L 
Contact time 
(min) 
DAm DCm DEu SFAm/Eu 
5 2.426 2.061 0.727 3.337 
10 2.611 2.336 0.847 3.083 
20 2.456 2.464 0.769 3.194 
30 2.415 2.326 0.778 3.104 
45 2.557 2.359 0.783 3.264 
60 2.585 2.545 0.777 3.326 
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